Background  ||| S:24 E:43 ||| NN
The  ||| S:43 E:47 ||| DT
bone  ||| S:47 E:52 ||| JJ
morphogenetic  ||| S:52 E:66 ||| JJ
proteins  ||| S:66 E:75 ||| NNS
( ||| S:75 E:76 ||| -LRB-
BMPs ||| S:76 E:80 ||| NNP
)  ||| S:80 E:82 ||| -RRB-
form  ||| S:82 E:87 ||| VB
a  ||| S:87 E:89 ||| DT
subfamily  ||| S:89 E:107 ||| NN
of  ||| S:107 E:110 ||| IN
the  ||| S:110 E:114 ||| DT
Transforming  ||| S:114 E:127 ||| NNP
Growth  ||| S:127 E:134 ||| NNP
Factor  ||| S:134 E:141 ||| NNP
β  ||| S:141 E:143 ||| NNS
( ||| S:143 E:144 ||| -LRB-
TGF-β ||| S:144 E:149 ||| NNP
)  ||| S:149 E:151 ||| -RRB-
superfamily  ||| S:151 E:163 ||| NNS
[  ||| S:163 E:165 ||| -LRB-
1  ||| S:165 E:175 ||| CD
2  ||| S:175 E:177 ||| CD
3  ||| S:177 E:179 ||| CD
4  ||| S:179 E:181 ||| CD
]  ||| S:181 E:183 ||| -RRB-
.  ||| S:183 E:185 ||| .
Members  ||| S:185 E:193 ||| NNS
of  ||| S:193 E:196 ||| IN
the  ||| S:196 E:200 ||| DT
BMP  ||| S:200 E:204 ||| NN
family  ||| S:204 E:211 ||| NN
were  ||| S:211 E:216 ||| VBD
initially  ||| S:216 E:234 ||| RB
identified  ||| S:234 E:245 ||| VBN
by  ||| S:245 E:248 ||| IN
their  ||| S:248 E:254 ||| PRP$
ability  ||| S:254 E:262 ||| NN
to  ||| S:262 E:265 ||| TO
induce  ||| S:265 E:272 ||| VB
ectopic  ||| S:272 E:280 ||| JJ
bone  ||| S:280 E:293 ||| NN
formation  ||| S:293 E:303 ||| NN
[  ||| S:303 E:305 ||| -LRB-
4  ||| S:305 E:307 ||| LS
]  ||| S:307 E:309 ||| -RRB-
.  ||| S:309 E:311 ||| .
Functional  ||| S:311 E:322 ||| JJ
characterization  ||| S:322 E:339 ||| NN
of  ||| S:339 E:342 ||| IN
BMPs  ||| S:342 E:347 ||| JJ
and  ||| S:347 E:359 ||| CC
the  ||| S:359 E:363 ||| DT
cloning  ||| S:363 E:371 ||| NN
of  ||| S:371 E:374 ||| IN
new  ||| S:374 E:378 ||| JJ
BMP  ||| S:378 E:382 ||| NN
family  ||| S:382 E:389 ||| NN
members  ||| S:389 E:397 ||| NNS
have  ||| S:397 E:402 ||| VBP
revealed  ||| S:402 E:411 ||| VBN
that  ||| S:411 E:424 ||| IN
BMPs  ||| S:424 E:429 ||| JJ
not  ||| S:429 E:433 ||| RB
only  ||| S:433 E:438 ||| RB
regulate  ||| S:438 E:447 ||| VB
bone  ||| S:447 E:452 ||| JJ
formation  ||| S:452 E:462 ||| NN
and  ||| S:462 E:466 ||| CC
homeostasis  ||| S:466 E:478 ||| NNS
but  ||| S:478 E:490 ||| CC
also  ||| S:490 E:495 ||| RB
function  ||| S:495 E:504 ||| VBP
as  ||| S:504 E:507 ||| RB
morphogenetic  ||| S:507 E:521 ||| JJ
factors  ||| S:521 E:529 ||| NNS
for  ||| S:529 E:533 ||| IN
many  ||| S:533 E:538 ||| JJ
other  ||| S:538 E:552 ||| JJ
tissues  ||| S:552 E:560 ||| NNS
and  ||| S:560 E:564 ||| CC
organs  ||| S:564 E:571 ||| NNS
[  ||| S:571 E:573 ||| -LRB-
2  ||| S:573 E:575 ||| LS
]  ||| S:575 E:577 ||| -RRB-
.  ||| S:577 E:579 ||| .
The  ||| S:579 E:583 ||| DT
critical  ||| S:583 E:592 ||| JJ
regulatory  ||| S:592 E:603 ||| JJ
roles  ||| S:603 E:609 ||| NNS
of  ||| S:609 E:620 ||| IN
BMPs  ||| S:620 E:625 ||| JJ
during  ||| S:625 E:632 ||| IN
early  ||| S:632 E:638 ||| JJ
embryogenesis ||| S:638 E:651 ||| NN
,  ||| S:651 E:653 ||| ,
such  ||| S:653 E:658 ||| JJ
as  ||| S:658 E:661 ||| IN
neurogenesis ||| S:661 E:673 ||| NN
,  ||| S:673 E:683 ||| ,
mesoderm  ||| S:683 E:692 ||| JJ
formation  ||| S:692 E:702 ||| NN
and  ||| S:702 E:706 ||| CC
patterning ||| S:706 E:716 ||| NN
,  ||| S:716 E:718 ||| ,
are  ||| S:718 E:722 ||| VBP
also  ||| S:722 E:727 ||| RB
well-recognized  ||| S:727 E:751 ||| JJ
[  ||| S:751 E:753 ||| -LRB-
1  ||| S:753 E:755 ||| CD
2  ||| S:755 E:757 ||| CD
3  ||| S:757 E:759 ||| CD
]  ||| S:759 E:761 ||| -RRB-
.  ||| S:761 E:771 ||| .
Like  ||| S:771 E:776 ||| IN
other  ||| S:776 E:782 ||| JJ
members  ||| S:782 E:790 ||| NNS
of  ||| S:790 E:793 ||| IN
the  ||| S:793 E:797 ||| DT
TGF-β  ||| S:797 E:803 ||| JJ
superfamily ||| S:803 E:814 ||| NN
,  ||| S:814 E:816 ||| ,
BMPs  ||| S:816 E:821 ||| JJ
induce  ||| S:821 E:836 ||| NNS
intracellular  ||| S:836 E:850 ||| VBP
signaling  ||| S:850 E:860 ||| VBG
via  ||| S:860 E:864 ||| IN
heteromeric  ||| S:864 E:876 ||| JJ
complexes  ||| S:876 E:886 ||| NNS
of  ||| S:886 E:889 ||| IN
the  ||| S:889 E:901 ||| DT
type  ||| S:901 E:906 ||| NN
I  ||| S:906 E:908 ||| PRP
and  ||| S:908 E:912 ||| CC
type  ||| S:912 E:917 ||| NN
II  ||| S:917 E:920 ||| NNP
serine-threonine  ||| S:920 E:937 ||| FW
kinase  ||| S:937 E:944 ||| FW
receptors  ||| S:944 E:954 ||| FW
[  ||| S:954 E:956 ||| -LRB-
5  ||| S:956 E:958 ||| CD
6  ||| S:958 E:968 ||| CD
]  ||| S:968 E:970 ||| -RRB-
.  ||| S:970 E:972 ||| .
The  ||| S:972 E:976 ||| DT
Smad  ||| S:976 E:981 ||| JJ
family  ||| S:981 E:988 ||| NN
proteins  ||| S:988 E:997 ||| NNS
are  ||| S:997 E:1001 ||| VBP
now  ||| S:1001 E:1005 ||| RB
known  ||| S:1005 E:1011 ||| VBN
to  ||| S:1011 E:1014 ||| TO
function  ||| S:1014 E:1023 ||| VB
as  ||| S:1023 E:1034 ||| IN
key  ||| S:1034 E:1038 ||| JJ
signal  ||| S:1038 E:1045 ||| NN
transducers  ||| S:1045 E:1057 ||| NN
downstream  ||| S:1057 E:1068 ||| NN
of  ||| S:1068 E:1071 ||| IN
the  ||| S:1071 E:1075 ||| DT
TGF-β  ||| S:1075 E:1081 ||| JJ
family  ||| S:1081 E:1088 ||| NN
type  ||| S:1088 E:1101 ||| NN
I  ||| S:1101 E:1103 ||| PRP
receptors  ||| S:1103 E:1113 ||| VBP
[  ||| S:1113 E:1115 ||| -LRB-
6  ||| S:1115 E:1117 ||| CD
7  ||| S:1117 E:1119 ||| CD
8  ||| S:1119 E:1121 ||| CD
]  ||| S:1121 E:1123 ||| -RRB-
.  ||| S:1123 E:1125 ||| .
The  ||| S:1125 E:1129 ||| DT
activated  ||| S:1129 E:1139 ||| JJ
BMP  ||| S:1139 E:1143 ||| NN
type  ||| S:1143 E:1148 ||| NN
I  ||| S:1148 E:1150 ||| PRP
receptors  ||| S:1150 E:1168 ||| VBP
directly  ||| S:1168 E:1177 ||| RB
recruit  ||| S:1177 E:1185 ||| VB
and  ||| S:1185 E:1189 ||| CC
phosphorylate  ||| S:1189 E:1203 ||| VBG
a  ||| S:1203 E:1205 ||| DT
set  ||| S:1205 E:1209 ||| NN
of  ||| S:1209 E:1212 ||| IN
cytoplasmic  ||| S:1212 E:1232 ||| JJ
Smad  ||| S:1232 E:1237 ||| JJ
proteins  ||| S:1237 E:1246 ||| NNS
that  ||| S:1246 E:1251 ||| WDT
are  ||| S:1251 E:1255 ||| VBP
specific  ||| S:1255 E:1264 ||| JJ
for  ||| S:1264 E:1268 ||| IN
the  ||| S:1268 E:1272 ||| DT
BMP  ||| S:1272 E:1276 ||| NN
type  ||| S:1276 E:1281 ||| NN
I  ||| S:1281 E:1291 ||| PRP
receptors ||| S:1291 E:1300 ||| VBD
.  ||| S:1300 E:1302 ||| .
Three  ||| S:1302 E:1308 ||| CD
such  ||| S:1308 E:1313 ||| JJ
BMP  ||| S:1313 E:1317 ||| NN
type  ||| S:1317 E:1322 ||| NN
I  ||| S:1322 E:1324 ||| PRP
receptor-regulated  ||| S:1324 E:1343 ||| JJ
Smads ||| S:1343 E:1348 ||| NNP
,  ||| S:1348 E:1358 ||| ,
Smad1 ||| S:1358 E:1363 ||| NNP
,  ||| S:1363 E:1365 ||| ,
5  ||| S:1365 E:1367 ||| CD
and  ||| S:1367 E:1371 ||| CC
8 ||| S:1371 E:1372 ||| CD
,  ||| S:1372 E:1374 ||| ,
have  ||| S:1374 E:1379 ||| VBP
been  ||| S:1379 E:1384 ||| VBN
identified  ||| S:1384 E:1395 ||| VBN
[  ||| S:1395 E:1397 ||| -LRB-
9  ||| S:1397 E:1399 ||| CD
]  ||| S:1399 E:1401 ||| -RRB-
.  ||| S:1401 E:1403 ||| .
Among  ||| S:1403 E:1409 ||| IN
them ||| S:1409 E:1413 ||| PRP
,  ||| S:1413 E:1423 ||| ,
Smad1  ||| S:1423 E:1429 ||| NNP
has  ||| S:1429 E:1433 ||| VBZ
been  ||| S:1433 E:1438 ||| VBN
studied  ||| S:1438 E:1446 ||| VBN
most  ||| S:1446 E:1451 ||| RBS
extensively ||| S:1451 E:1462 ||| JJ
.  ||| S:1462 E:1464 ||| .
The  ||| S:1464 E:1476 ||| DT
phosphorylation  ||| S:1476 E:1492 ||| NN
of  ||| S:1492 E:1495 ||| IN
Smad1  ||| S:1495 E:1501 ||| CD
at  ||| S:1501 E:1504 ||| IN
the  ||| S:1504 E:1508 ||| DT
carboxylterminal  ||| S:1508 E:1525 ||| JJ
SSVS  ||| S:1525 E:1530 ||| NNP
motif  ||| S:1530 E:1544 ||| NN
triggers  ||| S:1544 E:1553 ||| VBZ
the  ||| S:1553 E:1557 ||| DT
release  ||| S:1557 E:1565 ||| NN
of  ||| S:1565 E:1568 ||| IN
Smad1  ||| S:1568 E:1574 ||| CD
from  ||| S:1574 E:1579 ||| IN
the  ||| S:1579 E:1583 ||| DT
receptor ||| S:1583 E:1591 ||| NN
,  ||| S:1591 E:1593 ||| ,
the  ||| S:1593 E:1605 ||| DT
formation  ||| S:1605 E:1615 ||| NN
of  ||| S:1615 E:1618 ||| IN
homo-oligomers  ||| S:1618 E:1633 ||| JJ
of  ||| S:1633 E:1636 ||| IN
Smad1  ||| S:1636 E:1642 ||| NNP
and  ||| S:1642 E:1646 ||| CC
hetero-oligomers  ||| S:1646 E:1671 ||| JJ
of  ||| S:1671 E:1674 ||| IN
Smad1  ||| S:1674 E:1680 ||| NNP
and  ||| S:1680 E:1684 ||| CC
Smad4 ||| S:1684 E:1689 ||| NNP
,  ||| S:1689 E:1691 ||| ,
and  ||| S:1691 E:1695 ||| CC
the  ||| S:1695 E:1699 ||| DT
subsequent  ||| S:1699 E:1710 ||| JJ
nuclear  ||| S:1710 E:1726 ||| JJ
translocation  ||| S:1726 E:1740 ||| NN
of  ||| S:1740 E:1743 ||| IN
both  ||| S:1743 E:1748 ||| DT
Smad1  ||| S:1748 E:1754 ||| NNP
and  ||| S:1754 E:1758 ||| CC
Smad4  ||| S:1758 E:1764 ||| NNP
[  ||| S:1764 E:1766 ||| -LRB-
6  ||| S:1766 E:1768 ||| CD
9  ||| S:1768 E:1770 ||| CD
10  ||| S:1770 E:1773 ||| CD
]  ||| S:1773 E:1775 ||| -RRB-
.  ||| S:1775 E:1777 ||| .
In  ||| S:1777 E:1780 ||| IN
the  ||| S:1780 E:1792 ||| DT
nucleus ||| S:1792 E:1799 ||| NN
,  ||| S:1799 E:1801 ||| ,
Smad1  ||| S:1801 E:1807 ||| NNP
and  ||| S:1807 E:1811 ||| CC
Smad4  ||| S:1811 E:1817 ||| CD
function  ||| S:1817 E:1826 ||| NN
as  ||| S:1826 E:1829 ||| IN
DNA-binding  ||| S:1829 E:1849 ||| JJ
transcriptional  ||| S:1849 E:1865 ||| JJ
regulators  ||| S:1865 E:1876 ||| NNS
[  ||| S:1876 E:1878 ||| -LRB-
9  ||| S:1878 E:1880 ||| CD
]  ||| S:1880 E:1882 ||| -RRB-
.  ||| S:1882 E:1884 ||| .
However ||| S:1884 E:1891 ||| RB
,  ||| S:1891 E:1893 ||| ,
there  ||| S:1893 E:1899 ||| EX
is  ||| S:1899 E:1902 ||| VBZ
a  ||| S:1902 E:1912 ||| DT
unique  ||| S:1912 E:1919 ||| JJ
feature  ||| S:1919 E:1927 ||| NN
in  ||| S:1927 E:1930 ||| IN
Smad-regulated  ||| S:1930 E:1945 ||| JJ
transcription ||| S:1945 E:1958 ||| NN
.  ||| S:1958 E:1960 ||| .
Instead  ||| S:1960 E:1968 ||| RB
of  ||| S:1968 E:1979 ||| IN
independently  ||| S:1979 E:1993 ||| RB
binding  ||| S:1993 E:2001 ||| VBG
to  ||| S:2001 E:2004 ||| TO
specific  ||| S:2004 E:2013 ||| JJ
DNA  ||| S:2013 E:2017 ||| NN
sequence  ||| S:2017 E:2026 ||| NN
to  ||| S:2026 E:2029 ||| TO
regulate  ||| S:2029 E:2046 ||| VB
transcription ||| S:2046 E:2059 ||| NNS
,  ||| S:2059 E:2061 ||| ,
Smads  ||| S:2061 E:2067 ||| NNP
are  ||| S:2067 E:2071 ||| VBP
now  ||| S:2071 E:2075 ||| RB
considered  ||| S:2075 E:2086 ||| VBN
to  ||| S:2086 E:2089 ||| TO
be  ||| S:2089 E:2100 ||| VB
transcriptional  ||| S:2100 E:2116 ||| JJ
modulators  ||| S:2116 E:2127 ||| NN
since  ||| S:2127 E:2133 ||| IN
their  ||| S:2133 E:2139 ||| PRP$
ability  ||| S:2139 E:2147 ||| NN
to  ||| S:2147 E:2150 ||| TO
regulate  ||| S:2150 E:2167 ||| VB
transcription  ||| S:2167 E:2181 ||| NN
is  ||| S:2181 E:2184 ||| VBZ
dependent ||| S:2184 E:2193 ||| JJ
,  ||| S:2193 E:2195 ||| ,
in  ||| S:2195 E:2198 ||| IN
most  ||| S:2198 E:2203 ||| JJS
cases ||| S:2203 E:2208 ||| NNS
,  ||| S:2208 E:2210 ||| ,
on  ||| S:2210 E:2213 ||| IN
their  ||| S:2213 E:2227 ||| PRP$
physical  ||| S:2227 E:2236 ||| JJ
interaction  ||| S:2236 E:2248 ||| NN
with  ||| S:2248 E:2253 ||| IN
other  ||| S:2253 E:2259 ||| JJ
nearby  ||| S:2259 E:2266 ||| JJ
DNA-binding  ||| S:2266 E:2286 ||| JJ
transcription  ||| S:2286 E:2300 ||| JJ
factors  ||| S:2300 E:2308 ||| NNS
[  ||| S:2308 E:2310 ||| -LRB-
11  ||| S:2310 E:2313 ||| CD
]  ||| S:2313 E:2315 ||| -RRB-
.  ||| S:2315 E:2317 ||| .
Thus ||| S:2317 E:2321 ||| RB
,  ||| S:2321 E:2323 ||| ,
one  ||| S:2323 E:2327 ||| CD
of  ||| S:2327 E:2330 ||| IN
the  ||| S:2330 E:2334 ||| DT
fundamental  ||| S:2334 E:2354 ||| JJ
questions  ||| S:2354 E:2364 ||| NNS
in  ||| S:2364 E:2367 ||| IN
understanding  ||| S:2367 E:2381 ||| VBG
Smad-regulated  ||| S:2381 E:2396 ||| JJ
transcription  ||| S:2396 E:2410 ||| NN
is  ||| S:2410 E:2421 ||| VBZ
how  ||| S:2421 E:2425 ||| WRB
Smads  ||| S:2425 E:2431 ||| NNP
function  ||| S:2431 E:2440 ||| NN
as  ||| S:2440 E:2443 ||| IN
transcription  ||| S:2443 E:2457 ||| JJ
modulators ||| S:2457 E:2467 ||| NN
.  ||| S:2467 E:2477 ||| .
The  ||| S:2477 E:2481 ||| DT
transcriptional  ||| S:2481 E:2497 ||| JJ
regulatory  ||| S:2497 E:2508 ||| JJ
activities  ||| S:2508 E:2519 ||| NNS
of  ||| S:2519 E:2522 ||| IN
Smad1  ||| S:2522 E:2528 ||| CD
in  ||| S:2528 E:2539 ||| IN
the  ||| S:2539 E:2543 ||| DT
nucleus  ||| S:2543 E:2551 ||| NNS
are  ||| S:2551 E:2555 ||| VBP
associated  ||| S:2555 E:2566 ||| VBN
with  ||| S:2566 E:2571 ||| IN
its  ||| S:2571 E:2575 ||| PRP$
ability  ||| S:2575 E:2583 ||| NN
to  ||| S:2583 E:2586 ||| TO
directly  ||| S:2586 E:2603 ||| RB
bind  ||| S:2603 E:2608 ||| VBN
to  ||| S:2608 E:2611 ||| TO
DNA  ||| S:2611 E:2615 ||| NNP
[  ||| S:2615 E:2617 ||| -LRB-
12  ||| S:2617 E:2620 ||| CD
]  ||| S:2620 E:2622 ||| -RRB-
,  ||| S:2622 E:2624 ||| ,
its  ||| S:2624 E:2628 ||| PRP$
interaction  ||| S:2628 E:2640 ||| NN
with  ||| S:2640 E:2645 ||| IN
other  ||| S:2645 E:2651 ||| JJ
DNA-binding  ||| S:2651 E:2671 ||| JJ
transcription  ||| S:2671 E:2685 ||| JJ
factors ||| S:2685 E:2692 ||| NNS
,  ||| S:2692 E:2694 ||| ,
such  ||| S:2694 E:2699 ||| JJ
as  ||| S:2699 E:2702 ||| IN
OAZ ||| S:2702 E:2705 ||| NNP
,  ||| S:2705 E:2707 ||| ,
SIP1  ||| S:2707 E:2712 ||| NNP
and  ||| S:2712 E:2716 ||| CC
Hoxc-8  ||| S:2716 E:2723 ||| NNP
[  ||| S:2723 E:2725 ||| -LRB-
13  ||| S:2725 E:2728 ||| CD
14  ||| S:2728 E:2739 ||| CD
15  ||| S:2739 E:2742 ||| CD
]  ||| S:2742 E:2744 ||| -RRB-
,  ||| S:2744 E:2746 ||| ,
and  ||| S:2746 E:2750 ||| CC
also  ||| S:2750 E:2755 ||| RB
its  ||| S:2755 E:2759 ||| PRP$
interaction  ||| S:2759 E:2771 ||| NN
with  ||| S:2771 E:2776 ||| IN
the  ||| S:2776 E:2780 ||| DT
master  ||| S:2780 E:2795 ||| NN
transcriptional  ||| S:2795 E:2811 ||| FW
co-activator  ||| S:2811 E:2824 ||| FW
CBP ||| S:2824 E:2827 ||| FW
/ ||| S:2827 E:2828 ||| FW
p300  ||| S:2828 E:2833 ||| FW
[  ||| S:2833 E:2835 ||| -LRB-
16  ||| S:2835 E:2838 ||| CD
]  ||| S:2838 E:2840 ||| -RRB-
.  ||| S:2840 E:2842 ||| .
Smad4  ||| S:2842 E:2848 ||| NNP
is  ||| S:2848 E:2851 ||| VBZ
an  ||| S:2851 E:2862 ||| DT
essential  ||| S:2862 E:2872 ||| JJ
functional  ||| S:2872 E:2883 ||| JJ
partner  ||| S:2883 E:2891 ||| NN
in  ||| S:2891 E:2894 ||| IN
Smad-regulated  ||| S:2894 E:2917 ||| JJ
transcription  ||| S:2917 E:2931 ||| NN
and  ||| S:2931 E:2935 ||| CC
also  ||| S:2935 E:2940 ||| RB
interacts  ||| S:2940 E:2950 ||| VBN
with  ||| S:2950 E:2955 ||| IN
CBP ||| S:2955 E:2958 ||| NNP
/ ||| S:2958 E:2959 ||| NNP
p300  ||| S:2959 E:2964 ||| NNP
via  ||| S:2964 E:2968 ||| IN
a  ||| S:2968 E:2970 ||| DT
domain  ||| S:2970 E:2985 ||| NN
within  ||| S:2985 E:2992 ||| IN
the  ||| S:2992 E:2996 ||| DT
central  ||| S:2996 E:3004 ||| JJ
linker  ||| S:3004 E:3011 ||| JJ
region  ||| S:3011 E:3018 ||| NN
named  ||| S:3018 E:3024 ||| VBN
as  ||| S:3024 E:3027 ||| IN
SAD  ||| S:3027 E:3031 ||| NNP
( ||| S:3031 E:3032 ||| -LRB-
Smad  ||| S:3032 E:3045 ||| NNP
Activation  ||| S:3045 E:3056 ||| NNP
Domain ||| S:3056 E:3062 ||| NNP
)  ||| S:3062 E:3064 ||| -RRB-
[  ||| S:3064 E:3066 ||| -LRB-
13  ||| S:3066 E:3069 ||| CD
]  ||| S:3069 E:3071 ||| -RRB-
.  ||| S:3071 E:3073 ||| .
Since  ||| S:3073 E:3079 ||| IN
CBP ||| S:3079 E:3082 ||| NNP
/ ||| S:3082 E:3083 ||| NNP
p300  ||| S:3083 E:3088 ||| NNP
has  ||| S:3088 E:3092 ||| VBZ
intrinsic  ||| S:3092 E:3110 ||| JJ
histone  ||| S:3110 E:3118 ||| JJ
acetyltransferase  ||| S:3118 E:3136 ||| NNS
( ||| S:3136 E:3137 ||| -LRB-
HAT ||| S:3137 E:3140 ||| NNP
)  ||| S:3140 E:3142 ||| -RRB-
activity  ||| S:3142 E:3151 ||| NN
and  ||| S:3151 E:3155 ||| CC
participates  ||| S:3155 E:3176 ||| VBZ
in  ||| S:3176 E:3179 ||| IN
chromatin  ||| S:3179 E:3189 ||| JJ
remodeling ||| S:3189 E:3199 ||| NN
,  ||| S:3199 E:3201 ||| ,
the  ||| S:3201 E:3205 ||| DT
recruitment  ||| S:3205 E:3217 ||| NN
of  ||| S:3217 E:3220 ||| IN
CBP ||| S:3220 E:3223 ||| NNP
/ ||| S:3223 E:3224 ||| NNP
p300  ||| S:3224 E:3229 ||| NNP
into  ||| S:3229 E:3242 ||| IN
the  ||| S:3242 E:3246 ||| DT
DNA-binding  ||| S:3246 E:3258 ||| JJ
complexes  ||| S:3258 E:3268 ||| NNS
of  ||| S:3268 E:3271 ||| IN
Smad1  ||| S:3271 E:3277 ||| NNP
and  ||| S:3277 E:3281 ||| CC
Smad4  ||| S:3281 E:3287 ||| NNP
is  ||| S:3287 E:3290 ||| VBZ
likely  ||| S:3290 E:3297 ||| RB
a  ||| S:3297 E:3307 ||| DT
critical  ||| S:3307 E:3316 ||| JJ
step  ||| S:3316 E:3321 ||| NN
in  ||| S:3321 E:3324 ||| IN
Smad-regulated  ||| S:3324 E:3339 ||| JJ
gene  ||| S:3339 E:3344 ||| NN
activation ||| S:3344 E:3354 ||| NN
.  ||| S:3354 E:3356 ||| .
However ||| S:3356 E:3363 ||| RB
,  ||| S:3363 E:3373 ||| ,
our  ||| S:3373 E:3377 ||| PRP$
current  ||| S:3377 E:3385 ||| JJ
knowledge  ||| S:3385 E:3395 ||| NN
of  ||| S:3395 E:3398 ||| IN
the  ||| S:3398 E:3402 ||| DT
molecular  ||| S:3402 E:3412 ||| JJ
events  ||| S:3412 E:3419 ||| NNS
involved  ||| S:3419 E:3428 ||| VBN
in  ||| S:3428 E:3439 ||| IN
the  ||| S:3439 E:3443 ||| DT
recruitment  ||| S:3443 E:3455 ||| NN
of  ||| S:3455 E:3458 ||| IN
CBP ||| S:3458 E:3461 ||| NNP
/ ||| S:3461 E:3462 ||| NNP
p300  ||| S:3462 E:3467 ||| NNP
and  ||| S:3467 E:3471 ||| CC
other  ||| S:3471 E:3477 ||| JJ
transcriptional  ||| S:3477 E:3501 ||| JJ
co-activators  ||| S:3501 E:3515 ||| JJ
or  ||| S:3515 E:3518 ||| CC
co-repressors  ||| S:3518 E:3532 ||| JJ
by  ||| S:3532 E:3535 ||| IN
Smads  ||| S:3535 E:3541 ||| NNP
is  ||| S:3541 E:3544 ||| VBZ
still  ||| S:3544 E:3550 ||| RB
very  ||| S:3550 E:3563 ||| RB
limited ||| S:3563 E:3570 ||| VBN
.  ||| S:3570 E:3572 ||| .
Furthermore ||| S:3572 E:3583 ||| RB
,  ||| S:3583 E:3585 ||| ,
the  ||| S:3585 E:3589 ||| DT
molecular  ||| S:3589 E:3599 ||| JJ
mechanisms  ||| S:3599 E:3610 ||| NNS
underlying  ||| S:3610 E:3629 ||| VBG
the  ||| S:3629 E:3633 ||| DT
cooperative  ||| S:3633 E:3645 ||| JJ
functional  ||| S:3645 E:3656 ||| JJ
partnership  ||| S:3656 E:3668 ||| NN
between  ||| S:3668 E:3676 ||| IN
Smad1  ||| S:3676 E:3682 ||| NNP
and  ||| S:3682 E:3694 ||| CC
Smad4  ||| S:3694 E:3700 ||| CD
during  ||| S:3700 E:3707 ||| IN
transcriptional  ||| S:3707 E:3723 ||| JJ
regulation  ||| S:3723 E:3734 ||| NN
is  ||| S:3734 E:3737 ||| VBZ
not  ||| S:3737 E:3741 ||| RB
yet  ||| S:3741 E:3753 ||| RB
understood ||| S:3753 E:3763 ||| VBN
.  ||| S:3763 E:3773 ||| .
Protein-protein  ||| S:3773 E:3789 ||| JJ
interaction  ||| S:3789 E:3801 ||| NN
plays  ||| S:3801 E:3807 ||| VBZ
key  ||| S:3807 E:3811 ||| JJ
roles  ||| S:3811 E:3817 ||| NNS
in  ||| S:3817 E:3820 ||| IN
signal  ||| S:3820 E:3835 ||| NN
transduction ||| S:3835 E:3847 ||| NN
.  ||| S:3847 E:3849 ||| .
To  ||| S:3849 E:3852 ||| TO
gain  ||| S:3852 E:3857 ||| VB
further  ||| S:3857 E:3865 ||| JJ
understanding  ||| S:3865 E:3879 ||| NN
of  ||| S:3879 E:3882 ||| IN
the  ||| S:3882 E:3894 ||| DT
signaling  ||| S:3894 E:3904 ||| JJ
mechanisms  ||| S:3904 E:3915 ||| NNS
of  ||| S:3915 E:3918 ||| IN
Smad1 ||| S:3918 E:3923 ||| NNP
,  ||| S:3923 E:3925 ||| ,
we  ||| S:3925 E:3928 ||| PRP
carried  ||| S:3928 E:3936 ||| VBD
out  ||| S:3936 E:3940 ||| RP
a  ||| S:3940 E:3942 ||| DT
"blind ||| S:3942 E:3948 ||| NN
"  ||| S:3948 E:3958 ||| ''
search  ||| S:3958 E:3965 ||| NN
for  ||| S:3965 E:3969 ||| IN
proteins  ||| S:3969 E:3978 ||| NNS
that  ||| S:3978 E:3983 ||| WDT
bind  ||| S:3983 E:3988 ||| VBP
specifically  ||| S:3988 E:4001 ||| RB
to  ||| S:4001 E:4004 ||| TO
Smad1  ||| S:4004 E:4010 ||| CD
using  ||| S:4010 E:4024 ||| VBG
the  ||| S:4024 E:4028 ||| DT
yeast  ||| S:4028 E:4034 ||| NN
two-hybrid  ||| S:4034 E:4045 ||| JJ
system ||| S:4045 E:4051 ||| NN
.  ||| S:4051 E:4053 ||| .
Characterization  ||| S:4053 E:4070 ||| NN
of  ||| S:4070 E:4073 ||| IN
these  ||| S:4073 E:4087 ||| DT
interactors  ||| S:4087 E:4099 ||| NN
reveals  ||| S:4099 E:4107 ||| VBZ
an  ||| S:4107 E:4110 ||| DT
unexpected  ||| S:4110 E:4121 ||| JJ
physical  ||| S:4121 E:4130 ||| JJ
and  ||| S:4130 E:4134 ||| CC
functional  ||| S:4134 E:4153 ||| JJ
link  ||| S:4153 E:4158 ||| NN
between  ||| S:4158 E:4166 ||| IN
Smad1  ||| S:4166 E:4172 ||| NNP
and  ||| S:4172 E:4176 ||| CC
the  ||| S:4176 E:4180 ||| DT
proteasome-mediated  ||| S:4180 E:4200 ||| JJ
degradation  ||| S:4200 E:4220 ||| JJ
pathways ||| S:4220 E:4228 ||| NN
.  ||| S:4228 E:4230 ||| .
The  ||| S:4230 E:4234 ||| DT
26S  ||| S:4234 E:4238 ||| JJ
proteasome  ||| S:4238 E:4249 ||| NN
is  ||| S:4249 E:4252 ||| VBZ
responsible  ||| S:4252 E:4264 ||| JJ
for  ||| S:4264 E:4268 ||| IN
the  ||| S:4268 E:4272 ||| DT
bulk  ||| S:4272 E:4285 ||| JJ
turnover  ||| S:4285 E:4294 ||| NN
of  ||| S:4294 E:4297 ||| IN
cytoplasmic  ||| S:4297 E:4309 ||| NN
and  ||| S:4309 E:4313 ||| CC
nuclear  ||| S:4313 E:4321 ||| JJ
proteins  ||| S:4321 E:4330 ||| NNS
in  ||| S:4330 E:4333 ||| IN
eukaryotic  ||| S:4333 E:4352 ||| JJ
cells  ||| S:4352 E:4358 ||| NNS
and  ||| S:4358 E:4362 ||| CC
also  ||| S:4362 E:4367 ||| RB
plays  ||| S:4367 E:4373 ||| VBZ
a  ||| S:4373 E:4375 ||| DT
key  ||| S:4375 E:4379 ||| JJ
role  ||| S:4379 E:4384 ||| NN
in  ||| S:4384 E:4387 ||| IN
the  ||| S:4387 E:4391 ||| DT
regulation  ||| S:4391 E:4402 ||| NN
of  ||| S:4402 E:4405 ||| IN
cell  ||| S:4405 E:4418 ||| NN
cycle ||| S:4418 E:4423 ||| NN
,  ||| S:4423 E:4425 ||| ,
signal  ||| S:4425 E:4432 ||| NN
transduction ||| S:4432 E:4444 ||| NN
,  ||| S:4444 E:4446 ||| ,
transcription  ||| S:4446 E:4460 ||| VBG
as  ||| S:4460 E:4463 ||| IN
well  ||| S:4463 E:4468 ||| RB
as  ||| S:4468 E:4479 ||| IN
antigen  ||| S:4479 E:4487 ||| JJ
presentation  ||| S:4487 E:4500 ||| NN
[  ||| S:4500 E:4502 ||| -LRB-
17  ||| S:4502 E:4505 ||| CD
18  ||| S:4505 E:4508 ||| CD
19  ||| S:4508 E:4511 ||| CD
20  ||| S:4511 E:4514 ||| CD
21  ||| S:4514 E:4517 ||| CD
]  ||| S:4517 E:4519 ||| -RRB-
.  ||| S:4519 E:4521 ||| .
Most  ||| S:4521 E:4526 ||| JJS
of  ||| S:4526 E:4529 ||| IN
the  ||| S:4529 E:4533 ||| DT
known  ||| S:4533 E:4547 ||| VBN
proteasomal  ||| S:4547 E:4559 ||| JJ
substrates  ||| S:4559 E:4570 ||| NNS
are  ||| S:4570 E:4574 ||| VBP
marked  ||| S:4574 E:4581 ||| VBN
and  ||| S:4581 E:4585 ||| CC
targeted  ||| S:4585 E:4594 ||| VBN
to  ||| S:4594 E:4605 ||| TO
proteasome  ||| S:4605 E:4616 ||| VB
by  ||| S:4616 E:4619 ||| IN
ubiquitination  ||| S:4619 E:4634 ||| NNS
[  ||| S:4634 E:4636 ||| -LRB-
17  ||| S:4636 E:4639 ||| CD
19  ||| S:4639 E:4642 ||| CD
20  ||| S:4642 E:4645 ||| CD
]  ||| S:4645 E:4647 ||| -RRB-
.  ||| S:4647 E:4649 ||| .
Ubiquitination ||| S:4649 E:4663 ||| NNP
,  ||| S:4663 E:4673 ||| ,
however ||| S:4673 E:4680 ||| RB
,  ||| S:4680 E:4682 ||| ,
is  ||| S:4682 E:4685 ||| VBZ
not  ||| S:4685 E:4689 ||| RB
an  ||| S:4689 E:4692 ||| DT
obligatory  ||| S:4692 E:4703 ||| JJ
step  ||| S:4703 E:4708 ||| NN
for  ||| S:4708 E:4712 ||| IN
substrate  ||| S:4712 E:4722 ||| NNS
targeting  ||| S:4722 E:4740 ||| VBG
to  ||| S:4740 E:4743 ||| TO
proteasome  ||| S:4743 E:4754 ||| VB
[  ||| S:4754 E:4756 ||| -LRB-
17  ||| S:4756 E:4759 ||| CD
18  ||| S:4759 E:4762 ||| CD
20  ||| S:4762 E:4765 ||| CD
]  ||| S:4765 E:4767 ||| -RRB-
.  ||| S:4767 E:4769 ||| .
The  ||| S:4769 E:4773 ||| DT
degradation  ||| S:4773 E:4785 ||| NN
of  ||| S:4785 E:4788 ||| IN
the  ||| S:4788 E:4800 ||| DT
ornithine  ||| S:4800 E:4810 ||| JJ
decarboxylase  ||| S:4810 E:4824 ||| NNS
( ||| S:4824 E:4825 ||| -LRB-
ODC ||| S:4825 E:4828 ||| NNP
) ||| S:4828 E:4829 ||| -RRB-
,  ||| S:4829 E:4831 ||| ,
the  ||| S:4831 E:4835 ||| DT
rate-limiting  ||| S:4835 E:4849 ||| JJ
enzyme  ||| S:4849 E:4856 ||| NN
for  ||| S:4856 E:4868 ||| IN
polyamine  ||| S:4868 E:4878 ||| JJ
synthesis ||| S:4878 E:4887 ||| NN
,  ||| S:4887 E:4889 ||| ,
involves  ||| S:4889 E:4898 ||| VBZ
a  ||| S:4898 E:4900 ||| DT
protein  ||| S:4900 E:4908 ||| NN
named  ||| S:4908 E:4914 ||| VBN
antizyme  ||| S:4914 E:4931 ||| NNS
( ||| S:4931 E:4932 ||| -LRB-
Az ||| S:4932 E:4934 ||| NNP
) ||| S:4934 E:4935 ||| -RRB-
,  ||| S:4935 E:4937 ||| ,
which  ||| S:4937 E:4943 ||| WDT
binds  ||| S:4943 E:4949 ||| NNS
and  ||| S:4949 E:4953 ||| CC
targets  ||| S:4953 E:4961 ||| VBZ
ODC  ||| S:4961 E:4965 ||| NNP
to  ||| S:4965 E:4968 ||| TO
26S  ||| S:4968 E:4972 ||| CD
proteasome  ||| S:4972 E:4983 ||| NN
for  ||| S:4983 E:4995 ||| IN
degradation  ||| S:4995 E:5007 ||| NNS
[  ||| S:5007 E:5009 ||| -LRB-
18  ||| S:5009 E:5012 ||| CD
]  ||| S:5012 E:5014 ||| -RRB-
.  ||| S:5014 E:5016 ||| .
However ||| S:5016 E:5023 ||| RB
,  ||| S:5023 E:5025 ||| ,
ODC  ||| S:5025 E:5029 ||| NNP
has  ||| S:5029 E:5033 ||| VBZ
remained  ||| S:5033 E:5042 ||| VBN
an  ||| S:5042 E:5045 ||| DT
"orphan ||| S:5045 E:5052 ||| NN
"  ||| S:5052 E:5062 ||| ''
in  ||| S:5062 E:5065 ||| IN
Az-dependent  ||| S:5065 E:5078 ||| JJ
proteasomal  ||| S:5078 E:5090 ||| JJ
degradation ||| S:5090 E:5101 ||| NN
.  ||| S:5101 E:5111 ||| .
Interestingly ||| S:5111 E:5124 ||| RB
,  ||| S:5124 E:5126 ||| ,
both  ||| S:5126 E:5131 ||| DT
ubiquitin  ||| S:5131 E:5141 ||| NN
and  ||| S:5141 E:5145 ||| CC
Az  ||| S:5145 E:5148 ||| NNP
were  ||| S:5148 E:5153 ||| VBD
isolated  ||| S:5153 E:5162 ||| VBN
from  ||| S:5162 E:5175 ||| IN
the  ||| S:5175 E:5179 ||| DT
yeast  ||| S:5179 E:5185 ||| NN
two-hybrid  ||| S:5185 E:5196 ||| JJ
system  ||| S:5196 E:5203 ||| NN
as  ||| S:5203 E:5206 ||| IN
Smad1  ||| S:5206 E:5212 ||| CD
interactors ||| S:5212 E:5223 ||| NNS
.  ||| S:5223 E:5233 ||| .
Furthermore ||| S:5233 E:5244 ||| RB
,  ||| S:5244 E:5246 ||| ,
an  ||| S:5246 E:5249 ||| DT
integral  ||| S:5249 E:5258 ||| JJ
component  ||| S:5258 E:5268 ||| NN
of  ||| S:5268 E:5271 ||| IN
proteasome ||| S:5271 E:5281 ||| NN
,  ||| S:5281 E:5283 ||| ,
HsN3  ||| S:5283 E:5288 ||| NNP
[  ||| S:5288 E:5290 ||| -LRB-
22  ||| S:5290 E:5301 ||| CD
23  ||| S:5301 E:5304 ||| CD
24  ||| S:5304 E:5307 ||| CD
]  ||| S:5307 E:5309 ||| -RRB-
,  ||| S:5309 E:5311 ||| ,
which  ||| S:5311 E:5317 ||| WDT
is  ||| S:5317 E:5320 ||| VBZ
a  ||| S:5320 E:5322 ||| DT
β  ||| S:5322 E:5324 ||| JJ
subunit  ||| S:5324 E:5332 ||| NN
of  ||| S:5332 E:5335 ||| IN
the  ||| S:5335 E:5339 ||| DT
20S  ||| S:5339 E:5343 ||| JJ
catalytic  ||| S:5343 E:5353 ||| JJ
core ||| S:5353 E:5357 ||| NN
,  ||| S:5357 E:5367 ||| ,
was  ||| S:5367 E:5371 ||| VBD
also  ||| S:5371 E:5376 ||| RB
isolated  ||| S:5376 E:5385 ||| VBN
as  ||| S:5385 E:5388 ||| IN
a  ||| S:5388 E:5390 ||| DT
strong  ||| S:5390 E:5397 ||| JJ
and  ||| S:5397 E:5401 ||| CC
specific  ||| S:5401 E:5410 ||| JJ
Smad1  ||| S:5410 E:5424 ||| CD
interactor ||| S:5424 E:5434 ||| NNS
.  ||| S:5434 E:5436 ||| .
Functional  ||| S:5436 E:5447 ||| JJ
characterization  ||| S:5447 E:5464 ||| NN
of  ||| S:5464 E:5467 ||| IN
the  ||| S:5467 E:5471 ||| DT
interaction  ||| S:5471 E:5491 ||| NN
between  ||| S:5491 E:5499 ||| IN
Smad1 ||| S:5499 E:5504 ||| NNP
,  ||| S:5504 E:5506 ||| ,
Az  ||| S:5506 E:5509 ||| NNP
and  ||| S:5509 E:5513 ||| CC
HsN3  ||| S:5513 E:5518 ||| CD
in  ||| S:5518 E:5521 ||| IN
the  ||| S:5521 E:5525 ||| DT
signaling  ||| S:5525 E:5535 ||| JJ
pathways  ||| S:5535 E:5544 ||| NN
of  ||| S:5544 E:5555 ||| IN
BMPs  ||| S:5555 E:5560 ||| NNP
led  ||| S:5560 E:5564 ||| VBD
us  ||| S:5564 E:5567 ||| PRP
to  ||| S:5567 E:5570 ||| TO
find  ||| S:5570 E:5575 ||| VB
a  ||| S:5575 E:5577 ||| DT
novel  ||| S:5577 E:5583 ||| NN
functional  ||| S:5583 E:5594 ||| NN
link  ||| S:5594 E:5599 ||| NN
between  ||| S:5599 E:5607 ||| IN
Smad1  ||| S:5607 E:5621 ||| NNP
and  ||| S:5621 E:5625 ||| CC
proteasome-mediated  ||| S:5625 E:5645 ||| JJ
degradation  ||| S:5645 E:5657 ||| NN
events ||| S:5657 E:5663 ||| NNS
,  ||| S:5663 E:5665 ||| ,
through  ||| S:5665 E:5673 ||| IN
which  ||| S:5673 E:5679 ||| WDT
a  ||| S:5679 E:5689 ||| DT
novel  ||| S:5689 E:5695 ||| NN
CBP ||| S:5695 E:5698 ||| FW
/ ||| S:5698 E:5699 ||| FW
p300  ||| S:5699 E:5704 ||| FW
repressor ||| S:5704 E:5713 ||| FW
,  ||| S:5713 E:5715 ||| ,
SNIP1  ||| S:5715 E:5721 ||| NNP
[  ||| S:5721 E:5723 ||| -LRB-
25  ||| S:5723 E:5726 ||| CD
]  ||| S:5726 E:5728 ||| -RRB-
,  ||| S:5728 E:5730 ||| ,
is  ||| S:5730 E:5733 ||| VBZ
removed  ||| S:5733 E:5741 ||| VBN
to  ||| S:5741 E:5752 ||| TO
allow  ||| S:5752 E:5758 ||| VB
the  ||| S:5758 E:5762 ||| DT
transcriptional  ||| S:5762 E:5778 ||| JJ
activation  ||| S:5778 E:5789 ||| NN
of  ||| S:5789 E:5792 ||| IN
BMP-responsive  ||| S:5792 E:5815 ||| JJ
genes ||| S:5815 E:5820 ||| NNS
.  ||| S:5820 E:5844 ||| .
Results  ||| S:5844 E:5871 ||| NNS
The  ||| S:5871 E:5875 ||| DT
isolation  ||| S:5875 E:5885 ||| NN
of  ||| S:5885 E:5888 ||| IN
Smad1  ||| S:5888 E:5894 ||| CD
interacting  ||| S:5894 E:5906 ||| CD
proteins  ||| S:5906 E:5915 ||| NNS
reveals  ||| S:5915 E:5933 ||| VBZ
a  ||| S:5933 E:5935 ||| DT
physical  ||| S:5935 E:5944 ||| JJ
interaction  ||| S:5944 E:5956 ||| NN
between  ||| S:5956 E:5964 ||| IN
Smad1  ||| S:5964 E:5970 ||| NNP
and  ||| S:5970 E:5974 ||| CC
components  ||| S:5974 E:5985 ||| NNS
in  ||| S:5985 E:5998 ||| IN
proteasome-mediated  ||| S:5998 E:6018 ||| JJ
degradation  ||| S:6018 E:6030 ||| NN
pathways  ||| S:6030 E:6049 ||| VBD
We  ||| S:6049 E:6052 ||| PRP
applied  ||| S:6052 E:6060 ||| VBD
the  ||| S:6060 E:6064 ||| DT
yeast  ||| S:6064 E:6070 ||| NN
"Protein  ||| S:6070 E:6079 ||| NNP
Trap ||| S:6079 E:6083 ||| NNP
"  ||| S:6083 E:6085 ||| ''
system  ||| S:6085 E:6092 ||| NN
to  ||| S:6092 E:6095 ||| TO
isolate  ||| S:6095 E:6113 ||| VB
Smad1  ||| S:6113 E:6119 ||| CD
interactors  ||| S:6119 E:6131 ||| NNS
[  ||| S:6131 E:6133 ||| -LRB-
26  ||| S:6133 E:6136 ||| CD
27  ||| S:6136 E:6139 ||| CD
]  ||| S:6139 E:6141 ||| -RRB-
.  ||| S:6141 E:6143 ||| .
Full  ||| S:6143 E:6148 ||| JJ
length  ||| S:6148 E:6155 ||| NN
Smad1  ||| S:6155 E:6161 ||| NN
was  ||| S:6161 E:6165 ||| VBD
fused  ||| S:6165 E:6181 ||| VBN
with  ||| S:6181 E:6186 ||| IN
the  ||| S:6186 E:6190 ||| DT
DNA-binding  ||| S:6190 E:6202 ||| JJ
domain  ||| S:6202 E:6209 ||| NN
of  ||| S:6209 E:6212 ||| IN
LexA  ||| S:6212 E:6217 ||| JJ
to  ||| S:6217 E:6220 ||| TO
serve  ||| S:6220 E:6226 ||| VB
as  ||| S:6226 E:6229 ||| IN
bait ||| S:6229 E:6233 ||| NN
.  ||| S:6233 E:6235 ||| .
A  ||| S:6235 E:6247 ||| DT
human  ||| S:6247 E:6253 ||| JJ
fetal  ||| S:6253 E:6259 ||| JJ
brain  ||| S:6259 E:6265 ||| NN
cDNA  ||| S:6265 E:6270 ||| JJ
library  ||| S:6270 E:6278 ||| NN
with  ||| S:6278 E:6283 ||| IN
cDNA  ||| S:6283 E:6288 ||| JJ
inserts  ||| S:6288 E:6296 ||| NNS
fused  ||| S:6296 E:6312 ||| VBN
with  ||| S:6312 E:6317 ||| IN
the  ||| S:6317 E:6321 ||| DT
transcriptional  ||| S:6321 E:6337 ||| JJ
activation  ||| S:6337 E:6348 ||| JJ
domain  ||| S:6348 E:6355 ||| NN
B42  ||| S:6355 E:6359 ||| NN
was  ||| S:6359 E:6363 ||| VBD
used  ||| S:6363 E:6378 ||| VBN
for  ||| S:6378 E:6382 ||| IN
the  ||| S:6382 E:6386 ||| DT
screen ||| S:6386 E:6392 ||| NN
.  ||| S:6392 E:6394 ||| .
From  ||| S:6394 E:6399 ||| IN
screening  ||| S:6399 E:6409 ||| VBG
one  ||| S:6409 E:6413 ||| CD
million  ||| S:6413 E:6421 ||| CD
cDNA  ||| S:6421 E:6426 ||| JJ
clones ||| S:6426 E:6432 ||| NNS
,  ||| S:6432 E:6444 ||| ,
40  ||| S:6444 E:6447 ||| CD
clones  ||| S:6447 E:6454 ||| NNS
exhibited  ||| S:6454 E:6464 ||| VBP
strong  ||| S:6464 E:6471 ||| JJ
activation  ||| S:6471 E:6482 ||| NN
of  ||| S:6482 E:6485 ||| IN
both  ||| S:6485 E:6490 ||| DT
of  ||| S:6490 E:6493 ||| IN
the  ||| S:6493 E:6507 ||| DT
reporter  ||| S:6507 E:6516 ||| NN
genes  ||| S:6516 E:6522 ||| NNS
( ||| S:6522 E:6523 ||| -LRB-
LacZ  ||| S:6523 E:6528 ||| NNP
and  ||| S:6528 E:6532 ||| CC
Leu2 ||| S:6532 E:6536 ||| CD
) ||| S:6536 E:6537 ||| -RRB-
.  ||| S:6537 E:6539 ||| .
Thirteen  ||| S:6539 E:6548 ||| JJ
different  ||| S:6548 E:6558 ||| JJ
cDNA  ||| S:6558 E:6573 ||| JJ
inserts  ||| S:6573 E:6581 ||| NNS
were  ||| S:6581 E:6586 ||| VBD
identified  ||| S:6586 E:6597 ||| VBN
from  ||| S:6597 E:6602 ||| IN
these  ||| S:6602 E:6608 ||| DT
40  ||| S:6608 E:6611 ||| CD
clones ||| S:6611 E:6617 ||| NNS
.  ||| S:6617 E:6619 ||| .
The  ||| S:6619 E:6623 ||| DT
ability  ||| S:6623 E:6641 ||| NN
of  ||| S:6641 E:6644 ||| IN
these  ||| S:6644 E:6650 ||| DT
thirteen  ||| S:6650 E:6659 ||| JJ
candidate  ||| S:6659 E:6669 ||| NN
Smad1  ||| S:6669 E:6675 ||| VBZ
interactors  ||| S:6675 E:6687 ||| VBN
to  ||| S:6687 E:6690 ||| TO
bind  ||| S:6690 E:6705 ||| CD
Smad1 ||| S:6705 E:6710 ||| CD
,  ||| S:6710 E:6712 ||| ,
Smad2 ||| S:6712 E:6717 ||| NNP
,  ||| S:6717 E:6719 ||| ,
Smad3  ||| S:6719 E:6725 ||| NNP
and  ||| S:6725 E:6729 ||| CC
Smad4  ||| S:6729 E:6735 ||| NNP
were  ||| S:6735 E:6740 ||| VBD
directly  ||| S:6740 E:6749 ||| RB
tested  ||| S:6749 E:6756 ||| VBN
in  ||| S:6756 E:6759 ||| IN
the  ||| S:6759 E:6773 ||| DT
yeast  ||| S:6773 E:6779 ||| NN
two-hybrid  ||| S:6779 E:6790 ||| JJ
system  ||| S:6790 E:6797 ||| NN
( ||| S:6797 E:6798 ||| -LRB-
Fig.  ||| S:6798 E:6803 ||| NNP
1A ||| S:6803 E:6805 ||| NNP
) ||| S:6805 E:6806 ||| -RRB-
.  ||| S:6806 E:6808 ||| .
Among  ||| S:6808 E:6814 ||| IN
the  ||| S:6814 E:6818 ||| DT
thirteen  ||| S:6818 E:6837 ||| NN
isolated  ||| S:6837 E:6846 ||| VBD
Smad1  ||| S:6846 E:6852 ||| CD
interactors ||| S:6852 E:6863 ||| NN
,  ||| S:6863 E:6865 ||| ,
only  ||| S:6865 E:6870 ||| RB
clones  ||| S:6870 E:6877 ||| CD
13 ||| S:6877 E:6879 ||| CD
,  ||| S:6879 E:6881 ||| ,
17 ||| S:6881 E:6883 ||| CD
,  ||| S:6883 E:6885 ||| ,
19  ||| S:6885 E:6888 ||| CD
and  ||| S:6888 E:6892 ||| CC
21  ||| S:6892 E:6905 ||| CD
bind  ||| S:6905 E:6910 ||| CD
Smad2 ||| S:6910 E:6915 ||| CD
,  ||| S:6915 E:6917 ||| ,
whereas  ||| S:6917 E:6925 ||| IN
only  ||| S:6925 E:6930 ||| RB
clones  ||| S:6930 E:6937 ||| CD
1 ||| S:6937 E:6938 ||| CD
,  ||| S:6938 E:6940 ||| ,
17  ||| S:6940 E:6943 ||| CD
and  ||| S:6943 E:6947 ||| CC
21  ||| S:6947 E:6950 ||| CD
exhibit  ||| S:6950 E:6968 ||| NN
strong  ||| S:6968 E:6975 ||| JJ
interaction  ||| S:6975 E:6987 ||| NN
with  ||| S:6987 E:6992 ||| IN
Smad3 ||| S:6992 E:6997 ||| CD
.  ||| S:6997 E:6999 ||| .
Only  ||| S:6999 E:7004 ||| RB
one  ||| S:7004 E:7008 ||| CD
clone  ||| S:7008 E:7014 ||| NNS
( ||| S:7014 E:7015 ||| -LRB-
clone  ||| S:7015 E:7021 ||| CD
17 ||| S:7021 E:7023 ||| CD
)  ||| S:7023 E:7035 ||| -RRB-
among  ||| S:7035 E:7041 ||| IN
the  ||| S:7041 E:7045 ||| DT
thirteen  ||| S:7045 E:7054 ||| JJ
clones  ||| S:7054 E:7061 ||| JJ
interacts  ||| S:7061 E:7071 ||| NN
with  ||| S:7071 E:7076 ||| IN
Smad4 ||| S:7076 E:7081 ||| CD
.  ||| S:7081 E:7093 ||| .
Interestingly ||| S:7093 E:7106 ||| RB
,  ||| S:7106 E:7108 ||| ,
this  ||| S:7108 E:7113 ||| DT
clone  ||| S:7113 E:7119 ||| NN
encodes  ||| S:7119 E:7127 ||| VBD
a  ||| S:7127 E:7129 ||| DT
truncated  ||| S:7129 E:7139 ||| JJ
Smad1  ||| S:7139 E:7155 ||| NN
lacking  ||| S:7155 E:7163 ||| VBG
its  ||| S:7163 E:7167 ||| PRP$
MH1  ||| S:7167 E:7171 ||| JJ
domain ||| S:7171 E:7177 ||| NN
.  ||| S:7177 E:7179 ||| .
Such  ||| S:7179 E:7184 ||| PDT
an  ||| S:7184 E:7187 ||| DT
interaction  ||| S:7187 E:7199 ||| NN
is  ||| S:7199 E:7202 ||| VBZ
consistent  ||| S:7202 E:7223 ||| JJ
with  ||| S:7223 E:7228 ||| IN
the  ||| S:7228 E:7232 ||| DT
known  ||| S:7232 E:7238 ||| JJ
ability  ||| S:7238 E:7246 ||| NN
of  ||| S:7246 E:7249 ||| IN
Smad1  ||| S:7249 E:7255 ||| CD
to  ||| S:7255 E:7258 ||| TO
bind  ||| S:7258 E:7263 ||| CD
Smad4  ||| S:7263 E:7269 ||| CD
upon  ||| S:7269 E:7274 ||| IN
its  ||| S:7274 E:7288 ||| PRP$
activation  ||| S:7288 E:7299 ||| NN
in  ||| S:7299 E:7302 ||| IN
mammalian  ||| S:7302 E:7312 ||| JJ
cells  ||| S:7312 E:7318 ||| NNS
[  ||| S:7318 E:7320 ||| -LRB-
9  ||| S:7320 E:7322 ||| CD
]  ||| S:7322 E:7324 ||| -RRB-
.  ||| S:7324 E:7336 ||| .
The  ||| S:7336 E:7340 ||| DT
identities  ||| S:7340 E:7351 ||| NNS
of  ||| S:7351 E:7354 ||| IN
the  ||| S:7354 E:7358 ||| DT
thirteen  ||| S:7358 E:7367 ||| JJ
interactors  ||| S:7367 E:7379 ||| NNS
are  ||| S:7379 E:7393 ||| VBP
summarized  ||| S:7393 E:7404 ||| NNS
( ||| S:7404 E:7405 ||| -LRB-
Fig.  ||| S:7405 E:7410 ||| NNP
1B ||| S:7410 E:7412 ||| NNP
,  ||| S:7412 E:7414 ||| ,
top  ||| S:7414 E:7418 ||| JJ
panel ||| S:7418 E:7423 ||| NN
) ||| S:7423 E:7424 ||| -RRB-
.  ||| S:7424 E:7426 ||| .
We  ||| S:7426 E:7429 ||| PRP
divided  ||| S:7429 E:7437 ||| VBD
the  ||| S:7437 E:7451 ||| DT
interactors  ||| S:7451 E:7463 ||| NN
into  ||| S:7463 E:7468 ||| IN
three  ||| S:7468 E:7474 ||| CD
groups  ||| S:7474 E:7481 ||| NNS
( ||| S:7481 E:7482 ||| -LRB-
Fig.  ||| S:7482 E:7487 ||| NNP
1B ||| S:7487 E:7489 ||| NNP
,  ||| S:7489 E:7491 ||| ,
top  ||| S:7491 E:7495 ||| JJ
panel ||| S:7495 E:7500 ||| NN
) ||| S:7500 E:7501 ||| -RRB-
.  ||| S:7501 E:7503 ||| .
The  ||| S:7503 E:7517 ||| DT
first  ||| S:7517 E:7523 ||| JJ
group  ||| S:7523 E:7529 ||| NN
contains  ||| S:7529 E:7538 ||| VBZ
proteins  ||| S:7538 E:7547 ||| NNS
that  ||| S:7547 E:7552 ||| WDT
have  ||| S:7552 E:7557 ||| VBP
a  ||| S:7557 E:7559 ||| DT
functional  ||| S:7559 E:7570 ||| JJ
link  ||| S:7570 E:7585 ||| NN
to  ||| S:7585 E:7588 ||| TO
the  ||| S:7588 E:7592 ||| DT
degradation  ||| S:7592 E:7604 ||| JJ
pathways  ||| S:7604 E:7613 ||| NN
of  ||| S:7613 E:7616 ||| IN
the  ||| S:7616 E:7620 ||| DT
26S  ||| S:7620 E:7624 ||| JJ
proteasome ||| S:7624 E:7634 ||| NN
.  ||| S:7634 E:7636 ||| .
They  ||| S:7636 E:7651 ||| PRP
are ||| S:7651 E:7654 ||| VBP
:  ||| S:7654 E:7656 ||| :
two  ||| S:7656 E:7660 ||| CD
ubiquitin  ||| S:7660 E:7670 ||| CD
precursors  ||| S:7670 E:7681 ||| CD
UBA80  ||| S:7681 E:7687 ||| CD
( ||| S:7687 E:7688 ||| -LRB-
clone  ||| S:7688 E:7694 ||| CD
1 ||| S:7694 E:7695 ||| CD
)  ||| S:7695 E:7697 ||| -RRB-
and  ||| S:7697 E:7701 ||| CC
UBA52  ||| S:7701 E:7717 ||| NNP
( ||| S:7717 E:7718 ||| -LRB-
clone  ||| S:7718 E:7724 ||| CD
21 ||| S:7724 E:7726 ||| CD
) ||| S:7726 E:7727 ||| -RRB-
,  ||| S:7727 E:7729 ||| ,
the  ||| S:7729 E:7733 ||| DT
ornithine  ||| S:7733 E:7743 ||| FW
decarboxylase  ||| S:7743 E:7757 ||| FW
antizyme  ||| S:7757 E:7766 ||| FW
( ||| S:7766 E:7767 ||| -LRB-
Az ||| S:7767 E:7769 ||| NNP
)  ||| S:7769 E:7781 ||| -RRB-
( ||| S:7781 E:7782 ||| -LRB-
clone  ||| S:7782 E:7788 ||| CD
15 ||| S:7788 E:7790 ||| CD
)  ||| S:7790 E:7792 ||| -RRB-
and  ||| S:7792 E:7796 ||| CC
the  ||| S:7796 E:7800 ||| DT
proteasome  ||| S:7800 E:7811 ||| FW
β  ||| S:7811 E:7813 ||| FW
subunit  ||| S:7813 E:7821 ||| FW
HsN3  ||| S:7821 E:7826 ||| FW
( ||| S:7826 E:7827 ||| -LRB-
clone  ||| S:7827 E:7833 ||| CD
18 ||| S:7833 E:7835 ||| CD
) ||| S:7835 E:7836 ||| -RRB-
.  ||| S:7836 E:7848 ||| .
The  ||| S:7848 E:7852 ||| DT
second  ||| S:7852 E:7859 ||| JJ
group  ||| S:7859 E:7865 ||| NN
contains  ||| S:7865 E:7874 ||| VBZ
four  ||| S:7874 E:7879 ||| CD
known  ||| S:7879 E:7885 ||| JJ
proteins ||| S:7885 E:7893 ||| NNS
:  ||| S:7893 E:7895 ||| :
GST  ||| S:7895 E:7899 ||| NNP
( ||| S:7899 E:7900 ||| -LRB-
clone  ||| S:7900 E:7916 ||| CD
13 ||| S:7916 E:7918 ||| CD
) ||| S:7918 E:7919 ||| -RRB-
,  ||| S:7919 E:7921 ||| ,
MBP-1  ||| S:7921 E:7927 ||| NNP
( ||| S:7927 E:7928 ||| -LRB-
c-Myc  ||| S:7928 E:7934 ||| JJ
promoter  ||| S:7934 E:7943 ||| NN
Binding  ||| S:7943 E:7951 ||| NNP
Protein ||| S:7951 E:7958 ||| NNP
,  ||| S:7958 E:7960 ||| ,
clone  ||| S:7960 E:7966 ||| CD
14 ||| S:7966 E:7968 ||| CD
)  ||| S:7968 E:7970 ||| -RRB-
[  ||| S:7970 E:7982 ||| -LRB-
28  ||| S:7982 E:7985 ||| CD
]  ||| S:7985 E:7987 ||| -RRB-
,  ||| S:7987 E:7989 ||| ,
Smad1  ||| S:7989 E:7995 ||| NNP
( ||| S:7995 E:7996 ||| -LRB-
clone  ||| S:7996 E:8002 ||| CD
17 ||| S:8002 E:8004 ||| CD
) ||| S:8004 E:8005 ||| -RRB-
,  ||| S:8005 E:8007 ||| ,
TAG  ||| S:8007 E:8011 ||| NNP
( ||| S:8011 E:8012 ||| -LRB-
Tumor  ||| S:8012 E:8018 ||| NNP
Associated  ||| S:8018 E:8029 ||| NNP
Gene ||| S:8029 E:8033 ||| NNP
,  ||| S:8033 E:8045 ||| ,
clone  ||| S:8045 E:8051 ||| CD
31 ||| S:8051 E:8053 ||| CD
)  ||| S:8053 E:8055 ||| -RRB-
[  ||| S:8055 E:8057 ||| -LRB-
29  ||| S:8057 E:8060 ||| CD
]  ||| S:8060 E:8062 ||| -RRB-
and  ||| S:8062 E:8066 ||| CC
PAG  ||| S:8066 E:8070 ||| NNP
( ||| S:8070 E:8071 ||| -LRB-
Proliferation  ||| S:8071 E:8085 ||| NNP
Associated  ||| S:8085 E:8096 ||| NNP
Gene ||| S:8096 E:8100 ||| NNP
,  ||| S:8100 E:8112 ||| ,
clone  ||| S:8112 E:8118 ||| CD
35 ||| S:8118 E:8120 ||| CD
)  ||| S:8120 E:8122 ||| -RRB-
[  ||| S:8122 E:8124 ||| -LRB-
30  ||| S:8124 E:8127 ||| CD
]  ||| S:8127 E:8129 ||| -RRB-
.  ||| S:8129 E:8131 ||| .
The  ||| S:8131 E:8135 ||| DT
third  ||| S:8135 E:8141 ||| JJ
group  ||| S:8141 E:8147 ||| NN
contains  ||| S:8147 E:8156 ||| VBZ
four  ||| S:8156 E:8161 ||| CD
novel  ||| S:8161 E:8177 ||| NN
proteins ||| S:8177 E:8185 ||| NNS
:  ||| S:8185 E:8187 ||| :
clone  ||| S:8187 E:8193 ||| CD
19 ||| S:8193 E:8195 ||| CD
,  ||| S:8195 E:8197 ||| ,
12 ||| S:8197 E:8199 ||| CD
,  ||| S:8199 E:8201 ||| ,
27  ||| S:8201 E:8204 ||| CD
and  ||| S:8204 E:8208 ||| CC
28 ||| S:8208 E:8210 ||| CD
,  ||| S:8210 E:8212 ||| ,
which  ||| S:8212 E:8218 ||| WDT
we  ||| S:8218 E:8221 ||| PRP
named  ||| S:8221 E:8227 ||| VBD
as  ||| S:8227 E:8240 ||| IN
SNIP1 ||| S:8240 E:8245 ||| NNP
,  ||| S:8245 E:8247 ||| ,
SIP2 ||| S:8247 E:8251 ||| NNP
,  ||| S:8251 E:8253 ||| ,
SIP3  ||| S:8253 E:8258 ||| NNP
and  ||| S:8258 E:8262 ||| CC
SIP4 ||| S:8262 E:8266 ||| NNP
,  ||| S:8266 E:8268 ||| ,
respectively ||| S:8268 E:8280 ||| RB
.  ||| S:8280 E:8282 ||| .
The  ||| S:8282 E:8286 ||| DT
functional  ||| S:8286 E:8307 ||| JJ
characterization  ||| S:8307 E:8324 ||| NN
of  ||| S:8324 E:8327 ||| IN
clone  ||| S:8327 E:8333 ||| CD
19  ||| S:8333 E:8336 ||| CD
( ||| S:8336 E:8337 ||| -LRB-
SNIP1 ||| S:8337 E:8342 ||| NNP
)  ||| S:8342 E:8344 ||| -RRB-
as  ||| S:8344 E:8347 ||| IN
a  ||| S:8347 E:8349 ||| DT
novel  ||| S:8349 E:8355 ||| NN
CBP ||| S:8355 E:8358 ||| NNP
/ ||| S:8358 E:8359 ||| NNP
p300  ||| S:8359 E:8374 ||| NNP
interactor  ||| S:8374 E:8385 ||| NN
and  ||| S:8385 E:8389 ||| CC
repressor  ||| S:8389 E:8399 ||| NN
has  ||| S:8399 E:8403 ||| VBZ
been  ||| S:8403 E:8408 ||| VBN
reported  ||| S:8408 E:8417 ||| VBN
recently  ||| S:8417 E:8426 ||| RB
in  ||| S:8426 E:8439 ||| IN
the  ||| S:8439 E:8443 ||| DT
signaling  ||| S:8443 E:8453 ||| JJ
pathways  ||| S:8453 E:8462 ||| NN
of  ||| S:8462 E:8465 ||| IN
TGF-β  ||| S:8465 E:8471 ||| NNP
[  ||| S:8471 E:8473 ||| -LRB-
25  ||| S:8473 E:8476 ||| CD
]  ||| S:8476 E:8478 ||| -RRB-
.  ||| S:8478 E:8480 ||| .
The  ||| S:8480 E:8484 ||| DT
functional  ||| S:8484 E:8505 ||| JJ
characterization  ||| S:8505 E:8522 ||| NN
of  ||| S:8522 E:8525 ||| IN
clone  ||| S:8525 E:8531 ||| CD
12  ||| S:8531 E:8534 ||| CD
( ||| S:8534 E:8535 ||| -LRB-
SIP2 ||| S:8535 E:8539 ||| NNP
)  ||| S:8539 E:8541 ||| -RRB-
as  ||| S:8541 E:8544 ||| IN
a  ||| S:8544 E:8546 ||| DT
new  ||| S:8546 E:8550 ||| JJ
member  ||| S:8550 E:8557 ||| NN
of  ||| S:8557 E:8570 ||| IN
the  ||| S:8570 E:8574 ||| DT
sorting  ||| S:8574 E:8582 ||| JJ
nexin  ||| S:8582 E:8588 ||| JJ
family  ||| S:8588 E:8595 ||| NN
member  ||| S:8595 E:8602 ||| NN
has  ||| S:8602 E:8606 ||| VBZ
also  ||| S:8606 E:8611 ||| RB
been  ||| S:8611 E:8616 ||| VBN
reported  ||| S:8616 E:8625 ||| VBN
[  ||| S:8625 E:8637 ||| -LRB-
31  ||| S:8637 E:8640 ||| CD
]  ||| S:8640 E:8642 ||| -RRB-
.  ||| S:8642 E:8644 ||| .
Studies  ||| S:8644 E:8652 ||| NNS
of  ||| S:8652 E:8655 ||| IN
the  ||| S:8655 E:8659 ||| DT
novel  ||| S:8659 E:8665 ||| NN
protein  ||| S:8665 E:8673 ||| NN
SIP3  ||| S:8673 E:8678 ||| NN
will  ||| S:8678 E:8683 ||| MD
be  ||| S:8683 E:8686 ||| VB
reported  ||| S:8686 E:8705 ||| VBN
separately  ||| S:8705 E:8716 ||| RB
( ||| S:8716 E:8717 ||| -LRB-
Paralkar  ||| S:8717 E:8726 ||| FW
et  ||| S:8726 E:8729 ||| FW
al ||| S:8729 E:8731 ||| FW
,  ||| S:8731 E:8733 ||| ,
manuscript  ||| S:8733 E:8744 ||| NN
in  ||| S:8744 E:8757 ||| IN
preparation ||| S:8757 E:8768 ||| NN
) ||| S:8768 E:8769 ||| -RRB-
.  ||| S:8769 E:8781 ||| .
We  ||| S:8781 E:8784 ||| PRP
were  ||| S:8784 E:8789 ||| VBD
intrigued  ||| S:8789 E:8799 ||| VBN
by  ||| S:8799 E:8802 ||| IN
the  ||| S:8802 E:8806 ||| DT
fact  ||| S:8806 E:8811 ||| NN
that  ||| S:8811 E:8816 ||| IN
Smad1  ||| S:8816 E:8822 ||| CD
binds  ||| S:8822 E:8828 ||| NN
to  ||| S:8828 E:8831 ||| TO
Ub ||| S:8831 E:8833 ||| NNP
,  ||| S:8833 E:8845 ||| ,
Az  ||| S:8845 E:8848 ||| NNP
and  ||| S:8848 E:8852 ||| CC
HsN3 ||| S:8852 E:8856 ||| NNP
,  ||| S:8856 E:8858 ||| ,
all  ||| S:8858 E:8862 ||| DT
of  ||| S:8862 E:8865 ||| IN
which  ||| S:8865 E:8871 ||| WDT
are  ||| S:8871 E:8875 ||| VBP
involved  ||| S:8875 E:8884 ||| VBN
in  ||| S:8884 E:8897 ||| IN
proteasome-mediated  ||| S:8897 E:8917 ||| JJ
degradation  ||| S:8917 E:8929 ||| JJ
pathways ||| S:8929 E:8937 ||| NN
,  ||| S:8937 E:8939 ||| ,
as  ||| S:8939 E:8942 ||| RB
illustrated  ||| S:8942 E:8964 ||| VBN
in  ||| S:8964 E:8967 ||| IN
Fig.  ||| S:8967 E:8972 ||| CD
1B ||| S:8972 E:8974 ||| CD
,  ||| S:8974 E:8976 ||| ,
bottom  ||| S:8976 E:8983 ||| JJ
panel ||| S:8983 E:8988 ||| NN
.  ||| S:8988 E:8990 ||| .
The  ||| S:8990 E:8994 ||| DT
well-known  ||| S:8994 E:9015 ||| JJ
ubiquitin-dependent  ||| S:9015 E:9035 ||| JJ
pathway  ||| S:9035 E:9043 ||| NN
involves  ||| S:9043 E:9052 ||| VBZ
the  ||| S:9052 E:9056 ||| DT
covalent  ||| S:9056 E:9075 ||| JJ
attachment  ||| S:9075 E:9086 ||| NN
of  ||| S:9086 E:9089 ||| IN
ubiquitin  ||| S:9089 E:9099 ||| VBG
to  ||| S:9099 E:9102 ||| TO
substrate  ||| S:9102 E:9112 ||| VB
proteins  ||| S:9112 E:9121 ||| NNS
to  ||| S:9121 E:9124 ||| TO
form  ||| S:9124 E:9139 ||| VB
polyubiquitin  ||| S:9139 E:9153 ||| JJ
chain ||| S:9153 E:9158 ||| NN
,  ||| S:9158 E:9160 ||| ,
which  ||| S:9160 E:9166 ||| WDT
then  ||| S:9166 E:9171 ||| RB
targets  ||| S:9171 E:9179 ||| VBZ
the  ||| S:9179 E:9183 ||| DT
marked  ||| S:9183 E:9200 ||| JJ
substrates  ||| S:9200 E:9211 ||| NN
to  ||| S:9211 E:9214 ||| TO
proteasome  ||| S:9214 E:9225 ||| VB
for  ||| S:9225 E:9229 ||| IN
degradation  ||| S:9229 E:9241 ||| NNS
[  ||| S:9241 E:9243 ||| -LRB-
17  ||| S:9243 E:9246 ||| CD
19  ||| S:9246 E:9249 ||| CD
20  ||| S:9249 E:9252 ||| CD
]  ||| S:9252 E:9254 ||| -RRB-
.  ||| S:9254 E:9266 ||| .
The  ||| S:9266 E:9270 ||| DT
ubiquitin-independent  ||| S:9270 E:9292 ||| JJ
pathway  ||| S:9292 E:9300 ||| NN
is  ||| S:9300 E:9303 ||| VBZ
not  ||| S:9303 E:9307 ||| RB
well  ||| S:9307 E:9312 ||| RB
defined ||| S:9312 E:9319 ||| VBN
,  ||| S:9319 E:9331 ||| ,
but  ||| S:9331 E:9335 ||| CC
involves  ||| S:9335 E:9344 ||| VBZ
targeting  ||| S:9344 E:9354 ||| VBG
proteins  ||| S:9354 E:9363 ||| NNS
other  ||| S:9363 E:9369 ||| JJ
than  ||| S:9369 E:9374 ||| IN
ubiquitin ||| S:9374 E:9383 ||| NN
.  ||| S:9383 E:9385 ||| .
The  ||| S:9385 E:9399 ||| DT
best-characterized  ||| S:9399 E:9418 ||| JJ
example  ||| S:9418 E:9426 ||| NN
of  ||| S:9426 E:9429 ||| IN
ubiquitin-independent  ||| S:9429 E:9461 ||| JJ
degradation  ||| S:9461 E:9473 ||| NN
is  ||| S:9473 E:9476 ||| VBZ
the  ||| S:9476 E:9480 ||| DT
degradation  ||| S:9480 E:9492 ||| NN
of  ||| S:9492 E:9495 ||| IN
ornithine  ||| S:9495 E:9505 ||| JJ
decarboxylase  ||| S:9505 E:9529 ||| NNS
( ||| S:9529 E:9530 ||| -LRB-
ODC ||| S:9530 E:9533 ||| NNP
) ||| S:9533 E:9534 ||| -RRB-
,  ||| S:9534 E:9536 ||| ,
which  ||| S:9536 E:9542 ||| WDT
is  ||| S:9542 E:9545 ||| VBZ
dependent  ||| S:9545 E:9555 ||| JJ
upon  ||| S:9555 E:9560 ||| IN
ODC  ||| S:9560 E:9564 ||| NNP
interaction  ||| S:9564 E:9576 ||| NN
with  ||| S:9576 E:9581 ||| IN
the  ||| S:9581 E:9595 ||| DT
targeting  ||| S:9595 E:9605 ||| JJ
protein  ||| S:9605 E:9613 ||| NN
antizyme  ||| S:9613 E:9622 ||| NNS
( ||| S:9622 E:9623 ||| -LRB-
Az ||| S:9623 E:9625 ||| NNP
)  ||| S:9625 E:9627 ||| -RRB-
[  ||| S:9627 E:9629 ||| -LRB-
18  ||| S:9629 E:9632 ||| CD
]  ||| S:9632 E:9634 ||| -RRB-
.  ||| S:9634 E:9636 ||| .
How  ||| S:9636 E:9650 ||| WRB
ubiquitinated  ||| S:9650 E:9664 ||| JJ
substrates  ||| S:9664 E:9675 ||| NN
or  ||| S:9675 E:9678 ||| CC
Az-bound  ||| S:9678 E:9687 ||| NNP
ODC  ||| S:9687 E:9691 ||| NNP
is  ||| S:9691 E:9694 ||| VBZ
recognized  ||| S:9694 E:9705 ||| VBN
by  ||| S:9705 E:9718 ||| IN
the  ||| S:9718 E:9722 ||| DT
26S  ||| S:9722 E:9726 ||| JJ
proteasome  ||| S:9726 E:9737 ||| NN
is  ||| S:9737 E:9740 ||| VBZ
not  ||| S:9740 E:9744 ||| RB
well  ||| S:9744 E:9749 ||| RB
understood ||| S:9749 E:9759 ||| VBN
.  ||| S:9759 E:9761 ||| .
HsN3  ||| S:9761 E:9766 ||| NNP
is  ||| S:9766 E:9769 ||| VBZ
a  ||| S:9769 E:9771 ||| DT
β  ||| S:9771 E:9783 ||| JJ
subunit  ||| S:9783 E:9791 ||| NN
of  ||| S:9791 E:9794 ||| IN
the  ||| S:9794 E:9798 ||| DT
20S  ||| S:9798 E:9802 ||| JJ
core  ||| S:9802 E:9807 ||| NN
of  ||| S:9807 E:9810 ||| IN
the  ||| S:9810 E:9814 ||| DT
26S  ||| S:9814 E:9818 ||| CD
proteasome  ||| S:9818 E:9829 ||| NNS
and  ||| S:9829 E:9843 ||| CC
previously  ||| S:9843 E:9854 ||| RB
has  ||| S:9854 E:9858 ||| VBZ
also  ||| S:9858 E:9863 ||| RB
been  ||| S:9863 E:9868 ||| VBN
implicated  ||| S:9868 E:9879 ||| VBN
in  ||| S:9879 E:9882 ||| IN
targeting  ||| S:9882 E:9892 ||| VBG
its  ||| S:9892 E:9906 ||| PRP$
interacting  ||| S:9906 E:9918 ||| JJ
protein  ||| S:9918 E:9926 ||| NN
p105  ||| S:9926 E:9931 ||| CD
subunit  ||| S:9931 E:9939 ||| NN
of  ||| S:9939 E:9942 ||| IN
NF-κB  ||| S:9942 E:9948 ||| JJ
into  ||| S:9948 E:9953 ||| IN
the  ||| S:9953 E:9957 ||| DT
26S  ||| S:9957 E:9971 ||| CD
proteasome  ||| S:9971 E:9982 ||| NNS
[  ||| S:9982 E:9984 ||| -LRB-
22  ||| S:9984 E:9987 ||| CD
23  ||| S:9987 E:9990 ||| CD
24  ||| S:9990 E:9993 ||| CD
32  ||| S:9993 E:9996 ||| CD
]  ||| S:9996 E:9998 ||| -RRB-
.  ||| S:9998 E:10000 ||| .
Thus ||| S:10000 E:10004 ||| RB
,  ||| S:10004 E:10006 ||| ,
it  ||| S:10006 E:10009 ||| PRP
is  ||| S:10009 E:10012 ||| VBZ
interesting  ||| S:10012 E:10024 ||| JJ
that  ||| S:10024 E:10039 ||| IN
Smad1  ||| S:10039 E:10045 ||| NNP
can  ||| S:10045 E:10049 ||| MD
bind  ||| S:10049 E:10054 ||| VB
to  ||| S:10054 E:10057 ||| TO
two  ||| S:10057 E:10061 ||| CD
types  ||| S:10061 E:10067 ||| NNS
of  ||| S:10067 E:10070 ||| IN
proteasome  ||| S:10070 E:10091 ||| JJ
substrate-targeting  ||| S:10091 E:10111 ||| JJ
proteins  ||| S:10111 E:10120 ||| NNS
( ||| S:10120 E:10121 ||| -LRB-
ubiquitin  ||| S:10121 E:10131 ||| NN
and  ||| S:10131 E:10135 ||| CC
Az ||| S:10135 E:10137 ||| NNP
)  ||| S:10137 E:10139 ||| -RRB-
as  ||| S:10139 E:10142 ||| IN
well  ||| S:10142 E:10157 ||| RB
as  ||| S:10157 E:10160 ||| IN
a  ||| S:10160 E:10162 ||| DT
proteasome  ||| S:10162 E:10173 ||| JJ
component  ||| S:10173 E:10183 ||| NN
( ||| S:10183 E:10184 ||| -LRB-
HsN3 ||| S:10184 E:10188 ||| NNP
)  ||| S:10188 E:10190 ||| -RRB-
that  ||| S:10190 E:10195 ||| WDT
has  ||| S:10195 E:10199 ||| VBZ
a  ||| S:10199 E:10201 ||| DT
possible  ||| S:10201 E:10220 ||| JJ
substrate-targeting  ||| S:10220 E:10240 ||| JJ
role ||| S:10240 E:10244 ||| NN
.  ||| S:10244 E:10246 ||| .
Studies  ||| S:10246 E:10254 ||| NNS
were  ||| S:10254 E:10259 ||| VBD
then  ||| S:10259 E:10264 ||| RB
carried  ||| S:10264 E:10272 ||| VBN
out  ||| S:10272 E:10286 ||| RP
to  ||| S:10286 E:10289 ||| TO
further  ||| S:10289 E:10297 ||| RB
characterize  ||| S:10297 E:10310 ||| VB
Smad1  ||| S:10310 E:10316 ||| CD
interaction  ||| S:10316 E:10328 ||| NN
with  ||| S:10328 E:10333 ||| IN
HsN3  ||| S:10333 E:10338 ||| NNP
and  ||| S:10338 E:10352 ||| CC
Az  ||| S:10352 E:10355 ||| NNP
in  ||| S:10355 E:10358 ||| IN
mammalian  ||| S:10358 E:10368 ||| JJ
cells  ||| S:10368 E:10374 ||| NNS
and  ||| S:10374 E:10378 ||| CC
test  ||| S:10378 E:10383 ||| VB
a  ||| S:10383 E:10385 ||| DT
functional  ||| S:10385 E:10396 ||| JJ
role  ||| S:10396 E:10401 ||| NN
of  ||| S:10401 E:10404 ||| IN
these  ||| S:10404 E:10420 ||| DT
interactions  ||| S:10420 E:10433 ||| NN
in  ||| S:10433 E:10436 ||| IN
the  ||| S:10436 E:10440 ||| DT
signaling  ||| S:10440 E:10450 ||| JJ
pathways  ||| S:10450 E:10459 ||| NN
of  ||| S:10459 E:10462 ||| IN
BMPs  ||| S:10462 E:10467 ||| JJ
as  ||| S:10467 E:10480 ||| IN
detailed  ||| S:10480 E:10489 ||| JJ
below ||| S:10489 E:10494 ||| NN
.  ||| S:10494 E:10524 ||| .
Smad1  ||| S:10524 E:10530 ||| NNP
interacts  ||| S:10530 E:10540 ||| NN
with  ||| S:10540 E:10545 ||| IN
prosequence-containing  ||| S:10545 E:10568 ||| NNP
HsN3  ||| S:10568 E:10583 ||| NNP
but  ||| S:10583 E:10587 ||| CC
not  ||| S:10587 E:10591 ||| RB
processed  ||| S:10591 E:10601 ||| VBN
HsN3  ||| S:10601 E:10606 ||| CD
in  ||| S:10606 E:10609 ||| IN
the  ||| S:10609 E:10613 ||| DT
20S  ||| S:10613 E:10617 ||| CD
proteasome  ||| S:10617 E:10628 ||| NNS
and  ||| S:10628 E:10632 ||| CC
the  ||| S:10632 E:10646 ||| DT
activation  ||| S:10646 E:10657 ||| NN
of  ||| S:10657 E:10660 ||| IN
the  ||| S:10660 E:10664 ||| DT
BMP  ||| S:10664 E:10668 ||| NN
type  ||| S:10668 E:10673 ||| NN
I  ||| S:10673 E:10675 ||| PRP
receptor  ||| S:10675 E:10684 ||| VBP
enhances  ||| S:10684 E:10693 ||| VBG
the  ||| S:10693 E:10707 ||| DT
interaction  ||| S:10707 E:10729 ||| NN
We  ||| S:10729 E:10732 ||| PRP
first  ||| S:10732 E:10738 ||| RB
focused  ||| S:10738 E:10746 ||| VBN
upon  ||| S:10746 E:10751 ||| IN
the  ||| S:10751 E:10755 ||| DT
physical  ||| S:10755 E:10764 ||| JJ
interaction  ||| S:10764 E:10776 ||| NN
between  ||| S:10776 E:10794 ||| IN
Smad1  ||| S:10794 E:10800 ||| NNP
and  ||| S:10800 E:10804 ||| CC
HsN3 ||| S:10804 E:10808 ||| NNP
.  ||| S:10808 E:10810 ||| .
As  ||| S:10810 E:10813 ||| IN
one  ||| S:10813 E:10817 ||| CD
of  ||| S:10817 E:10820 ||| IN
the  ||| S:10820 E:10824 ||| DT
seven  ||| S:10824 E:10830 ||| CD
β  ||| S:10830 E:10832 ||| JJ
subunits  ||| S:10832 E:10841 ||| NN
of  ||| S:10841 E:10844 ||| IN
the  ||| S:10844 E:10848 ||| DT
20S  ||| S:10848 E:10862 ||| JJ
proteasome ||| S:10862 E:10872 ||| NN
,  ||| S:10872 E:10874 ||| ,
the  ||| S:10874 E:10878 ||| DT
newly  ||| S:10878 E:10884 ||| RB
translated  ||| S:10884 E:10895 ||| VBN
HsN3  ||| S:10895 E:10900 ||| NNP
has  ||| S:10900 E:10904 ||| VBZ
an  ||| S:10904 E:10907 ||| DT
N-terminal  ||| S:10907 E:10928 ||| JJ
44  ||| S:10928 E:10931 ||| CD
amino-acid  ||| S:10931 E:10942 ||| JJ
prosequence ||| S:10942 E:10953 ||| NN
,  ||| S:10953 E:10955 ||| ,
which  ||| S:10955 E:10961 ||| WDT
is  ||| S:10961 E:10964 ||| VBZ
processed  ||| S:10964 E:10974 ||| VBN
upon  ||| S:10974 E:10979 ||| IN
the  ||| S:10979 E:10993 ||| DT
complete  ||| S:10993 E:11002 ||| JJ
assembly  ||| S:11002 E:11011 ||| NN
of  ||| S:11011 E:11014 ||| IN
HsN3  ||| S:11014 E:11019 ||| CD
into  ||| S:11019 E:11024 ||| IN
the  ||| S:11024 E:11028 ||| DT
mature  ||| S:11028 E:11035 ||| JJ
20S  ||| S:11035 E:11039 ||| CD
proteasome  ||| S:11039 E:11060 ||| NNS
[  ||| S:11060 E:11062 ||| -LRB-
22  ||| S:11062 E:11065 ||| CD
23  ||| S:11065 E:11068 ||| CD
24  ||| S:11068 E:11071 ||| CD
]  ||| S:11071 E:11073 ||| -RRB-
.  ||| S:11073 E:11075 ||| .
The  ||| S:11075 E:11079 ||| DT
assembly  ||| S:11079 E:11088 ||| NN
of  ||| S:11088 E:11091 ||| IN
the  ||| S:11091 E:11095 ||| DT
20S  ||| S:11095 E:11099 ||| JJ
proteasome  ||| S:11099 E:11120 ||| NN
involves  ||| S:11120 E:11129 ||| VBZ
multiple  ||| S:11129 E:11138 ||| JJ
steps  ||| S:11138 E:11144 ||| NNS
and  ||| S:11144 E:11148 ||| CC
the  ||| S:11148 E:11152 ||| DT
formation  ||| S:11152 E:11162 ||| NN
of  ||| S:11162 E:11165 ||| IN
assembly  ||| S:11165 E:11184 ||| NN
intermediates  ||| S:11184 E:11198 ||| NNS
[  ||| S:11198 E:11200 ||| -LRB-
33  ||| S:11200 E:11203 ||| CD
34  ||| S:11203 E:11206 ||| CD
35  ||| S:11206 E:11209 ||| CD
36  ||| S:11209 E:11212 ||| CD
]  ||| S:11212 E:11214 ||| -RRB-
.  ||| S:11214 E:11216 ||| .
As  ||| S:11216 E:11219 ||| RB
illustrated  ||| S:11219 E:11231 ||| VBN
in  ||| S:11231 E:11234 ||| IN
Fig.  ||| S:11234 E:11249 ||| CD
2A ||| S:11249 E:11251 ||| CD
,  ||| S:11251 E:11253 ||| ,
seven  ||| S:11253 E:11259 ||| CD
single  ||| S:11259 E:11266 ||| JJ
α  ||| S:11266 E:11268 ||| NNS
subunits  ||| S:11268 E:11277 ||| VBP
first  ||| S:11277 E:11283 ||| RB
form  ||| S:11283 E:11288 ||| VB
the  ||| S:11288 E:11292 ||| DT
α  ||| S:11292 E:11294 ||| JJ
ring ||| S:11294 E:11298 ||| NN
,  ||| S:11298 E:11300 ||| ,
which  ||| S:11300 E:11316 ||| WDT
serves  ||| S:11316 E:11323 ||| VBZ
as  ||| S:11323 E:11326 ||| IN
the  ||| S:11326 E:11330 ||| DT
template  ||| S:11330 E:11339 ||| NN
for  ||| S:11339 E:11343 ||| IN
seven  ||| S:11343 E:11349 ||| CD
β  ||| S:11349 E:11351 ||| JJ
subunits  ||| S:11351 E:11360 ||| NN
to  ||| S:11360 E:11363 ||| TO
assemble  ||| S:11363 E:11382 ||| VB
the  ||| S:11382 E:11386 ||| DT
β  ||| S:11386 E:11388 ||| JJ
ring ||| S:11388 E:11392 ||| NN
.  ||| S:11392 E:11394 ||| .
The  ||| S:11394 E:11398 ||| DT
half  ||| S:11398 E:11403 ||| NN
proteasomes  ||| S:11403 E:11415 ||| VBZ
containing  ||| S:11415 E:11426 ||| VBG
one  ||| S:11426 E:11430 ||| CD
α  ||| S:11430 E:11432 ||| NNS
and  ||| S:11432 E:11436 ||| CC
one  ||| S:11436 E:11450 ||| CD
β  ||| S:11450 E:11452 ||| CD
rings  ||| S:11452 E:11458 ||| NNS
are  ||| S:11458 E:11462 ||| VBP
further  ||| S:11462 E:11470 ||| RB
assembled  ||| S:11470 E:11480 ||| VBN
into  ||| S:11480 E:11485 ||| IN
20S  ||| S:11485 E:11489 ||| CD
proteasome ||| S:11489 E:11499 ||| NN
,  ||| S:11499 E:11501 ||| ,
a  ||| S:11501 E:11513 ||| DT
process  ||| S:11513 E:11521 ||| NN
involving  ||| S:11521 E:11531 ||| VBG
the  ||| S:11531 E:11535 ||| DT
proteolytic  ||| S:11535 E:11547 ||| JJ
cleavage  ||| S:11547 E:11556 ||| NN
of  ||| S:11556 E:11559 ||| IN
the  ||| S:11559 E:11573 ||| DT
prosequences  ||| S:11573 E:11586 ||| NN
of  ||| S:11586 E:11589 ||| IN
five  ||| S:11589 E:11594 ||| CD
β  ||| S:11594 E:11596 ||| JJ
subunits ||| S:11596 E:11604 ||| NN
,  ||| S:11604 E:11606 ||| ,
including  ||| S:11606 E:11616 ||| VBG
HsN3 ||| S:11616 E:11620 ||| CD
.  ||| S:11620 E:11622 ||| .
The  ||| S:11622 E:11626 ||| DT
20S  ||| S:11626 E:11640 ||| NNP
proteasome  ||| S:11640 E:11651 ||| VBD
then  ||| S:11651 E:11656 ||| RB
combines  ||| S:11656 E:11665 ||| VBZ
with  ||| S:11665 E:11670 ||| IN
two  ||| S:11670 E:11674 ||| CD
19S  ||| S:11674 E:11678 ||| CD
regulatory  ||| S:11678 E:11689 ||| JJ
complex  ||| S:11689 E:11707 ||| NN
to  ||| S:11707 E:11710 ||| TO
form  ||| S:11710 E:11715 ||| VB
the  ||| S:11715 E:11719 ||| DT
26S  ||| S:11719 E:11723 ||| JJ
proteasome ||| S:11723 E:11733 ||| NN
,  ||| S:11733 E:11735 ||| ,
which  ||| S:11735 E:11741 ||| WDT
is  ||| S:11741 E:11744 ||| VBZ
the  ||| S:11744 E:11748 ||| DT
degradation  ||| S:11748 E:11770 ||| JJ
machinery  ||| S:11770 E:11780 ||| NN
responsible  ||| S:11780 E:11792 ||| JJ
for  ||| S:11792 E:11796 ||| IN
both  ||| S:11796 E:11801 ||| DT
ubiquitin-dependent  ||| S:11801 E:11821 ||| JJ
and  ||| S:11821 E:11835 ||| CC
ubiquitin-independent  ||| S:11835 E:11857 ||| JJ
degradation  ||| S:11857 E:11869 ||| NNS
[  ||| S:11869 E:11871 ||| -LRB-
37  ||| S:11871 E:11874 ||| CD
]  ||| S:11874 E:11876 ||| -RRB-
.  ||| S:11876 E:11878 ||| .
The  ||| S:11878 E:11892 ||| DT
prosequences  ||| S:11892 E:11905 ||| NN
of  ||| S:11905 E:11908 ||| IN
the  ||| S:11908 E:11912 ||| DT
proteolytic  ||| S:11912 E:11924 ||| JJ
β  ||| S:11924 E:11926 ||| JJ
subunits  ||| S:11926 E:11935 ||| NNS
are  ||| S:11935 E:11939 ||| VBP
important  ||| S:11939 E:11959 ||| JJ
to  ||| S:11959 E:11962 ||| TO
keep  ||| S:11962 E:11967 ||| VB
the  ||| S:11967 E:11971 ||| DT
proteolytic  ||| S:11971 E:11983 ||| JJ
sites  ||| S:11983 E:11989 ||| NNS
inaccessible  ||| S:11989 E:12002 ||| VBP
to  ||| S:12002 E:12005 ||| TO
the  ||| S:12005 E:12019 ||| DT
substrates ||| S:12019 E:12029 ||| NN
.  ||| S:12029 E:12031 ||| .
In  ||| S:12031 E:12034 ||| IN
addition ||| S:12034 E:12042 ||| NN
,  ||| S:12042 E:12044 ||| ,
the  ||| S:12044 E:12048 ||| DT
prosequences  ||| S:12048 E:12061 ||| NN
still  ||| S:12061 E:12067 ||| RB
bind  ||| S:12067 E:12072 ||| VBN
to  ||| S:12072 E:12085 ||| TO
the  ||| S:12085 E:12089 ||| DT
β  ||| S:12089 E:12091 ||| JJ
subunits  ||| S:12091 E:12100 ||| NN
after  ||| S:12100 E:12106 ||| IN
its  ||| S:12106 E:12110 ||| PRP$
cleavage  ||| S:12110 E:12119 ||| NN
and  ||| S:12119 E:12123 ||| CC
may  ||| S:12123 E:12127 ||| MD
serve  ||| S:12127 E:12133 ||| VB
important  ||| S:12133 E:12153 ||| JJ
chaperon  ||| S:12153 E:12162 ||| JJ
roles  ||| S:12162 E:12168 ||| NNS
for  ||| S:12168 E:12172 ||| IN
the  ||| S:12172 E:12176 ||| DT
β  ||| S:12176 E:12178 ||| JJ
subunits  ||| S:12178 E:12187 ||| NN
to  ||| S:12187 E:12190 ||| TO
be  ||| S:12190 E:12193 ||| VB
properly  ||| S:12193 E:12212 ||| RB
positioned  ||| S:12212 E:12223 ||| VBN
into  ||| S:12223 E:12228 ||| IN
assembly  ||| S:12228 E:12237 ||| NN
complex ||| S:12237 E:12244 ||| NN
.  ||| S:12244 E:12246 ||| .
This  ||| S:12246 E:12251 ||| DT
was  ||| S:12251 E:12255 ||| VBD
demonstrated  ||| S:12255 E:12278 ||| VBN
previously  ||| S:12278 E:12289 ||| RB
by  ||| S:12289 E:12292 ||| IN
artificially  ||| S:12292 E:12305 ||| RB
removing  ||| S:12305 E:12314 ||| VBG
the  ||| S:12314 E:12318 ||| DT
prosequence  ||| S:12318 E:12330 ||| NN
of  ||| S:12330 E:12343 ||| IN
one  ||| S:12343 E:12347 ||| CD
β  ||| S:12347 E:12349 ||| CD
subunit  ||| S:12349 E:12357 ||| NNS
and  ||| S:12357 E:12361 ||| CC
showed  ||| S:12361 E:12368 ||| VBD
that  ||| S:12368 E:12373 ||| IN
the  ||| S:12373 E:12377 ||| DT
assembly  ||| S:12377 E:12386 ||| NN
of  ||| S:12386 E:12389 ||| IN
this  ||| S:12389 E:12394 ||| DT
β  ||| S:12394 E:12406 ||| JJ
subunit  ||| S:12406 E:12414 ||| NN
is  ||| S:12414 E:12417 ||| VBZ
completely  ||| S:12417 E:12428 ||| RB
blocked  ||| S:12428 E:12436 ||| VBN
while  ||| S:12436 E:12442 ||| IN
separate  ||| S:12442 E:12451 ||| JJ
expression  ||| S:12451 E:12472 ||| NN
of  ||| S:12472 E:12475 ||| IN
the  ||| S:12475 E:12479 ||| DT
prosequence  ||| S:12479 E:12491 ||| NN
was  ||| S:12491 E:12495 ||| VBD
enough  ||| S:12495 E:12502 ||| RB
to  ||| S:12502 E:12505 ||| TO
restore  ||| S:12505 E:12513 ||| VB
the  ||| S:12513 E:12517 ||| DT
assembly  ||| S:12517 E:12526 ||| NN
[  ||| S:12526 E:12538 ||| -LRB-
19  ||| S:12538 E:12541 ||| CD
]  ||| S:12541 E:12543 ||| -RRB-
.  ||| S:12543 E:12545 ||| .
The  ||| S:12545 E:12549 ||| DT
defective  ||| S:12549 E:12559 ||| JJ
assembly  ||| S:12559 E:12568 ||| NN
of  ||| S:12568 E:12571 ||| IN
a  ||| S:12571 E:12573 ||| DT
β  ||| S:12573 E:12575 ||| JJ
subunit  ||| S:12575 E:12583 ||| JJ
due  ||| S:12583 E:12587 ||| JJ
to  ||| S:12587 E:12590 ||| TO
the  ||| S:12590 E:12604 ||| DT
lack  ||| S:12604 E:12609 ||| NN
of  ||| S:12609 E:12612 ||| IN
prosequence  ||| S:12612 E:12624 ||| NN
is  ||| S:12624 E:12627 ||| VBZ
illustrated  ||| S:12627 E:12639 ||| VBN
in  ||| S:12639 E:12642 ||| IN
Fig.  ||| S:12642 E:12647 ||| CD
2B ||| S:12647 E:12649 ||| CD
.  ||| S:12649 E:12661 ||| .
To  ||| S:12661 E:12664 ||| TO
follow  ||| S:12664 E:12671 ||| VB
up  ||| S:12671 E:12674 ||| RP
the  ||| S:12674 E:12678 ||| DT
observed  ||| S:12678 E:12687 ||| JJ
interaction  ||| S:12687 E:12699 ||| NN
between  ||| S:12699 E:12707 ||| IN
Smad1  ||| S:12707 E:12723 ||| NNP
and  ||| S:12723 E:12727 ||| CC
HsN3  ||| S:12727 E:12732 ||| CD
in  ||| S:12732 E:12735 ||| IN
mammalian  ||| S:12735 E:12745 ||| JJ
cells ||| S:12745 E:12750 ||| NNS
,  ||| S:12750 E:12752 ||| ,
we  ||| S:12752 E:12755 ||| PRP
first  ||| S:12755 E:12761 ||| RB
constructed  ||| S:12761 E:12773 ||| VBN
three  ||| S:12773 E:12789 ||| CD
HsN3  ||| S:12789 E:12794 ||| CD
expression  ||| S:12794 E:12805 ||| NN
constructs ||| S:12805 E:12815 ||| NN
.  ||| S:12815 E:12817 ||| .
The  ||| S:12817 E:12821 ||| DT
first  ||| S:12821 E:12827 ||| JJ
construct  ||| S:12827 E:12837 ||| NN
contains  ||| S:12837 E:12856 ||| VBZ
a  ||| S:12856 E:12858 ||| DT
Flag-epitope  ||| S:12858 E:12871 ||| JJ
placed  ||| S:12871 E:12878 ||| VBN
at  ||| S:12878 E:12881 ||| IN
the  ||| S:12881 E:12885 ||| DT
C-terminus  ||| S:12885 E:12896 ||| JJ
of  ||| S:12896 E:12899 ||| IN
HsN3  ||| S:12899 E:12904 ||| NNP
( ||| S:12904 E:12905 ||| -LRB-
N3-F ||| S:12905 E:12909 ||| NNP
) ||| S:12909 E:12910 ||| -RRB-
,  ||| S:12910 E:12922 ||| ,
since  ||| S:12922 E:12928 ||| IN
the  ||| S:12928 E:12932 ||| DT
C-terminus  ||| S:12932 E:12943 ||| JJ
of  ||| S:12943 E:12946 ||| IN
HsN3  ||| S:12946 E:12951 ||| NNP
is  ||| S:12951 E:12954 ||| VBZ
not  ||| S:12954 E:12958 ||| RB
buried  ||| S:12958 E:12965 ||| VBN
inside  ||| S:12965 E:12972 ||| IN
of  ||| S:12972 E:12975 ||| IN
the  ||| S:12975 E:12989 ||| DT
mature  ||| S:12989 E:12996 ||| JJ
proteasome ||| S:12996 E:13006 ||| NN
,  ||| S:13006 E:13008 ||| ,
according  ||| S:13008 E:13018 ||| VBG
to  ||| S:13018 E:13021 ||| TO
the  ||| S:13021 E:13025 ||| DT
crystal  ||| S:13025 E:13033 ||| NN
structure  ||| S:13033 E:13043 ||| NN
of  ||| S:13043 E:13056 ||| IN
HsN3  ||| S:13056 E:13061 ||| NNP
[  ||| S:13061 E:13063 ||| -LRB-
38  ||| S:13063 E:13066 ||| CD
]  ||| S:13066 E:13068 ||| -RRB-
.  ||| S:13068 E:13070 ||| .
The  ||| S:13070 E:13074 ||| DT
second  ||| S:13074 E:13081 ||| JJ
and  ||| S:13081 E:13085 ||| CC
the  ||| S:13085 E:13089 ||| DT
third  ||| S:13089 E:13095 ||| JJ
constructs  ||| S:13095 E:13106 ||| NNS
contain  ||| S:13106 E:13124 ||| VBP
either  ||| S:13124 E:13131 ||| RB
the  ||| S:13131 E:13135 ||| DT
Flag  ||| S:13135 E:13140 ||| NNP
or  ||| S:13140 E:13143 ||| CC
the  ||| S:13143 E:13147 ||| DT
T7  ||| S:13147 E:13150 ||| NNP
epitopes  ||| S:13150 E:13159 ||| VBD
placed  ||| S:13159 E:13166 ||| VBN
at  ||| S:13166 E:13169 ||| IN
the  ||| S:13169 E:13183 ||| DT
N-terminus  ||| S:13183 E:13194 ||| JJ
of  ||| S:13194 E:13197 ||| IN
HsN3  ||| S:13197 E:13202 ||| NNP
( ||| S:13202 E:13203 ||| -LRB-
F-ΔN3 ||| S:13203 E:13208 ||| NNP
,  ||| S:13208 E:13210 ||| ,
T7-ΔN3 ||| S:13210 E:13216 ||| CD
) ||| S:13216 E:13217 ||| -RRB-
.  ||| S:13217 E:13219 ||| .
Since  ||| S:13219 E:13225 ||| IN
the  ||| S:13225 E:13229 ||| DT
N-terminal  ||| S:13229 E:13250 ||| JJ
prosequence  ||| S:13250 E:13262 ||| NN
of  ||| S:13262 E:13265 ||| IN
HsN3  ||| S:13265 E:13270 ||| NNP
is  ||| S:13270 E:13273 ||| VBZ
processed  ||| S:13273 E:13283 ||| VBN
upon  ||| S:13283 E:13288 ||| IN
assembly  ||| S:13288 E:13297 ||| NN
into  ||| S:13297 E:13302 ||| IN
the  ||| S:13302 E:13316 ||| DT
20S  ||| S:13316 E:13320 ||| JJ
proteasome ||| S:13320 E:13330 ||| NN
,  ||| S:13330 E:13332 ||| ,
we  ||| S:13332 E:13335 ||| PRP
deleted  ||| S:13335 E:13343 ||| VBD
the  ||| S:13343 E:13347 ||| DT
prosequence  ||| S:13347 E:13359 ||| NN
of  ||| S:13359 E:13362 ||| IN
HsN3  ||| S:13362 E:13367 ||| NNP
and  ||| S:13367 E:13381 ||| CC
replaced  ||| S:13381 E:13390 ||| VBD
it  ||| S:13390 E:13393 ||| PRP
with  ||| S:13393 E:13398 ||| IN
the  ||| S:13398 E:13402 ||| DT
Flag ||| S:13402 E:13406 ||| NNP
/ ||| S:13406 E:13407 ||| NNP
T7-epitopes  ||| S:13407 E:13419 ||| NNP
to  ||| S:13419 E:13422 ||| TO
assure  ||| S:13422 E:13429 ||| VB
that  ||| S:13429 E:13434 ||| IN
the  ||| S:13434 E:13448 ||| DT
epitopes  ||| S:13448 E:13457 ||| NN
will  ||| S:13457 E:13462 ||| MD
not  ||| S:13462 E:13466 ||| RB
be  ||| S:13466 E:13469 ||| VB
lost  ||| S:13469 E:13474 ||| VBN
due  ||| S:13474 E:13478 ||| JJ
to  ||| S:13478 E:13481 ||| TO
prosequence-processing ||| S:13481 E:13503 ||| JJ
.  ||| S:13503 E:13515 ||| .
We  ||| S:13515 E:13518 ||| PRP
first  ||| S:13518 E:13524 ||| RB
expressed  ||| S:13524 E:13534 ||| VBD
these  ||| S:13534 E:13540 ||| DT
constructs  ||| S:13540 E:13551 ||| NN
into  ||| S:13551 E:13556 ||| IN
COS1  ||| S:13556 E:13561 ||| CD
cells  ||| S:13561 E:13567 ||| NNS
and  ||| S:13567 E:13581 ||| CC
examined  ||| S:13581 E:13590 ||| VBD
their  ||| S:13590 E:13596 ||| PRP$
expression  ||| S:13596 E:13607 ||| NN
and  ||| S:13607 E:13611 ||| CC
assembly  ||| S:13611 E:13620 ||| NN
properties  ||| S:13620 E:13631 ||| NNS
by  ||| S:13631 E:13644 ||| IN
immunoprecipitation  ||| S:13644 E:13664 ||| NN
of  ||| S:13664 E:13667 ||| IN
each  ||| S:13667 E:13672 ||| DT
expressed  ||| S:13672 E:13682 ||| JJ
protein  ||| S:13682 E:13690 ||| NN
from  ||| S:13690 E:13705 ||| IN
metabolically  ||| S:13705 E:13719 ||| NN
labeled  ||| S:13719 E:13727 ||| VBD
COS1  ||| S:13727 E:13732 ||| CD
cells  ||| S:13732 E:13738 ||| NNS
( ||| S:13738 E:13739 ||| -LRB-
Fig.  ||| S:13739 E:13744 ||| NNP
2C ||| S:13744 E:13746 ||| NNP
) ||| S:13746 E:13747 ||| -RRB-
.  ||| S:13747 E:13749 ||| .
Multiple  ||| S:13749 E:13768 ||| JJ
endogenous  ||| S:13768 E:13779 ||| JJ
proteins  ||| S:13779 E:13788 ||| NNS
from  ||| S:13788 E:13793 ||| IN
COS1  ||| S:13793 E:13798 ||| CD
cells  ||| S:13798 E:13804 ||| NNS
were  ||| S:13804 E:13809 ||| VBD
co-precipitated  ||| S:13809 E:13835 ||| JJ
with  ||| S:13835 E:13840 ||| IN
Flag  ||| S:13840 E:13845 ||| NNP
tagged  ||| S:13845 E:13852 ||| FW
wild  ||| S:13852 E:13857 ||| FW
type  ||| S:13857 E:13862 ||| FW
HsN3  ||| S:13862 E:13867 ||| FW
( ||| S:13867 E:13868 ||| -LRB-
Fig.  ||| S:13868 E:13873 ||| NNP
2C ||| S:13873 E:13875 ||| NNP
,  ||| S:13875 E:13877 ||| ,
lane  ||| S:13877 E:13882 ||| CD
2 ||| S:13882 E:13883 ||| CD
) ||| S:13883 E:13884 ||| -RRB-
,  ||| S:13884 E:13886 ||| ,
while  ||| S:13886 E:13902 ||| IN
much  ||| S:13902 E:13907 ||| JJ
few  ||| S:13907 E:13911 ||| JJ
proteins  ||| S:13911 E:13920 ||| NNS
were  ||| S:13920 E:13925 ||| VBD
detected  ||| S:13925 E:13934 ||| VBN
in  ||| S:13934 E:13937 ||| IN
the  ||| S:13937 E:13941 ||| DT
immunoprecipitates  ||| S:13941 E:13970 ||| NN
of  ||| S:13970 E:13973 ||| IN
the  ||| S:13973 E:13977 ||| DT
two  ||| S:13977 E:13981 ||| CD
deletion  ||| S:13981 E:13990 ||| CD
versions  ||| S:13990 E:13999 ||| NNS
of  ||| S:13999 E:14002 ||| IN
HsN3  ||| S:14002 E:14007 ||| CD
lacking  ||| S:14007 E:14015 ||| VBG
the  ||| S:14015 E:14029 ||| DT
prosequence  ||| S:14029 E:14041 ||| NN
( ||| S:14041 E:14042 ||| -LRB-
Fig.  ||| S:14042 E:14047 ||| NNP
2C ||| S:14047 E:14049 ||| NNP
,  ||| S:14049 E:14051 ||| ,
lanes  ||| S:14051 E:14057 ||| CD
3  ||| S:14057 E:14059 ||| CD
&  ||| S:14059 E:14061 ||| CC
4 ||| S:14061 E:14062 ||| LS
) ||| S:14062 E:14063 ||| -RRB-
.  ||| S:14063 E:14065 ||| .
The  ||| S:14065 E:14069 ||| DT
predominant  ||| S:14069 E:14091 ||| JJ
band  ||| S:14091 E:14096 ||| NN
in  ||| S:14096 E:14099 ||| IN
the  ||| S:14099 E:14103 ||| DT
immunoprecipitation  ||| S:14103 E:14123 ||| NN
of  ||| S:14123 E:14126 ||| IN
wild  ||| S:14126 E:14131 ||| JJ
type  ||| S:14131 E:14136 ||| NN
HsN3  ||| S:14136 E:14141 ||| NN
is  ||| S:14141 E:14144 ||| VBZ
the  ||| S:14144 E:14158 ||| DT
prosequence-containing  ||| S:14158 E:14181 ||| JJ
HsN3  ||| S:14181 E:14186 ||| NNP
( ||| S:14186 E:14187 ||| -LRB-
Pro-N3-F ||| S:14187 E:14195 ||| NNP
) ||| S:14195 E:14196 ||| -RRB-
,  ||| S:14196 E:14198 ||| ,
as  ||| S:14198 E:14201 ||| RB
indicated  ||| S:14201 E:14211 ||| VBN
by  ||| S:14211 E:14224 ||| IN
its  ||| S:14224 E:14228 ||| PRP$
molecular  ||| S:14228 E:14238 ||| JJ
weight  ||| S:14238 E:14245 ||| NN
and  ||| S:14245 E:14249 ||| CC
the  ||| S:14249 E:14253 ||| DT
ability  ||| S:14253 E:14261 ||| NN
of  ||| S:14261 E:14264 ||| IN
anti-Flag  ||| S:14264 E:14284 ||| JJ
antibody  ||| S:14284 E:14293 ||| NN
to  ||| S:14293 E:14296 ||| TO
detect  ||| S:14296 E:14303 ||| VB
it  ||| S:14303 E:14306 ||| PRP
in  ||| S:14306 E:14309 ||| IN
a  ||| S:14309 E:14311 ||| DT
parallel  ||| S:14311 E:14320 ||| JJ
Western  ||| S:14320 E:14328 ||| JJ
blot ||| S:14328 E:14332 ||| NN
.  ||| S:14332 E:14334 ||| .
The  ||| S:14334 E:14348 ||| DT
other  ||| S:14348 E:14354 ||| JJ
predominant  ||| S:14354 E:14366 ||| JJ
band  ||| S:14366 E:14371 ||| NN
immediately  ||| S:14371 E:14383 ||| RB
below  ||| S:14383 E:14389 ||| IN
Pro-N3-F  ||| S:14389 E:14398 ||| NNP
is  ||| S:14398 E:14401 ||| VBZ
the  ||| S:14401 E:14415 ||| DT
mature  ||| S:14415 E:14422 ||| JJ
form  ||| S:14422 E:14427 ||| NN
of  ||| S:14427 E:14430 ||| IN
Pro-N3-F ||| S:14430 E:14438 ||| NNP
,  ||| S:14438 E:14440 ||| ,
as  ||| S:14440 E:14443 ||| RB
indicated  ||| S:14443 E:14453 ||| VBN
by  ||| S:14453 E:14456 ||| IN
the  ||| S:14456 E:14460 ||| DT
ability  ||| S:14460 E:14468 ||| NN
of  ||| S:14468 E:14481 ||| IN
this  ||| S:14481 E:14486 ||| DT
band  ||| S:14486 E:14491 ||| NN
to  ||| S:14491 E:14494 ||| TO
be  ||| S:14494 E:14497 ||| VB
also  ||| S:14497 E:14502 ||| RB
detected  ||| S:14502 E:14511 ||| VBN
by  ||| S:14511 E:14514 ||| IN
anti-Flag  ||| S:14514 E:14524 ||| JJ
on  ||| S:14524 E:14527 ||| IN
the  ||| S:14527 E:14531 ||| DT
Western  ||| S:14531 E:14549 ||| JJ
blot  ||| S:14549 E:14554 ||| NN
and  ||| S:14554 E:14558 ||| CC
by  ||| S:14558 E:14561 ||| IN
its  ||| S:14561 E:14565 ||| PRP$
co-migration  ||| S:14565 E:14578 ||| JJ
with  ||| S:14578 E:14583 ||| IN
the  ||| S:14583 E:14587 ||| DT
deletion  ||| S:14587 E:14596 ||| JJ
version  ||| S:14596 E:14604 ||| NN
of  ||| S:14604 E:14617 ||| IN
N3  ||| S:14617 E:14620 ||| CD
lacking  ||| S:14620 E:14628 ||| VBG
the  ||| S:14628 E:14632 ||| DT
prosequence  ||| S:14632 E:14644 ||| NN
( ||| S:14644 E:14645 ||| -LRB-
F-ΔN3  ||| S:14645 E:14651 ||| NNP
in  ||| S:14651 E:14654 ||| IN
lane  ||| S:14654 E:14659 ||| CD
3 ||| S:14659 E:14660 ||| CD
) ||| S:14660 E:14661 ||| -RRB-
.  ||| S:14661 E:14663 ||| .
The  ||| S:14663 E:14667 ||| DT
rest  ||| S:14667 E:14672 ||| NN
of  ||| S:14672 E:14685 ||| IN
the  ||| S:14685 E:14689 ||| DT
proteins  ||| S:14689 E:14698 ||| NNS
detected  ||| S:14698 E:14707 ||| VBD
in  ||| S:14707 E:14710 ||| IN
the  ||| S:14710 E:14714 ||| DT
immunoprecipitates  ||| S:14714 E:14733 ||| NN
of  ||| S:14733 E:14736 ||| IN
wild  ||| S:14736 E:14751 ||| JJ
type  ||| S:14751 E:14756 ||| NN
full  ||| S:14756 E:14761 ||| JJ
length  ||| S:14761 E:14768 ||| NN
HsN3  ||| S:14768 E:14773 ||| NNP
( ||| S:14773 E:14774 ||| -LRB-
Fig.  ||| S:14774 E:14779 ||| NNP
2C ||| S:14779 E:14781 ||| NNP
,  ||| S:14781 E:14783 ||| ,
lane  ||| S:14783 E:14788 ||| CD
2 ||| S:14788 E:14789 ||| CD
)  ||| S:14789 E:14791 ||| -RRB-
are  ||| S:14791 E:14795 ||| VBP
predominantly  ||| S:14795 E:14819 ||| RB
different  ||| S:14819 E:14829 ||| JJ
subunits  ||| S:14829 E:14838 ||| NN
of  ||| S:14838 E:14841 ||| IN
the  ||| S:14841 E:14845 ||| DT
20S  ||| S:14845 E:14849 ||| CD
proteasome  ||| S:14849 E:14860 ||| NNS
and  ||| S:14860 E:14864 ||| CC
19S  ||| S:14864 E:14878 ||| CD
regulators ||| S:14878 E:14888 ||| NNS
,  ||| S:14888 E:14890 ||| ,
as  ||| S:14890 E:14893 ||| RB
indicated  ||| S:14893 E:14903 ||| VBN
by  ||| S:14903 E:14906 ||| IN
their  ||| S:14906 E:14912 ||| PRP$
molecular  ||| S:14912 E:14922 ||| JJ
weights  ||| S:14922 E:14930 ||| NNS
and  ||| S:14930 E:14944 ||| CC
their  ||| S:14944 E:14950 ||| PRP$
ability  ||| S:14950 E:14958 ||| NN
to  ||| S:14958 E:14961 ||| TO
be  ||| S:14961 E:14964 ||| VB
recognized  ||| S:14964 E:14975 ||| VBN
by  ||| S:14975 E:14978 ||| IN
anti-20S  ||| S:14978 E:14987 ||| NNP
and  ||| S:14987 E:14991 ||| CC
anti-19S  ||| S:14991 E:15010 ||| CD
antibodies  ||| S:15010 E:15021 ||| NNS
( ||| S:15021 E:15022 ||| -LRB-
data  ||| S:15022 E:15027 ||| NNS
not  ||| S:15027 E:15031 ||| RB
shown ||| S:15031 E:15036 ||| VBN
) ||| S:15036 E:15037 ||| -RRB-
.  ||| S:15037 E:15039 ||| .
The  ||| S:15039 E:15043 ||| DT
lack  ||| S:15043 E:15048 ||| NN
of  ||| S:15048 E:15051 ||| IN
most  ||| S:15051 E:15056 ||| JJS
of  ||| S:15056 E:15059 ||| IN
these  ||| S:15059 E:15075 ||| DT
endogenous  ||| S:15075 E:15086 ||| JJ
proteasome  ||| S:15086 E:15097 ||| JJ
components  ||| S:15097 E:15108 ||| NNS
in  ||| S:15108 E:15111 ||| IN
the  ||| S:15111 E:15125 ||| DT
immunoprecipitates  ||| S:15125 E:15144 ||| NN
of  ||| S:15144 E:15147 ||| IN
the  ||| S:15147 E:15151 ||| DT
two  ||| S:15151 E:15155 ||| CD
deletion  ||| S:15155 E:15164 ||| JJ
version  ||| S:15164 E:15172 ||| NN
of  ||| S:15172 E:15175 ||| IN
HsN3  ||| S:15175 E:15190 ||| CD
whose  ||| S:15190 E:15196 ||| WP$
prosequences  ||| S:15196 E:15209 ||| NNS
have  ||| S:15209 E:15214 ||| VBP
been  ||| S:15214 E:15219 ||| VBN
artificially  ||| S:15219 E:15232 ||| RB
removed  ||| S:15232 E:15240 ||| VBN
via  ||| S:15240 E:15254 ||| IN
deletions  ||| S:15254 E:15264 ||| NN
indicates  ||| S:15264 E:15274 ||| VBZ
that  ||| S:15274 E:15279 ||| IN
the  ||| S:15279 E:15283 ||| DT
prosequence  ||| S:15283 E:15295 ||| NN
of  ||| S:15295 E:15298 ||| IN
HsN3  ||| S:15298 E:15303 ||| NNP
is  ||| S:15303 E:15306 ||| VBZ
also  ||| S:15306 E:15321 ||| RB
important  ||| S:15321 E:15331 ||| JJ
for  ||| S:15331 E:15335 ||| IN
its  ||| S:15335 E:15339 ||| PRP$
successful  ||| S:15339 E:15350 ||| JJ
assembly  ||| S:15350 E:15359 ||| NN
into  ||| S:15359 E:15364 ||| IN
the  ||| S:15364 E:15368 ||| DT
mature  ||| S:15368 E:15375 ||| JJ
20S  ||| S:15375 E:15389 ||| CD
proteasome ||| S:15389 E:15399 ||| NNS
.  ||| S:15399 E:15401 ||| .
The  ||| S:15401 E:15405 ||| DT
slight  ||| S:15405 E:15412 ||| JJ
different  ||| S:15412 E:15422 ||| JJ
band  ||| S:15422 E:15427 ||| NN
patterns  ||| S:15427 E:15436 ||| NNS
detected  ||| S:15436 E:15455 ||| VBD
in  ||| S:15455 E:15458 ||| IN
the  ||| S:15458 E:15462 ||| DT
immunoprecipitates  ||| S:15462 E:15481 ||| NN
of  ||| S:15481 E:15484 ||| IN
F-ΔN3  ||| S:15484 E:15490 ||| NNP
and  ||| S:15490 E:15494 ||| CC
T7-ΔN3  ||| S:15494 E:15501 ||| NNP
suggests  ||| S:15501 E:15520 ||| VBZ
that  ||| S:15520 E:15525 ||| DT
different  ||| S:15525 E:15535 ||| JJ
epitope  ||| S:15535 E:15543 ||| JJ
tags  ||| S:15543 E:15548 ||| NNS
may  ||| S:15548 E:15552 ||| MD
influence  ||| S:15552 E:15562 ||| VB
N3  ||| S:15562 E:15565 ||| CD
interaction  ||| S:15565 E:15587 ||| NN
with  ||| S:15587 E:15592 ||| IN
endogenous  ||| S:15592 E:15603 ||| JJ
proteasome  ||| S:15603 E:15614 ||| JJ
components ||| S:15614 E:15624 ||| NNS
.  ||| S:15624 E:15626 ||| .
Since  ||| S:15626 E:15632 ||| IN
mature  ||| S:15632 E:15639 ||| JJ
β  ||| S:15639 E:15651 ||| JJ
subunits  ||| S:15651 E:15660 ||| NNS
are  ||| S:15660 E:15664 ||| VBP
only  ||| S:15664 E:15669 ||| RB
found  ||| S:15669 E:15675 ||| VBN
in  ||| S:15675 E:15678 ||| IN
the  ||| S:15678 E:15682 ||| DT
20S  ||| S:15682 E:15686 ||| CD
proteasome  ||| S:15686 E:15697 ||| NNS
[  ||| S:15697 E:15699 ||| -LRB-
19  ||| S:15699 E:15702 ||| CD
]  ||| S:15702 E:15704 ||| -RRB-
,  ||| S:15704 E:15716 ||| ,
the  ||| S:15716 E:15720 ||| DT
detection  ||| S:15720 E:15730 ||| NN
of  ||| S:15730 E:15733 ||| IN
the  ||| S:15733 E:15737 ||| DT
mature  ||| S:15737 E:15744 ||| JJ
form  ||| S:15744 E:15749 ||| NN
of  ||| S:15749 E:15752 ||| IN
the  ||| S:15752 E:15756 ||| DT
Flag-tagged  ||| S:15756 E:15768 ||| JJ
HsN3  ||| S:15768 E:15783 ||| NN
assured  ||| S:15783 E:15791 ||| VBD
us  ||| S:15791 E:15794 ||| PRP
that  ||| S:15794 E:15799 ||| IN
the  ||| S:15799 E:15803 ||| DT
exogenous  ||| S:15803 E:15813 ||| JJ
Flag-tagged  ||| S:15813 E:15825 ||| JJ
HsN3  ||| S:15825 E:15830 ||| CD
proteins  ||| S:15830 E:15849 ||| NNS
are  ||| S:15849 E:15853 ||| VBP
normal  ||| S:15853 E:15860 ||| JJ
in  ||| S:15860 E:15863 ||| IN
their  ||| S:15863 E:15869 ||| PRP$
ability  ||| S:15869 E:15877 ||| NN
to  ||| S:15877 E:15880 ||| TO
be  ||| S:15880 E:15883 ||| VB
incorporated  ||| S:15883 E:15896 ||| VBN
into  ||| S:15896 E:15901 ||| IN
the  ||| S:15901 E:15915 ||| DT
20S  ||| S:15915 E:15919 ||| JJ
proteasome ||| S:15919 E:15929 ||| NN
.  ||| S:15929 E:15941 ||| .
We  ||| S:15941 E:15944 ||| PRP
then  ||| S:15944 E:15949 ||| RB
tested  ||| S:15949 E:15956 ||| VBN
the  ||| S:15956 E:15960 ||| DT
ability  ||| S:15960 E:15968 ||| NN
of  ||| S:15968 E:15971 ||| IN
HsN3  ||| S:15971 E:15976 ||| CD
to  ||| S:15976 E:15979 ||| TO
bind  ||| S:15979 E:15984 ||| CD
Smad1  ||| S:15984 E:15990 ||| CD
in  ||| S:15990 E:16003 ||| IN
COS1  ||| S:16003 E:16008 ||| CD
cells  ||| S:16008 E:16014 ||| NNS
by  ||| S:16014 E:16017 ||| IN
transient  ||| S:16017 E:16027 ||| JJ
transfection  ||| S:16027 E:16040 ||| NNS
followed  ||| S:16040 E:16049 ||| VBN
by  ||| S:16049 E:16062 ||| IN
immunoprecipitation  ||| S:16062 E:16082 ||| JJ
assays ||| S:16082 E:16088 ||| NN
.  ||| S:16088 E:16090 ||| .
To  ||| S:16090 E:16093 ||| TO
monitor  ||| S:16093 E:16101 ||| VB
the  ||| S:16101 E:16115 ||| DT
co-precipitation  ||| S:16115 E:16132 ||| JJ
of  ||| S:16132 E:16135 ||| IN
Smad1  ||| S:16135 E:16141 ||| CD
with  ||| S:16141 E:16146 ||| IN
HsN3-containing  ||| S:16146 E:16162 ||| CD
proteasome  ||| S:16162 E:16183 ||| CD
complexes ||| S:16183 E:16192 ||| NNS
,  ||| S:16192 E:16194 ||| ,
immunoprecipitation  ||| S:16194 E:16214 ||| NN
were  ||| S:16214 E:16219 ||| VBD
carried  ||| S:16219 E:16227 ||| VBN
out  ||| S:16227 E:16231 ||| RP
using  ||| S:16231 E:16247 ||| VBG
total  ||| S:16247 E:16253 ||| JJ
cellular  ||| S:16253 E:16262 ||| JJ
proteins  ||| S:16262 E:16271 ||| NNS
from  ||| S:16271 E:16276 ||| IN
metabolically  ||| S:16276 E:16290 ||| NN
labeled  ||| S:16290 E:16298 ||| VBD
COS1  ||| S:16298 E:16313 ||| CD
cells ||| S:16313 E:16318 ||| NNS
.  ||| S:16318 E:16320 ||| .
Upon  ||| S:16320 E:16325 ||| IN
the  ||| S:16325 E:16329 ||| DT
immunoprecipitation  ||| S:16329 E:16349 ||| NN
of  ||| S:16349 E:16352 ||| IN
Smad1 ||| S:16352 E:16357 ||| NNP
,  ||| S:16357 E:16359 ||| ,
only  ||| S:16359 E:16364 ||| RB
the  ||| S:16364 E:16378 ||| DT
full-length  ||| S:16378 E:16390 ||| JJ
HsN3  ||| S:16390 E:16395 ||| CD
protein ||| S:16395 E:16402 ||| NN
,  ||| S:16402 E:16404 ||| ,
but  ||| S:16404 E:16408 ||| CC
not  ||| S:16408 E:16412 ||| RB
the  ||| S:16412 E:16416 ||| DT
processed  ||| S:16416 E:16426 ||| JJ
mature  ||| S:16426 E:16443 ||| JJ
form  ||| S:16443 E:16448 ||| NN
of  ||| S:16448 E:16451 ||| IN
HsN3 ||| S:16451 E:16455 ||| NNP
,  ||| S:16455 E:16457 ||| ,
was  ||| S:16457 E:16461 ||| VBD
detected  ||| S:16461 E:16470 ||| VBN
to  ||| S:16470 E:16473 ||| TO
co-precipitate  ||| S:16473 E:16488 ||| JJ
with  ||| S:16488 E:16493 ||| IN
Smad1  ||| S:16493 E:16509 ||| NNP
( ||| S:16509 E:16510 ||| -LRB-
Fig.  ||| S:16510 E:16515 ||| NNP
3A ||| S:16515 E:16517 ||| NNP
,  ||| S:16517 E:16519 ||| ,
right  ||| S:16519 E:16525 ||| JJ
panel ||| S:16525 E:16530 ||| NN
,  ||| S:16530 E:16532 ||| ,
lane  ||| S:16532 E:16537 ||| CD
4 ||| S:16537 E:16538 ||| CD
) ||| S:16538 E:16539 ||| -RRB-
.  ||| S:16539 E:16541 ||| .
Although  ||| S:16541 E:16550 ||| IN
the  ||| S:16550 E:16564 ||| DT
overexpressed  ||| S:16564 E:16578 ||| JJ
HsN3  ||| S:16578 E:16583 ||| NN
is  ||| S:16583 E:16586 ||| VBZ
associated  ||| S:16586 E:16597 ||| VBN
with  ||| S:16597 E:16602 ||| IN
many  ||| S:16602 E:16607 ||| JJ
other  ||| S:16607 E:16623 ||| JJ
endogenous  ||| S:16623 E:16634 ||| JJ
proteasome  ||| S:16634 E:16645 ||| JJ
components  ||| S:16645 E:16656 ||| NNS
from  ||| S:16656 E:16661 ||| IN
the  ||| S:16661 E:16665 ||| DT
COS  ||| S:16665 E:16669 ||| NNP
cells  ||| S:16669 E:16675 ||| NNS
( ||| S:16675 E:16676 ||| -LRB-
Fig.  ||| S:16676 E:16691 ||| NNP
3A ||| S:16691 E:16693 ||| NNP
,  ||| S:16693 E:16695 ||| ,
left  ||| S:16695 E:16700 ||| VBN
panel ||| S:16700 E:16705 ||| NN
,  ||| S:16705 E:16707 ||| ,
lane  ||| S:16707 E:16712 ||| CD
4 ||| S:16712 E:16713 ||| CD
) ||| S:16713 E:16714 ||| -RRB-
,  ||| S:16714 E:16716 ||| ,
these  ||| S:16716 E:16722 ||| DT
endogenous  ||| S:16722 E:16733 ||| JJ
proteins  ||| S:16733 E:16742 ||| NNS
also  ||| S:16742 E:16757 ||| RB
were  ||| S:16757 E:16762 ||| VBD
not  ||| S:16762 E:16766 ||| RB
detected  ||| S:16766 E:16775 ||| VBN
in  ||| S:16775 E:16778 ||| IN
the  ||| S:16778 E:16782 ||| DT
immunoprecipitates  ||| S:16782 E:16801 ||| NN
of  ||| S:16801 E:16804 ||| IN
Smad1  ||| S:16804 E:16820 ||| NNP
( ||| S:16820 E:16821 ||| -LRB-
Fig.  ||| S:16821 E:16826 ||| NNP
3A ||| S:16826 E:16828 ||| NNP
,  ||| S:16828 E:16830 ||| ,
right  ||| S:16830 E:16836 ||| JJ
panel ||| S:16836 E:16841 ||| NN
,  ||| S:16841 E:16843 ||| ,
lane  ||| S:16843 E:16848 ||| CD
4 ||| S:16848 E:16849 ||| CD
) ||| S:16849 E:16850 ||| -RRB-
.  ||| S:16850 E:16852 ||| .
Thus ||| S:16852 E:16856 ||| RB
,  ||| S:16856 E:16858 ||| ,
Smad1  ||| S:16858 E:16864 ||| NNP
only  ||| S:16864 E:16869 ||| RB
binds  ||| S:16869 E:16885 ||| VB
the  ||| S:16885 E:16889 ||| DT
prosequence-containing  ||| S:16889 E:16912 ||| JJ
HsN3  ||| S:16912 E:16917 ||| NNP
( ||| S:16917 E:16918 ||| -LRB-
pro-N3-F ||| S:16918 E:16926 ||| NNP
) ||| S:16926 E:16927 ||| -RRB-
,  ||| S:16927 E:16929 ||| ,
which ||| S:16929 E:16934 ||| WDT
,  ||| S:16934 E:16936 ||| ,
as  ||| S:16936 E:16949 ||| RB
illustrated  ||| S:16949 E:16961 ||| VBN
in  ||| S:16961 E:16964 ||| IN
Fig.  ||| S:16964 E:16969 ||| CD
2A ||| S:16969 E:16971 ||| CD
,  ||| S:16971 E:16973 ||| ,
only  ||| S:16973 E:16978 ||| RB
exists  ||| S:16978 E:16985 ||| VBZ
transiently  ||| S:16985 E:16997 ||| VBN
before  ||| S:16997 E:17014 ||| IN
the  ||| S:17014 E:17018 ||| DT
formation  ||| S:17018 E:17028 ||| NN
of  ||| S:17028 E:17031 ||| IN
20S  ||| S:17031 E:17035 ||| CD
proteasome ||| S:17035 E:17045 ||| NNS
.  ||| S:17045 E:17047 ||| .
Our  ||| S:17047 E:17051 ||| PRP$
domain  ||| S:17051 E:17058 ||| NN
mapping  ||| S:17058 E:17076 ||| NN
studies  ||| S:17076 E:17084 ||| NNS
in  ||| S:17084 E:17087 ||| IN
yeast  ||| S:17087 E:17093 ||| JJ
two-hybrid  ||| S:17093 E:17104 ||| JJ
system  ||| S:17104 E:17111 ||| NN
have  ||| S:17111 E:17116 ||| VBP
previously  ||| S:17116 E:17137 ||| RB
suggested  ||| S:17137 E:17147 ||| VBN
that  ||| S:17147 E:17152 ||| IN
the  ||| S:17152 E:17156 ||| DT
MH2  ||| S:17156 E:17160 ||| JJ
domain  ||| S:17160 E:17167 ||| NN
of  ||| S:17167 E:17170 ||| IN
Smad1  ||| S:17170 E:17176 ||| NNP
is  ||| S:17176 E:17179 ||| VBZ
necessary  ||| S:17179 E:17189 ||| JJ
for  ||| S:17189 E:17203 ||| IN
its  ||| S:17203 E:17207 ||| PRP$
interaction  ||| S:17207 E:17219 ||| NN
with  ||| S:17219 E:17224 ||| IN
HsN3  ||| S:17224 E:17229 ||| NNP
[  ||| S:17229 E:17231 ||| -LRB-
39  ||| S:17231 E:17234 ||| CD
]  ||| S:17234 E:17236 ||| -RRB-
.  ||| S:17236 E:17238 ||| .
Thus  ||| S:17238 E:17243 ||| RB
we  ||| S:17243 E:17246 ||| PRP
also  ||| S:17246 E:17251 ||| RB
tested  ||| S:17251 E:17268 ||| VBN
the  ||| S:17268 E:17272 ||| DT
interaction  ||| S:17272 E:17284 ||| NN
between  ||| S:17284 E:17292 ||| IN
HsN3  ||| S:17292 E:17297 ||| NNP
and  ||| S:17297 E:17301 ||| CC
Smad1  ||| S:17301 E:17307 ||| CD
MH2  ||| S:17307 E:17311 ||| CD
domain ||| S:17311 E:17317 ||| NN
.  ||| S:17317 E:17329 ||| .
Pro-N3-F  ||| S:17329 E:17338 ||| NNP
was  ||| S:17338 E:17342 ||| VBD
also  ||| S:17342 E:17347 ||| RB
detected  ||| S:17347 E:17356 ||| VBN
in  ||| S:17356 E:17359 ||| IN
the  ||| S:17359 E:17363 ||| DT
immunoprecipitates  ||| S:17363 E:17382 ||| NN
of  ||| S:17382 E:17395 ||| IN
Smad1MH2  ||| S:17395 E:17404 ||| NNP
( ||| S:17404 E:17405 ||| -LRB-
Fig.  ||| S:17405 E:17410 ||| NNP
3A ||| S:17410 E:17412 ||| NNP
,  ||| S:17412 E:17414 ||| ,
right  ||| S:17414 E:17420 ||| JJ
panel ||| S:17420 E:17425 ||| NN
,  ||| S:17425 E:17427 ||| ,
lane  ||| S:17427 E:17432 ||| CD
3 ||| S:17432 E:17433 ||| CD
) ||| S:17433 E:17434 ||| -RRB-
,  ||| S:17434 E:17436 ||| ,
suggesting  ||| S:17436 E:17447 ||| VBG
that  ||| S:17447 E:17462 ||| IN
the  ||| S:17462 E:17466 ||| DT
MH2  ||| S:17466 E:17470 ||| JJ
domain  ||| S:17470 E:17477 ||| NN
is  ||| S:17477 E:17480 ||| VBZ
sufficient  ||| S:17480 E:17491 ||| JJ
to  ||| S:17491 E:17494 ||| TO
bind  ||| S:17494 E:17499 ||| VB
to  ||| S:17499 E:17502 ||| TO
the  ||| S:17502 E:17506 ||| DT
pre-assembled  ||| S:17506 E:17530 ||| JJ
HsN3 ||| S:17530 E:17534 ||| NN
.  ||| S:17534 E:17546 ||| .
To  ||| S:17546 E:17549 ||| TO
test  ||| S:17549 E:17554 ||| VB
whether  ||| S:17554 E:17562 ||| IN
the  ||| S:17562 E:17566 ||| DT
observed  ||| S:17566 E:17575 ||| JJ
interaction  ||| S:17575 E:17587 ||| NN
between  ||| S:17587 E:17595 ||| IN
Smad1  ||| S:17595 E:17611 ||| NNP
and  ||| S:17611 E:17615 ||| CC
Pro-N3-F ||| S:17615 E:17623 ||| NNP
,  ||| S:17623 E:17625 ||| ,
the  ||| S:17625 E:17629 ||| DT
pre-assembled  ||| S:17629 E:17643 ||| JJ
form  ||| S:17643 E:17648 ||| NN
of  ||| S:17648 E:17651 ||| IN
HsN3 ||| S:17651 E:17655 ||| NNP
,  ||| S:17655 E:17657 ||| ,
is  ||| S:17657 E:17670 ||| VBZ
regulated  ||| S:17670 E:17680 ||| VBN
by  ||| S:17680 E:17683 ||| IN
BMP  ||| S:17683 E:17687 ||| NN
type  ||| S:17687 E:17692 ||| NN
I  ||| S:17692 E:17694 ||| PRP
receptor  ||| S:17694 E:17703 ||| VBP
activation ||| S:17703 E:17713 ||| VBN
,  ||| S:17713 E:17715 ||| ,
we  ||| S:17715 E:17728 ||| PRP
co-expressed  ||| S:17728 E:17741 ||| JJ
Smad1  ||| S:17741 E:17747 ||| NN
and  ||| S:17747 E:17751 ||| CC
HsN3  ||| S:17751 E:17756 ||| CD
with  ||| S:17756 E:17761 ||| IN
a  ||| S:17761 E:17763 ||| DT
mutant  ||| S:17763 E:17770 ||| JJ
type  ||| S:17770 E:17775 ||| NN
I  ||| S:17775 E:17787 ||| PRP
receptor ||| S:17787 E:17795 ||| VBP
,  ||| S:17795 E:17797 ||| ,
ALK3Q233D ||| S:17797 E:17806 ||| NNP
.  ||| S:17806 E:17808 ||| .
ALK3Q233D  ||| S:17808 E:17818 ||| NNP
is  ||| S:17818 E:17821 ||| VBZ
constitutively  ||| S:17821 E:17836 ||| JJ
active  ||| S:17836 E:17853 ||| JJ
in  ||| S:17853 E:17856 ||| IN
inducing  ||| S:17856 E:17865 ||| VBG
downstream  ||| S:17865 E:17876 ||| NNS
signaling  ||| S:17876 E:17886 ||| VBG
events  ||| S:17886 E:17893 ||| NNS
in  ||| S:17893 E:17896 ||| IN
the  ||| S:17896 E:17900 ||| DT
absence  ||| S:17900 E:17908 ||| NN
of  ||| S:17908 E:17921 ||| IN
BMPs  ||| S:17921 E:17926 ||| JJ
or  ||| S:17926 E:17929 ||| CC
the  ||| S:17929 E:17933 ||| DT
type  ||| S:17933 E:17938 ||| NN
II  ||| S:17938 E:17941 ||| NNP
receptor  ||| S:17941 E:17950 ||| NN
[  ||| S:17950 E:17952 ||| -LRB-
40  ||| S:17952 E:17955 ||| CD
]  ||| S:17955 E:17957 ||| -RRB-
.  ||| S:17957 E:17959 ||| .
The  ||| S:17959 E:17963 ||| DT
co-expression  ||| S:17963 E:17987 ||| JJ
of  ||| S:17987 E:17990 ||| IN
ALK3Q233D  ||| S:17990 E:18000 ||| CD
with  ||| S:18000 E:18005 ||| IN
Smad1  ||| S:18005 E:18011 ||| NNP
and  ||| S:18011 E:18015 ||| CC
HsN3  ||| S:18015 E:18020 ||| NNP
significantly  ||| S:18020 E:18034 ||| RB
increased  ||| S:18034 E:18054 ||| VBD
the  ||| S:18054 E:18058 ||| DT
amount  ||| S:18058 E:18065 ||| NN
of  ||| S:18065 E:18068 ||| IN
the  ||| S:18068 E:18072 ||| DT
pre-assembled  ||| S:18072 E:18086 ||| JJ
HsN3  ||| S:18086 E:18091 ||| NN
that  ||| S:18091 E:18096 ||| WDT
was  ||| S:18096 E:18110 ||| VBD
co-precipitated  ||| S:18110 E:18126 ||| JJ
with  ||| S:18126 E:18131 ||| IN
Smad1  ||| S:18131 E:18137 ||| NNP
( ||| S:18137 E:18138 ||| -LRB-
Fig.  ||| S:18138 E:18143 ||| NNP
3B ||| S:18143 E:18145 ||| NNP
,  ||| S:18145 E:18147 ||| ,
right  ||| S:18147 E:18153 ||| JJ
panel ||| S:18153 E:18158 ||| NN
,  ||| S:18158 E:18160 ||| ,
compare  ||| S:18160 E:18178 ||| VBP
lanes  ||| S:18178 E:18184 ||| RB
2  ||| S:18184 E:18186 ||| CD
&  ||| S:18186 E:18188 ||| CC
3 ||| S:18188 E:18189 ||| LS
) ||| S:18189 E:18190 ||| -RRB-
.  ||| S:18190 E:18192 ||| .
Smad1  ||| S:18192 E:18198 ||| NNP
was  ||| S:18198 E:18202 ||| VBD
also  ||| S:18202 E:18207 ||| RB
detected  ||| S:18207 E:18216 ||| VBN
in  ||| S:18216 E:18219 ||| IN
the  ||| S:18219 E:18233 ||| DT
immunoprecipitates  ||| S:18233 E:18252 ||| NN
of  ||| S:18252 E:18255 ||| IN
HsN3  ||| S:18255 E:18260 ||| NNP
( ||| S:18260 E:18261 ||| -LRB-
Fig.  ||| S:18261 E:18266 ||| NNP
3B ||| S:18266 E:18268 ||| NNP
,  ||| S:18268 E:18270 ||| ,
lanes  ||| S:18270 E:18276 ||| CD
2  ||| S:18276 E:18278 ||| CD
&  ||| S:18278 E:18280 ||| CC
3 ||| S:18280 E:18281 ||| LS
) ||| S:18281 E:18282 ||| -RRB-
.  ||| S:18282 E:18294 ||| .
Since  ||| S:18294 E:18300 ||| IN
equal  ||| S:18300 E:18306 ||| JJ
transfection  ||| S:18306 E:18319 ||| JJ
efficiency  ||| S:18319 E:18330 ||| NN
was  ||| S:18330 E:18334 ||| VBD
monitored  ||| S:18334 E:18344 ||| VBN
and  ||| S:18344 E:18358 ||| CC
equal  ||| S:18358 E:18364 ||| JJ
total  ||| S:18364 E:18370 ||| JJ
proteins  ||| S:18370 E:18379 ||| NNS
were  ||| S:18379 E:18384 ||| VBD
used  ||| S:18384 E:18389 ||| VBN
for  ||| S:18389 E:18393 ||| IN
the  ||| S:18393 E:18407 ||| DT
immunoprecipitation ||| S:18407 E:18426 ||| NN
,  ||| S:18426 E:18428 ||| ,
the  ||| S:18428 E:18432 ||| DT
increased  ||| S:18432 E:18442 ||| JJ
signals  ||| S:18442 E:18450 ||| NNS
of  ||| S:18450 E:18453 ||| IN
pro-N3-F  ||| S:18453 E:18472 ||| NNP
and  ||| S:18472 E:18476 ||| CC
its  ||| S:18476 E:18480 ||| PRP$
associated  ||| S:18480 E:18491 ||| JJ
proteins  ||| S:18491 E:18500 ||| NNS
in  ||| S:18500 E:18503 ||| IN
Fig.  ||| S:18503 E:18508 ||| CD
3B ||| S:18508 E:18510 ||| CD
,  ||| S:18510 E:18512 ||| ,
lane  ||| S:18512 E:18517 ||| CD
3 ||| S:18517 E:18518 ||| CD
,  ||| S:18518 E:18520 ||| ,
left  ||| S:18520 E:18535 ||| VBN
panel ||| S:18535 E:18540 ||| NN
,  ||| S:18540 E:18542 ||| ,
may  ||| S:18542 E:18546 ||| MD
reflect  ||| S:18546 E:18554 ||| VB
an  ||| S:18554 E:18557 ||| DT
increased  ||| S:18557 E:18567 ||| JJ
stability  ||| S:18567 E:18577 ||| NN
of  ||| S:18577 E:18580 ||| IN
HsN3  ||| S:18580 E:18585 ||| CD
due  ||| S:18585 E:18589 ||| JJ
to  ||| S:18589 E:18602 ||| TO
complex  ||| S:18602 E:18610 ||| JJ
formation  ||| S:18610 E:18620 ||| NN
with  ||| S:18620 E:18625 ||| IN
Smad1 ||| S:18625 E:18630 ||| NNP
,  ||| S:18630 E:18632 ||| ,
upon  ||| S:18632 E:18637 ||| IN
BMP  ||| S:18637 E:18641 ||| NN
receptor  ||| S:18641 E:18660 ||| NN
activation ||| S:18660 E:18670 ||| NN
.  ||| S:18670 E:18682 ||| .
The  ||| S:18682 E:18686 ||| DT
association  ||| S:18686 E:18698 ||| NN
between  ||| S:18698 E:18706 ||| IN
Smad1  ||| S:18706 E:18712 ||| NNP
and  ||| S:18712 E:18716 ||| CC
HsN3  ||| S:18716 E:18721 ||| NNP
was  ||| S:18721 E:18725 ||| VBD
further  ||| S:18725 E:18743 ||| RB
confirmed  ||| S:18743 E:18753 ||| VBN
by  ||| S:18753 E:18756 ||| IN
immunoprecipitation  ||| S:18756 E:18776 ||| VBG
followed  ||| S:18776 E:18785 ||| VBN
by  ||| S:18785 E:18788 ||| IN
Western  ||| S:18788 E:18796 ||| JJ
blot  ||| S:18796 E:18811 ||| JJ
analyses ||| S:18811 E:18819 ||| NNS
.  ||| S:18819 E:18821 ||| .
As  ||| S:18821 E:18824 ||| RB
shown  ||| S:18824 E:18830 ||| VBN
in  ||| S:18830 E:18833 ||| IN
Fig.  ||| S:18833 E:18838 ||| CD
4Aand  ||| S:18838 E:18844 ||| CD
Fig.  ||| S:18844 E:18849 ||| CD
4B ||| S:18849 E:18851 ||| CD
,  ||| S:18851 E:18853 ||| ,
Pro-N3-F  ||| S:18853 E:18862 ||| NNP
was  ||| S:18862 E:18876 ||| VBD
specifically  ||| S:18876 E:18889 ||| RB
detected  ||| S:18889 E:18898 ||| VBN
in  ||| S:18898 E:18901 ||| IN
the  ||| S:18901 E:18905 ||| DT
immunoprecipitates  ||| S:18905 E:18924 ||| NN
of  ||| S:18924 E:18927 ||| IN
Smad1  ||| S:18927 E:18943 ||| NNP
but  ||| S:18943 E:18947 ||| CC
not  ||| S:18947 E:18951 ||| RB
those  ||| S:18951 E:18957 ||| DT
of  ||| S:18957 E:18960 ||| IN
Smad2 ||| S:18960 E:18965 ||| CD
.  ||| S:18965 E:18967 ||| .
When  ||| S:18967 E:18972 ||| WRB
the  ||| S:18972 E:18976 ||| DT
activated  ||| S:18976 E:18986 ||| JJ
BMP  ||| S:18986 E:18990 ||| NN
type  ||| S:18990 E:18995 ||| NN
I  ||| S:18995 E:19007 ||| PRP
receptor  ||| S:19007 E:19016 ||| RB
was  ||| S:19016 E:19020 ||| VBD
co-expressed  ||| S:19020 E:19033 ||| JJ
with  ||| S:19033 E:19038 ||| IN
Smad1  ||| S:19038 E:19044 ||| NNP
and  ||| S:19044 E:19048 ||| CC
HsN3 ||| S:19048 E:19052 ||| NNP
,  ||| S:19052 E:19054 ||| ,
a  ||| S:19054 E:19066 ||| DT
reduction  ||| S:19066 E:19076 ||| NN
of  ||| S:19076 E:19079 ||| IN
Smad1  ||| S:19079 E:19085 ||| CD
level  ||| S:19085 E:19091 ||| NN
was  ||| S:19091 E:19095 ||| VBD
detected  ||| S:19095 E:19104 ||| VBN
and  ||| S:19104 E:19108 ||| CC
the  ||| S:19108 E:19112 ||| DT
reduction  ||| S:19112 E:19132 ||| NN
is  ||| S:19132 E:19135 ||| VBZ
blocked  ||| S:19135 E:19143 ||| VBN
by  ||| S:19143 E:19146 ||| IN
the  ||| S:19146 E:19150 ||| DT
addition  ||| S:19150 E:19159 ||| NN
of  ||| S:19159 E:19162 ||| IN
the  ||| S:19162 E:19166 ||| DT
proteasome  ||| S:19166 E:19177 ||| JJ
inhibitor  ||| S:19177 E:19197 ||| JJ
lactacystin ||| S:19197 E:19208 ||| NN
,  ||| S:19208 E:19210 ||| ,
indicating  ||| S:19210 E:19221 ||| VBG
the  ||| S:19221 E:19225 ||| DT
proteasomal  ||| S:19225 E:19237 ||| JJ
degradation  ||| S:19237 E:19249 ||| NN
of  ||| S:19249 E:19262 ||| IN
Smad1  ||| S:19262 E:19268 ||| CD
induced  ||| S:19268 E:19276 ||| NN
by  ||| S:19276 E:19279 ||| IN
BMP  ||| S:19279 E:19283 ||| NN
type  ||| S:19283 E:19288 ||| NN
I  ||| S:19288 E:19290 ||| PRP
receptor  ||| S:19290 E:19299 ||| VBP
activation ||| S:19299 E:19309 ||| VBN
.  ||| S:19309 E:19311 ||| .
This  ||| S:19311 E:19326 ||| DT
phenomenon  ||| S:19326 E:19337 ||| NN
was  ||| S:19337 E:19341 ||| VBD
further  ||| S:19341 E:19349 ||| RB
investigated  ||| S:19349 E:19362 ||| VBN
and  ||| S:19362 E:19366 ||| CC
confirmed  ||| S:19366 E:19376 ||| VBD
in  ||| S:19376 E:19379 ||| IN
a  ||| S:19379 E:19391 ||| DT
separate  ||| S:19391 E:19400 ||| JJ
study  ||| S:19400 E:19406 ||| NN
[  ||| S:19406 E:19408 ||| -LRB-
39  ||| S:19408 E:19411 ||| CD
]  ||| S:19411 E:19413 ||| -RRB-
.  ||| S:19413 E:19415 ||| .
The  ||| S:19415 E:19419 ||| DT
interaction  ||| S:19419 E:19431 ||| NN
between  ||| S:19431 E:19439 ||| IN
Pro-N3-F  ||| S:19439 E:19458 ||| NNP
and  ||| S:19458 E:19462 ||| CC
Smad1  ||| S:19462 E:19468 ||| NNP
was  ||| S:19468 E:19472 ||| VBD
also  ||| S:19472 E:19477 ||| RB
stabilized  ||| S:19477 E:19488 ||| VBN
in  ||| S:19488 E:19491 ||| IN
the  ||| S:19491 E:19495 ||| DT
presence  ||| S:19495 E:19504 ||| NN
of  ||| S:19504 E:19517 ||| IN
proteasome  ||| S:19517 E:19528 ||| FW
inhibitor  ||| S:19528 E:19538 ||| FW
lactacystin  ||| S:19538 E:19550 ||| FW
( ||| S:19550 E:19551 ||| -LRB-
Fig.  ||| S:19551 E:19556 ||| NNP
4B ||| S:19556 E:19558 ||| NNP
,  ||| S:19558 E:19560 ||| ,
lanes  ||| S:19560 E:19566 ||| CD
4 ||| S:19566 E:19567 ||| CD
) ||| S:19567 E:19568 ||| -RRB-
.  ||| S:19568 E:19580 ||| .
Western  ||| S:19580 E:19588 ||| NNP
blot  ||| S:19588 E:19593 ||| VBZ
using  ||| S:19593 E:19599 ||| VBG
anti-26S  ||| S:19599 E:19608 ||| CD
proteasome  ||| S:19608 E:19619 ||| NNS
was  ||| S:19619 E:19623 ||| VBD
also  ||| S:19623 E:19628 ||| RB
carried  ||| S:19628 E:19646 ||| VBN
out  ||| S:19646 E:19650 ||| RP
to  ||| S:19650 E:19653 ||| TO
show  ||| S:19653 E:19658 ||| VB
that  ||| S:19658 E:19663 ||| IN
only  ||| S:19663 E:19668 ||| RB
Pro-N3-F ||| S:19668 E:19676 ||| CD
,  ||| S:19676 E:19678 ||| ,
not  ||| S:19678 E:19682 ||| RB
mature  ||| S:19682 E:19689 ||| VB
N3 ||| S:19689 E:19691 ||| CD
,  ||| S:19691 E:19693 ||| ,
nor  ||| S:19693 E:19697 ||| CC
other  ||| S:19697 E:19713 ||| JJ
proteasome  ||| S:19713 E:19724 ||| JJ
components ||| S:19724 E:19734 ||| NNS
,  ||| S:19734 E:19736 ||| ,
was  ||| S:19736 E:19740 ||| VBD
co-precipitated  ||| S:19740 E:19756 ||| JJ
with  ||| S:19756 E:19761 ||| IN
Smad1  ||| S:19761 E:19777 ||| NNP
( ||| S:19777 E:19778 ||| -LRB-
data  ||| S:19778 E:19783 ||| NNS
not  ||| S:19783 E:19787 ||| RB
shown ||| S:19787 E:19792 ||| VBN
) ||| S:19792 E:19793 ||| -RRB-
.  ||| S:19793 E:19823 ||| .
Smad1  ||| S:19823 E:19829 ||| NNP
can  ||| S:19829 E:19833 ||| MD
interact  ||| S:19833 E:19842 ||| VB
with  ||| S:19842 E:19847 ||| IN
prosequence-deleted  ||| S:19847 E:19867 ||| JJ
HsN3  ||| S:19867 E:19872 ||| NN
in  ||| S:19872 E:19885 ||| IN
HsN3  ||| S:19885 E:19890 ||| CD
assembly  ||| S:19890 E:19899 ||| NN
intermediates  ||| S:19899 E:19923 ||| VBD
The  ||| S:19923 E:19927 ||| DT
lack  ||| S:19927 E:19932 ||| NN
of  ||| S:19932 E:19935 ||| IN
mature  ||| S:19935 E:19942 ||| JJ
HsN3  ||| S:19942 E:19947 ||| NN
and  ||| S:19947 E:19951 ||| CC
other  ||| S:19951 E:19957 ||| JJ
proteasome  ||| S:19957 E:19978 ||| JJ
components  ||| S:19978 E:19989 ||| NNS
in  ||| S:19989 E:19992 ||| IN
the  ||| S:19992 E:19996 ||| DT
immunoprecipitates  ||| S:19996 E:20015 ||| NN
of  ||| S:20015 E:20018 ||| IN
Smad1  ||| S:20018 E:20024 ||| NNP
could  ||| S:20024 E:20030 ||| MD
be  ||| S:20030 E:20043 ||| VB
mediated  ||| S:20043 E:20052 ||| VBN
by  ||| S:20052 E:20055 ||| IN
two  ||| S:20055 E:20059 ||| CD
different  ||| S:20059 E:20069 ||| JJ
mechanisms ||| S:20069 E:20079 ||| NNS
.  ||| S:20079 E:20081 ||| .
First ||| S:20081 E:20086 ||| NNP
,  ||| S:20086 E:20088 ||| ,
the  ||| S:20088 E:20102 ||| DT
prosequence  ||| S:20102 E:20114 ||| NN
of  ||| S:20114 E:20117 ||| IN
HsN3 ||| S:20117 E:20121 ||| NNP
,  ||| S:20121 E:20123 ||| ,
which  ||| S:20123 E:20129 ||| WDT
is  ||| S:20129 E:20132 ||| VBZ
processed  ||| S:20132 E:20142 ||| VBN
from  ||| S:20142 E:20147 ||| IN
the  ||| S:20147 E:20151 ||| DT
mature  ||| S:20151 E:20168 ||| JJ
HsN3 ||| S:20168 E:20172 ||| NN
,  ||| S:20172 E:20174 ||| ,
is  ||| S:20174 E:20177 ||| VBZ
necessary  ||| S:20177 E:20187 ||| JJ
for  ||| S:20187 E:20191 ||| IN
Smad1  ||| S:20191 E:20197 ||| CD
to  ||| S:20197 E:20200 ||| TO
bind  ||| S:20200 E:20205 ||| VB
to  ||| S:20205 E:20208 ||| TO
HsN3 ||| S:20208 E:20212 ||| CD
.  ||| S:20212 E:20214 ||| .
Second ||| S:20214 E:20220 ||| LS
,  ||| S:20220 E:20222 ||| ,
the  ||| S:20222 E:20236 ||| DT
final  ||| S:20236 E:20242 ||| JJ
maturation  ||| S:20242 E:20253 ||| NN
of  ||| S:20253 E:20256 ||| IN
the  ||| S:20256 E:20260 ||| DT
20S  ||| S:20260 E:20264 ||| NNP
proteasome  ||| S:20264 E:20275 ||| VBD
resulted  ||| S:20275 E:20284 ||| VBN
from  ||| S:20284 E:20289 ||| IN
the  ||| S:20289 E:20303 ||| DT
assembly  ||| S:20303 E:20312 ||| NN
of  ||| S:20312 E:20315 ||| IN
two  ||| S:20315 E:20319 ||| CD
half  ||| S:20319 E:20324 ||| NN
proteasomes  ||| S:20324 E:20336 ||| NN
into  ||| S:20336 E:20341 ||| IN
the  ||| S:20341 E:20345 ||| DT
four  ||| S:20345 E:20350 ||| CD
stacked  ||| S:20350 E:20368 ||| JJ
ring  ||| S:20368 E:20373 ||| NN
structure  ||| S:20373 E:20383 ||| NN
could  ||| S:20383 E:20389 ||| MD
trap  ||| S:20389 E:20394 ||| VB
the  ||| S:20394 E:20398 ||| DT
already  ||| S:20398 E:20406 ||| RB
bound  ||| S:20406 E:20412 ||| VBN
Smad1  ||| S:20412 E:20418 ||| CD
inside  ||| S:20418 E:20435 ||| IN
the  ||| S:20435 E:20439 ||| DT
proteasome  ||| S:20439 E:20450 ||| NN
for  ||| S:20450 E:20454 ||| IN
rapid  ||| S:20454 E:20460 ||| JJ
degradation  ||| S:20460 E:20472 ||| NN
or  ||| S:20472 E:20475 ||| CC
lead  ||| S:20475 E:20480 ||| VB
to  ||| S:20480 E:20483 ||| TO
the  ||| S:20483 E:20497 ||| DT
dissociation  ||| S:20497 E:20510 ||| NN
of  ||| S:20510 E:20513 ||| IN
Smad1  ||| S:20513 E:20519 ||| CD
from  ||| S:20519 E:20524 ||| IN
mature  ||| S:20524 E:20531 ||| JJ
20S  ||| S:20531 E:20535 ||| CD
proteasome  ||| S:20535 E:20546 ||| CD
due  ||| S:20546 E:20550 ||| JJ
to  ||| S:20550 E:20563 ||| TO
the  ||| S:20563 E:20567 ||| DT
inaccessibility  ||| S:20567 E:20583 ||| NN
of  ||| S:20583 E:20586 ||| IN
Smad1  ||| S:20586 E:20592 ||| CD
binding  ||| S:20592 E:20600 ||| JJ
site  ||| S:20600 E:20605 ||| NN
on  ||| S:20605 E:20608 ||| IN
the  ||| S:20608 E:20622 ||| DT
incorporated  ||| S:20622 E:20635 ||| JJ
HsN3 ||| S:20635 E:20639 ||| NN
.  ||| S:20639 E:20641 ||| .
We  ||| S:20641 E:20644 ||| PRP
first  ||| S:20644 E:20650 ||| RB
tested  ||| S:20650 E:20657 ||| VBN
the  ||| S:20657 E:20661 ||| DT
role  ||| S:20661 E:20666 ||| NN
of  ||| S:20666 E:20669 ||| IN
the  ||| S:20669 E:20683 ||| DT
prosequence  ||| S:20683 E:20695 ||| NN
of  ||| S:20695 E:20698 ||| IN
HsN3  ||| S:20698 E:20703 ||| CD
in  ||| S:20703 E:20706 ||| IN
binding  ||| S:20706 E:20714 ||| VBG
to  ||| S:20714 E:20717 ||| TO
Smad1 ||| S:20717 E:20722 ||| CD
.  ||| S:20722 E:20724 ||| .
As  ||| S:20724 E:20727 ||| RB
shown  ||| S:20727 E:20733 ||| VBN
in  ||| S:20733 E:20736 ||| IN
Fig.  ||| S:20736 E:20751 ||| CD
4C ||| S:20751 E:20753 ||| CD
,  ||| S:20753 E:20755 ||| ,
artificial  ||| S:20755 E:20766 ||| JJ
removal  ||| S:20766 E:20774 ||| NN
of  ||| S:20774 E:20777 ||| IN
the  ||| S:20777 E:20781 ||| DT
prosequence  ||| S:20781 E:20793 ||| NN
of  ||| S:20793 E:20796 ||| IN
HsN3  ||| S:20796 E:20801 ||| NNP
( ||| S:20801 E:20802 ||| -LRB-
ΔN3 ||| S:20802 E:20805 ||| NNP
)  ||| S:20805 E:20817 ||| -RRB-
did  ||| S:20817 E:20821 ||| VBD
not  ||| S:20821 E:20825 ||| RB
abolish  ||| S:20825 E:20833 ||| VB
Smad1  ||| S:20833 E:20839 ||| CD
binding  ||| S:20839 E:20847 ||| NN
to  ||| S:20847 E:20850 ||| TO
HsN3 ||| S:20850 E:20854 ||| CD
.  ||| S:20854 E:20856 ||| .
In  ||| S:20856 E:20859 ||| IN
fact ||| S:20859 E:20863 ||| NN
,  ||| S:20863 E:20865 ||| ,
the  ||| S:20865 E:20879 ||| DT
interaction  ||| S:20879 E:20891 ||| NN
between  ||| S:20891 E:20899 ||| IN
ΔN3  ||| S:20899 E:20903 ||| NNP
and  ||| S:20903 E:20907 ||| CC
Smad1  ||| S:20907 E:20913 ||| NNP
was  ||| S:20913 E:20917 ||| VBD
even  ||| S:20917 E:20922 ||| RB
stronger  ||| S:20922 E:20931 ||| JJR
when  ||| S:20931 E:20946 ||| WRB
directly  ||| S:20946 E:20955 ||| RB
compared  ||| S:20955 E:20964 ||| VBN
with  ||| S:20964 E:20969 ||| IN
the  ||| S:20969 E:20973 ||| DT
interaction  ||| S:20973 E:20985 ||| NN
between  ||| S:20985 E:20993 ||| IN
wild  ||| S:20993 E:20998 ||| JJ
type  ||| S:20998 E:21013 ||| NN
HsN3  ||| S:21013 E:21018 ||| NN
and  ||| S:21018 E:21022 ||| CC
Smad1  ||| S:21022 E:21028 ||| NNP
( ||| S:21028 E:21029 ||| -LRB-
data  ||| S:21029 E:21034 ||| NNS
not  ||| S:21034 E:21038 ||| RB
shown ||| S:21038 E:21043 ||| VBN
) ||| S:21043 E:21044 ||| -RRB-
.  ||| S:21044 E:21046 ||| .
Thus ||| S:21046 E:21050 ||| RB
,  ||| S:21050 E:21052 ||| ,
HsN3  ||| S:21052 E:21057 ||| NNP
does  ||| S:21057 E:21062 ||| VBZ
not  ||| S:21062 E:21076 ||| RB
require  ||| S:21076 E:21084 ||| VB
the  ||| S:21084 E:21088 ||| DT
prosequence  ||| S:21088 E:21100 ||| NN
to  ||| S:21100 E:21103 ||| TO
bind  ||| S:21103 E:21108 ||| CD
Smad1 ||| S:21108 E:21113 ||| CD
.  ||| S:21113 E:21115 ||| .
Since  ||| S:21115 E:21121 ||| IN
we  ||| S:21121 E:21124 ||| PRP
have  ||| S:21124 E:21139 ||| VBP
shown  ||| S:21139 E:21145 ||| VBN
that  ||| S:21145 E:21150 ||| IN
artificial  ||| S:21150 E:21161 ||| JJ
removal  ||| S:21161 E:21169 ||| NN
of  ||| S:21169 E:21172 ||| IN
the  ||| S:21172 E:21176 ||| DT
prosequence  ||| S:21176 E:21188 ||| NN
of  ||| S:21188 E:21191 ||| IN
HsN3  ||| S:21191 E:21206 ||| NNP
leads  ||| S:21206 E:21212 ||| VBZ
to  ||| S:21212 E:21215 ||| TO
a  ||| S:21215 E:21217 ||| DT
blockage  ||| S:21217 E:21226 ||| NN
of  ||| S:21226 E:21229 ||| IN
the  ||| S:21229 E:21233 ||| DT
normal  ||| S:21233 E:21240 ||| JJ
assembly  ||| S:21240 E:21249 ||| NN
of  ||| S:21249 E:21252 ||| IN
HsN3  ||| S:21252 E:21257 ||| CD
into  ||| S:21257 E:21272 ||| IN
the  ||| S:21272 E:21276 ||| DT
mature  ||| S:21276 E:21283 ||| JJ
proteasome  ||| S:21283 E:21294 ||| NNS
( ||| S:21294 E:21295 ||| -LRB-
Fig.  ||| S:21295 E:21300 ||| NNP
2C ||| S:21300 E:21302 ||| NNP
) ||| S:21302 E:21303 ||| -RRB-
,  ||| S:21303 E:21305 ||| ,
we  ||| S:21305 E:21308 ||| PRP
suspect  ||| S:21308 E:21316 ||| VBP
that  ||| S:21316 E:21321 ||| IN
the  ||| S:21321 E:21335 ||| DT
detected  ||| S:21335 E:21344 ||| JJ
strong  ||| S:21344 E:21351 ||| JJ
signals  ||| S:21351 E:21359 ||| NNS
of  ||| S:21359 E:21362 ||| IN
ΔN3  ||| S:21362 E:21366 ||| CD
from  ||| S:21366 E:21371 ||| IN
Smad1  ||| S:21371 E:21387 ||| CD
immunoprecipitates  ||| S:21387 E:21406 ||| NNS
reflect  ||| S:21406 E:21414 ||| VBP
the  ||| S:21414 E:21418 ||| DT
accumulated  ||| S:21418 E:21430 ||| JJ
HsN3  ||| S:21430 E:21435 ||| NN
within  ||| S:21435 E:21452 ||| IN
the  ||| S:21452 E:21456 ||| DT
defective  ||| S:21456 E:21466 ||| JJ
assembly  ||| S:21466 E:21475 ||| NN
intermediates ||| S:21475 E:21488 ||| NN
,  ||| S:21488 E:21490 ||| ,
as  ||| S:21490 E:21493 ||| RB
illustrated  ||| S:21493 E:21505 ||| VBN
in  ||| S:21505 E:21518 ||| IN
Fig.  ||| S:21518 E:21523 ||| CD
2B ||| S:21523 E:21525 ||| CD
.  ||| S:21525 E:21527 ||| .
To  ||| S:21527 E:21530 ||| TO
test  ||| S:21530 E:21535 ||| VB
this  ||| S:21535 E:21540 ||| DT
possibility ||| S:21540 E:21551 ||| NN
,  ||| S:21551 E:21553 ||| ,
we  ||| S:21553 E:21556 ||| PRP
directly  ||| S:21556 E:21565 ||| RB
compared  ||| S:21565 E:21584 ||| VBN
the  ||| S:21584 E:21588 ||| DT
ability  ||| S:21588 E:21596 ||| NN
of  ||| S:21596 E:21599 ||| IN
Smad1  ||| S:21599 E:21605 ||| CD
MH2  ||| S:21605 E:21609 ||| CD
domain  ||| S:21609 E:21616 ||| NN
to  ||| S:21616 E:21619 ||| TO
bind  ||| S:21619 E:21624 ||| VB
wild  ||| S:21624 E:21629 ||| JJ
type  ||| S:21629 E:21634 ||| NN
HsN3  ||| S:21634 E:21649 ||| NN
and  ||| S:21649 E:21653 ||| CC
prosequence-less  ||| S:21653 E:21670 ||| JJ
mutant  ||| S:21670 E:21677 ||| JJ
HsN3  ||| S:21677 E:21682 ||| NN
in  ||| S:21682 E:21685 ||| IN
metabolically  ||| S:21685 E:21699 ||| NN
labeled  ||| S:21699 E:21717 ||| VBD
COS  ||| S:21717 E:21721 ||| NNP
1  ||| S:21721 E:21723 ||| CD
cells  ||| S:21723 E:21729 ||| NNS
( ||| S:21729 E:21730 ||| -LRB-
Fig.  ||| S:21730 E:21735 ||| NNP
4D ||| S:21735 E:21737 ||| NNP
&  ||| S:21737 E:21739 ||| CC
4E ||| S:21739 E:21741 ||| CD
) ||| S:21741 E:21742 ||| -RRB-
.  ||| S:21742 E:21744 ||| .
When  ||| S:21744 E:21749 ||| WRB
COS1  ||| S:21749 E:21754 ||| JJ
cells  ||| S:21754 E:21760 ||| NNS
were  ||| S:21760 E:21775 ||| VBD
expressing  ||| S:21775 E:21786 ||| VBG
wild  ||| S:21786 E:21791 ||| JJ
type  ||| S:21791 E:21796 ||| NN
HsN3 ||| S:21796 E:21800 ||| NN
,  ||| S:21800 E:21802 ||| ,
only  ||| S:21802 E:21807 ||| RB
the  ||| S:21807 E:21811 ||| DT
Pro-N3-F  ||| S:21811 E:21820 ||| NNP
was  ||| S:21820 E:21824 ||| VBD
detected  ||| S:21824 E:21843 ||| VBN
in  ||| S:21843 E:21846 ||| IN
the  ||| S:21846 E:21850 ||| DT
immunoprecipitates  ||| S:21850 E:21869 ||| NN
of  ||| S:21869 E:21872 ||| IN
Smad1MH2  ||| S:21872 E:21881 ||| NNP
( ||| S:21881 E:21882 ||| -LRB-
Fig.  ||| S:21882 E:21887 ||| NNP
4D ||| S:21887 E:21889 ||| NNP
,  ||| S:21889 E:21891 ||| ,
lane  ||| S:21891 E:21896 ||| CD
4 ||| S:21896 E:21897 ||| CD
) ||| S:21897 E:21898 ||| -RRB-
.  ||| S:21898 E:21910 ||| .
When  ||| S:21910 E:21915 ||| WRB
COS1  ||| S:21915 E:21920 ||| JJ
cells  ||| S:21920 E:21926 ||| NNS
were  ||| S:21926 E:21931 ||| VBD
expressing  ||| S:21931 E:21942 ||| VBG
the  ||| S:21942 E:21946 ||| DT
mutant  ||| S:21946 E:21953 ||| JJ
HsN3  ||| S:21953 E:21958 ||| NN
lacking  ||| S:21958 E:21976 ||| VBG
the  ||| S:21976 E:21980 ||| DT
prosequence ||| S:21980 E:21991 ||| NN
,  ||| S:21991 E:21993 ||| ,
the  ||| S:21993 E:21997 ||| DT
mutant  ||| S:21997 E:22004 ||| JJ
N3  ||| S:22004 E:22007 ||| NNP
( ||| S:22007 E:22008 ||| -LRB-
ΔN3 ||| S:22008 E:22011 ||| NNP
)  ||| S:22011 E:22013 ||| -RRB-
and  ||| S:22013 E:22017 ||| CC
ΔN3  ||| S:22017 E:22021 ||| RB
associated  ||| S:22021 E:22042 ||| VBN
endogenous  ||| S:22042 E:22053 ||| JJ
proteins  ||| S:22053 E:22062 ||| NNS
were  ||| S:22062 E:22067 ||| VBD
detected  ||| S:22067 E:22076 ||| VBN
in  ||| S:22076 E:22079 ||| IN
the  ||| S:22079 E:22093 ||| DT
immunoprecipitates  ||| S:22093 E:22112 ||| NN
of  ||| S:22112 E:22115 ||| IN
Smad1MH2  ||| S:22115 E:22124 ||| NNP
( ||| S:22124 E:22125 ||| -LRB-
Fig.  ||| S:22125 E:22130 ||| NNP
4E ||| S:22130 E:22132 ||| NNP
,  ||| S:22132 E:22134 ||| ,
lane  ||| S:22134 E:22139 ||| CD
4 ||| S:22139 E:22140 ||| CD
) ||| S:22140 E:22141 ||| -RRB-
.  ||| S:22141 E:22143 ||| .
In  ||| S:22143 E:22156 ||| IN
addition ||| S:22156 E:22164 ||| NN
,  ||| S:22164 E:22166 ||| ,
four  ||| S:22166 E:22171 ||| CD
distinct  ||| S:22171 E:22180 ||| JJ
small  ||| S:22180 E:22186 ||| JJ
molecular  ||| S:22186 E:22196 ||| JJ
weight  ||| S:22196 E:22203 ||| NN
proteins  ||| S:22203 E:22222 ||| NNS
with  ||| S:22222 E:22227 ||| IN
unknown  ||| S:22227 E:22235 ||| JJ
identity  ||| S:22235 E:22244 ||| NN
were  ||| S:22244 E:22249 ||| VBD
also  ||| S:22249 E:22254 ||| RB
recruited  ||| S:22254 E:22264 ||| VBN
into  ||| S:22264 E:22269 ||| IN
the  ||| S:22269 E:22283 ||| DT
ΔN3 ||| S:22283 E:22286 ||| CD
/ ||| S:22286 E:22287 ||| CD
MH2-containing  ||| S:22287 E:22302 ||| CD
complex  ||| S:22302 E:22310 ||| NN
( ||| S:22310 E:22311 ||| -LRB-
Fig.  ||| S:22311 E:22316 ||| NNP
4E ||| S:22316 E:22318 ||| NNP
,  ||| S:22318 E:22320 ||| ,
lane  ||| S:22320 E:22325 ||| CD
2  ||| S:22325 E:22327 ||| CD
and  ||| S:22327 E:22331 ||| CC
lane  ||| S:22331 E:22336 ||| CD
4 ||| S:22336 E:22337 ||| CD
) ||| S:22337 E:22338 ||| -RRB-
.  ||| S:22338 E:22350 ||| .
These  ||| S:22350 E:22356 ||| DT
four  ||| S:22356 E:22361 ||| CD
bands  ||| S:22361 E:22367 ||| NNS
were  ||| S:22367 E:22372 ||| VBD
specifically  ||| S:22372 E:22385 ||| RB
detected  ||| S:22385 E:22394 ||| VBD
only  ||| S:22394 E:22399 ||| RB
when  ||| S:22399 E:22414 ||| WRB
Smad1MH2  ||| S:22414 E:22423 ||| NNP
and  ||| S:22423 E:22427 ||| CC
ΔN3  ||| S:22427 E:22431 ||| NNP
were  ||| S:22431 E:22436 ||| VBD
co-expressed ||| S:22436 E:22448 ||| JJ
.  ||| S:22448 E:22450 ||| .
When  ||| S:22450 E:22455 ||| WRB
Smad1MH2  ||| S:22455 E:22464 ||| NNP
was  ||| S:22464 E:22478 ||| VBD
replaced  ||| S:22478 E:22487 ||| VBN
with  ||| S:22487 E:22492 ||| IN
full  ||| S:22492 E:22497 ||| JJ
length  ||| S:22497 E:22504 ||| NN
Smad1 ||| S:22504 E:22509 ||| NN
,  ||| S:22509 E:22511 ||| ,
the  ||| S:22511 E:22515 ||| DT
ΔN3-containing  ||| S:22515 E:22540 ||| JJ
complex  ||| S:22540 E:22548 ||| NN
was  ||| S:22548 E:22552 ||| VBD
also  ||| S:22552 E:22557 ||| RB
detected  ||| S:22557 E:22566 ||| VBN
in  ||| S:22566 E:22569 ||| IN
the  ||| S:22569 E:22573 ||| DT
immunoprecipitates  ||| S:22573 E:22592 ||| NN
of  ||| S:22592 E:22605 ||| IN
Smad1  ||| S:22605 E:22611 ||| NNP
( ||| S:22611 E:22612 ||| -LRB-
Fig.  ||| S:22612 E:22617 ||| NNP
4F ||| S:22617 E:22619 ||| NNP
) ||| S:22619 E:22620 ||| -RRB-
.  ||| S:22620 E:22622 ||| .
Thus ||| S:22622 E:22626 ||| RB
,  ||| S:22626 E:22628 ||| ,
a  ||| S:22628 E:22630 ||| DT
blockage  ||| S:22630 E:22639 ||| NN
of  ||| S:22639 E:22642 ||| IN
HsN3  ||| S:22642 E:22647 ||| CD
assembly  ||| S:22647 E:22666 ||| NN
resulted  ||| S:22666 E:22675 ||| VBD
from  ||| S:22675 E:22680 ||| IN
deleting  ||| S:22680 E:22689 ||| VBG
the  ||| S:22689 E:22693 ||| DT
prosequence  ||| S:22693 E:22705 ||| NN
of  ||| S:22705 E:22708 ||| IN
HsN3  ||| S:22708 E:22713 ||| NNP
allows  ||| S:22713 E:22720 ||| VBZ
the  ||| S:22720 E:22734 ||| DT
detection  ||| S:22734 E:22744 ||| NN
of  ||| S:22744 E:22747 ||| IN
a  ||| S:22747 E:22749 ||| DT
stable  ||| S:22749 E:22756 ||| JJ
complex  ||| S:22756 E:22764 ||| NN
between  ||| S:22764 E:22772 ||| IN
Smad1  ||| S:22772 E:22778 ||| NNP
and  ||| S:22778 E:22782 ||| CC
HsN3  ||| S:22782 E:22797 ||| CD
assembly  ||| S:22797 E:22806 ||| NN
intermediates ||| S:22806 E:22819 ||| NN
.  ||| S:22819 E:22821 ||| .
These  ||| S:22821 E:22827 ||| DT
data  ||| S:22827 E:22832 ||| NNS
suggest  ||| S:22832 E:22840 ||| VBP
that  ||| S:22840 E:22845 ||| IN
Smad1  ||| S:22845 E:22861 ||| CD
interacts  ||| S:22861 E:22871 ||| NN
with  ||| S:22871 E:22876 ||| IN
HsN3  ||| S:22876 E:22881 ||| CD
transiently  ||| S:22881 E:22893 ||| NN
when  ||| S:22893 E:22898 ||| WRB
HsN3  ||| S:22898 E:22903 ||| NNP
is  ||| S:22903 E:22906 ||| VBZ
either  ||| S:22906 E:22913 ||| RB
in  ||| S:22913 E:22926 ||| IN
single  ||| S:22926 E:22933 ||| JJ
Pro-HsN3  ||| S:22933 E:22942 ||| CD
form ||| S:22942 E:22946 ||| NN
,  ||| S:22946 E:22948 ||| ,
or  ||| S:22948 E:22951 ||| CC
in  ||| S:22951 E:22954 ||| IN
Pro-HsN3  ||| S:22954 E:22963 ||| CD
assembly  ||| S:22963 E:22982 ||| NN
intermediates ||| S:22982 E:22995 ||| NN
.  ||| S:22995 E:22997 ||| .
The  ||| S:22997 E:23001 ||| DT
lack  ||| S:23001 E:23006 ||| NN
of  ||| S:23006 E:23009 ||| IN
mature  ||| S:23009 E:23016 ||| JJ
HsN3  ||| S:23016 E:23021 ||| NN
in  ||| S:23021 E:23024 ||| IN
Smad1  ||| S:23024 E:23040 ||| CD
immunoprecipitates  ||| S:23040 E:23059 ||| NN
does  ||| S:23059 E:23064 ||| VBZ
not  ||| S:23064 E:23068 ||| RB
reflect  ||| S:23068 E:23076 ||| VB
the  ||| S:23076 E:23080 ||| DT
inability  ||| S:23080 E:23090 ||| NN
of  ||| S:23090 E:23103 ||| IN
Smad1  ||| S:23103 E:23109 ||| CD
to  ||| S:23109 E:23112 ||| TO
bind  ||| S:23112 E:23117 ||| VB
prosequence-less  ||| S:23117 E:23134 ||| JJ
HsN3 ||| S:23134 E:23138 ||| NN
,  ||| S:23138 E:23140 ||| ,
but  ||| S:23140 E:23144 ||| CC
is  ||| S:23144 E:23147 ||| VBZ
likely  ||| S:23147 E:23154 ||| JJ
due  ||| S:23154 E:23158 ||| JJ
to  ||| S:23158 E:23171 ||| TO
either  ||| S:23171 E:23178 ||| VB
the  ||| S:23178 E:23182 ||| DT
trapping ||| S:23182 E:23190 ||| JJ
/ ||| S:23190 E:23191 ||| CD
degradation  ||| S:23191 E:23203 ||| NN
of  ||| S:23203 E:23206 ||| IN
Smad1  ||| S:23206 E:23212 ||| CD
inside  ||| S:23212 E:23219 ||| NN
of  ||| S:23219 E:23222 ||| IN
the  ||| S:23222 E:23236 ||| DT
proteasome ||| S:23236 E:23246 ||| NN
,  ||| S:23246 E:23248 ||| ,
or  ||| S:23248 E:23251 ||| CC
the  ||| S:23251 E:23255 ||| DT
rapid  ||| S:23255 E:23261 ||| JJ
dissociation  ||| S:23261 E:23274 ||| NN
of  ||| S:23274 E:23277 ||| IN
Smad1  ||| S:23277 E:23283 ||| CD
from  ||| S:23283 E:23288 ||| IN
HsN3 ||| S:23288 E:23292 ||| CD
.  ||| S:23292 E:23304 ||| .
The  ||| S:23304 E:23308 ||| DT
degradation  ||| S:23308 E:23320 ||| NN
of  ||| S:23320 E:23323 ||| IN
Smad1  ||| S:23323 E:23329 ||| CD
by  ||| S:23329 E:23332 ||| IN
proteasome  ||| S:23332 E:23343 ||| NN
is  ||| S:23343 E:23346 ||| VBZ
reported  ||| S:23346 E:23355 ||| VBN
in  ||| S:23355 E:23358 ||| IN
a  ||| S:23358 E:23370 ||| DT
separate  ||| S:23370 E:23379 ||| JJ
study  ||| S:23379 E:23385 ||| NN
[  ||| S:23385 E:23387 ||| -LRB-
39  ||| S:23387 E:23390 ||| CD
]  ||| S:23390 E:23392 ||| -RRB-
.  ||| S:23392 E:23394 ||| .
The  ||| S:23394 E:23398 ||| DT
dissociation  ||| S:23398 E:23411 ||| NN
of  ||| S:23411 E:23414 ||| IN
Smad1  ||| S:23414 E:23420 ||| CD
from  ||| S:23420 E:23435 ||| IN
the  ||| S:23435 E:23439 ||| DT
mature  ||| S:23439 E:23446 ||| JJ
20S  ||| S:23446 E:23450 ||| CD
proteasome  ||| S:23450 E:23461 ||| NNS
could  ||| S:23461 E:23467 ||| MD
be  ||| S:23467 E:23470 ||| VB
due  ||| S:23470 E:23474 ||| JJ
to  ||| S:23474 E:23477 ||| TO
the  ||| S:23477 E:23481 ||| DT
competition  ||| S:23481 E:23503 ||| NN
of  ||| S:23503 E:23506 ||| IN
Smad1  ||| S:23506 E:23512 ||| CD
binding  ||| S:23512 E:23520 ||| NN
by  ||| S:23520 E:23523 ||| IN
a  ||| S:23523 E:23525 ||| DT
19S  ||| S:23525 E:23529 ||| JJ
regulator  ||| S:23529 E:23539 ||| NN
protein  ||| S:23539 E:23547 ||| NN
or  ||| S:23547 E:23550 ||| CC
simply  ||| S:23550 E:23557 ||| RB
due  ||| S:23557 E:23571 ||| JJ
to  ||| S:23571 E:23574 ||| TO
the  ||| S:23574 E:23578 ||| DT
inaccessibility  ||| S:23578 E:23594 ||| NN
of  ||| S:23594 E:23597 ||| IN
the  ||| S:23597 E:23601 ||| DT
binding  ||| S:23601 E:23609 ||| JJ
site  ||| S:23609 E:23614 ||| NN
on  ||| S:23614 E:23617 ||| IN
HsN3  ||| S:23617 E:23622 ||| CD
when  ||| S:23622 E:23637 ||| WRB
two  ||| S:23637 E:23641 ||| CD
half  ||| S:23641 E:23646 ||| NN
proteasomes  ||| S:23646 E:23658 ||| NN
assembly  ||| S:23658 E:23667 ||| NN
into  ||| S:23667 E:23672 ||| IN
the  ||| S:23672 E:23676 ||| DT
mature  ||| S:23676 E:23693 ||| JJ
proteasome ||| S:23693 E:23703 ||| NN
.  ||| S:23703 E:23733 ||| .
Two  ||| S:23733 E:23737 ||| CD
separate  ||| S:23737 E:23746 ||| JJ
domains  ||| S:23746 E:23754 ||| NN
on  ||| S:23754 E:23757 ||| IN
Az  ||| S:23757 E:23760 ||| NNP
mediate  ||| S:23760 E:23768 ||| VBD
interaction  ||| S:23768 E:23780 ||| VBN
with  ||| S:23780 E:23795 ||| IN
Smad1  ||| S:23795 E:23801 ||| NNP
and  ||| S:23801 E:23805 ||| CC
HsN3  ||| S:23805 E:23810 ||| CD
prior  ||| S:23810 E:23816 ||| JJ
to  ||| S:23816 E:23819 ||| TO
HsN3  ||| S:23819 E:23824 ||| CD
incorporation  ||| S:23824 E:23838 ||| NN
into  ||| S:23838 E:23843 ||| IN
the  ||| S:23843 E:23847 ||| DT
20S  ||| S:23847 E:23861 ||| NNP
proteasome  ||| S:23861 E:23882 ||| VBD
We  ||| S:23882 E:23885 ||| PRP
next  ||| S:23885 E:23890 ||| RB
examined  ||| S:23890 E:23899 ||| VBD
the  ||| S:23899 E:23903 ||| DT
interaction  ||| S:23903 E:23915 ||| NN
between  ||| S:23915 E:23923 ||| IN
Az  ||| S:23923 E:23926 ||| NNP
and  ||| S:23926 E:23930 ||| CC
Smad1  ||| S:23930 E:23946 ||| CD
in  ||| S:23946 E:23949 ||| IN
COS1  ||| S:23949 E:23954 ||| CD
cells ||| S:23954 E:23959 ||| NNS
.  ||| S:23959 E:23961 ||| .
In  ||| S:23961 E:23964 ||| IN
the  ||| S:23964 E:23968 ||| DT
absence  ||| S:23968 E:23976 ||| NN
of  ||| S:23976 E:23979 ||| IN
the  ||| S:23979 E:23983 ||| DT
co-expressed  ||| S:23983 E:23996 ||| JJ
HsN3 ||| S:23996 E:24000 ||| NN
,  ||| S:24000 E:24012 ||| ,
Smad1  ||| S:24012 E:24018 ||| NNP
was  ||| S:24018 E:24022 ||| VBD
co-precipitated  ||| S:24022 E:24038 ||| JJ
with  ||| S:24038 E:24043 ||| IN
Az  ||| S:24043 E:24046 ||| NNP
( ||| S:24046 E:24047 ||| -LRB-
Fig.  ||| S:24047 E:24052 ||| NNP
5A ||| S:24052 E:24054 ||| NNP
,  ||| S:24054 E:24056 ||| ,
top  ||| S:24056 E:24060 ||| JJ
panel ||| S:24060 E:24065 ||| NN
,  ||| S:24065 E:24077 ||| ,
lane  ||| S:24077 E:24082 ||| CD
1 ||| S:24082 E:24083 ||| CD
) ||| S:24083 E:24084 ||| -RRB-
.  ||| S:24084 E:24086 ||| .
The  ||| S:24086 E:24090 ||| DT
interaction  ||| S:24090 E:24102 ||| NN
was  ||| S:24102 E:24106 ||| VBD
diminished  ||| S:24106 E:24117 ||| VBN
when  ||| S:24117 E:24122 ||| WRB
cells  ||| S:24122 E:24128 ||| NNS
were  ||| S:24128 E:24143 ||| VBD
co-transfected  ||| S:24143 E:24158 ||| JJ
with  ||| S:24158 E:24163 ||| IN
the  ||| S:24163 E:24167 ||| DT
activated  ||| S:24167 E:24177 ||| JJ
BMP  ||| S:24177 E:24181 ||| NN
type  ||| S:24181 E:24186 ||| NN
I  ||| S:24186 E:24188 ||| PRP
receptor  ||| S:24188 E:24207 ||| VBD
ALK3Q233D  ||| S:24207 E:24217 ||| CD
( ||| S:24217 E:24218 ||| -LRB-
Fig.  ||| S:24218 E:24223 ||| NNP
5A ||| S:24223 E:24225 ||| NNP
,  ||| S:24225 E:24227 ||| ,
top  ||| S:24227 E:24231 ||| JJ
panel ||| S:24231 E:24236 ||| NN
,  ||| S:24236 E:24238 ||| ,
lane  ||| S:24238 E:24243 ||| CD
3 ||| S:24243 E:24244 ||| CD
) ||| S:24244 E:24245 ||| -RRB-
.  ||| S:24245 E:24247 ||| .
However ||| S:24247 E:24254 ||| RB
,  ||| S:24254 E:24256 ||| ,
the  ||| S:24256 E:24270 ||| DT
addition  ||| S:24270 E:24279 ||| NN
of  ||| S:24279 E:24282 ||| IN
proteasome  ||| S:24282 E:24293 ||| JJ
inhibitor  ||| S:24293 E:24303 ||| JJ
LLnL  ||| S:24303 E:24308 ||| NN
stabilizes  ||| S:24308 E:24319 ||| VBZ
the  ||| S:24319 E:24333 ||| DT
interaction  ||| S:24333 E:24345 ||| NN
( ||| S:24345 E:24346 ||| -LRB-
Fig.  ||| S:24346 E:24351 ||| NNP
5A ||| S:24351 E:24353 ||| NNP
,  ||| S:24353 E:24355 ||| ,
top  ||| S:24355 E:24359 ||| JJ
panel ||| S:24359 E:24364 ||| NN
,  ||| S:24364 E:24366 ||| ,
lane  ||| S:24366 E:24371 ||| CD
2 ||| S:24371 E:24372 ||| CD
) ||| S:24372 E:24373 ||| -RRB-
.  ||| S:24373 E:24375 ||| .
Thus ||| S:24375 E:24379 ||| RB
,  ||| S:24379 E:24381 ||| ,
Smad1  ||| S:24381 E:24397 ||| CD
interacts  ||| S:24397 E:24407 ||| NN
with  ||| S:24407 E:24412 ||| IN
Az  ||| S:24412 E:24415 ||| NNP
in  ||| S:24415 E:24418 ||| IN
mammalian  ||| S:24418 E:24428 ||| JJ
cells  ||| S:24428 E:24434 ||| NNS
and  ||| S:24434 E:24438 ||| CC
the  ||| S:24438 E:24442 ||| DT
interaction  ||| S:24442 E:24464 ||| NN
is  ||| S:24464 E:24467 ||| VBZ
also  ||| S:24467 E:24472 ||| RB
enhanced  ||| S:24472 E:24481 ||| VBN
upon  ||| S:24481 E:24486 ||| IN
BMP  ||| S:24486 E:24490 ||| NN
type  ||| S:24490 E:24495 ||| NN
I  ||| S:24495 E:24497 ||| PRP
receptor  ||| S:24497 E:24506 ||| VBP
activation ||| S:24506 E:24516 ||| VBN
.  ||| S:24516 E:24518 ||| .
In  ||| S:24518 E:24531 ||| IN
the  ||| S:24531 E:24535 ||| DT
yeast  ||| S:24535 E:24541 ||| NN
two-hybrid  ||| S:24541 E:24552 ||| JJ
tests ||| S:24552 E:24557 ||| NNS
,  ||| S:24557 E:24559 ||| ,
we  ||| S:24559 E:24562 ||| PRP
also  ||| S:24562 E:24567 ||| RB
observed  ||| S:24567 E:24576 ||| VBD
the  ||| S:24576 E:24580 ||| DT
ability  ||| S:24580 E:24598 ||| NN
of  ||| S:24598 E:24601 ||| IN
Az  ||| S:24601 E:24604 ||| NNP
to  ||| S:24604 E:24607 ||| TO
bind  ||| S:24607 E:24612 ||| VB
HsN3  ||| S:24612 E:24617 ||| NNP
[  ||| S:24617 E:24619 ||| -LRB-
39  ||| S:24619 E:24622 ||| CD
]  ||| S:24622 E:24624 ||| -RRB-
.  ||| S:24624 E:24626 ||| .
Domain  ||| S:24626 E:24633 ||| JJ
mapping  ||| S:24633 E:24641 ||| NN
analyses  ||| S:24641 E:24650 ||| NNS
of  ||| S:24650 E:24653 ||| IN
Az  ||| S:24653 E:24666 ||| NNP
reveals  ||| S:24666 E:24674 ||| VBZ
two  ||| S:24674 E:24678 ||| CD
separate  ||| S:24678 E:24687 ||| JJ
domains  ||| S:24687 E:24695 ||| NN
on  ||| S:24695 E:24698 ||| IN
Az  ||| S:24698 E:24701 ||| NNP
that  ||| S:24701 E:24706 ||| WDT
are  ||| S:24706 E:24710 ||| VBP
involved  ||| S:24710 E:24719 ||| VBN
in  ||| S:24719 E:24732 ||| IN
binding  ||| S:24732 E:24740 ||| VBG
to  ||| S:24740 E:24743 ||| TO
Smad1  ||| S:24743 E:24749 ||| CD
and  ||| S:24749 E:24753 ||| CC
HsN3  ||| S:24753 E:24758 ||| NNP
( ||| S:24758 E:24759 ||| -LRB-
Fig.  ||| S:24759 E:24764 ||| NNP
5B ||| S:24764 E:24766 ||| NNP
) ||| S:24766 E:24767 ||| -RRB-
.  ||| S:24767 E:24769 ||| .
In  ||| S:24769 E:24772 ||| IN
mammalian  ||| S:24772 E:24782 ||| JJ
cells ||| S:24782 E:24787 ||| NNS
,  ||| S:24787 E:24799 ||| ,
co-expression  ||| S:24799 E:24813 ||| JJ
of  ||| S:24813 E:24816 ||| IN
Az  ||| S:24816 E:24819 ||| NNP
with  ||| S:24819 E:24824 ||| IN
Smad1  ||| S:24824 E:24830 ||| NNP
and  ||| S:24830 E:24834 ||| CC
HsN3  ||| S:24834 E:24839 ||| NNP
leads  ||| S:24839 E:24845 ||| VBZ
to  ||| S:24845 E:24848 ||| TO
the  ||| S:24848 E:24862 ||| DT
detection  ||| S:24862 E:24872 ||| NN
of  ||| S:24872 E:24875 ||| IN
both  ||| S:24875 E:24880 ||| DT
Smad1  ||| S:24880 E:24886 ||| NNP
and  ||| S:24886 E:24890 ||| CC
Pro-N3  ||| S:24890 E:24897 ||| CD
in  ||| S:24897 E:24900 ||| IN
the  ||| S:24900 E:24914 ||| DT
immunoprecipitates  ||| S:24914 E:24933 ||| NN
of  ||| S:24933 E:24936 ||| IN
Az  ||| S:24936 E:24939 ||| NNP
( ||| S:24939 E:24940 ||| -LRB-
Fig.  ||| S:24940 E:24945 ||| NNP
5C ||| S:24945 E:24947 ||| NNP
,  ||| S:24947 E:24949 ||| ,
top  ||| S:24949 E:24953 ||| JJ
panel ||| S:24953 E:24958 ||| NN
,  ||| S:24958 E:24960 ||| ,
lane  ||| S:24960 E:24965 ||| CD
6 ||| S:24965 E:24966 ||| CD
) ||| S:24966 E:24967 ||| -RRB-
.  ||| S:24967 E:24979 ||| .
There  ||| S:24979 E:24985 ||| EX
appears  ||| S:24985 E:24993 ||| VBZ
to  ||| S:24993 E:24996 ||| TO
be  ||| S:24996 E:24999 ||| VB
a  ||| S:24999 E:25001 ||| DT
stoichiomatric  ||| S:25001 E:25016 ||| JJ
relationship  ||| S:25016 E:25029 ||| NN
between  ||| S:25029 E:25047 ||| IN
these  ||| S:25047 E:25053 ||| DT
three  ||| S:25053 E:25059 ||| CD
proteins ||| S:25059 E:25067 ||| NNS
,  ||| S:25067 E:25069 ||| ,
since  ||| S:25069 E:25075 ||| IN
the  ||| S:25075 E:25079 ||| DT
relative  ||| S:25079 E:25088 ||| JJ
levels  ||| S:25088 E:25095 ||| NNS
of  ||| S:25095 E:25098 ||| IN
these  ||| S:25098 E:25114 ||| DT
three  ||| S:25114 E:25120 ||| CD
proteins  ||| S:25120 E:25129 ||| NNS
influence  ||| S:25129 E:25139 ||| VBP
the  ||| S:25139 E:25143 ||| DT
interaction  ||| S:25143 E:25155 ||| JJ
properties  ||| S:25155 E:25166 ||| NNS
( ||| S:25166 E:25167 ||| -LRB-
Fig.  ||| S:25167 E:25182 ||| NNP
5C ||| S:25182 E:25184 ||| NNP
) ||| S:25184 E:25185 ||| -RRB-
.  ||| S:25185 E:25187 ||| .
These  ||| S:25187 E:25193 ||| DT
data  ||| S:25193 E:25198 ||| NNS
suggest  ||| S:25198 E:25206 ||| VBP
that  ||| S:25206 E:25211 ||| IN
Smad1 ||| S:25211 E:25216 ||| NNP
,  ||| S:25216 E:25218 ||| ,
Az  ||| S:25218 E:25221 ||| NNP
and  ||| S:25221 E:25225 ||| CC
HsN3  ||| S:25225 E:25230 ||| NNP
might  ||| S:25230 E:25246 ||| MD
form  ||| S:25246 E:25251 ||| VB
a  ||| S:25251 E:25253 ||| DT
ternary  ||| S:25253 E:25261 ||| JJ
complex ||| S:25261 E:25268 ||| NN
.  ||| S:25268 E:25270 ||| .
Since  ||| S:25270 E:25276 ||| IN
we  ||| S:25276 E:25279 ||| PRP
again  ||| S:25279 E:25285 ||| RB
only  ||| S:25285 E:25290 ||| RB
detected  ||| S:25290 E:25299 ||| VBD
the  ||| S:25299 E:25313 ||| DT
pro-sequence  ||| S:25313 E:25326 ||| JJ
form  ||| S:25326 E:25331 ||| NN
of  ||| S:25331 E:25334 ||| IN
HsN3  ||| S:25334 E:25339 ||| CD
in  ||| S:25339 E:25342 ||| IN
Az  ||| S:25342 E:25345 ||| NNP
precipitates ||| S:25345 E:25357 ||| NN
,  ||| S:25357 E:25359 ||| ,
such  ||| S:25359 E:25364 ||| PDT
a  ||| S:25364 E:25376 ||| DT
ternary  ||| S:25376 E:25384 ||| JJ
complex  ||| S:25384 E:25392 ||| NN
is  ||| S:25392 E:25395 ||| VBZ
likely  ||| S:25395 E:25402 ||| RB
formed  ||| S:25402 E:25409 ||| VBN
along  ||| S:25409 E:25415 ||| IN
the  ||| S:25415 E:25419 ||| DT
assembly  ||| S:25419 E:25438 ||| NN
pathways  ||| S:25438 E:25447 ||| NN
of  ||| S:25447 E:25450 ||| IN
HsN3 ||| S:25450 E:25454 ||| CD
.  ||| S:25454 E:25484 ||| .
The  ||| S:25484 E:25488 ||| DT
Activation  ||| S:25488 E:25499 ||| NNP
of  ||| S:25499 E:25502 ||| IN
the  ||| S:25502 E:25506 ||| DT
BMP  ||| S:25506 E:25510 ||| NN
type  ||| S:25510 E:25515 ||| NN
I  ||| S:25515 E:25517 ||| PRP
receptor  ||| S:25517 E:25526 ||| VBD
induces  ||| S:25526 E:25544 ||| CD
Smad1-dependent  ||| S:25544 E:25560 ||| CD
nuclear  ||| S:25560 E:25568 ||| JJ
translocation  ||| S:25568 E:25582 ||| NN
of  ||| S:25582 E:25585 ||| IN
both  ||| S:25585 E:25590 ||| DT
HsN3  ||| S:25590 E:25595 ||| NNP
and  ||| S:25595 E:25609 ||| CC
Az  ||| S:25609 E:25622 ||| NNP
Smad1  ||| S:25622 E:25628 ||| NNP
is  ||| S:25628 E:25631 ||| VBZ
translocated  ||| S:25631 E:25644 ||| VBN
from  ||| S:25644 E:25649 ||| IN
the  ||| S:25649 E:25653 ||| DT
cytoplasm  ||| S:25653 E:25663 ||| NN
to  ||| S:25663 E:25666 ||| TO
the  ||| S:25666 E:25680 ||| DT
nucleus  ||| S:25680 E:25688 ||| NN
upon  ||| S:25688 E:25693 ||| IN
its  ||| S:25693 E:25697 ||| PRP$
activation  ||| S:25697 E:25708 ||| NN
by  ||| S:25708 E:25711 ||| IN
the  ||| S:25711 E:25715 ||| DT
BMP  ||| S:25715 E:25719 ||| NN
type  ||| S:25719 E:25724 ||| NN
I  ||| S:25724 E:25726 ||| PRP
receptors  ||| S:25726 E:25736 ||| VBP
[  ||| S:25736 E:25748 ||| -LRB-
40  ||| S:25748 E:25751 ||| CD
]  ||| S:25751 E:25753 ||| -RRB-
.  ||| S:25753 E:25755 ||| .
The  ||| S:25755 E:25759 ||| DT
physical  ||| S:25759 E:25768 ||| JJ
interaction  ||| S:25768 E:25780 ||| NN
between  ||| S:25780 E:25788 ||| IN
Smad1 ||| S:25788 E:25793 ||| NNP
,  ||| S:25793 E:25795 ||| ,
Az  ||| S:25795 E:25798 ||| NNP
and  ||| S:25798 E:25812 ||| CC
HsN3  ||| S:25812 E:25817 ||| NNP
suggests  ||| S:25817 E:25826 ||| VBZ
that  ||| S:25826 E:25831 ||| DT
BMP  ||| S:25831 E:25835 ||| NN
signaling  ||| S:25835 E:25845 ||| NNS
might  ||| S:25845 E:25851 ||| MD
regulate  ||| S:25851 E:25860 ||| VB
the  ||| S:25860 E:25874 ||| DT
intracellular  ||| S:25874 E:25888 ||| JJ
localization  ||| S:25888 E:25901 ||| NN
of  ||| S:25901 E:25904 ||| IN
Az  ||| S:25904 E:25907 ||| NNP
and  ||| S:25907 E:25911 ||| CC
HsN3 ||| S:25911 E:25915 ||| NNP
.  ||| S:25915 E:25917 ||| .
We  ||| S:25917 E:25920 ||| PRP
tested  ||| S:25920 E:25927 ||| VBD
the  ||| S:25927 E:25941 ||| DT
localization  ||| S:25941 E:25954 ||| NN
of  ||| S:25954 E:25957 ||| IN
endogenous  ||| S:25957 E:25968 ||| JJ
HsN3  ||| S:25968 E:25973 ||| NN
in  ||| S:25973 E:25976 ||| IN
COS1  ||| S:25976 E:25981 ||| CD
cell  ||| S:25981 E:25986 ||| NN
line ||| S:25986 E:25990 ||| NN
,  ||| S:25990 E:25992 ||| ,
which  ||| S:25992 E:26008 ||| WDT
was  ||| S:26008 E:26012 ||| VBD
transiently  ||| S:26012 E:26024 ||| JJ
transfected  ||| S:26024 E:26036 ||| NN
with  ||| S:26036 E:26041 ||| IN
Smad1 ||| S:26041 E:26046 ||| NNP
,  ||| S:26046 E:26048 ||| ,
ALK3  ||| S:26048 E:26053 ||| NNP
and  ||| S:26053 E:26057 ||| CC
the  ||| S:26057 E:26061 ||| DT
BMP  ||| S:26061 E:26075 ||| NN
type  ||| S:26075 E:26080 ||| NN
II  ||| S:26080 E:26083 ||| NNP
receptor ||| S:26083 E:26091 ||| NN
.  ||| S:26091 E:26093 ||| .
Cells  ||| S:26093 E:26099 ||| NNS
were  ||| S:26099 E:26104 ||| VBD
either  ||| S:26104 E:26111 ||| RB
not  ||| S:26111 E:26115 ||| RB
exposed  ||| S:26115 E:26123 ||| VBN
to  ||| S:26123 E:26126 ||| TO
BMP2  ||| S:26126 E:26141 ||| CD
( ||| S:26141 E:26142 ||| -LRB-
Fig.  ||| S:26142 E:26147 ||| NNP
6A ||| S:26147 E:26149 ||| NNP
) ||| S:26149 E:26150 ||| -RRB-
,  ||| S:26150 E:26152 ||| ,
or  ||| S:26152 E:26155 ||| CC
treated  ||| S:26155 E:26163 ||| VBN
with  ||| S:26163 E:26168 ||| IN
BMP2  ||| S:26168 E:26173 ||| CD
for  ||| S:26173 E:26177 ||| IN
30  ||| S:26177 E:26180 ||| CD
mins  ||| S:26180 E:26185 ||| NNS
( ||| S:26185 E:26186 ||| -LRB-
Fig.  ||| S:26186 E:26191 ||| NNP
6B ||| S:26191 E:26193 ||| NNP
)  ||| S:26193 E:26195 ||| -RRB-
or  ||| S:26195 E:26208 ||| CC
60  ||| S:26208 E:26211 ||| CD
mins  ||| S:26211 E:26216 ||| NNS
( ||| S:26216 E:26217 ||| -LRB-
Fig.  ||| S:26217 E:26222 ||| NNP
6C ||| S:26222 E:26224 ||| NNP
) ||| S:26224 E:26225 ||| -RRB-
.  ||| S:26225 E:26227 ||| .
Cells  ||| S:26227 E:26233 ||| NNS
were  ||| S:26233 E:26238 ||| VBD
stained  ||| S:26238 E:26246 ||| VBN
with  ||| S:26246 E:26251 ||| IN
a  ||| S:26251 E:26253 ||| DT
monoclonal  ||| S:26253 E:26274 ||| JJ
anti-HsN3  ||| S:26274 E:26284 ||| CD
antibody  ||| S:26284 E:26293 ||| NN
and  ||| S:26293 E:26297 ||| CC
FITC-conjugated  ||| S:26297 E:26313 ||| JJ
anti-mouse  ||| S:26313 E:26334 ||| JJ
secondary  ||| S:26334 E:26344 ||| JJ
( ||| S:26344 E:26345 ||| -LRB-
Fig.  ||| S:26345 E:26350 ||| NNP
6A ||| S:26350 E:26352 ||| NNP
, ||| S:26352 E:26353 ||| ,
6B ||| S:26353 E:26355 ||| NNP
, ||| S:26355 E:26356 ||| ,
6C ||| S:26356 E:26358 ||| NNP
,  ||| S:26358 E:26360 ||| ,
panels  ||| S:26360 E:26367 ||| CD
1 ||| S:26367 E:26368 ||| CD
)  ||| S:26368 E:26370 ||| -RRB-
and  ||| S:26370 E:26374 ||| CC
simultaneously  ||| S:26374 E:26399 ||| RB
with  ||| S:26399 E:26404 ||| IN
a  ||| S:26404 E:26406 ||| DT
polyclonal  ||| S:26406 E:26417 ||| JJ
anti-Smad1  ||| S:26417 E:26428 ||| CD
antibody  ||| S:26428 E:26437 ||| NN
and  ||| S:26437 E:26451 ||| CC
rhodamine-conjugated  ||| S:26451 E:26472 ||| JJ
anti-rabbit  ||| S:26472 E:26484 ||| JJ
secondary  ||| S:26484 E:26494 ||| JJ
antibody  ||| S:26494 E:26503 ||| NN
( ||| S:26503 E:26504 ||| -LRB-
Fig.  ||| S:26504 E:26519 ||| NNP
6A ||| S:26519 E:26521 ||| NNP
, ||| S:26521 E:26522 ||| ,
6B ||| S:26522 E:26524 ||| NNP
, ||| S:26524 E:26525 ||| ,
6C ||| S:26525 E:26527 ||| NNP
,  ||| S:26527 E:26529 ||| ,
panels  ||| S:26529 E:26536 ||| CD
2 ||| S:26536 E:26537 ||| CD
) ||| S:26537 E:26538 ||| -RRB-
.  ||| S:26538 E:26540 ||| .
The  ||| S:26540 E:26544 ||| DT
co-localization  ||| S:26544 E:26560 ||| JJ
of  ||| S:26560 E:26563 ||| IN
Smad1  ||| S:26563 E:26569 ||| NNP
and  ||| S:26569 E:26583 ||| CC
HsN3  ||| S:26583 E:26588 ||| NNP
was  ||| S:26588 E:26592 ||| VBD
detected  ||| S:26592 E:26601 ||| VBN
by  ||| S:26601 E:26604 ||| IN
overlaying  ||| S:26604 E:26615 ||| VBG
the  ||| S:26615 E:26619 ||| DT
signals  ||| S:26619 E:26627 ||| NNS
in  ||| S:26627 E:26630 ||| IN
panels  ||| S:26630 E:26637 ||| CD
1  ||| S:26637 E:26649 ||| CD
and  ||| S:26649 E:26653 ||| CC
panels  ||| S:26653 E:26660 ||| CD
2  ||| S:26660 E:26662 ||| CD
and  ||| S:26662 E:26666 ||| CC
shown  ||| S:26666 E:26672 ||| VBN
in  ||| S:26672 E:26675 ||| IN
panels  ||| S:26675 E:26682 ||| CD
3 ||| S:26682 E:26683 ||| CD
.  ||| S:26683 E:26685 ||| .
Smad1  ||| S:26685 E:26691 ||| NNP
and  ||| S:26691 E:26695 ||| CC
HsN3  ||| S:26695 E:26700 ||| NNP
were  ||| S:26700 E:26715 ||| VBD
detected  ||| S:26715 E:26724 ||| VBN
in  ||| S:26724 E:26727 ||| IN
both  ||| S:26727 E:26732 ||| PDT
the  ||| S:26732 E:26736 ||| DT
cytoplasm  ||| S:26736 E:26746 ||| NN
and  ||| S:26746 E:26750 ||| CC
the  ||| S:26750 E:26754 ||| DT
nucleus  ||| S:26754 E:26762 ||| NN
in  ||| S:26762 E:26765 ||| IN
cells  ||| S:26765 E:26781 ||| NNS
that  ||| S:26781 E:26786 ||| WDT
were  ||| S:26786 E:26791 ||| VBD
not  ||| S:26791 E:26795 ||| RB
exposed  ||| S:26795 E:26803 ||| VBN
to  ||| S:26803 E:26806 ||| TO
BMP2  ||| S:26806 E:26811 ||| CD
( ||| S:26811 E:26812 ||| -LRB-
Fig.  ||| S:26812 E:26817 ||| NNP
6A ||| S:26817 E:26819 ||| NNP
,  ||| S:26819 E:26821 ||| ,
panels  ||| S:26821 E:26828 ||| CD
1-3 ||| S:26828 E:26831 ||| CD
) ||| S:26831 E:26832 ||| -RRB-
.  ||| S:26832 E:26834 ||| .
In  ||| S:26834 E:26847 ||| IN
cells  ||| S:26847 E:26853 ||| NNS
treated  ||| S:26853 E:26861 ||| VBN
with  ||| S:26861 E:26866 ||| IN
BMP2  ||| S:26866 E:26871 ||| CD
for  ||| S:26871 E:26875 ||| IN
30  ||| S:26875 E:26878 ||| CD
mins ||| S:26878 E:26882 ||| NN
,  ||| S:26882 E:26884 ||| ,
most  ||| S:26884 E:26889 ||| RBS
HsN3  ||| S:26889 E:26894 ||| JJ
and  ||| S:26894 E:26898 ||| CC
Smad1  ||| S:26898 E:26914 ||| NNP
were  ||| S:26914 E:26919 ||| VBD
concentrated  ||| S:26919 E:26932 ||| VBN
in  ||| S:26932 E:26935 ||| IN
the  ||| S:26935 E:26939 ||| DT
nucleus  ||| S:26939 E:26947 ||| NN
( ||| S:26947 E:26948 ||| -LRB-
Fig.  ||| S:26948 E:26953 ||| NNP
6B ||| S:26953 E:26955 ||| NNP
,  ||| S:26955 E:26957 ||| ,
panels  ||| S:26957 E:26964 ||| CD
1  ||| S:26964 E:26966 ||| CD
&  ||| S:26966 E:26978 ||| CC
2 ||| S:26978 E:26979 ||| LS
)  ||| S:26979 E:26981 ||| -RRB-
and  ||| S:26981 E:26985 ||| CC
co-localization  ||| S:26985 E:27001 ||| JJ
of  ||| S:27001 E:27004 ||| IN
Smad1  ||| S:27004 E:27010 ||| NNP
and  ||| S:27010 E:27014 ||| CC
HsN3  ||| S:27014 E:27019 ||| NNP
was  ||| S:27019 E:27023 ||| VBD
detected  ||| S:27023 E:27032 ||| VBN
in  ||| S:27032 E:27045 ||| IN
the  ||| S:27045 E:27049 ||| DT
nucleus  ||| S:27049 E:27057 ||| NN
( ||| S:27057 E:27058 ||| -LRB-
Fig.  ||| S:27058 E:27063 ||| NNP
6B ||| S:27063 E:27065 ||| NNP
,  ||| S:27065 E:27067 ||| ,
panel  ||| S:27067 E:27073 ||| NN
3 ||| S:27073 E:27074 ||| LS
) ||| S:27074 E:27075 ||| -RRB-
.  ||| S:27075 E:27077 ||| .
In  ||| S:27077 E:27080 ||| IN
cells  ||| S:27080 E:27086 ||| NNS
treated  ||| S:27086 E:27094 ||| VBN
with  ||| S:27094 E:27109 ||| IN
BMP2  ||| S:27109 E:27114 ||| CD
for  ||| S:27114 E:27118 ||| IN
60  ||| S:27118 E:27121 ||| CD
mins ||| S:27121 E:27125 ||| NN
,  ||| S:27125 E:27127 ||| ,
all  ||| S:27127 E:27131 ||| DT
signals  ||| S:27131 E:27139 ||| NNS
of  ||| S:27139 E:27142 ||| IN
Smad1  ||| S:27142 E:27148 ||| NNP
and  ||| S:27148 E:27152 ||| CC
HsN3  ||| S:27152 E:27157 ||| NNP
were  ||| S:27157 E:27172 ||| VBD
detected  ||| S:27172 E:27181 ||| VBN
to  ||| S:27181 E:27184 ||| TO
be  ||| S:27184 E:27187 ||| VB
co-localized  ||| S:27187 E:27200 ||| JJ
in  ||| S:27200 E:27203 ||| IN
the  ||| S:27203 E:27207 ||| DT
nucleus  ||| S:27207 E:27215 ||| NN
( ||| S:27215 E:27216 ||| -LRB-
Fig.  ||| S:27216 E:27221 ||| NNP
6C ||| S:27221 E:27223 ||| NNP
,  ||| S:27223 E:27235 ||| ,
panels  ||| S:27235 E:27242 ||| CD
1-3 ||| S:27242 E:27245 ||| CD
) ||| S:27245 E:27246 ||| -RRB-
.  ||| S:27246 E:27258 ||| .
We  ||| S:27258 E:27261 ||| PRP
further  ||| S:27261 E:27269 ||| RB
tested  ||| S:27269 E:27276 ||| VBN
the  ||| S:27276 E:27280 ||| DT
role  ||| S:27280 E:27285 ||| NN
of  ||| S:27285 E:27288 ||| IN
Smad1  ||| S:27288 E:27294 ||| CD
in  ||| S:27294 E:27297 ||| IN
the  ||| S:27297 E:27301 ||| DT
nuclear  ||| S:27301 E:27319 ||| JJ
translocation  ||| S:27319 E:27333 ||| NN
of  ||| S:27333 E:27336 ||| IN
HsN3 ||| S:27336 E:27340 ||| CD
.  ||| S:27340 E:27342 ||| .
HsN3  ||| S:27342 E:27347 ||| NNP
was  ||| S:27347 E:27351 ||| VBD
detected  ||| S:27351 E:27360 ||| VBN
in  ||| S:27360 E:27363 ||| IN
speckled  ||| S:27363 E:27382 ||| JJ
pattern  ||| S:27382 E:27390 ||| NN
throughout  ||| S:27390 E:27401 ||| IN
the  ||| S:27401 E:27405 ||| DT
cytoplasm  ||| S:27405 E:27415 ||| NN
and  ||| S:27415 E:27419 ||| CC
the  ||| S:27419 E:27423 ||| DT
nucleus  ||| S:27423 E:27431 ||| NN
when  ||| S:27431 E:27436 ||| WRB
it  ||| S:27436 E:27449 ||| PRP
was  ||| S:27449 E:27453 ||| VBD
expressed  ||| S:27453 E:27463 ||| VBN
alone  ||| S:27463 E:27469 ||| RB
in  ||| S:27469 E:27472 ||| IN
COS1  ||| S:27472 E:27477 ||| CD
cells  ||| S:27477 E:27483 ||| NNS
( ||| S:27483 E:27484 ||| -LRB-
Fig.  ||| S:27484 E:27489 ||| NNP
6D ||| S:27489 E:27491 ||| NNP
,  ||| S:27491 E:27493 ||| ,
panel  ||| S:27493 E:27499 ||| NN
1 ||| S:27499 E:27500 ||| CD
) ||| S:27500 E:27501 ||| -RRB-
.  ||| S:27501 E:27513 ||| .
Similar  ||| S:27513 E:27521 ||| JJ
localization  ||| S:27521 E:27534 ||| JJ
pattern  ||| S:27534 E:27542 ||| NN
was  ||| S:27542 E:27546 ||| VBD
detected  ||| S:27546 E:27555 ||| VBN
when  ||| S:27555 E:27560 ||| WRB
HsN3  ||| S:27560 E:27565 ||| NNP
was  ||| S:27565 E:27579 ||| VBD
co-expressed  ||| S:27579 E:27592 ||| JJ
with  ||| S:27592 E:27597 ||| IN
Smad1  ||| S:27597 E:27603 ||| NNP
( ||| S:27603 E:27604 ||| -LRB-
Fig.  ||| S:27604 E:27609 ||| NNP
6D ||| S:27609 E:27611 ||| NNP
,  ||| S:27611 E:27613 ||| ,
panel  ||| S:27613 E:27619 ||| NN
2 ||| S:27619 E:27620 ||| CD
)  ||| S:27620 E:27622 ||| -RRB-
or  ||| S:27622 E:27625 ||| CC
with  ||| S:27625 E:27640 ||| IN
ALK3Q233D  ||| S:27640 E:27650 ||| NNP
( ||| S:27650 E:27651 ||| -LRB-
Fig.  ||| S:27651 E:27656 ||| NNP
6D ||| S:27656 E:27658 ||| NNP
,  ||| S:27658 E:27660 ||| ,
panel  ||| S:27660 E:27666 ||| NN
3 ||| S:27666 E:27667 ||| LS
) ||| S:27667 E:27668 ||| -RRB-
.  ||| S:27668 E:27670 ||| .
However ||| S:27670 E:27677 ||| RB
,  ||| S:27677 E:27679 ||| ,
when  ||| S:27679 E:27684 ||| WRB
HsN3  ||| S:27684 E:27689 ||| NNP
was  ||| S:27689 E:27703 ||| VBD
co-expressed  ||| S:27703 E:27716 ||| JJ
with  ||| S:27716 E:27721 ||| IN
both  ||| S:27721 E:27726 ||| DT
Smad1  ||| S:27726 E:27732 ||| NNP
and  ||| S:27732 E:27736 ||| CC
ALK3Q233D ||| S:27736 E:27745 ||| NNP
,  ||| S:27745 E:27747 ||| ,
the  ||| S:27747 E:27751 ||| DT
majority  ||| S:27751 E:27770 ||| NN
of  ||| S:27770 E:27773 ||| IN
HsN3  ||| S:27773 E:27778 ||| CD
signals  ||| S:27778 E:27786 ||| NNS
were  ||| S:27786 E:27791 ||| VBD
detected  ||| S:27791 E:27800 ||| VBN
in  ||| S:27800 E:27803 ||| IN
the  ||| S:27803 E:27807 ||| DT
nucleus  ||| S:27807 E:27815 ||| NN
( ||| S:27815 E:27816 ||| -LRB-
Fig.  ||| S:27816 E:27821 ||| NNP
6D ||| S:27821 E:27823 ||| NNP
,  ||| S:27823 E:27835 ||| ,
panel  ||| S:27835 E:27841 ||| NN
4 ||| S:27841 E:27842 ||| CD
) ||| S:27842 E:27843 ||| -RRB-
.  ||| S:27843 E:27845 ||| .
Thus ||| S:27845 E:27849 ||| RB
,  ||| S:27849 E:27851 ||| ,
the  ||| S:27851 E:27855 ||| DT
nuclear  ||| S:27855 E:27863 ||| JJ
translocation  ||| S:27863 E:27877 ||| NN
of  ||| S:27877 E:27880 ||| IN
HsN3  ||| S:27880 E:27885 ||| NNP
is  ||| S:27885 E:27898 ||| VBZ
dependent  ||| S:27898 E:27908 ||| JJ
upon  ||| S:27908 E:27913 ||| IN
both  ||| S:27913 E:27918 ||| PDT
the  ||| S:27918 E:27922 ||| DT
receptor  ||| S:27922 E:27931 ||| NN
activation  ||| S:27931 E:27942 ||| NNS
and  ||| S:27942 E:27946 ||| CC
the  ||| S:27946 E:27960 ||| DT
presence  ||| S:27960 E:27969 ||| NN
of  ||| S:27969 E:27972 ||| IN
Smad1 ||| S:27972 E:27977 ||| CD
.  ||| S:27977 E:27979 ||| .
Similarly ||| S:27979 E:27988 ||| RB
,  ||| S:27988 E:27990 ||| ,
the  ||| S:27990 E:27994 ||| DT
localization  ||| S:27994 E:28007 ||| NN
of  ||| S:28007 E:28010 ||| IN
Az  ||| S:28010 E:28013 ||| NNP
is  ||| S:28013 E:28026 ||| VBZ
also  ||| S:28026 E:28031 ||| RB
dependent  ||| S:28031 E:28041 ||| JJ
upon  ||| S:28041 E:28046 ||| IN
the  ||| S:28046 E:28050 ||| DT
co-expression  ||| S:28050 E:28064 ||| JJ
of  ||| S:28064 E:28067 ||| IN
Smad1  ||| S:28067 E:28073 ||| NNP
and  ||| S:28073 E:28077 ||| CC
the  ||| S:28077 E:28091 ||| DT
activated  ||| S:28091 E:28101 ||| JJ
BMP  ||| S:28101 E:28105 ||| NN
type  ||| S:28105 E:28110 ||| NN
I  ||| S:28110 E:28112 ||| PRP
receptor  ||| S:28112 E:28121 ||| VBP
( ||| S:28121 E:28122 ||| -LRB-
Fig.  ||| S:28122 E:28127 ||| NNP
6E ||| S:28127 E:28129 ||| NNP
,  ||| S:28129 E:28131 ||| ,
panels  ||| S:28131 E:28138 ||| CD
1-4 ||| S:28138 E:28141 ||| CD
) ||| S:28141 E:28142 ||| -RRB-
.  ||| S:28142 E:28144 ||| .
When  ||| S:28144 E:28159 ||| WRB
Smad1  ||| S:28159 E:28165 ||| NNP
was  ||| S:28165 E:28169 ||| VBD
replaced  ||| S:28169 E:28178 ||| VBN
by  ||| S:28178 E:28181 ||| IN
Smad2 ||| S:28181 E:28186 ||| NNP
,  ||| S:28186 E:28188 ||| ,
Az  ||| S:28188 E:28191 ||| NNP
was  ||| S:28191 E:28195 ||| VBD
found  ||| S:28195 E:28201 ||| VBN
in  ||| S:28201 E:28204 ||| IN
both  ||| S:28204 E:28209 ||| PDT
the  ||| S:28209 E:28223 ||| DT
cytoplasm  ||| S:28223 E:28233 ||| NN
and  ||| S:28233 E:28237 ||| CC
the  ||| S:28237 E:28241 ||| DT
nucleus  ||| S:28241 E:28249 ||| NN
upon  ||| S:28249 E:28254 ||| IN
the  ||| S:28254 E:28258 ||| DT
co-expression  ||| S:28258 E:28272 ||| JJ
of  ||| S:28272 E:28285 ||| IN
ALK3Q233D  ||| S:28285 E:28295 ||| NNP
( ||| S:28295 E:28296 ||| -LRB-
Fig.  ||| S:28296 E:28301 ||| NNP
6E ||| S:28301 E:28303 ||| NNP
,  ||| S:28303 E:28305 ||| ,
panel  ||| S:28305 E:28311 ||| NN
4 ||| S:28311 E:28312 ||| CD
) ||| S:28312 E:28313 ||| -RRB-
,  ||| S:28313 E:28315 ||| ,
although  ||| S:28315 E:28324 ||| IN
cytoplasmic  ||| S:28324 E:28346 ||| JJ
signals  ||| S:28346 E:28354 ||| NNS
of  ||| S:28354 E:28357 ||| IN
Az  ||| S:28357 E:28360 ||| NNP
were  ||| S:28360 E:28365 ||| VBD
slightly  ||| S:28365 E:28374 ||| RB
decreased ||| S:28374 E:28383 ||| VBN
.  ||| S:28383 E:28385 ||| .
This  ||| S:28385 E:28390 ||| DT
could  ||| S:28390 E:28396 ||| MD
be  ||| S:28396 E:28399 ||| VB
due  ||| S:28399 E:28413 ||| JJ
to  ||| S:28413 E:28416 ||| TO
the  ||| S:28416 E:28420 ||| DT
presence  ||| S:28420 E:28429 ||| NN
of  ||| S:28429 E:28432 ||| IN
endogenous  ||| S:28432 E:28443 ||| JJ
Smad1  ||| S:28443 E:28449 ||| NN
in  ||| S:28449 E:28452 ||| IN
COS1  ||| S:28452 E:28457 ||| CD
cells ||| S:28457 E:28462 ||| NNS
.  ||| S:28462 E:28474 ||| .
Thus ||| S:28474 E:28478 ||| RB
,  ||| S:28478 E:28480 ||| ,
the  ||| S:28480 E:28484 ||| DT
localization  ||| S:28484 E:28497 ||| NN
of  ||| S:28497 E:28500 ||| IN
both  ||| S:28500 E:28505 ||| DT
Az  ||| S:28505 E:28508 ||| NNP
and  ||| S:28508 E:28512 ||| CC
HsN3  ||| S:28512 E:28517 ||| NNP
is  ||| S:28517 E:28530 ||| VBZ
regulated  ||| S:28530 E:28540 ||| VBN
by  ||| S:28540 E:28543 ||| IN
the  ||| S:28543 E:28547 ||| DT
BMP  ||| S:28547 E:28551 ||| NN
type  ||| S:28551 E:28556 ||| NN
I  ||| S:28556 E:28558 ||| PRP
receptor  ||| S:28558 E:28567 ||| VBD
in  ||| S:28567 E:28570 ||| IN
a  ||| S:28570 E:28572 ||| DT
Smad1-dependent  ||| S:28572 E:28598 ||| JJ
manner ||| S:28598 E:28604 ||| NN
.  ||| S:28604 E:28606 ||| .
This  ||| S:28606 E:28611 ||| DT
data  ||| S:28611 E:28616 ||| NN
confirms  ||| S:28616 E:28625 ||| VBZ
the  ||| S:28625 E:28629 ||| DT
physical  ||| S:28629 E:28638 ||| JJ
interaction  ||| S:28638 E:28660 ||| NN
between  ||| S:28660 E:28668 ||| IN
Smad1 ||| S:28668 E:28673 ||| NNP
,  ||| S:28673 E:28675 ||| ,
HsN3  ||| S:28675 E:28680 ||| NNP
and  ||| S:28680 E:28684 ||| CC
Az  ||| S:28684 E:28687 ||| NNP
detected  ||| S:28687 E:28696 ||| VBD
by  ||| S:28696 E:28709 ||| IN
immunoprecipitation  ||| S:28709 E:28729 ||| NN
and  ||| S:28729 E:28733 ||| CC
further  ||| S:28733 E:28741 ||| RB
suggests  ||| S:28741 E:28750 ||| VBZ
that  ||| S:28750 E:28755 ||| IN
the  ||| S:28755 E:28769 ||| DT
cytoplasmic  ||| S:28769 E:28781 ||| JJ
Smad1  ||| S:28781 E:28787 ||| CD
forms  ||| S:28787 E:28793 ||| NNS
a  ||| S:28793 E:28795 ||| DT
complex  ||| S:28795 E:28803 ||| NN
with  ||| S:28803 E:28808 ||| IN
Az  ||| S:28808 E:28811 ||| NNP
and  ||| S:28811 E:28815 ||| CC
HsN3  ||| S:28815 E:28820 ||| NNP
and  ||| S:28820 E:28834 ||| CC
brings  ||| S:28834 E:28841 ||| VBZ
these  ||| S:28841 E:28847 ||| DT
two  ||| S:28847 E:28851 ||| CD
proteins  ||| S:28851 E:28860 ||| NNS
into  ||| S:28860 E:28865 ||| IN
the  ||| S:28865 E:28869 ||| DT
nucleus  ||| S:28869 E:28877 ||| NN
upon  ||| S:28877 E:28882 ||| IN
the  ||| S:28882 E:28896 ||| DT
activation  ||| S:28896 E:28907 ||| NN
of  ||| S:28907 E:28910 ||| IN
BMP  ||| S:28910 E:28914 ||| NN
type  ||| S:28914 E:28919 ||| NN
I  ||| S:28919 E:28921 ||| PRP
receptor ||| S:28921 E:28929 ||| VBD
.  ||| S:28929 E:28959 ||| .
The  ||| S:28959 E:28963 ||| DT
novel  ||| S:28963 E:28969 ||| NN
CBP ||| S:28969 E:28972 ||| FW
/ ||| S:28972 E:28973 ||| FW
p300  ||| S:28973 E:28978 ||| FW
repressor  ||| S:28978 E:28988 ||| FW
SNIP1  ||| S:28988 E:28994 ||| FW
is  ||| S:28994 E:28997 ||| VBZ
recruited  ||| S:28997 E:29007 ||| VBN
to  ||| S:29007 E:29020 ||| TO
Az  ||| S:29020 E:29023 ||| NNP
upon  ||| S:29023 E:29028 ||| IN
the  ||| S:29028 E:29032 ||| DT
activation  ||| S:29032 E:29043 ||| NN
of  ||| S:29043 E:29046 ||| IN
BMP  ||| S:29046 E:29050 ||| NN
type  ||| S:29050 E:29055 ||| NN
I  ||| S:29055 E:29057 ||| PRP
receptor  ||| S:29057 E:29076 ||| VBD
The  ||| S:29076 E:29080 ||| DT
observed  ||| S:29080 E:29089 ||| JJ
physical  ||| S:29089 E:29098 ||| JJ
interaction  ||| S:29098 E:29110 ||| NN
between  ||| S:29110 E:29118 ||| IN
Smad1 ||| S:29118 E:29123 ||| NNP
,  ||| S:29123 E:29125 ||| ,
HsN3  ||| S:29125 E:29140 ||| NNP
and  ||| S:29140 E:29144 ||| CC
Az  ||| S:29144 E:29147 ||| NNP
and  ||| S:29147 E:29151 ||| CC
the  ||| S:29151 E:29155 ||| DT
regulation  ||| S:29155 E:29166 ||| NN
of  ||| S:29166 E:29169 ||| IN
the  ||| S:29169 E:29173 ||| DT
complex  ||| S:29173 E:29181 ||| JJ
formation  ||| S:29181 E:29191 ||| NN
by  ||| S:29191 E:29204 ||| IN
BMPs  ||| S:29204 E:29209 ||| NNP
suggests  ||| S:29209 E:29218 ||| VBZ
a  ||| S:29218 E:29220 ||| DT
functional  ||| S:29220 E:29231 ||| JJ
role  ||| S:29231 E:29236 ||| NN
of  ||| S:29236 E:29239 ||| IN
Az  ||| S:29239 E:29242 ||| NNP
and  ||| S:29242 E:29246 ||| CC
HsN3  ||| S:29246 E:29251 ||| CD
in  ||| S:29251 E:29254 ||| IN
the  ||| S:29254 E:29268 ||| DT
signaling  ||| S:29268 E:29278 ||| JJ
function  ||| S:29278 E:29287 ||| NN
of  ||| S:29287 E:29290 ||| IN
Smad1 ||| S:29290 E:29295 ||| CD
.  ||| S:29295 E:29297 ||| .
In  ||| S:29297 E:29300 ||| IN
a  ||| S:29300 E:29302 ||| DT
separate  ||| S:29302 E:29311 ||| JJ
study ||| S:29311 E:29316 ||| NN
,  ||| S:29316 E:29318 ||| ,
we  ||| S:29318 E:29321 ||| PRP
have  ||| S:29321 E:29336 ||| VBP
shown  ||| S:29336 E:29342 ||| VBN
that  ||| S:29342 E:29347 ||| IN
Az  ||| S:29347 E:29350 ||| NNP
and  ||| S:29350 E:29354 ||| CC
HsN3  ||| S:29354 E:29359 ||| NNP
play  ||| S:29359 E:29364 ||| VBP
targeting  ||| S:29364 E:29374 ||| VBG
roles  ||| S:29374 E:29380 ||| NNS
in  ||| S:29380 E:29383 ||| IN
the  ||| S:29383 E:29397 ||| DT
proteasomal  ||| S:29397 E:29409 ||| JJ
degradation  ||| S:29409 E:29421 ||| NN
of  ||| S:29421 E:29424 ||| IN
Smad1  ||| S:29424 E:29430 ||| CD
upon  ||| S:29430 E:29435 ||| IN
the  ||| S:29435 E:29439 ||| DT
activation  ||| S:29439 E:29450 ||| NN
of  ||| S:29450 E:29463 ||| IN
BMP  ||| S:29463 E:29467 ||| NN
type  ||| S:29467 E:29472 ||| NN
I  ||| S:29472 E:29474 ||| PRP
receptors  ||| S:29474 E:29484 ||| VBP
[  ||| S:29484 E:29486 ||| -LRB-
39  ||| S:29486 E:29489 ||| CD
]  ||| S:29489 E:29491 ||| -RRB-
.  ||| S:29491 E:29493 ||| .
The  ||| S:29493 E:29497 ||| DT
observed  ||| S:29497 E:29506 ||| JJ
proteasomal  ||| S:29506 E:29528 ||| JJ
degradation  ||| S:29528 E:29540 ||| NN
of  ||| S:29540 E:29543 ||| IN
Smad1  ||| S:29543 E:29549 ||| CD
upon  ||| S:29549 E:29554 ||| IN
the  ||| S:29554 E:29558 ||| DT
activation  ||| S:29558 E:29569 ||| NN
of  ||| S:29569 E:29572 ||| IN
BMP  ||| S:29572 E:29576 ||| NN
signaling  ||| S:29576 E:29596 ||| NNS
could  ||| S:29596 E:29602 ||| MD
simply  ||| S:29602 E:29609 ||| RB
serve  ||| S:29609 E:29615 ||| VB
to  ||| S:29615 E:29618 ||| TO
irreversibly  ||| S:29618 E:29631 ||| FW
terminate  ||| S:29631 E:29651 ||| FW
Smad1-mediated  ||| S:29651 E:29666 ||| FW
signaling  ||| S:29666 E:29676 ||| FW
pathways  ||| S:29676 E:29685 ||| FW
of  ||| S:29685 E:29688 ||| IN
BMPs ||| S:29688 E:29692 ||| JJ
.  ||| S:29692 E:29694 ||| .
However ||| S:29694 E:29701 ||| RB
,  ||| S:29701 E:29703 ||| ,
we  ||| S:29703 E:29716 ||| PRP
observed  ||| S:29716 E:29725 ||| VBD
that  ||| S:29725 E:29730 ||| IN
Az  ||| S:29730 E:29733 ||| NNP
and  ||| S:29733 E:29737 ||| CC
HsN3  ||| S:29737 E:29742 ||| NNP
also  ||| S:29742 E:29747 ||| RB
interact  ||| S:29747 E:29756 ||| VBN
with  ||| S:29756 E:29761 ||| IN
several  ||| S:29761 E:29779 ||| JJ
isolated  ||| S:29779 E:29788 ||| JJ
Smad1  ||| S:29788 E:29794 ||| CD
interactors ||| S:29794 E:29805 ||| NNS
.  ||| S:29805 E:29807 ||| .
Furthermore ||| S:29807 E:29818 ||| RB
,  ||| S:29818 E:29820 ||| ,
the  ||| S:29820 E:29824 ||| DT
nuclear  ||| S:29824 E:29842 ||| JJ
co-translocation  ||| S:29842 E:29859 ||| NN
of  ||| S:29859 E:29862 ||| IN
Az  ||| S:29862 E:29865 ||| NNP
and  ||| S:29865 E:29869 ||| CC
HsN3  ||| S:29869 E:29874 ||| CD
with  ||| S:29874 E:29879 ||| IN
Smad1  ||| S:29879 E:29885 ||| NNP
also  ||| S:29885 E:29890 ||| RB
suggests  ||| S:29890 E:29909 ||| VBZ
potential  ||| S:29909 E:29919 ||| JJ
proteasomal  ||| S:29919 E:29931 ||| NNS
targeting  ||| S:29931 E:29941 ||| VBG
role  ||| S:29941 E:29946 ||| NN
of  ||| S:29946 E:29949 ||| IN
Az  ||| S:29949 E:29952 ||| NNP
and  ||| S:29952 E:29956 ||| CC
HsN3  ||| S:29956 E:29961 ||| CD
in  ||| S:29961 E:29974 ||| IN
the  ||| S:29974 E:29978 ||| DT
nucleus ||| S:29978 E:29985 ||| NN
.  ||| S:29985 E:29987 ||| .
Thus ||| S:29987 E:29991 ||| RB
,  ||| S:29991 E:29993 ||| ,
we  ||| S:29993 E:29996 ||| PRP
tested  ||| S:29996 E:30003 ||| VBD
the  ||| S:30003 E:30007 ||| DT
hypothesis  ||| S:30007 E:30018 ||| NN
that  ||| S:30018 E:30023 ||| IN
Az  ||| S:30023 E:30026 ||| NNP
and  ||| S:30026 E:30040 ||| CC
HsN3  ||| S:30040 E:30045 ||| NNP
also  ||| S:30045 E:30050 ||| RB
target  ||| S:30050 E:30057 ||| VB
Smad1  ||| S:30057 E:30063 ||| CD
interacting  ||| S:30063 E:30075 ||| CD
proteins  ||| S:30075 E:30084 ||| NNS
in  ||| S:30084 E:30087 ||| IN
the  ||| S:30087 E:30101 ||| DT
nucleus ||| S:30101 E:30108 ||| NN
.  ||| S:30108 E:30120 ||| .
Among  ||| S:30120 E:30126 ||| IN
the  ||| S:30126 E:30130 ||| DT
isolated  ||| S:30130 E:30139 ||| JJ
Smad1  ||| S:30139 E:30145 ||| NN
interactors  ||| S:30145 E:30157 ||| VBZ
shown  ||| S:30157 E:30163 ||| VBN
in  ||| S:30163 E:30166 ||| IN
Fig.  ||| S:30166 E:30171 ||| CD
1 ||| S:30171 E:30172 ||| CD
,  ||| S:30172 E:30184 ||| ,
clone  ||| S:30184 E:30190 ||| CD
19  ||| S:30190 E:30193 ||| CD
encodes  ||| S:30193 E:30201 ||| CD
a  ||| S:30201 E:30203 ||| DT
novel  ||| S:30203 E:30209 ||| NN
nuclear  ||| S:30209 E:30217 ||| JJ
protein  ||| S:30217 E:30225 ||| NN
named  ||| S:30225 E:30231 ||| VBN
as  ||| S:30231 E:30234 ||| IN
Smad1  ||| S:30234 E:30250 ||| NNP
Nuclear  ||| S:30250 E:30258 ||| NNP
Interacting  ||| S:30258 E:30270 ||| NNP
Protein-1  ||| S:30270 E:30280 ||| NNP
( ||| S:30280 E:30281 ||| -LRB-
SNIP-1 ||| S:30281 E:30287 ||| NNP
) ||| S:30287 E:30288 ||| -RRB-
.  ||| S:30288 E:30290 ||| .
Our  ||| S:30290 E:30294 ||| PRP$
recent  ||| S:30294 E:30311 ||| JJ
studies  ||| S:30311 E:30319 ||| NNS
suggested  ||| S:30319 E:30329 ||| VBD
that  ||| S:30329 E:30334 ||| IN
SNIP1  ||| S:30334 E:30340 ||| NNP
is  ||| S:30340 E:30343 ||| VBZ
a  ||| S:30343 E:30345 ||| DT
novel  ||| S:30345 E:30351 ||| NN
CBP ||| S:30351 E:30354 ||| FW
/ ||| S:30354 E:30355 ||| FW
p300  ||| S:30355 E:30370 ||| FW
repressor  ||| S:30370 E:30380 ||| FW
[  ||| S:30380 E:30382 ||| -LRB-
25  ||| S:30382 E:30385 ||| CD
]  ||| S:30385 E:30387 ||| -RRB-
.  ||| S:30387 E:30389 ||| .
SNIP1 ||| S:30389 E:30394 ||| NNP
,  ||| S:30394 E:30396 ||| ,
when  ||| S:30396 E:30401 ||| WRB
expressed  ||| S:30401 E:30411 ||| VBN
in  ||| S:30411 E:30414 ||| IN
COS1  ||| S:30414 E:30419 ||| CD
cells ||| S:30419 E:30424 ||| NNS
,  ||| S:30424 E:30436 ||| ,
is  ||| S:30436 E:30439 ||| VBZ
entirely  ||| S:30439 E:30448 ||| RB
localized  ||| S:30448 E:30458 ||| VBN
to  ||| S:30458 E:30461 ||| TO
distinct  ||| S:30461 E:30470 ||| JJ
areas  ||| S:30470 E:30476 ||| NNS
within  ||| S:30476 E:30483 ||| IN
the  ||| S:30483 E:30497 ||| DT
nucleus  ||| S:30497 E:30505 ||| NN
( ||| S:30505 E:30506 ||| -LRB-
Fig.  ||| S:30506 E:30511 ||| NNP
7A ||| S:30511 E:30513 ||| NNP
) ||| S:30513 E:30514 ||| -RRB-
.  ||| S:30514 E:30516 ||| .
Interestingly ||| S:30516 E:30529 ||| RB
,  ||| S:30529 E:30531 ||| ,
SNIP1  ||| S:30531 E:30537 ||| CD
binds  ||| S:30537 E:30543 ||| NN
to  ||| S:30543 E:30546 ||| TO
Az  ||| S:30546 E:30549 ||| NNP
and  ||| S:30549 E:30563 ||| CC
HsN3  ||| S:30563 E:30568 ||| CD
in  ||| S:30568 E:30571 ||| IN
the  ||| S:30571 E:30575 ||| DT
yeast  ||| S:30575 E:30581 ||| NN
two-hybrid  ||| S:30581 E:30592 ||| JJ
system ||| S:30592 E:30598 ||| NN
,  ||| S:30598 E:30600 ||| ,
in  ||| S:30600 E:30603 ||| IN
addition  ||| S:30603 E:30612 ||| NN
to  ||| S:30612 E:30615 ||| TO
its  ||| S:30615 E:30629 ||| PRP$
ability  ||| S:30629 E:30637 ||| NN
to  ||| S:30637 E:30640 ||| TO
bind  ||| S:30640 E:30645 ||| VB
Smad1  ||| S:30645 E:30651 ||| NNP
( ||| S:30651 E:30652 ||| -LRB-
Fig.  ||| S:30652 E:30657 ||| NNP
7B ||| S:30657 E:30659 ||| NNP
) ||| S:30659 E:30660 ||| -RRB-
.  ||| S:30660 E:30662 ||| .
SNIP1  ||| S:30662 E:30668 ||| NNP
and  ||| S:30668 E:30672 ||| CC
ODC  ||| S:30672 E:30676 ||| NNP
exhibited  ||| S:30676 E:30696 ||| VBD
similar  ||| S:30696 E:30704 ||| JJ
affinity  ||| S:30704 E:30713 ||| NN
to  ||| S:30713 E:30716 ||| TO
Az  ||| S:30716 E:30719 ||| NNP
in  ||| S:30719 E:30722 ||| IN
the  ||| S:30722 E:30726 ||| DT
yeast  ||| S:30726 E:30732 ||| NN
two-hybrid  ||| S:30732 E:30743 ||| JJ
test  ||| S:30743 E:30748 ||| NN
( ||| S:30748 E:30749 ||| -LRB-
Fig.  ||| S:30749 E:30764 ||| NNP
7B ||| S:30764 E:30766 ||| NNP
) ||| S:30766 E:30767 ||| -RRB-
.  ||| S:30767 E:30769 ||| .
Domain  ||| S:30769 E:30776 ||| JJ
mapping  ||| S:30776 E:30784 ||| NN
studies  ||| S:30784 E:30792 ||| NNS
showed  ||| S:30792 E:30799 ||| VBD
that  ||| S:30799 E:30804 ||| IN
the  ||| S:30804 E:30808 ||| DT
linker  ||| S:30808 E:30815 ||| JJ
region  ||| S:30815 E:30832 ||| NN
of  ||| S:30832 E:30835 ||| IN
Smad1  ||| S:30835 E:30841 ||| NNP
was  ||| S:30841 E:30845 ||| VBD
sufficient  ||| S:30845 E:30856 ||| JJ
to  ||| S:30856 E:30859 ||| TO
bind  ||| S:30859 E:30864 ||| VB
SNIP1  ||| S:30864 E:30870 ||| NNP
( ||| S:30870 E:30871 ||| -LRB-
Fig.  ||| S:30871 E:30876 ||| NNP
7C ||| S:30876 E:30878 ||| NNP
) ||| S:30878 E:30879 ||| -RRB-
.  ||| S:30879 E:30881 ||| .
To  ||| S:30881 E:30894 ||| TO
confirm  ||| S:30894 E:30902 ||| VB
the  ||| S:30902 E:30906 ||| DT
interaction  ||| S:30906 E:30918 ||| NN
between  ||| S:30918 E:30926 ||| IN
SNIP1  ||| S:30926 E:30932 ||| NNP
and  ||| S:30932 E:30936 ||| CC
Az  ||| S:30936 E:30939 ||| NNP
or  ||| S:30939 E:30942 ||| CC
HsN3  ||| S:30942 E:30947 ||| RB
seen  ||| S:30947 E:30962 ||| VBN
in  ||| S:30962 E:30965 ||| IN
the  ||| S:30965 E:30969 ||| DT
yeast  ||| S:30969 E:30975 ||| NN
two-hybrid  ||| S:30975 E:30986 ||| JJ
system ||| S:30986 E:30992 ||| NN
,  ||| S:30992 E:30994 ||| ,
we  ||| S:30994 E:30997 ||| PRP
transfected  ||| S:30997 E:31009 ||| VBD
COS1  ||| S:31009 E:31014 ||| CD
cells  ||| S:31014 E:31030 ||| NNS
with  ||| S:31030 E:31035 ||| IN
each  ||| S:31035 E:31040 ||| DT
pair  ||| S:31040 E:31045 ||| NN
of  ||| S:31045 E:31048 ||| IN
proteins  ||| S:31048 E:31057 ||| NNS
and  ||| S:31057 E:31061 ||| CC
tested  ||| S:31061 E:31068 ||| VBD
the  ||| S:31068 E:31072 ||| DT
interactions  ||| S:31072 E:31085 ||| NN
by  ||| S:31085 E:31098 ||| IN
immunoprecipitation  ||| S:31098 E:31118 ||| JJ
assays ||| S:31118 E:31124 ||| NN
.  ||| S:31124 E:31126 ||| .
Upon  ||| S:31126 E:31131 ||| IN
the  ||| S:31131 E:31135 ||| DT
co-expression  ||| S:31135 E:31149 ||| JJ
with  ||| S:31149 E:31164 ||| IN
SNIP1 ||| S:31164 E:31169 ||| NNP
,  ||| S:31169 E:31171 ||| ,
the  ||| S:31171 E:31175 ||| DT
pre-assembled  ||| S:31175 E:31189 ||| JJ
form  ||| S:31189 E:31194 ||| NN
of  ||| S:31194 E:31197 ||| IN
HsN3  ||| S:31197 E:31202 ||| NNP
but  ||| S:31202 E:31206 ||| CC
not  ||| S:31206 E:31210 ||| RB
Az  ||| S:31210 E:31213 ||| NNP
was  ||| S:31213 E:31227 ||| VBD
co-precipitated  ||| S:31227 E:31243 ||| JJ
with  ||| S:31243 E:31248 ||| IN
SNIP1  ||| S:31248 E:31254 ||| NNP
( ||| S:31254 E:31255 ||| -LRB-
Fig.  ||| S:31255 E:31260 ||| NNP
7D ||| S:31260 E:31262 ||| NNP
,  ||| S:31262 E:31264 ||| ,
lanes  ||| S:31264 E:31270 ||| CD
1  ||| S:31270 E:31272 ||| CD
&  ||| S:31272 E:31274 ||| CC
2 ||| S:31274 E:31275 ||| LS
) ||| S:31275 E:31276 ||| -RRB-
.  ||| S:31276 E:31288 ||| .
Since  ||| S:31288 E:31294 ||| IN
SNIP1  ||| S:31294 E:31300 ||| NNP
is  ||| S:31300 E:31303 ||| VBZ
a  ||| S:31303 E:31305 ||| DT
nuclear  ||| S:31305 E:31313 ||| JJ
protein ||| S:31313 E:31320 ||| NN
,  ||| S:31320 E:31322 ||| ,
the  ||| S:31322 E:31326 ||| DT
interaction  ||| S:31326 E:31338 ||| NN
between  ||| S:31338 E:31356 ||| IN
SNIP1  ||| S:31356 E:31362 ||| NNP
and  ||| S:31362 E:31366 ||| CC
Az  ||| S:31366 E:31369 ||| NNP
may  ||| S:31369 E:31373 ||| MD
require  ||| S:31373 E:31381 ||| VB
the  ||| S:31381 E:31385 ||| DT
nuclear  ||| S:31385 E:31393 ||| JJ
translocation  ||| S:31393 E:31407 ||| NN
of  ||| S:31407 E:31410 ||| IN
Az ||| S:31410 E:31412 ||| NNP
.  ||| S:31412 E:31424 ||| .
Based  ||| S:31424 E:31430 ||| VBN
upon  ||| S:31430 E:31435 ||| IN
the  ||| S:31435 E:31439 ||| DT
observation  ||| S:31439 E:31451 ||| NN
that  ||| S:31451 E:31456 ||| IN
the  ||| S:31456 E:31460 ||| DT
nuclear  ||| S:31460 E:31468 ||| JJ
translocation  ||| S:31468 E:31492 ||| NN
of  ||| S:31492 E:31495 ||| IN
Az  ||| S:31495 E:31498 ||| NNP
is  ||| S:31498 E:31501 ||| VBZ
dependent  ||| S:31501 E:31511 ||| JJ
upon  ||| S:31511 E:31516 ||| IN
Smad1  ||| S:31516 E:31522 ||| NNP
and  ||| S:31522 E:31526 ||| CC
BMP  ||| S:31526 E:31530 ||| NN
type  ||| S:31530 E:31535 ||| NN
I  ||| S:31535 E:31537 ||| PRP
receptor  ||| S:31537 E:31556 ||| VBP
activation  ||| S:31556 E:31567 ||| NNS
( ||| S:31567 E:31568 ||| -LRB-
Fig.  ||| S:31568 E:31573 ||| NNP
6E ||| S:31573 E:31575 ||| NNP
) ||| S:31575 E:31576 ||| -RRB-
,  ||| S:31576 E:31578 ||| ,
we  ||| S:31578 E:31581 ||| PRP
therefore  ||| S:31581 E:31591 ||| RB
tested  ||| S:31591 E:31598 ||| VBN
Az  ||| S:31598 E:31601 ||| JJ
interaction  ||| S:31601 E:31623 ||| NN
with  ||| S:31623 E:31628 ||| IN
SNIP1  ||| S:31628 E:31634 ||| CD
in  ||| S:31634 E:31637 ||| IN
the  ||| S:31637 E:31641 ||| DT
presence  ||| S:31641 E:31650 ||| NN
of  ||| S:31650 E:31653 ||| IN
the  ||| S:31653 E:31657 ||| DT
co-expression  ||| S:31657 E:31671 ||| JJ
of  ||| S:31671 E:31674 ||| IN
Smad1 ||| S:31674 E:31679 ||| NNP
,  ||| S:31679 E:31691 ||| ,
Smad4  ||| S:31691 E:31697 ||| NNP
and  ||| S:31697 E:31701 ||| CC
ALK3Q233D ||| S:31701 E:31710 ||| NNP
.  ||| S:31710 E:31712 ||| .
In  ||| S:31712 E:31715 ||| IN
the  ||| S:31715 E:31719 ||| DT
absence  ||| S:31719 E:31727 ||| NN
of  ||| S:31727 E:31730 ||| IN
ALK3Q233D ||| S:31730 E:31739 ||| NNP
,  ||| S:31739 E:31741 ||| ,
no  ||| S:31741 E:31744 ||| DT
F-Az  ||| S:31744 E:31759 ||| NN
was  ||| S:31759 E:31763 ||| VBD
detected  ||| S:31763 E:31772 ||| VBN
in  ||| S:31772 E:31775 ||| IN
the  ||| S:31775 E:31779 ||| DT
precipitates  ||| S:31779 E:31792 ||| NN
of  ||| S:31792 E:31795 ||| IN
SNIP1  ||| S:31795 E:31801 ||| NNP
( ||| S:31801 E:31802 ||| -LRB-
Fig.  ||| S:31802 E:31807 ||| NNP
7E ||| S:31807 E:31809 ||| NNP
,  ||| S:31809 E:31811 ||| ,
top  ||| S:31811 E:31825 ||| JJ
panel ||| S:31825 E:31830 ||| NN
,  ||| S:31830 E:31832 ||| ,
lane  ||| S:31832 E:31837 ||| CD
2 ||| S:31837 E:31838 ||| CD
) ||| S:31838 E:31839 ||| -RRB-
.  ||| S:31839 E:31841 ||| .
However ||| S:31841 E:31848 ||| RB
,  ||| S:31848 E:31850 ||| ,
the  ||| S:31850 E:31854 ||| DT
co-expression  ||| S:31854 E:31868 ||| JJ
of  ||| S:31868 E:31871 ||| IN
ALK3Q233D  ||| S:31871 E:31891 ||| NNP
allowed  ||| S:31891 E:31899 ||| VBD
the  ||| S:31899 E:31903 ||| DT
detection  ||| S:31903 E:31913 ||| NN
of  ||| S:31913 E:31916 ||| IN
F-Az  ||| S:31916 E:31921 ||| JJ
in  ||| S:31921 E:31924 ||| IN
SNIP1  ||| S:31924 E:31930 ||| CD
immunoprecipitates  ||| S:31930 E:31959 ||| NNS
( ||| S:31959 E:31960 ||| -LRB-
Fig.  ||| S:31960 E:31965 ||| NNP
7E ||| S:31965 E:31967 ||| NNP
,  ||| S:31967 E:31969 ||| ,
top  ||| S:31969 E:31973 ||| JJ
panel ||| S:31973 E:31978 ||| NN
,  ||| S:31978 E:31980 ||| ,
lane  ||| S:31980 E:31985 ||| CD
3 ||| S:31985 E:31986 ||| CD
) ||| S:31986 E:31987 ||| -RRB-
.  ||| S:31987 E:31989 ||| .
A  ||| S:31989 E:31991 ||| DT
weak  ||| S:31991 E:31996 ||| JJ
Smad1  ||| S:31996 E:32002 ||| CD
signal  ||| S:32002 E:32009 ||| NN
but  ||| S:32009 E:32013 ||| CC
no  ||| S:32013 E:32026 ||| DT
Smad4  ||| S:32026 E:32032 ||| JJ
signal  ||| S:32032 E:32039 ||| NN
was  ||| S:32039 E:32043 ||| VBD
detected  ||| S:32043 E:32052 ||| VBN
in  ||| S:32052 E:32055 ||| IN
SNIP1  ||| S:32055 E:32071 ||| CD
immunoprecipitates ||| S:32071 E:32089 ||| NNS
.  ||| S:32089 E:32101 ||| .
Thus ||| S:32101 E:32105 ||| RB
,  ||| S:32105 E:32107 ||| ,
in  ||| S:32107 E:32110 ||| IN
the  ||| S:32110 E:32114 ||| DT
mammalian  ||| S:32114 E:32124 ||| JJ
overexpression  ||| S:32124 E:32139 ||| JJ
system ||| S:32139 E:32145 ||| NN
,  ||| S:32145 E:32147 ||| ,
the  ||| S:32147 E:32161 ||| DT
pre-assembled  ||| S:32161 E:32175 ||| JJ
HsN3  ||| S:32175 E:32180 ||| NN
exhibits  ||| S:32180 E:32189 ||| VBZ
constitutive  ||| S:32189 E:32202 ||| JJ
interaction  ||| S:32202 E:32214 ||| NN
with  ||| S:32214 E:32229 ||| IN
SNIP1 ||| S:32229 E:32234 ||| NNP
,  ||| S:32234 E:32236 ||| ,
whereas  ||| S:32236 E:32244 ||| IN
Az  ||| S:32244 E:32247 ||| NNP
is  ||| S:32247 E:32250 ||| VBZ
only  ||| S:32250 E:32255 ||| RB
recruited  ||| S:32255 E:32265 ||| VBN
to  ||| S:32265 E:32268 ||| TO
SNIP1  ||| S:32268 E:32274 ||| CD
upon  ||| S:32274 E:32289 ||| IN
receptor  ||| S:32289 E:32298 ||| JJ
activation ||| S:32298 E:32308 ||| NN
.  ||| S:32308 E:32310 ||| .
The  ||| S:32310 E:32314 ||| DT
lack  ||| S:32314 E:32319 ||| NN
of  ||| S:32319 E:32322 ||| IN
strong  ||| S:32322 E:32329 ||| JJ
signals  ||| S:32329 E:32337 ||| NNS
of  ||| S:32337 E:32340 ||| IN
Smad1  ||| S:32340 E:32356 ||| NNP
or  ||| S:32356 E:32359 ||| CC
Smad4  ||| S:32359 E:32365 ||| CD
in  ||| S:32365 E:32368 ||| IN
the  ||| S:32368 E:32372 ||| DT
immunoprecipitates  ||| S:32372 E:32391 ||| NN
of  ||| S:32391 E:32394 ||| IN
SNIP1  ||| S:32394 E:32400 ||| CD
in  ||| S:32400 E:32403 ||| IN
the  ||| S:32403 E:32417 ||| DT
presence  ||| S:32417 E:32426 ||| NN
of  ||| S:32426 E:32429 ||| IN
BMP  ||| S:32429 E:32433 ||| NN
type  ||| S:32433 E:32438 ||| NN
I  ||| S:32438 E:32440 ||| PRP
receptor  ||| S:32440 E:32449 ||| VBP
activation  ||| S:32449 E:32460 ||| NNS
may  ||| S:32460 E:32464 ||| MD
be  ||| S:32464 E:32467 ||| VB
due  ||| S:32467 E:32471 ||| JJ
to  ||| S:32471 E:32484 ||| TO
the  ||| S:32484 E:32488 ||| DT
transient  ||| S:32488 E:32498 ||| JJ
nature  ||| S:32498 E:32505 ||| NN
of  ||| S:32505 E:32508 ||| IN
the  ||| S:32508 E:32512 ||| DT
complex ||| S:32512 E:32519 ||| NN
,  ||| S:32519 E:32521 ||| ,
which ||| S:32521 E:32526 ||| WDT
,  ||| S:32526 E:32528 ||| ,
as  ||| S:32528 E:32531 ||| RB
shown  ||| S:32531 E:32547 ||| VBN
below ||| S:32547 E:32552 ||| RB
,  ||| S:32552 E:32554 ||| ,
is  ||| S:32554 E:32557 ||| VBZ
targeted  ||| S:32557 E:32566 ||| VBN
to  ||| S:32566 E:32569 ||| TO
proteasome  ||| S:32569 E:32580 ||| VB
for  ||| S:32580 E:32584 ||| IN
degradation ||| S:32584 E:32595 ||| NN
.  ||| S:32595 E:32625 ||| .
BMP  ||| S:32625 E:32629 ||| NNP
type  ||| S:32629 E:32634 ||| NN
I  ||| S:32634 E:32636 ||| PRP
receptor  ||| S:32636 E:32645 ||| VBP
activation  ||| S:32645 E:32656 ||| RB
induces  ||| S:32656 E:32664 ||| VBZ
SNIP1  ||| S:32664 E:32680 ||| CD
degradation  ||| S:32680 E:32692 ||| NNS
that  ||| S:32692 E:32697 ||| WDT
is  ||| S:32697 E:32700 ||| VBZ
regulated  ||| S:32700 E:32710 ||| VBN
by  ||| S:32710 E:32713 ||| IN
Smad1 ||| S:32713 E:32718 ||| NNP
,  ||| S:32718 E:32720 ||| ,
Smad4  ||| S:32720 E:32726 ||| NNP
and  ||| S:32726 E:32740 ||| CC
Az  ||| S:32740 E:32753 ||| NNP
To  ||| S:32753 E:32756 ||| TO
follow  ||| S:32756 E:32763 ||| VB
the  ||| S:32763 E:32767 ||| DT
observed  ||| S:32767 E:32776 ||| JJ
reduction  ||| S:32776 E:32786 ||| NN
of  ||| S:32786 E:32789 ||| IN
SNIP1  ||| S:32789 E:32795 ||| CD
level  ||| S:32795 E:32801 ||| NN
upon  ||| S:32801 E:32816 ||| IN
the  ||| S:32816 E:32820 ||| DT
expression  ||| S:32820 E:32831 ||| NN
of  ||| S:32831 E:32834 ||| IN
high  ||| S:32834 E:32839 ||| JJ
level  ||| S:32839 E:32845 ||| NN
of  ||| S:32845 E:32848 ||| IN
ALK3Q233D ||| S:32848 E:32857 ||| NNP
,  ||| S:32857 E:32859 ||| ,
as  ||| S:32859 E:32862 ||| RB
mentioned  ||| S:32862 E:32882 ||| VBN
above ||| S:32882 E:32887 ||| IN
,  ||| S:32887 E:32889 ||| ,
we  ||| S:32889 E:32892 ||| PRP
co-expressed  ||| S:32892 E:32905 ||| JJ
SNIP1  ||| S:32905 E:32911 ||| NN
together  ||| S:32911 E:32920 ||| RB
with  ||| S:32920 E:32925 ||| IN
Smad1 ||| S:32925 E:32930 ||| NNP
,  ||| S:32930 E:32932 ||| ,
Smad4 ||| S:32932 E:32937 ||| NNP
,  ||| S:32937 E:32949 ||| ,
Az  ||| S:32949 E:32952 ||| NNP
and  ||| S:32952 E:32956 ||| CC
high  ||| S:32956 E:32961 ||| JJ
dose  ||| S:32961 E:32966 ||| NN
( ||| S:32966 E:32967 ||| -LRB-
6  ||| S:32967 E:32969 ||| CD
μg ||| S:32969 E:32971 ||| CD
)  ||| S:32971 E:32973 ||| -RRB-
of  ||| S:32973 E:32976 ||| IN
either  ||| S:32976 E:32983 ||| RB
the  ||| S:32983 E:32987 ||| DT
wild  ||| S:32987 E:32992 ||| JJ
type  ||| S:32992 E:32997 ||| NN
ALK3  ||| S:32997 E:33002 ||| NN
or  ||| S:33002 E:33015 ||| CC
the  ||| S:33015 E:33019 ||| DT
constitutive  ||| S:33019 E:33032 ||| JJ
active  ||| S:33032 E:33039 ||| JJ
ALK3Q233D ||| S:33039 E:33048 ||| NN
.  ||| S:33048 E:33050 ||| .
The  ||| S:33050 E:33054 ||| DT
protein  ||| S:33054 E:33062 ||| NN
levels  ||| S:33062 E:33069 ||| NNS
of  ||| S:33069 E:33082 ||| IN
each  ||| S:33082 E:33087 ||| DT
protein  ||| S:33087 E:33095 ||| NN
were  ||| S:33095 E:33100 ||| VBD
analyzed  ||| S:33100 E:33109 ||| VBN
by  ||| S:33109 E:33112 ||| IN
Western  ||| S:33112 E:33120 ||| JJ
blot  ||| S:33120 E:33125 ||| NNS
( ||| S:33125 E:33126 ||| -LRB-
Fig.  ||| S:33126 E:33131 ||| NNP
8A ||| S:33131 E:33133 ||| NNP
) ||| S:33133 E:33134 ||| -RRB-
.  ||| S:33134 E:33136 ||| .
A  ||| S:33136 E:33148 ||| DT
dramatic  ||| S:33148 E:33157 ||| JJ
decrease  ||| S:33157 E:33166 ||| NN
of  ||| S:33166 E:33169 ||| IN
SNIP1  ||| S:33169 E:33175 ||| CD
level  ||| S:33175 E:33181 ||| NN
was  ||| S:33181 E:33185 ||| VBD
detected  ||| S:33185 E:33194 ||| VBN
in  ||| S:33194 E:33207 ||| IN
ALK3Q233D-transfected  ||| S:33207 E:33229 ||| CD
cells  ||| S:33229 E:33235 ||| NNS
( ||| S:33235 E:33236 ||| -LRB-
Fig.  ||| S:33236 E:33241 ||| NNP
8A ||| S:33241 E:33243 ||| NNP
,  ||| S:33243 E:33245 ||| ,
panel  ||| S:33245 E:33251 ||| NN
1 ||| S:33251 E:33252 ||| CD
,  ||| S:33252 E:33254 ||| ,
lanes  ||| S:33254 E:33260 ||| CD
1  ||| S:33260 E:33272 ||| CD
&  ||| S:33272 E:33274 ||| CC
2 ||| S:33274 E:33275 ||| LS
) ||| S:33275 E:33276 ||| -RRB-
.  ||| S:33276 E:33278 ||| .
The  ||| S:33278 E:33282 ||| DT
receptor  ||| S:33282 E:33291 ||| JJ
activation-induced  ||| S:33291 E:33310 ||| JJ
decrease  ||| S:33310 E:33319 ||| NN
of  ||| S:33319 E:33332 ||| IN
SNIP1  ||| S:33332 E:33338 ||| NNP
is  ||| S:33338 E:33341 ||| VBZ
partially  ||| S:33341 E:33351 ||| RB
sensitive  ||| S:33351 E:33361 ||| JJ
to  ||| S:33361 E:33364 ||| TO
the  ||| S:33364 E:33368 ||| DT
proteasome-specific  ||| S:33368 E:33398 ||| JJ
inhibitor  ||| S:33398 E:33408 ||| JJ
lactacystin ||| S:33408 E:33419 ||| NN
,  ||| S:33419 E:33421 ||| ,
suggesting  ||| S:33421 E:33432 ||| VBG
the  ||| S:33432 E:33436 ||| DT
involvement  ||| S:33436 E:33448 ||| NN
of  ||| S:33448 E:33461 ||| IN
proteasomal  ||| S:33461 E:33473 ||| JJ
degradation  ||| S:33473 E:33485 ||| NNS
( ||| S:33485 E:33486 ||| -LRB-
Fig.  ||| S:33486 E:33491 ||| NNP
8A ||| S:33491 E:33493 ||| NNP
,  ||| S:33493 E:33495 ||| ,
panel  ||| S:33495 E:33501 ||| NN
1 ||| S:33501 E:33502 ||| CD
,  ||| S:33502 E:33504 ||| ,
lane  ||| S:33504 E:33509 ||| CD
3 ||| S:33509 E:33510 ||| CD
) ||| S:33510 E:33511 ||| -RRB-
.  ||| S:33511 E:33513 ||| .
The  ||| S:33513 E:33527 ||| DT
incomplete  ||| S:33527 E:33538 ||| JJ
rescue  ||| S:33538 E:33545 ||| NN
of  ||| S:33545 E:33548 ||| IN
SNIP1  ||| S:33548 E:33554 ||| CD
level  ||| S:33554 E:33560 ||| NN
by  ||| S:33560 E:33563 ||| IN
lactacystin  ||| S:33563 E:33575 ||| NN
suggests  ||| S:33575 E:33594 ||| VBZ
the  ||| S:33594 E:33598 ||| DT
involvement  ||| S:33598 E:33610 ||| NN
of  ||| S:33610 E:33613 ||| IN
additional  ||| S:33613 E:33624 ||| JJ
mechanisms  ||| S:33624 E:33635 ||| NNS
other  ||| S:33635 E:33641 ||| JJ
than  ||| S:33641 E:33646 ||| IN
26S  ||| S:33646 E:33660 ||| CD
proteasome  ||| S:33660 E:33671 ||| NN
in  ||| S:33671 E:33674 ||| IN
SNIP1  ||| S:33674 E:33680 ||| CD
degradation ||| S:33680 E:33691 ||| NN
.  ||| S:33691 E:33693 ||| .
To  ||| S:33693 E:33696 ||| TO
systematically  ||| S:33696 E:33721 ||| RB
demonstrate  ||| S:33721 E:33733 ||| VB
the  ||| S:33733 E:33737 ||| DT
role  ||| S:33737 E:33742 ||| NN
of  ||| S:33742 E:33745 ||| IN
Smad1 ||| S:33745 E:33750 ||| NNP
,  ||| S:33750 E:33752 ||| ,
Smad4  ||| S:33752 E:33758 ||| NNP
and  ||| S:33758 E:33762 ||| CC
Az  ||| S:33762 E:33765 ||| NNP
in  ||| S:33765 E:33768 ||| IN
the  ||| S:33768 E:33782 ||| DT
observed  ||| S:33782 E:33791 ||| JJ
decrease  ||| S:33791 E:33800 ||| NN
of  ||| S:33800 E:33803 ||| IN
SNIP1  ||| S:33803 E:33809 ||| CD
protein  ||| S:33809 E:33817 ||| NN
level ||| S:33817 E:33822 ||| NN
,  ||| S:33822 E:33824 ||| ,
we  ||| S:33824 E:33827 ||| PRP
sequentially  ||| S:33827 E:33850 ||| VBP
left  ||| S:33850 E:33855 ||| VBN
out  ||| S:33855 E:33859 ||| RP
one  ||| S:33859 E:33863 ||| CD
of  ||| S:33863 E:33866 ||| IN
these  ||| S:33866 E:33872 ||| DT
three  ||| S:33872 E:33878 ||| CD
proteins  ||| S:33878 E:33887 ||| NNS
in  ||| S:33887 E:33890 ||| IN
the  ||| S:33890 E:33894 ||| DT
above  ||| S:33894 E:33900 ||| JJ
assay ||| S:33900 E:33905 ||| NN
.  ||| S:33905 E:33917 ||| .
The  ||| S:33917 E:33921 ||| DT
ALK3Q233D-induced  ||| S:33921 E:33939 ||| JJ
degradation  ||| S:33939 E:33951 ||| NN
of  ||| S:33951 E:33954 ||| IN
SNIP1  ||| S:33954 E:33960 ||| NNP
was  ||| S:33960 E:33974 ||| VBD
significantly  ||| S:33974 E:33988 ||| RB
blocked  ||| S:33988 E:33996 ||| VBN
in  ||| S:33996 E:33999 ||| IN
the  ||| S:33999 E:34003 ||| DT
absence  ||| S:34003 E:34011 ||| NN
of  ||| S:34011 E:34014 ||| IN
Az  ||| S:34014 E:34017 ||| NNP
( ||| S:34017 E:34018 ||| -LRB-
Fig.  ||| S:34018 E:34023 ||| NNP
8A ||| S:34023 E:34025 ||| NNP
,  ||| S:34025 E:34037 ||| ,
panel  ||| S:34037 E:34043 ||| NN
1 ||| S:34043 E:34044 ||| CD
,  ||| S:34044 E:34046 ||| ,
lanes  ||| S:34046 E:34052 ||| CD
4  ||| S:34052 E:34054 ||| CD
&  ||| S:34054 E:34056 ||| CC
5 ||| S:34056 E:34057 ||| CD
) ||| S:34057 E:34058 ||| -RRB-
,  ||| S:34058 E:34060 ||| ,
Smad4  ||| S:34060 E:34066 ||| NNP
( ||| S:34066 E:34067 ||| -LRB-
lanes  ||| S:34067 E:34073 ||| CD
6  ||| S:34073 E:34075 ||| CD
&  ||| S:34075 E:34077 ||| CC
7 ||| S:34077 E:34078 ||| CD
) ||| S:34078 E:34079 ||| -RRB-
,  ||| S:34079 E:34081 ||| ,
or  ||| S:34081 E:34094 ||| CC
Smad1  ||| S:34094 E:34100 ||| NNP
( ||| S:34100 E:34101 ||| -LRB-
lanes  ||| S:34101 E:34107 ||| CD
8  ||| S:34107 E:34109 ||| CD
&  ||| S:34109 E:34111 ||| CC
9 ||| S:34111 E:34112 ||| CD
) ||| S:34112 E:34113 ||| -RRB-
.  ||| S:34113 E:34115 ||| .
Thus ||| S:34115 E:34119 ||| RB
,  ||| S:34119 E:34121 ||| ,
the  ||| S:34121 E:34125 ||| DT
ALK3Q233D-induced  ||| S:34125 E:34153 ||| JJ
degradation  ||| S:34153 E:34165 ||| NN
of  ||| S:34165 E:34168 ||| IN
SNIP1  ||| S:34168 E:34174 ||| NNP
is  ||| S:34174 E:34177 ||| VBZ
regulated  ||| S:34177 E:34187 ||| VBN
by  ||| S:34187 E:34190 ||| IN
the  ||| S:34190 E:34194 ||| DT
protein  ||| S:34194 E:34202 ||| NN
levels  ||| S:34202 E:34219 ||| NNS
of  ||| S:34219 E:34222 ||| IN
Smad1 ||| S:34222 E:34227 ||| NNP
,  ||| S:34227 E:34229 ||| ,
Smad4 ||| S:34229 E:34234 ||| NNP
,  ||| S:34234 E:34236 ||| ,
Az  ||| S:34236 E:34239 ||| NNP
and  ||| S:34239 E:34243 ||| CC
is  ||| S:34243 E:34246 ||| VBZ
only  ||| S:34246 E:34251 ||| RB
induced  ||| S:34251 E:34259 ||| VBN
by  ||| S:34259 E:34262 ||| IN
high  ||| S:34262 E:34267 ||| JJ
dose  ||| S:34267 E:34272 ||| NN
of  ||| S:34272 E:34285 ||| IN
the  ||| S:34285 E:34289 ||| DT
activated  ||| S:34289 E:34299 ||| JJ
BMP  ||| S:34299 E:34303 ||| NN
type  ||| S:34303 E:34308 ||| NN
I  ||| S:34308 E:34310 ||| PRP
receptor ||| S:34310 E:34318 ||| VBD
.  ||| S:34318 E:34320 ||| .
Interestingly ||| S:34320 E:34333 ||| RB
,  ||| S:34333 E:34335 ||| ,
by  ||| S:34335 E:34348 ||| IN
simply  ||| S:34348 E:34355 ||| RB
replacing  ||| S:34355 E:34365 ||| VBG
Smad1  ||| S:34365 E:34371 ||| NN
with  ||| S:34371 E:34376 ||| IN
the  ||| S:34376 E:34380 ||| DT
Smad1  ||| S:34380 E:34386 ||| FW
mutant  ||| S:34386 E:34393 ||| FW
Smad1G419S  ||| S:34393 E:34404 ||| FW
[  ||| S:34404 E:34416 ||| -LRB-
40  ||| S:34416 E:34419 ||| CD
]  ||| S:34419 E:34421 ||| -RRB-
,  ||| S:34421 E:34423 ||| ,
which  ||| S:34423 E:34429 ||| WDT
is  ||| S:34429 E:34432 ||| VBZ
defective  ||| S:34432 E:34442 ||| JJ
in  ||| S:34442 E:34445 ||| IN
binding  ||| S:34445 E:34453 ||| VBG
to  ||| S:34453 E:34456 ||| TO
BMP  ||| S:34456 E:34460 ||| NN
type  ||| S:34460 E:34465 ||| NN
I  ||| S:34465 E:34477 ||| PRP
receptor  ||| S:34477 E:34486 ||| VBD
for  ||| S:34486 E:34490 ||| IN
receptor-mediated  ||| S:34490 E:34508 ||| JJ
phosphorylation  ||| S:34508 E:34524 ||| NN
and  ||| S:34524 E:34528 ||| CC
the  ||| S:34528 E:34542 ||| DT
subsequent  ||| S:34542 E:34553 ||| JJ
nuclear  ||| S:34553 E:34561 ||| JJ
translocation ||| S:34561 E:34574 ||| NN
,  ||| S:34574 E:34576 ||| ,
SNIP1  ||| S:34576 E:34582 ||| CD
degradation  ||| S:34582 E:34594 ||| NNS
was  ||| S:34594 E:34608 ||| VBD
also  ||| S:34608 E:34613 ||| RB
inhibited  ||| S:34613 E:34623 ||| JJ
( ||| S:34623 E:34624 ||| -LRB-
Fig.  ||| S:34624 E:34629 ||| NNP
8A ||| S:34629 E:34631 ||| NNP
,  ||| S:34631 E:34633 ||| ,
panel  ||| S:34633 E:34639 ||| NN
1 ||| S:34639 E:34640 ||| CD
,  ||| S:34640 E:34642 ||| ,
lanes  ||| S:34642 E:34648 ||| CD
10  ||| S:34648 E:34651 ||| CD
&  ||| S:34651 E:34653 ||| CC
11 ||| S:34653 E:34655 ||| CD
) ||| S:34655 E:34656 ||| -RRB-
,  ||| S:34656 E:34668 ||| ,
suggesting  ||| S:34668 E:34679 ||| VBG
that  ||| S:34679 E:34684 ||| IN
the  ||| S:34684 E:34688 ||| DT
degradation  ||| S:34688 E:34700 ||| NN
of  ||| S:34700 E:34703 ||| IN
SNIP1  ||| S:34703 E:34709 ||| NNP
is  ||| S:34709 E:34712 ||| VBZ
dependent  ||| S:34712 E:34732 ||| JJ
upon  ||| S:34732 E:34737 ||| IN
the  ||| S:34737 E:34741 ||| DT
type  ||| S:34741 E:34746 ||| NN
I  ||| S:34746 E:34748 ||| PRP
receptor-mediated  ||| S:34748 E:34766 ||| JJ
phosphorylation  ||| S:34766 E:34782 ||| NN
of  ||| S:34782 E:34795 ||| IN
Smad1 ||| S:34795 E:34800 ||| CD
.  ||| S:34800 E:34802 ||| .
The  ||| S:34802 E:34806 ||| DT
levels  ||| S:34806 E:34813 ||| NNS
of  ||| S:34813 E:34816 ||| IN
SNIP1  ||| S:34816 E:34822 ||| CD
in  ||| S:34822 E:34825 ||| IN
Fig.  ||| S:34825 E:34830 ||| CD
8Atop  ||| S:34830 E:34836 ||| CD
panel  ||| S:34836 E:34842 ||| NN
are  ||| S:34842 E:34856 ||| VBP
quantified  ||| S:34856 E:34867 ||| VBN
and  ||| S:34867 E:34871 ||| CC
plotted  ||| S:34871 E:34879 ||| NN
as  ||| S:34879 E:34882 ||| IN
Integrated  ||| S:34882 E:34893 ||| NNP
Optical  ||| S:34893 E:34901 ||| NNP
Density  ||| S:34901 E:34919 ||| NNP
( ||| S:34919 E:34920 ||| -LRB-
IOD ||| S:34920 E:34923 ||| NNP
)  ||| S:34923 E:34925 ||| -RRB-
of  ||| S:34925 E:34928 ||| IN
SNIP1  ||| S:34928 E:34934 ||| NNP
( ||| S:34934 E:34935 ||| -LRB-
Fig.  ||| S:34935 E:34940 ||| NNP
8A ||| S:34940 E:34942 ||| NNP
,  ||| S:34942 E:34944 ||| ,
right  ||| S:34944 E:34950 ||| JJ
panel ||| S:34950 E:34955 ||| NN
) ||| S:34955 E:34956 ||| -RRB-
.  ||| S:34956 E:34968 ||| .
We  ||| S:34968 E:34971 ||| PRP
noted  ||| S:34971 E:34977 ||| VBD
that  ||| S:34977 E:34982 ||| IN
the  ||| S:34982 E:34986 ||| DT
protein  ||| S:34986 E:34994 ||| NN
levels  ||| S:34994 E:35001 ||| NNS
of  ||| S:35001 E:35004 ||| IN
Smad1 ||| S:35004 E:35009 ||| NNP
,  ||| S:35009 E:35011 ||| ,
Smad4  ||| S:35011 E:35017 ||| NNP
and  ||| S:35017 E:35031 ||| CC
Az  ||| S:35031 E:35034 ||| NNP
were  ||| S:35034 E:35039 ||| VBD
co-regulated  ||| S:35039 E:35052 ||| JJ
with  ||| S:35052 E:35057 ||| IN
that  ||| S:35057 E:35062 ||| DT
of  ||| S:35062 E:35065 ||| IN
SNIP1 ||| S:35065 E:35070 ||| CD
.  ||| S:35070 E:35072 ||| .
For  ||| S:35072 E:35076 ||| IN
example ||| S:35076 E:35083 ||| NN
,  ||| S:35083 E:35085 ||| ,
the  ||| S:35085 E:35099 ||| DT
protein  ||| S:35099 E:35107 ||| NN
levels  ||| S:35107 E:35114 ||| NNS
of  ||| S:35114 E:35117 ||| IN
Smad1 ||| S:35117 E:35122 ||| NNP
,  ||| S:35122 E:35124 ||| ,
Smad4  ||| S:35124 E:35130 ||| NNP
and  ||| S:35130 E:35134 ||| CC
Az  ||| S:35134 E:35137 ||| NNP
were  ||| S:35137 E:35142 ||| VBD
all  ||| S:35142 E:35146 ||| DT
sensitive  ||| S:35146 E:35166 ||| JJ
to  ||| S:35166 E:35169 ||| TO
lactacystin  ||| S:35169 E:35181 ||| VB
( ||| S:35181 E:35182 ||| -LRB-
Fig.  ||| S:35182 E:35187 ||| NNP
8A ||| S:35187 E:35189 ||| NNP
,  ||| S:35189 E:35191 ||| ,
all  ||| S:35191 E:35195 ||| DT
panels ||| S:35195 E:35201 ||| NNS
,  ||| S:35201 E:35203 ||| ,
compare  ||| S:35203 E:35211 ||| VBP
lane  ||| S:35211 E:35216 ||| RB
2  ||| S:35216 E:35218 ||| CD
and  ||| S:35218 E:35232 ||| CC
lane  ||| S:35232 E:35237 ||| CD
3 ||| S:35237 E:35238 ||| CD
) ||| S:35238 E:35239 ||| -RRB-
.  ||| S:35239 E:35241 ||| .
Blocking  ||| S:35241 E:35250 ||| VBG
SNIP1  ||| S:35250 E:35256 ||| CD
degradation  ||| S:35256 E:35268 ||| NNS
was  ||| S:35268 E:35272 ||| VBD
accompanied  ||| S:35272 E:35284 ||| VBN
by  ||| S:35284 E:35297 ||| IN
increased  ||| S:35297 E:35307 ||| JJ
protein  ||| S:35307 E:35315 ||| NN
levels  ||| S:35315 E:35322 ||| NNS
of  ||| S:35322 E:35325 ||| IN
Smad1 ||| S:35325 E:35330 ||| NNP
,  ||| S:35330 E:35332 ||| ,
Smad4  ||| S:35332 E:35338 ||| NNP
and  ||| S:35338 E:35342 ||| CC
Az  ||| S:35342 E:35345 ||| NNP
in  ||| S:35345 E:35348 ||| IN
cells  ||| S:35348 E:35364 ||| NNS
expressing  ||| S:35364 E:35375 ||| VBG
the  ||| S:35375 E:35379 ||| DT
activated  ||| S:35379 E:35389 ||| JJ
ALK3  ||| S:35389 E:35394 ||| NNP
( ||| S:35394 E:35395 ||| -LRB-
Fig.  ||| S:35395 E:35400 ||| NNP
8A ||| S:35400 E:35402 ||| NNP
,  ||| S:35402 E:35404 ||| ,
lanes  ||| S:35404 E:35410 ||| CD
5 ||| S:35410 E:35411 ||| CD
,  ||| S:35411 E:35413 ||| ,
7 ||| S:35413 E:35414 ||| CD
,  ||| S:35414 E:35416 ||| ,
9 ||| S:35416 E:35417 ||| CD
,  ||| S:35417 E:35429 ||| ,
11 ||| S:35429 E:35431 ||| CD
) ||| S:35431 E:35432 ||| -RRB-
.  ||| S:35432 E:35434 ||| .
The  ||| S:35434 E:35438 ||| DT
lower  ||| S:35438 E:35444 ||| JJR
levels  ||| S:35444 E:35451 ||| NNS
of  ||| S:35451 E:35454 ||| IN
Smad1 ||| S:35454 E:35459 ||| NNP
,  ||| S:35459 E:35461 ||| ,
Smad4 ||| S:35461 E:35466 ||| NNP
,  ||| S:35466 E:35468 ||| ,
Az  ||| S:35468 E:35471 ||| NNP
and  ||| S:35471 E:35475 ||| CC
SNIP1  ||| S:35475 E:35481 ||| CD
in  ||| S:35481 E:35494 ||| IN
lane  ||| S:35494 E:35499 ||| CD
1  ||| S:35499 E:35501 ||| CD
compared  ||| S:35501 E:35510 ||| VBN
with  ||| S:35510 E:35515 ||| IN
those  ||| S:35515 E:35521 ||| DT
in  ||| S:35521 E:35524 ||| IN
lane  ||| S:35524 E:35529 ||| CD
10  ||| S:35529 E:35532 ||| CD
suggest  ||| S:35532 E:35540 ||| VBP
that  ||| S:35540 E:35545 ||| IN
the  ||| S:35545 E:35559 ||| DT
leaky  ||| S:35559 E:35565 ||| JJ
signaling  ||| S:35565 E:35575 ||| NN
by  ||| S:35575 E:35578 ||| IN
the  ||| S:35578 E:35582 ||| DT
overexpressed  ||| S:35582 E:35596 ||| JJ
ALK3 ||| S:35596 E:35600 ||| NN
,  ||| S:35600 E:35602 ||| ,
which  ||| S:35602 E:35608 ||| WDT
we  ||| S:35608 E:35611 ||| PRP
have  ||| S:35611 E:35626 ||| VBP
demonstrated  ||| S:35626 E:35639 ||| VBN
recently  ||| S:35639 E:35648 ||| RB
[  ||| S:35648 E:35650 ||| -LRB-
39  ||| S:35650 E:35653 ||| CD
]  ||| S:35653 E:35655 ||| -RRB-
,  ||| S:35655 E:35657 ||| ,
caused  ||| S:35657 E:35664 ||| VBD
a  ||| S:35664 E:35666 ||| DT
constitutive  ||| S:35666 E:35689 ||| JJ
reduction  ||| S:35689 E:35699 ||| NN
of  ||| S:35699 E:35702 ||| IN
Smad4 ||| S:35702 E:35707 ||| NNP
,  ||| S:35707 E:35709 ||| ,
Az  ||| S:35709 E:35712 ||| NNP
and  ||| S:35712 E:35716 ||| CC
SNIP1  ||| S:35716 E:35722 ||| CD
level  ||| S:35722 E:35728 ||| NN
that  ||| S:35728 E:35733 ||| WDT
is  ||| S:35733 E:35736 ||| VBZ
dependent  ||| S:35736 E:35756 ||| JJ
upon  ||| S:35756 E:35761 ||| IN
the  ||| S:35761 E:35765 ||| DT
activation  ||| S:35765 E:35776 ||| NN
of  ||| S:35776 E:35779 ||| IN
Smad1 ||| S:35779 E:35784 ||| CD
.  ||| S:35784 E:35786 ||| .
These  ||| S:35786 E:35792 ||| DT
data  ||| S:35792 E:35797 ||| NNS
thus  ||| S:35797 E:35802 ||| RB
suggest  ||| S:35802 E:35820 ||| VB
that  ||| S:35820 E:35825 ||| IN
SNIP1  ||| S:35825 E:35831 ||| NNP
is  ||| S:35831 E:35834 ||| VBZ
targeted  ||| S:35834 E:35843 ||| VBN
to  ||| S:35843 E:35846 ||| TO
proteasome  ||| S:35846 E:35857 ||| VB
for  ||| S:35857 E:35861 ||| IN
degradation  ||| S:35861 E:35883 ||| VBG
together  ||| S:35883 E:35892 ||| RP
with  ||| S:35892 E:35897 ||| IN
Smad1 ||| S:35897 E:35902 ||| NNP
,  ||| S:35902 E:35904 ||| ,
Az  ||| S:35904 E:35907 ||| NNP
and  ||| S:35907 E:35911 ||| CC
Smad4 ||| S:35911 E:35916 ||| NNP
.  ||| S:35916 E:35928 ||| .
The  ||| S:35928 E:35932 ||| DT
ability  ||| S:35932 E:35940 ||| NN
of  ||| S:35940 E:35943 ||| IN
Smad1  ||| S:35943 E:35949 ||| CD
in  ||| S:35949 E:35952 ||| IN
regulating  ||| S:35952 E:35963 ||| VBG
SNIP1  ||| S:35963 E:35969 ||| CD
degradation  ||| S:35969 E:35991 ||| NNS
was  ||| S:35991 E:35995 ||| VBD
further  ||| S:35995 E:36003 ||| RB
demonstrated  ||| S:36003 E:36016 ||| VBN
by  ||| S:36016 E:36019 ||| IN
increased  ||| S:36019 E:36029 ||| JJ
expression  ||| S:36029 E:36040 ||| NN
of  ||| S:36040 E:36043 ||| IN
Smad1  ||| S:36043 E:36059 ||| CD
in  ||| S:36059 E:36062 ||| IN
COS1  ||| S:36062 E:36067 ||| CD
cells  ||| S:36067 E:36073 ||| NNS
that  ||| S:36073 E:36078 ||| WDT
were  ||| S:36078 E:36083 ||| VBD
transfected  ||| S:36083 E:36095 ||| VBN
with  ||| S:36095 E:36100 ||| IN
a  ||| S:36100 E:36102 ||| DT
constant  ||| S:36102 E:36121 ||| JJ
amount  ||| S:36121 E:36128 ||| NN
of  ||| S:36128 E:36131 ||| IN
Smad4 ||| S:36131 E:36136 ||| NNP
,  ||| S:36136 E:36138 ||| ,
Az ||| S:36138 E:36140 ||| NNP
,  ||| S:36140 E:36142 ||| ,
ALK3Q233D  ||| S:36142 E:36152 ||| NNP
and  ||| S:36152 E:36156 ||| CC
SNIP1  ||| S:36156 E:36162 ||| NNP
( ||| S:36162 E:36163 ||| -LRB-
Fig.  ||| S:36163 E:36168 ||| NNP
8B ||| S:36168 E:36170 ||| NNP
) ||| S:36170 E:36171 ||| -RRB-
.  ||| S:36171 E:36173 ||| .
A  ||| S:36173 E:36185 ||| DT
dose-dependent  ||| S:36185 E:36200 ||| JJ
effect  ||| S:36200 E:36207 ||| NN
of  ||| S:36207 E:36210 ||| IN
Smad1  ||| S:36210 E:36216 ||| CD
on  ||| S:36216 E:36219 ||| IN
receptor-induced  ||| S:36219 E:36246 ||| JJ
degradation  ||| S:36246 E:36258 ||| NN
of  ||| S:36258 E:36261 ||| IN
SNIP1  ||| S:36261 E:36267 ||| NNP
was  ||| S:36267 E:36271 ||| VBD
observed  ||| S:36271 E:36280 ||| VBN
( ||| S:36280 E:36281 ||| -LRB-
Fig.  ||| S:36281 E:36286 ||| NNP
8B ||| S:36286 E:36288 ||| NNP
,  ||| S:36288 E:36290 ||| ,
compare  ||| S:36290 E:36298 ||| VBP
lanes  ||| S:36298 E:36314 ||| RB
1  ||| S:36314 E:36316 ||| CD
&  ||| S:36316 E:36318 ||| CC
2  ||| S:36318 E:36320 ||| CD
with  ||| S:36320 E:36325 ||| IN
lanes  ||| S:36325 E:36331 ||| CD
5  ||| S:36331 E:36333 ||| CD
&  ||| S:36333 E:36335 ||| CC
6 ||| S:36335 E:36336 ||| CD
) ||| S:36336 E:36337 ||| -RRB-
.  ||| S:36337 E:36349 ||| .
To  ||| S:36349 E:36352 ||| TO
confirm  ||| S:36352 E:36360 ||| VB
SNIP1  ||| S:36360 E:36366 ||| CD
degradation  ||| S:36366 E:36378 ||| NN
in  ||| S:36378 E:36381 ||| IN
non-overexpression  ||| S:36381 E:36410 ||| JJ
systems ||| S:36410 E:36417 ||| NNS
,  ||| S:36417 E:36419 ||| ,
we  ||| S:36419 E:36422 ||| PRP
monitored  ||| S:36422 E:36432 ||| VBD
the  ||| S:36432 E:36436 ||| DT
steady  ||| S:36436 E:36443 ||| JJ
state  ||| S:36443 E:36449 ||| NN
levels  ||| S:36449 E:36456 ||| NNS
of  ||| S:36456 E:36469 ||| IN
endogenous  ||| S:36469 E:36480 ||| JJ
SNIP1  ||| S:36480 E:36486 ||| NN
in  ||| S:36486 E:36489 ||| IN
the  ||| S:36489 E:36493 ||| DT
human  ||| S:36493 E:36499 ||| JJ
keratinocyte  ||| S:36499 E:36512 ||| JJ
HaCaT  ||| S:36512 E:36518 ||| JJ
and  ||| S:36518 E:36532 ||| CC
mouse  ||| S:36532 E:36538 ||| NN
myoblast  ||| S:36538 E:36547 ||| VBD
L6 ||| S:36547 E:36549 ||| CD
.  ||| S:36549 E:36551 ||| .
Cells  ||| S:36551 E:36557 ||| NNS
were  ||| S:36557 E:36562 ||| VBD
treated  ||| S:36562 E:36570 ||| VBN
with  ||| S:36570 E:36575 ||| IN
BMP7  ||| S:36575 E:36580 ||| CD
for  ||| S:36580 E:36594 ||| IN
different  ||| S:36594 E:36604 ||| JJ
periods  ||| S:36604 E:36612 ||| NNS
of  ||| S:36612 E:36615 ||| IN
time ||| S:36615 E:36619 ||| NN
.  ||| S:36619 E:36621 ||| .
Western  ||| S:36621 E:36629 ||| JJ
blot  ||| S:36629 E:36634 ||| JJ
analyses  ||| S:36634 E:36643 ||| NNS
using  ||| S:36643 E:36649 ||| VBG
an  ||| S:36649 E:36662 ||| DT
anti-SNIP1  ||| S:36662 E:36673 ||| JJ
antibody  ||| S:36673 E:36682 ||| NN
detected  ||| S:36682 E:36691 ||| VBD
two  ||| S:36691 E:36695 ||| CD
forms  ||| S:36695 E:36701 ||| NNS
of  ||| S:36701 E:36704 ||| IN
SNIP1  ||| S:36704 E:36710 ||| CD
with  ||| S:36710 E:36725 ||| IN
slightly  ||| S:36725 E:36734 ||| RB
different  ||| S:36734 E:36744 ||| JJ
mobility ||| S:36744 E:36752 ||| NN
,  ||| S:36752 E:36754 ||| ,
which  ||| S:36754 E:36760 ||| WDT
are  ||| S:36760 E:36764 ||| VBP
named  ||| S:36764 E:36770 ||| VBN
as  ||| S:36770 E:36773 ||| IN
SNIP1.A  ||| S:36773 E:36791 ||| NNP
and  ||| S:36791 E:36795 ||| CC
SNIP1.B  ||| S:36795 E:36803 ||| NNP
( ||| S:36803 E:36804 ||| -LRB-
Fig.  ||| S:36804 E:36809 ||| NNP
8C ||| S:36809 E:36811 ||| NNP
,  ||| S:36811 E:36813 ||| ,
top  ||| S:36813 E:36817 ||| JJ
panel ||| S:36817 E:36822 ||| NN
) ||| S:36822 E:36823 ||| -RRB-
.  ||| S:36823 E:36825 ||| .
The  ||| S:36825 E:36829 ||| DT
IOD  ||| S:36829 E:36833 ||| NNP
of  ||| S:36833 E:36836 ||| IN
each  ||| S:36836 E:36841 ||| DT
form  ||| S:36841 E:36846 ||| NN
of  ||| S:36846 E:36859 ||| IN
SNIP1  ||| S:36859 E:36865 ||| CD
as  ||| S:36865 E:36868 ||| IN
well  ||| S:36868 E:36873 ||| RB
as  ||| S:36873 E:36876 ||| IN
the  ||| S:36876 E:36880 ||| DT
total  ||| S:36880 E:36886 ||| JJ
IOD  ||| S:36886 E:36890 ||| NN
of  ||| S:36890 E:36893 ||| IN
both  ||| S:36893 E:36898 ||| DT
forms  ||| S:36898 E:36904 ||| NNS
are  ||| S:36904 E:36908 ||| VBP
plotted  ||| S:36908 E:36926 ||| NNS
( ||| S:36926 E:36927 ||| -LRB-
Fig.  ||| S:36927 E:36932 ||| NNP
8C ||| S:36932 E:36934 ||| NNP
,  ||| S:36934 E:36936 ||| ,
right  ||| S:36936 E:36942 ||| JJ
panel ||| S:36942 E:36947 ||| NN
) ||| S:36947 E:36948 ||| -RRB-
.  ||| S:36948 E:36950 ||| .
In  ||| S:36950 E:36953 ||| IN
HaCaT  ||| S:36953 E:36959 ||| JJ
cells ||| S:36959 E:36964 ||| NNS
,  ||| S:36964 E:36966 ||| ,
the  ||| S:36966 E:36970 ||| DT
protein  ||| S:36970 E:36988 ||| NN
levels  ||| S:36988 E:36995 ||| NNS
of  ||| S:36995 E:36998 ||| IN
both  ||| S:36998 E:37003 ||| DT
forms  ||| S:37003 E:37009 ||| NNS
of  ||| S:37009 E:37012 ||| IN
SNIP1  ||| S:37012 E:37018 ||| NNP
were  ||| S:37018 E:37023 ||| VBD
significantly  ||| S:37023 E:37047 ||| RB
decreased  ||| S:37047 E:37057 ||| VBN
after  ||| S:37057 E:37063 ||| IN
3  ||| S:37063 E:37065 ||| CD
hrs  ||| S:37065 E:37069 ||| NN
of  ||| S:37069 E:37072 ||| IN
BMP7  ||| S:37072 E:37077 ||| CD
treatment  ||| S:37077 E:37087 ||| NN
and  ||| S:37087 E:37091 ||| CC
were  ||| S:37091 E:37096 ||| VBD
almost  ||| S:37096 E:37113 ||| RB
diminished  ||| S:37113 E:37124 ||| VBN
by  ||| S:37124 E:37127 ||| IN
22  ||| S:37127 E:37130 ||| CD
hrs ||| S:37130 E:37133 ||| NNS
.  ||| S:37133 E:37135 ||| .
Interestingly ||| S:37135 E:37148 ||| RB
,  ||| S:37148 E:37150 ||| ,
a  ||| S:37150 E:37152 ||| DT
different  ||| S:37152 E:37162 ||| JJ
response  ||| S:37162 E:37181 ||| NN
was  ||| S:37181 E:37185 ||| VBD
observed  ||| S:37185 E:37194 ||| VBN
in  ||| S:37194 E:37197 ||| IN
L6  ||| S:37197 E:37200 ||| CD
cells ||| S:37200 E:37205 ||| NNS
.  ||| S:37205 E:37207 ||| .
The  ||| S:37207 E:37211 ||| DT
levels  ||| S:37211 E:37218 ||| NNS
of  ||| S:37218 E:37221 ||| IN
SNIP1  ||| S:37221 E:37227 ||| NNP
were  ||| S:37227 E:37242 ||| VBD
somewhat  ||| S:37242 E:37251 ||| RB
increased  ||| S:37251 E:37261 ||| VBN
after  ||| S:37261 E:37267 ||| IN
3  ||| S:37267 E:37269 ||| CD
hrs  ||| S:37269 E:37273 ||| NNS
and  ||| S:37273 E:37277 ||| CC
peaked  ||| S:37277 E:37284 ||| VBN
at  ||| S:37284 E:37287 ||| IN
3.5  ||| S:37287 E:37291 ||| CD
hrs ||| S:37291 E:37294 ||| NN
,  ||| S:37294 E:37296 ||| ,
but  ||| S:37296 E:37310 ||| CC
then  ||| S:37310 E:37315 ||| RB
started  ||| S:37315 E:37323 ||| VBN
to  ||| S:37323 E:37326 ||| TO
decline  ||| S:37326 E:37334 ||| VB
at  ||| S:37334 E:37337 ||| IN
7  ||| S:37337 E:37339 ||| CD
hrs  ||| S:37339 E:37343 ||| NNS
and  ||| S:37343 E:37347 ||| CC
were  ||| S:37347 E:37352 ||| VBD
diminished  ||| S:37352 E:37363 ||| VBN
at  ||| S:37363 E:37376 ||| IN
22  ||| S:37376 E:37379 ||| CD
hrs ||| S:37379 E:37382 ||| NNS
.  ||| S:37382 E:37412 ||| .
SNIP1  ||| S:37412 E:37418 ||| NNP
is  ||| S:37418 E:37421 ||| VBZ
a  ||| S:37421 E:37423 ||| DT
nuclear  ||| S:37423 E:37431 ||| JJ
repressor  ||| S:37431 E:37441 ||| NN
of  ||| S:37441 E:37444 ||| IN
the  ||| S:37444 E:37448 ||| DT
BMP-induced  ||| S:37448 E:37470 ||| JJ
transcription  ||| S:37470 E:37484 ||| JJ
responses  ||| S:37484 E:37504 ||| NNS
To  ||| S:37504 E:37507 ||| TO
determine  ||| S:37507 E:37517 ||| VB
the  ||| S:37517 E:37521 ||| DT
functional  ||| S:37521 E:37532 ||| JJ
significance  ||| S:37532 E:37545 ||| NN
of  ||| S:37545 E:37548 ||| IN
the  ||| S:37548 E:37562 ||| DT
observed  ||| S:37562 E:37571 ||| JJ
SNIP1  ||| S:37571 E:37577 ||| NN
degradation  ||| S:37577 E:37589 ||| VBZ
induced  ||| S:37589 E:37597 ||| VBN
by  ||| S:37597 E:37600 ||| IN
BMPs ||| S:37600 E:37604 ||| NNP
,  ||| S:37604 E:37606 ||| ,
we  ||| S:37606 E:37609 ||| PRP
tested  ||| S:37609 E:37616 ||| VBD
the  ||| S:37616 E:37630 ||| DT
role  ||| S:37630 E:37635 ||| NN
of  ||| S:37635 E:37638 ||| IN
SNIP1  ||| S:37638 E:37644 ||| CD
in  ||| S:37644 E:37647 ||| IN
Smad1-regulated  ||| S:37647 E:37663 ||| CD
gene  ||| S:37663 E:37668 ||| NN
responses  ||| S:37668 E:37678 ||| NNS
of  ||| S:37678 E:37681 ||| IN
BMPs ||| S:37681 E:37685 ||| JJ
.  ||| S:37685 E:37697 ||| .
We  ||| S:37697 E:37700 ||| PRP
first  ||| S:37700 E:37706 ||| RB
tested  ||| S:37706 E:37713 ||| VBN
the  ||| S:37713 E:37717 ||| DT
effect  ||| S:37717 E:37724 ||| NN
of  ||| S:37724 E:37727 ||| IN
SNIP1  ||| S:37727 E:37733 ||| CD
on  ||| S:37733 E:37736 ||| IN
the  ||| S:37736 E:37740 ||| DT
BMP-induced  ||| S:37740 E:37762 ||| JJ
activation  ||| S:37762 E:37773 ||| NN
of  ||| S:37773 E:37776 ||| IN
the  ||| S:37776 E:37780 ||| DT
Tlx2  ||| S:37780 E:37785 ||| JJ
promoter ||| S:37785 E:37793 ||| NN
,  ||| S:37793 E:37795 ||| ,
which  ||| S:37795 E:37801 ||| WDT
involves  ||| S:37801 E:37810 ||| VBZ
Smad1  ||| S:37810 E:37816 ||| NNP
[  ||| S:37816 E:37828 ||| -LRB-
41  ||| S:37828 E:37831 ||| CD
]  ||| S:37831 E:37833 ||| -RRB-
.  ||| S:37833 E:37835 ||| .
Full  ||| S:37835 E:37840 ||| JJ
length  ||| S:37840 E:37847 ||| NN
SNIP1  ||| S:37847 E:37853 ||| NN
exhibits  ||| S:37853 E:37862 ||| VBZ
dose-dependent  ||| S:37862 E:37887 ||| JJ
inhibition  ||| S:37887 E:37898 ||| NN
of  ||| S:37898 E:37901 ||| IN
the  ||| S:37901 E:37905 ||| DT
BMP-induced  ||| S:37905 E:37917 ||| JJ
gene  ||| S:37917 E:37922 ||| NN
activation ||| S:37922 E:37932 ||| NN
,  ||| S:37932 E:37934 ||| ,
as  ||| S:37934 E:37947 ||| RB
monitored  ||| S:37947 E:37957 ||| VBN
by  ||| S:37957 E:37960 ||| IN
the  ||| S:37960 E:37964 ||| DT
luciferase  ||| S:37964 E:37975 ||| JJ
activities  ||| S:37975 E:37986 ||| NNS
( ||| S:37986 E:37987 ||| -LRB-
Fig.  ||| S:37987 E:37992 ||| NNP
9A ||| S:37992 E:37994 ||| NNP
) ||| S:37994 E:37995 ||| -RRB-
.  ||| S:37995 E:37997 ||| .
Thus ||| S:37997 E:38001 ||| RB
,  ||| S:38001 E:38013 ||| ,
SNIP1  ||| S:38013 E:38019 ||| NNP
is  ||| S:38019 E:38022 ||| VBZ
an  ||| S:38022 E:38025 ||| DT
inhibitor  ||| S:38025 E:38035 ||| NN
of  ||| S:38035 E:38038 ||| IN
BMP-induced  ||| S:38038 E:38050 ||| JJ
gene  ||| S:38050 E:38055 ||| NN
response ||| S:38055 E:38063 ||| NN
.  ||| S:38063 E:38065 ||| .
Since  ||| S:38065 E:38081 ||| IN
we  ||| S:38081 E:38084 ||| PRP
have  ||| S:38084 E:38089 ||| VBP
previously  ||| S:38089 E:38100 ||| RB
shown  ||| S:38100 E:38106 ||| VBN
that  ||| S:38106 E:38111 ||| IN
SNIP1  ||| S:38111 E:38117 ||| CD
binds  ||| S:38117 E:38123 ||| NNS
and  ||| S:38123 E:38127 ||| CC
inhibits  ||| S:38127 E:38146 ||| JJ
CBP ||| S:38146 E:38149 ||| NNP
/ ||| S:38149 E:38150 ||| NNP
p300  ||| S:38150 E:38155 ||| NNP
via  ||| S:38155 E:38159 ||| IN
its  ||| S:38159 E:38163 ||| PRP$
N-terminal  ||| S:38163 E:38174 ||| JJ
domain  ||| S:38174 E:38181 ||| NN
[  ||| S:38181 E:38183 ||| -LRB-
25  ||| S:38183 E:38186 ||| CD
]  ||| S:38186 E:38188 ||| -RRB-
,  ||| S:38188 E:38190 ||| ,
the  ||| S:38190 E:38194 ||| DT
deletion  ||| S:38194 E:38213 ||| JJ
mutant  ||| S:38213 E:38220 ||| NN
of  ||| S:38220 E:38223 ||| IN
SNIP1  ||| S:38223 E:38229 ||| CD
lacking  ||| S:38229 E:38237 ||| VBG
the  ||| S:38237 E:38241 ||| DT
CBP ||| S:38241 E:38244 ||| NNP
/ ||| S:38244 E:38245 ||| NNP
p300  ||| S:38245 E:38250 ||| NNP
binding  ||| S:38250 E:38258 ||| JJ
site ||| S:38258 E:38262 ||| NN
,  ||| S:38262 E:38264 ||| ,
SNIP1  ||| S:38264 E:38280 ||| NNP
( ||| S:38280 E:38281 ||| -LRB-
142-369 ||| S:38281 E:38288 ||| NNP
) ||| S:38288 E:38289 ||| -RRB-
,  ||| S:38289 E:38291 ||| ,
was  ||| S:38291 E:38295 ||| VBD
tested  ||| S:38295 E:38302 ||| VBN
in  ||| S:38302 E:38305 ||| IN
the  ||| S:38305 E:38309 ||| DT
same  ||| S:38309 E:38314 ||| JJ
assay ||| S:38314 E:38319 ||| NN
.  ||| S:38319 E:38321 ||| .
SNIP1  ||| S:38321 E:38327 ||| NNP
( ||| S:38327 E:38328 ||| -LRB-
142-369 ||| S:38328 E:38335 ||| NNP
)  ||| S:38335 E:38347 ||| -RRB-
exhibits  ||| S:38347 E:38356 ||| VBZ
little  ||| S:38356 E:38363 ||| RB
inhibitory  ||| S:38363 E:38374 ||| JJ
activity  ||| S:38374 E:38383 ||| NN
towards  ||| S:38383 E:38391 ||| IN
the  ||| S:38391 E:38395 ||| DT
gene  ||| S:38395 E:38410 ||| NN
response  ||| S:38410 E:38419 ||| NN
( ||| S:38419 E:38420 ||| -LRB-
Fig.  ||| S:38420 E:38425 ||| NNP
9A ||| S:38425 E:38427 ||| NNP
,  ||| S:38427 E:38429 ||| ,
see  ||| S:38429 E:38433 ||| VB
ΔN-SNIP1 ||| S:38433 E:38441 ||| CD
) ||| S:38441 E:38442 ||| -RRB-
.  ||| S:38442 E:38444 ||| .
This  ||| S:38444 E:38449 ||| DT
data  ||| S:38449 E:38454 ||| NNS
further  ||| S:38454 E:38472 ||| RB
suggests  ||| S:38472 E:38481 ||| VBZ
that  ||| S:38481 E:38486 ||| IN
the  ||| S:38486 E:38490 ||| DT
inhibitory  ||| S:38490 E:38501 ||| JJ
activity  ||| S:38501 E:38510 ||| NN
of  ||| S:38510 E:38513 ||| IN
SNIP1  ||| S:38513 E:38519 ||| NNP
is  ||| S:38519 E:38532 ||| VBZ
mediated  ||| S:38532 E:38541 ||| VBN
by  ||| S:38541 E:38544 ||| IN
its  ||| S:38544 E:38548 ||| PRP$
interaction  ||| S:38548 E:38560 ||| NN
with  ||| S:38560 E:38565 ||| IN
CBP ||| S:38565 E:38568 ||| NNP
/ ||| S:38568 E:38569 ||| NNP
p300 ||| S:38569 E:38573 ||| NNP
,  ||| S:38573 E:38575 ||| ,
similar  ||| S:38575 E:38583 ||| JJ
to  ||| S:38583 E:38596 ||| TO
what  ||| S:38596 E:38601 ||| WP
has  ||| S:38601 E:38605 ||| VBZ
been  ||| S:38605 E:38610 ||| VBN
reported  ||| S:38610 E:38619 ||| VBN
in  ||| S:38619 E:38622 ||| IN
the  ||| S:38622 E:38626 ||| DT
TGF-β  ||| S:38626 E:38632 ||| JJ
pathways  ||| S:38632 E:38641 ||| NNS
[  ||| S:38641 E:38643 ||| -LRB-
25  ||| S:38643 E:38646 ||| CD
]  ||| S:38646 E:38648 ||| -RRB-
.  ||| S:38648 E:38650 ||| .
We  ||| S:38650 E:38663 ||| PRP
next  ||| S:38663 E:38668 ||| RB
tested  ||| S:38668 E:38675 ||| VBN
the  ||| S:38675 E:38679 ||| DT
inhibitory  ||| S:38679 E:38690 ||| JJ
activity  ||| S:38690 E:38699 ||| NN
of  ||| S:38699 E:38702 ||| IN
SNIP1  ||| S:38702 E:38708 ||| CD
on  ||| S:38708 E:38711 ||| IN
the  ||| S:38711 E:38725 ||| DT
transcriptional  ||| S:38725 E:38741 ||| JJ
activity  ||| S:38741 E:38750 ||| NN
of  ||| S:38750 E:38753 ||| IN
Smad1 ||| S:38753 E:38758 ||| NNP
,  ||| S:38758 E:38760 ||| ,
using  ||| S:38760 E:38766 ||| VBG
the  ||| S:38766 E:38770 ||| DT
GAL4-Smad1  ||| S:38770 E:38791 ||| NNP
and  ||| S:38791 E:38795 ||| CC
GAL4-Luc  ||| S:38795 E:38804 ||| CD
reporter  ||| S:38804 E:38813 ||| NN
system ||| S:38813 E:38819 ||| NN
,  ||| S:38819 E:38821 ||| ,
as  ||| S:38821 E:38824 ||| RB
described  ||| S:38824 E:38834 ||| VBN
previously  ||| S:38834 E:38845 ||| RB
[  ||| S:38845 E:38857 ||| -LRB-
42  ||| S:38857 E:38860 ||| CD
43  ||| S:38860 E:38863 ||| CD
]  ||| S:38863 E:38865 ||| -RRB-
.  ||| S:38865 E:38867 ||| .
SNIP1  ||| S:38867 E:38873 ||| NNP
inhibited  ||| S:38873 E:38883 ||| VBD
BMP-induced  ||| S:38883 E:38895 ||| JJ
activation  ||| S:38895 E:38906 ||| NN
of  ||| S:38906 E:38919 ||| IN
GAL4-Luc  ||| S:38919 E:38928 ||| CD
in  ||| S:38928 E:38931 ||| IN
p19  ||| S:38931 E:38935 ||| CD
cells  ||| S:38935 E:38941 ||| NNS
transfected  ||| S:38941 E:38953 ||| VBN
with  ||| S:38953 E:38958 ||| IN
GAL4-Smad1  ||| S:38958 E:38969 ||| NNP
( ||| S:38969 E:38970 ||| -LRB-
Fig.  ||| S:38970 E:38985 ||| NNP
9B ||| S:38985 E:38987 ||| NNP
) ||| S:38987 E:38988 ||| -RRB-
.  ||| S:38988 E:38990 ||| .
The  ||| S:38990 E:38994 ||| DT
proteasome  ||| S:38994 E:39005 ||| JJ
specific  ||| S:39005 E:39014 ||| JJ
inhibitor  ||| S:39014 E:39024 ||| NNS
lactacystin  ||| S:39024 E:39036 ||| VBP
also  ||| S:39036 E:39051 ||| RB
inhibited  ||| S:39051 E:39061 ||| VBD
the  ||| S:39061 E:39065 ||| DT
BMP-induced  ||| S:39065 E:39077 ||| JJ
GAL4-Smad1  ||| S:39077 E:39088 ||| CD
transcriptional  ||| S:39088 E:39114 ||| JJ
activity  ||| S:39114 E:39123 ||| NN
( ||| S:39123 E:39124 ||| -LRB-
Fig.  ||| S:39124 E:39129 ||| NNP
9B ||| S:39129 E:39131 ||| NNP
) ||| S:39131 E:39132 ||| -RRB-
,  ||| S:39132 E:39134 ||| ,
consistent  ||| S:39134 E:39145 ||| JJ
with  ||| S:39145 E:39150 ||| IN
a  ||| S:39150 E:39152 ||| DT
role  ||| S:39152 E:39157 ||| NN
of  ||| S:39157 E:39160 ||| IN
proteasomal  ||| S:39160 E:39182 ||| JJ
degradation  ||| S:39182 E:39194 ||| NN
in  ||| S:39194 E:39197 ||| IN
Smad1-mediated  ||| S:39197 E:39212 ||| CD
transcription ||| S:39212 E:39225 ||| NNS
.  ||| S:39225 E:39227 ||| .
The  ||| S:39227 E:39231 ||| DT
effect  ||| S:39231 E:39248 ||| NN
of  ||| S:39248 E:39251 ||| IN
lactacystin  ||| S:39251 E:39263 ||| NN
is  ||| S:39263 E:39266 ||| VBZ
specific ||| S:39266 E:39274 ||| JJ
,  ||| S:39274 E:39276 ||| ,
since  ||| S:39276 E:39282 ||| IN
the  ||| S:39282 E:39286 ||| DT
control  ||| S:39286 E:39294 ||| NN
reporter  ||| S:39294 E:39313 ||| NN
gene  ||| S:39313 E:39318 ||| NN
β-Gal  ||| S:39318 E:39324 ||| NN
was  ||| S:39324 E:39328 ||| VBD
not  ||| S:39328 E:39332 ||| RB
inhibited  ||| S:39332 E:39342 ||| VBN
by  ||| S:39342 E:39345 ||| IN
lactacystin  ||| S:39345 E:39357 ||| NNS
( ||| S:39357 E:39358 ||| -LRB-
data  ||| S:39358 E:39363 ||| NNS
not  ||| S:39363 E:39377 ||| RB
shown ||| S:39377 E:39382 ||| VBN
) ||| S:39382 E:39383 ||| -RRB-
.  ||| S:39383 E:39385 ||| .
In  ||| S:39385 E:39388 ||| IN
a  ||| S:39388 E:39390 ||| DT
separate  ||| S:39390 E:39399 ||| JJ
study ||| S:39399 E:39404 ||| NN
,  ||| S:39404 E:39406 ||| ,
we  ||| S:39406 E:39409 ||| PRP
also  ||| S:39409 E:39414 ||| RB
demonstrated  ||| S:39414 E:39427 ||| VBN
that  ||| S:39427 E:39442 ||| IN
proteasomal  ||| S:39442 E:39454 ||| JJ
degradation  ||| S:39454 E:39466 ||| NN
also  ||| S:39466 E:39471 ||| RB
plays  ||| S:39471 E:39477 ||| VBZ
an  ||| S:39477 E:39480 ||| DT
essential  ||| S:39480 E:39490 ||| JJ
role  ||| S:39490 E:39495 ||| NN
in  ||| S:39495 E:39508 ||| IN
BMP  ||| S:39508 E:39512 ||| NN
induced  ||| S:39512 E:39520 ||| VBN
dendritic  ||| S:39520 E:39530 ||| JJ
formation  ||| S:39530 E:39540 ||| NN
of  ||| S:39540 E:39543 ||| IN
rat  ||| S:39543 E:39547 ||| JJ
sympathetic  ||| S:39547 E:39569 ||| JJ
neurons  ||| S:39569 E:39577 ||| NNS
[  ||| S:39577 E:39579 ||| -LRB-
44  ||| S:39579 E:39582 ||| CD
]  ||| S:39582 E:39584 ||| -RRB-
.  ||| S:39584 E:39617 ||| .
Discussion  ||| S:39617 E:39636 ||| NN
The  ||| S:39636 E:39640 ||| DT
bone  ||| S:39640 E:39645 ||| JJ
morphogenetic  ||| S:39645 E:39659 ||| JJ
proteins  ||| S:39659 E:39668 ||| NNS
( ||| S:39668 E:39669 ||| -LRB-
BMPs ||| S:39669 E:39673 ||| NNP
)  ||| S:39673 E:39675 ||| -RRB-
are  ||| S:39675 E:39687 ||| VBP
multi-functional  ||| S:39687 E:39704 ||| JJ
regulators  ||| S:39704 E:39715 ||| NNS
of  ||| S:39715 E:39718 ||| IN
early  ||| S:39718 E:39724 ||| JJ
embryogenesis  ||| S:39724 E:39738 ||| NN
and  ||| S:39738 E:39750 ||| CC
tissue ||| S:39750 E:39756 ||| FW
/ ||| S:39756 E:39757 ||| FW
organ  ||| S:39757 E:39763 ||| FW
morphogenesis ||| S:39763 E:39776 ||| FW
.  ||| S:39776 E:39778 ||| .
Observations  ||| S:39778 E:39791 ||| NNS
made  ||| S:39791 E:39796 ||| VBN
in  ||| S:39796 E:39799 ||| IN
the  ||| S:39799 E:39803 ||| DT
past  ||| S:39803 E:39816 ||| JJ
several  ||| S:39816 E:39824 ||| JJ
years  ||| S:39824 E:39830 ||| NNS
suggest  ||| S:39830 E:39838 ||| VBP
that  ||| S:39838 E:39843 ||| IN
a  ||| S:39843 E:39845 ||| DT
subset  ||| S:39845 E:39852 ||| NN
of  ||| S:39852 E:39855 ||| IN
Smad  ||| S:39855 E:39860 ||| NNP
family  ||| S:39860 E:39867 ||| NN
proteins  ||| S:39867 E:39884 ||| NNS
play  ||| S:39884 E:39889 ||| VBP
key  ||| S:39889 E:39893 ||| JJ
roles  ||| S:39893 E:39899 ||| NNS
in  ||| S:39899 E:39902 ||| IN
transmitting  ||| S:39902 E:39915 ||| VBG
the  ||| S:39915 E:39919 ||| DT
signals  ||| S:39919 E:39927 ||| NNS
of  ||| S:39927 E:39930 ||| IN
BMPs  ||| S:39930 E:39935 ||| JJ
from  ||| S:39935 E:39940 ||| IN
the  ||| S:39940 E:39952 ||| DT
activated  ||| S:39952 E:39962 ||| JJ
receptors  ||| S:39962 E:39972 ||| NNS
at  ||| S:39972 E:39975 ||| IN
the  ||| S:39975 E:39979 ||| DT
cell  ||| S:39979 E:39984 ||| NN
surface  ||| S:39984 E:39992 ||| NN
to  ||| S:39992 E:39995 ||| TO
the  ||| S:39995 E:39999 ||| DT
nucleus  ||| S:39999 E:40007 ||| NN
to  ||| S:40007 E:40018 ||| TO
regulate  ||| S:40018 E:40027 ||| VB
gene  ||| S:40027 E:40032 ||| NN
expression ||| S:40032 E:40042 ||| NN
.  ||| S:40042 E:40044 ||| .
Smad1 ||| S:40044 E:40049 ||| NNP
,  ||| S:40049 E:40051 ||| ,
as  ||| S:40051 E:40054 ||| IN
one  ||| S:40054 E:40058 ||| CD
of  ||| S:40058 E:40061 ||| IN
the  ||| S:40061 E:40065 ||| DT
three  ||| S:40065 E:40071 ||| CD
known  ||| S:40071 E:40085 ||| VBN
R-Smads  ||| S:40085 E:40093 ||| JJ
of  ||| S:40093 E:40096 ||| IN
BMPs ||| S:40096 E:40100 ||| NNP
,  ||| S:40100 E:40102 ||| ,
has  ||| S:40102 E:40106 ||| VBZ
been  ||| S:40106 E:40111 ||| VBN
extensively  ||| S:40111 E:40123 ||| RB
studied  ||| S:40123 E:40131 ||| VBN
within  ||| S:40131 E:40138 ||| IN
the  ||| S:40138 E:40150 ||| DT
scope  ||| S:40150 E:40156 ||| NN
of  ||| S:40156 E:40159 ||| IN
its  ||| S:40159 E:40163 ||| PRP$
phosphorylation ||| S:40163 E:40178 ||| NN
,  ||| S:40178 E:40180 ||| ,
interaction  ||| S:40180 E:40192 ||| VBG
with  ||| S:40192 E:40197 ||| IN
Smad4 ||| S:40197 E:40202 ||| NNP
,  ||| S:40202 E:40212 ||| ,
nuclear  ||| S:40212 E:40220 ||| JJ
translocation ||| S:40220 E:40233 ||| NN
,  ||| S:40233 E:40235 ||| ,
DNA  ||| S:40235 E:40239 ||| NNP
binding  ||| S:40239 E:40247 ||| NN
and  ||| S:40247 E:40251 ||| CC
protein-protein  ||| S:40251 E:40275 ||| JJ
interactions  ||| S:40275 E:40288 ||| NNS
related  ||| S:40288 E:40296 ||| VBN
to  ||| S:40296 E:40299 ||| TO
its  ||| S:40299 E:40303 ||| PRP$
function  ||| S:40303 E:40312 ||| NN
as  ||| S:40312 E:40315 ||| IN
a  ||| S:40315 E:40317 ||| DT
transcriptional  ||| S:40317 E:40341 ||| JJ
regulator ||| S:40341 E:40350 ||| NN
.  ||| S:40350 E:40352 ||| .
Currently ||| S:40352 E:40361 ||| RB
,  ||| S:40361 E:40363 ||| ,
Smad1  ||| S:40363 E:40369 ||| NNP
is  ||| S:40369 E:40372 ||| VBZ
regarded  ||| S:40372 E:40381 ||| VBN
as  ||| S:40381 E:40384 ||| IN
a  ||| S:40384 E:40386 ||| DT
DNA-binding  ||| S:40386 E:40406 ||| JJ
transcriptional  ||| S:40406 E:40422 ||| JJ
modulator  ||| S:40422 E:40432 ||| NN
that  ||| S:40432 E:40437 ||| WDT
is  ||| S:40437 E:40440 ||| VBZ
activated  ||| S:40440 E:40450 ||| VBN
by  ||| S:40450 E:40453 ||| IN
the  ||| S:40453 E:40457 ||| DT
BMP  ||| S:40457 E:40461 ||| NN
type  ||| S:40461 E:40474 ||| NN
I  ||| S:40474 E:40476 ||| PRP
receptors ||| S:40476 E:40485 ||| VBD
.  ||| S:40485 E:40487 ||| .
Considering  ||| S:40487 E:40499 ||| VBG
the  ||| S:40499 E:40503 ||| DT
sophisticated  ||| S:40503 E:40517 ||| JJ
mode  ||| S:40517 E:40522 ||| NN
of  ||| S:40522 E:40533 ||| IN
regulation  ||| S:40533 E:40544 ||| NN
characteristic  ||| S:40544 E:40559 ||| NN
of  ||| S:40559 E:40562 ||| IN
the  ||| S:40562 E:40566 ||| DT
TGF-β ||| S:40566 E:40571 ||| JJ
/ ||| S:40571 E:40572 ||| CD
BMP  ||| S:40572 E:40576 ||| NN
family  ||| S:40576 E:40583 ||| NN
ligands ||| S:40583 E:40590 ||| NN
,  ||| S:40590 E:40600 ||| ,
it  ||| S:40600 E:40603 ||| PRP
is  ||| S:40603 E:40606 ||| VBZ
expected  ||| S:40606 E:40615 ||| VBN
that  ||| S:40615 E:40620 ||| IN
that  ||| S:40620 E:40625 ||| DT
signaling  ||| S:40625 E:40635 ||| JJ
mechanisms  ||| S:40635 E:40646 ||| NNS
of  ||| S:40646 E:40649 ||| IN
Smads  ||| S:40649 E:40663 ||| NNP
should  ||| S:40663 E:40670 ||| MD
have  ||| S:40670 E:40675 ||| VB
a  ||| S:40675 E:40677 ||| DT
nature  ||| S:40677 E:40684 ||| NN
of  ||| S:40684 E:40687 ||| IN
complexity  ||| S:40687 E:40698 ||| NN
that  ||| S:40698 E:40703 ||| WDT
can  ||| S:40703 E:40707 ||| MD
accommodate  ||| S:40707 E:40719 ||| VB
the  ||| S:40719 E:40731 ||| DT
vast  ||| S:40731 E:40736 ||| JJ
biological  ||| S:40736 E:40747 ||| JJ
functions  ||| S:40747 E:40757 ||| NNS
of  ||| S:40757 E:40760 ||| IN
these  ||| S:40760 E:40766 ||| DT
regulators ||| S:40766 E:40776 ||| NNS
.  ||| S:40776 E:40778 ||| .
We  ||| S:40778 E:40781 ||| PRP
took  ||| S:40781 E:40786 ||| VBD
a  ||| S:40786 E:40796 ||| DT
discovery-driven  ||| S:40796 E:40813 ||| JJ
approach  ||| S:40813 E:40822 ||| NN
to  ||| S:40822 E:40825 ||| TO
study  ||| S:40825 E:40831 ||| VB
the  ||| S:40831 E:40835 ||| DT
signaling  ||| S:40835 E:40845 ||| JJ
mechanism  ||| S:40845 E:40863 ||| NN
of  ||| S:40863 E:40866 ||| IN
Smad1 ||| S:40866 E:40871 ||| NNP
,  ||| S:40871 E:40873 ||| ,
by  ||| S:40873 E:40876 ||| IN
systematically  ||| S:40876 E:40891 ||| RB
searching  ||| S:40891 E:40901 ||| VBG
for  ||| S:40901 E:40905 ||| IN
proteins  ||| S:40905 E:40914 ||| NNS
that  ||| S:40914 E:40919 ||| WDT
can  ||| S:40919 E:40931 ||| MD
physically  ||| S:40931 E:40942 ||| RB
interact  ||| S:40942 E:40951 ||| VBN
with  ||| S:40951 E:40956 ||| IN
Smad1 ||| S:40956 E:40961 ||| CD
.  ||| S:40961 E:40963 ||| .
Such  ||| S:40963 E:40968 ||| PDT
an  ||| S:40968 E:40971 ||| DT
approach  ||| S:40971 E:40980 ||| NN
led  ||| S:40980 E:40984 ||| VBD
to  ||| S:40984 E:40987 ||| TO
the  ||| S:40987 E:40999 ||| DT
identification  ||| S:40999 E:41014 ||| NN
of  ||| S:41014 E:41017 ||| IN
a  ||| S:41017 E:41019 ||| DT
set  ||| S:41019 E:41023 ||| NN
of  ||| S:41023 E:41026 ||| IN
proteins  ||| S:41026 E:41035 ||| NNS
that  ||| S:41035 E:41040 ||| WDT
can  ||| S:41040 E:41044 ||| MD
specifically  ||| S:41044 E:41065 ||| RB
bind  ||| S:41065 E:41070 ||| VBN
to  ||| S:41070 E:41073 ||| TO
Smad1 ||| S:41073 E:41078 ||| CD
.  ||| S:41078 E:41080 ||| .
This  ||| S:41080 E:41085 ||| DT
report  ||| S:41085 E:41092 ||| NN
has  ||| S:41092 E:41096 ||| VBZ
focused  ||| S:41096 E:41104 ||| VBN
upon  ||| S:41104 E:41109 ||| IN
the  ||| S:41109 E:41113 ||| DT
functional  ||| S:41113 E:41132 ||| JJ
characterization  ||| S:41132 E:41149 ||| NN
of  ||| S:41149 E:41152 ||| IN
two  ||| S:41152 E:41156 ||| CD
proteins  ||| S:41156 E:41165 ||| NNS
that  ||| S:41165 E:41170 ||| IN
function  ||| S:41170 E:41179 ||| NN
along  ||| S:41179 E:41185 ||| IN
the  ||| S:41185 E:41197 ||| DT
degradation  ||| S:41197 E:41209 ||| JJ
pathways  ||| S:41209 E:41218 ||| NN
of  ||| S:41218 E:41221 ||| IN
the  ||| S:41221 E:41225 ||| DT
26S  ||| S:41225 E:41229 ||| CD
proteasome ||| S:41229 E:41239 ||| NNS
:  ||| S:41239 E:41241 ||| :
antizyme  ||| S:41241 E:41250 ||| CD
( ||| S:41250 E:41251 ||| -LRB-
Az ||| S:41251 E:41253 ||| NNP
)  ||| S:41253 E:41263 ||| -RRB-
and  ||| S:41263 E:41267 ||| CC
HsN3 ||| S:41267 E:41271 ||| NNP
.  ||| S:41271 E:41281 ||| .
Az  ||| S:41281 E:41284 ||| NNP
was  ||| S:41284 E:41288 ||| VBD
previously  ||| S:41288 E:41299 ||| RB
identified  ||| S:41299 E:41310 ||| VBN
as  ||| S:41310 E:41313 ||| IN
a  ||| S:41313 E:41315 ||| DT
polyamine-inducible  ||| S:41315 E:41343 ||| JJ
factor  ||| S:41343 E:41350 ||| NN
that  ||| S:41350 E:41355 ||| IN
binds  ||| S:41355 E:41361 ||| NN
and  ||| S:41361 E:41365 ||| CC
targets  ||| S:41365 E:41373 ||| VBZ
the  ||| S:41373 E:41377 ||| DT
ornithine  ||| S:41377 E:41387 ||| JJ
decarboxylase  ||| S:41387 E:41409 ||| NNS
( ||| S:41409 E:41410 ||| -LRB-
ODC ||| S:41410 E:41413 ||| NNP
)  ||| S:41413 E:41415 ||| -RRB-
to  ||| S:41415 E:41418 ||| TO
proteasome  ||| S:41418 E:41429 ||| VB
for  ||| S:41429 E:41433 ||| IN
degradation  ||| S:41433 E:41445 ||| NNS
[  ||| S:41445 E:41447 ||| -LRB-
18  ||| S:41447 E:41450 ||| CD
45  ||| S:41450 E:41453 ||| CD
]  ||| S:41453 E:41455 ||| -RRB-
.  ||| S:41455 E:41457 ||| .
Until  ||| S:41457 E:41463 ||| IN
now ||| S:41463 E:41466 ||| RB
,  ||| S:41466 E:41476 ||| ,
ODC  ||| S:41476 E:41480 ||| NNP
is  ||| S:41480 E:41483 ||| VBZ
the  ||| S:41483 E:41487 ||| DT
only  ||| S:41487 E:41492 ||| JJ
protein  ||| S:41492 E:41500 ||| NN
known  ||| S:41500 E:41506 ||| VBN
to  ||| S:41506 E:41509 ||| TO
be  ||| S:41509 E:41512 ||| VB
targeted  ||| S:41512 E:41521 ||| VBN
by  ||| S:41521 E:41524 ||| IN
Az  ||| S:41524 E:41527 ||| NNP
to  ||| S:41527 E:41538 ||| TO
proteasome ||| S:41538 E:41548 ||| VB
,  ||| S:41548 E:41550 ||| ,
although  ||| S:41550 E:41559 ||| IN
the  ||| S:41559 E:41563 ||| DT
existence  ||| S:41563 E:41573 ||| NN
of  ||| S:41573 E:41576 ||| IN
additional  ||| S:41576 E:41587 ||| JJ
proteins  ||| S:41587 E:41604 ||| NNS
targeted  ||| S:41604 E:41613 ||| VBN
by  ||| S:41613 E:41616 ||| IN
Az  ||| S:41616 E:41619 ||| NNP
to  ||| S:41619 E:41622 ||| TO
proteasome  ||| S:41622 E:41633 ||| NN
has  ||| S:41633 E:41637 ||| VBZ
been  ||| S:41637 E:41642 ||| VBN
suspected  ||| S:41642 E:41652 ||| VBN
[  ||| S:41652 E:41654 ||| -LRB-
20  ||| S:41654 E:41657 ||| CD
]  ||| S:41657 E:41659 ||| -RRB-
.  ||| S:41659 E:41661 ||| .
We  ||| S:41661 E:41672 ||| PRP
now  ||| S:41672 E:41676 ||| RB
find  ||| S:41676 E:41681 ||| VB
two  ||| S:41681 E:41685 ||| CD
new  ||| S:41685 E:41689 ||| JJ
Az  ||| S:41689 E:41692 ||| JJ
interactors ||| S:41692 E:41703 ||| NN
:  ||| S:41703 E:41705 ||| :
Smad1 ||| S:41705 E:41710 ||| CD
,  ||| S:41710 E:41712 ||| ,
the  ||| S:41712 E:41716 ||| DT
key  ||| S:41716 E:41720 ||| JJ
signal  ||| S:41720 E:41735 ||| NN
transducer  ||| S:41735 E:41746 ||| NN
of  ||| S:41746 E:41749 ||| IN
BMPs ||| S:41749 E:41753 ||| NNP
,  ||| S:41753 E:41755 ||| ,
as  ||| S:41755 E:41758 ||| RB
well  ||| S:41758 E:41763 ||| RB
as  ||| S:41763 E:41766 ||| IN
SNIP1 ||| S:41766 E:41771 ||| NNP
,  ||| S:41771 E:41773 ||| ,
the  ||| S:41773 E:41777 ||| DT
nuclear  ||| S:41777 E:41785 ||| JJ
repressor  ||| S:41785 E:41803 ||| NN
of  ||| S:41803 E:41806 ||| IN
CBP ||| S:41806 E:41809 ||| NNP
/ ||| S:41809 E:41810 ||| NNP
p300 ||| S:41810 E:41814 ||| NNP
.  ||| S:41814 E:41816 ||| .
In  ||| S:41816 E:41819 ||| IN
a  ||| S:41819 E:41821 ||| DT
separate  ||| S:41821 E:41830 ||| JJ
study ||| S:41830 E:41835 ||| NN
,  ||| S:41835 E:41837 ||| ,
we  ||| S:41837 E:41840 ||| PRP
demonstrated  ||| S:41840 E:41853 ||| VBD
that  ||| S:41853 E:41866 ||| IN
Smad1  ||| S:41866 E:41872 ||| NNP
is  ||| S:41872 E:41875 ||| VBZ
targeted  ||| S:41875 E:41884 ||| VBN
to  ||| S:41884 E:41887 ||| TO
proteasome  ||| S:41887 E:41898 ||| VB
for  ||| S:41898 E:41902 ||| IN
degradation ||| S:41902 E:41913 ||| NN
,  ||| S:41913 E:41915 ||| ,
a  ||| S:41915 E:41917 ||| DT
process  ||| S:41917 E:41933 ||| NN
involving  ||| S:41933 E:41943 ||| VBG
the  ||| S:41943 E:41947 ||| DT
co-targeting  ||| S:41947 E:41960 ||| JJ
role  ||| S:41960 E:41965 ||| NN
of  ||| S:41965 E:41968 ||| IN
Az  ||| S:41968 E:41971 ||| NNP
and  ||| S:41971 E:41975 ||| CC
HsN3  ||| S:41975 E:41980 ||| NNP
[  ||| S:41980 E:41982 ||| -LRB-
39  ||| S:41982 E:41985 ||| CD
]  ||| S:41985 E:41987 ||| -RRB-
.  ||| S:41987 E:41997 ||| .
Here  ||| S:41997 E:42002 ||| RB
we  ||| S:42002 E:42005 ||| PRP
showed  ||| S:42005 E:42012 ||| VBD
that  ||| S:42012 E:42017 ||| IN
SNIP1 ||| S:42017 E:42022 ||| NNP
,  ||| S:42022 E:42024 ||| ,
after  ||| S:42024 E:42030 ||| IN
being  ||| S:42030 E:42036 ||| VBG
recruited  ||| S:42036 E:42046 ||| VBN
to  ||| S:42046 E:42049 ||| TO
Az ||| S:42049 E:42051 ||| NNP
,  ||| S:42051 E:42053 ||| ,
is  ||| S:42053 E:42064 ||| VBZ
targeted ||| S:42064 E:42072 ||| VBN
,  ||| S:42072 E:42074 ||| ,
together  ||| S:42074 E:42083 ||| RB
with  ||| S:42083 E:42088 ||| IN
Smad1 ||| S:42088 E:42093 ||| NNP
,  ||| S:42093 E:42095 ||| ,
to  ||| S:42095 E:42098 ||| TO
proteasome  ||| S:42098 E:42109 ||| VB
for  ||| S:42109 E:42121 ||| IN
degradation ||| S:42121 E:42132 ||| NN
.  ||| S:42132 E:42134 ||| .
These  ||| S:42134 E:42140 ||| DT
data  ||| S:42140 E:42145 ||| NNS
indicate  ||| S:42145 E:42154 ||| VBP
that  ||| S:42154 E:42159 ||| IN
Az  ||| S:42159 E:42162 ||| NNP
has  ||| S:42162 E:42166 ||| VBZ
a  ||| S:42166 E:42168 ||| DT
more  ||| S:42168 E:42173 ||| RBR
general  ||| S:42173 E:42189 ||| JJ
role  ||| S:42189 E:42194 ||| NN
in  ||| S:42194 E:42197 ||| IN
targeting  ||| S:42197 E:42207 ||| VBG
different  ||| S:42207 E:42217 ||| JJ
substrates  ||| S:42217 E:42228 ||| NN
to  ||| S:42228 E:42231 ||| TO
proteasome  ||| S:42231 E:42242 ||| VB
for  ||| S:42242 E:42254 ||| IN
degradation ||| S:42254 E:42265 ||| NN
.  ||| S:42265 E:42267 ||| .
However ||| S:42267 E:42274 ||| RB
,  ||| S:42274 E:42276 ||| ,
unlike  ||| S:42276 E:42283 ||| IN
the  ||| S:42283 E:42287 ||| DT
known  ||| S:42287 E:42293 ||| JJ
ability  ||| S:42293 E:42301 ||| NN
of  ||| S:42301 E:42304 ||| IN
Az  ||| S:42304 E:42307 ||| NNP
to  ||| S:42307 E:42318 ||| TO
bind  ||| S:42318 E:42323 ||| VB
ODC  ||| S:42323 E:42327 ||| JJ
constitutively ||| S:42327 E:42341 ||| NN
,  ||| S:42341 E:42343 ||| ,
the  ||| S:42343 E:42347 ||| DT
interaction  ||| S:42347 E:42359 ||| NN
between  ||| S:42359 E:42367 ||| IN
SNIP1  ||| S:42367 E:42373 ||| NNP
and  ||| S:42373 E:42385 ||| CC
Az  ||| S:42385 E:42388 ||| NNP
is  ||| S:42388 E:42391 ||| VBZ
dependent  ||| S:42391 E:42401 ||| JJ
upon  ||| S:42401 E:42406 ||| IN
the  ||| S:42406 E:42410 ||| DT
activation  ||| S:42410 E:42421 ||| NN
of  ||| S:42421 E:42424 ||| IN
BMP  ||| S:42424 E:42428 ||| NN
type  ||| S:42428 E:42433 ||| NN
I  ||| S:42433 E:42435 ||| NN
receptor  ||| S:42435 E:42452 ||| NN
and  ||| S:42452 E:42456 ||| CC
occurs  ||| S:42456 E:42463 ||| VBZ
in  ||| S:42463 E:42466 ||| IN
the  ||| S:42466 E:42470 ||| DT
presence  ||| S:42470 E:42479 ||| NN
of  ||| S:42479 E:42482 ||| IN
Smad1  ||| S:42482 E:42488 ||| NNP
and  ||| S:42488 E:42492 ||| CC
Smad4 ||| S:42492 E:42497 ||| NNP
.  ||| S:42497 E:42499 ||| .
This  ||| S:42499 E:42512 ||| DT
suggests  ||| S:42512 E:42521 ||| VBZ
the  ||| S:42521 E:42525 ||| DT
existence  ||| S:42525 E:42535 ||| NN
of  ||| S:42535 E:42538 ||| IN
a  ||| S:42538 E:42540 ||| DT
novel  ||| S:42540 E:42546 ||| NN
BMP-regulated  ||| S:42546 E:42568 ||| JJ
"conditional ||| S:42568 E:42580 ||| NN
"  ||| S:42580 E:42582 ||| ''
targeting  ||| S:42582 E:42592 ||| VBG
activity  ||| S:42592 E:42601 ||| NN
of  ||| S:42601 E:42604 ||| IN
Az  ||| S:42604 E:42607 ||| NNP
that  ||| S:42607 E:42612 ||| WDT
is  ||| S:42612 E:42615 ||| VBZ
distinct  ||| S:42615 E:42632 ||| VBN
from  ||| S:42632 E:42637 ||| IN
the  ||| S:42637 E:42641 ||| DT
constitutive  ||| S:42641 E:42654 ||| NN
targeting  ||| S:42654 E:42664 ||| VBG
activity  ||| S:42664 E:42673 ||| NN
of  ||| S:42673 E:42676 ||| IN
Az  ||| S:42676 E:42679 ||| NNP
towards  ||| S:42679 E:42695 ||| IN
ODC ||| S:42695 E:42698 ||| NNP
.  ||| S:42698 E:42708 ||| .
HsN3  ||| S:42708 E:42713 ||| NNP
is  ||| S:42713 E:42716 ||| VBZ
one  ||| S:42716 E:42720 ||| CD
of  ||| S:42720 E:42723 ||| IN
the  ||| S:42723 E:42727 ||| DT
seven  ||| S:42727 E:42733 ||| CD
β  ||| S:42733 E:42735 ||| JJ
subunits  ||| S:42735 E:42744 ||| NN
of  ||| S:42744 E:42747 ||| IN
the  ||| S:42747 E:42751 ||| DT
20S  ||| S:42751 E:42763 ||| JJ
proteasome ||| S:42763 E:42773 ||| NN
,  ||| S:42773 E:42775 ||| ,
which  ||| S:42775 E:42781 ||| WDT
is  ||| S:42781 E:42784 ||| VBZ
the  ||| S:42784 E:42788 ||| DT
catalytic  ||| S:42788 E:42798 ||| JJ
core  ||| S:42798 E:42803 ||| NN
of  ||| S:42803 E:42806 ||| IN
the  ||| S:42806 E:42810 ||| DT
26S  ||| S:42810 E:42822 ||| CD
proteasome  ||| S:42822 E:42833 ||| NNS
[  ||| S:42833 E:42835 ||| -LRB-
22  ||| S:42835 E:42838 ||| CD
23  ||| S:42838 E:42841 ||| CD
24  ||| S:42841 E:42844 ||| CD
]  ||| S:42844 E:42846 ||| -RRB-
.  ||| S:42846 E:42848 ||| .
Besides  ||| S:42848 E:42856 ||| IN
its  ||| S:42856 E:42860 ||| PRP$
role  ||| S:42860 E:42865 ||| NN
as  ||| S:42865 E:42868 ||| IN
an  ||| S:42868 E:42879 ||| DT
indispensable  ||| S:42879 E:42893 ||| JJ
component  ||| S:42893 E:42903 ||| NN
of  ||| S:42903 E:42906 ||| IN
the  ||| S:42906 E:42910 ||| DT
20S  ||| S:42910 E:42914 ||| JJ
proteasome ||| S:42914 E:42924 ||| NN
,  ||| S:42924 E:42926 ||| ,
HsN3  ||| S:42926 E:42931 ||| NNP
and  ||| S:42931 E:42935 ||| CC
the  ||| S:42935 E:42947 ||| DT
α  ||| S:42947 E:42949 ||| JJ
subunit  ||| S:42949 E:42957 ||| JJ
HC9  ||| S:42957 E:42961 ||| NN
of  ||| S:42961 E:42964 ||| IN
the  ||| S:42964 E:42968 ||| DT
20S  ||| S:42968 E:42972 ||| CD
proteasome  ||| S:42972 E:42983 ||| NNS
have  ||| S:42983 E:42988 ||| VBP
been  ||| S:42988 E:42993 ||| VBN
shown  ||| S:42993 E:42999 ||| VBN
to  ||| S:42999 E:43010 ||| TO
interact  ||| S:43010 E:43019 ||| VB
with  ||| S:43019 E:43024 ||| IN
the  ||| S:43024 E:43028 ||| DT
viral  ||| S:43028 E:43034 ||| JJ
protein  ||| S:43034 E:43042 ||| NN
Tax ||| S:43042 E:43045 ||| NN
.  ||| S:43045 E:43047 ||| .
This  ||| S:43047 E:43052 ||| DT
interaction  ||| S:43052 E:43064 ||| NN
was  ||| S:43064 E:43076 ||| VBD
suggested  ||| S:43076 E:43086 ||| VBN
to  ||| S:43086 E:43089 ||| TO
play  ||| S:43089 E:43094 ||| VB
a  ||| S:43094 E:43096 ||| DT
role  ||| S:43096 E:43101 ||| NN
in  ||| S:43101 E:43104 ||| IN
Tax-induced  ||| S:43104 E:43116 ||| JJ
proteasomal  ||| S:43116 E:43136 ||| JJ
processing  ||| S:43136 E:43147 ||| NN
of  ||| S:43147 E:43150 ||| IN
the  ||| S:43150 E:43154 ||| DT
P105  ||| S:43154 E:43159 ||| JJ
subunit  ||| S:43159 E:43167 ||| NN
of  ||| S:43167 E:43170 ||| IN
NF-κB  ||| S:43170 E:43176 ||| NNP
[  ||| S:43176 E:43178 ||| -LRB-
32  ||| S:43178 E:43181 ||| CD
]  ||| S:43181 E:43183 ||| -RRB-
.  ||| S:43183 E:43185 ||| .
Other  ||| S:43185 E:43199 ||| JJ
proteasome  ||| S:43199 E:43210 ||| JJ
integral  ||| S:43210 E:43219 ||| JJ
components ||| S:43219 E:43229 ||| NNS
,  ||| S:43229 E:43231 ||| ,
especially  ||| S:43231 E:43242 ||| RB
those  ||| S:43242 E:43248 ||| DT
in  ||| S:43248 E:43251 ||| IN
the  ||| S:43251 E:43255 ||| DT
19S  ||| S:43255 E:43267 ||| JJ
regulator  ||| S:43267 E:43277 ||| NN
of  ||| S:43277 E:43280 ||| IN
the  ||| S:43280 E:43284 ||| DT
26S  ||| S:43284 E:43288 ||| JJ
proteasome ||| S:43288 E:43298 ||| NN
,  ||| S:43298 E:43300 ||| ,
have  ||| S:43300 E:43305 ||| VBP
also  ||| S:43305 E:43310 ||| RB
been  ||| S:43310 E:43315 ||| VBN
shown  ||| S:43315 E:43321 ||| VBN
to  ||| S:43321 E:43332 ||| TO
bring  ||| S:43332 E:43338 ||| VB
proteins  ||| S:43338 E:43347 ||| NNS
to  ||| S:43347 E:43350 ||| TO
proteasome  ||| S:43350 E:43361 ||| VB
for  ||| S:43361 E:43365 ||| IN
degradation  ||| S:43365 E:43377 ||| NNS
[  ||| S:43377 E:43379 ||| -LRB-
21  ||| S:43379 E:43382 ||| CD
]  ||| S:43382 E:43384 ||| -RRB-
.  ||| S:43384 E:43386 ||| .
Here  ||| S:43386 E:43399 ||| RB
we  ||| S:43399 E:43402 ||| PRP
identified  ||| S:43402 E:43413 ||| VBD
a  ||| S:43413 E:43415 ||| DT
unique  ||| S:43415 E:43422 ||| JJ
role  ||| S:43422 E:43427 ||| NN
of  ||| S:43427 E:43430 ||| IN
HsN3  ||| S:43430 E:43435 ||| CD
in  ||| S:43435 E:43438 ||| IN
the  ||| S:43438 E:43442 ||| DT
Az-involved  ||| S:43442 E:43462 ||| JJ
targeting  ||| S:43462 E:43472 ||| VBG
pathway  ||| S:43472 E:43480 ||| NNS
that  ||| S:43480 E:43485 ||| WDT
is  ||| S:43485 E:43488 ||| VBZ
coupled  ||| S:43488 E:43496 ||| VBN
to  ||| S:43496 E:43499 ||| TO
BMP  ||| S:43499 E:43503 ||| NN
type  ||| S:43503 E:43508 ||| NN
I  ||| S:43508 E:43510 ||| PRP
receptor  ||| S:43510 E:43527 ||| VBP
activation ||| S:43527 E:43537 ||| VBN
.  ||| S:43537 E:43539 ||| .
Our  ||| S:43539 E:43543 ||| PRP$
data  ||| S:43543 E:43548 ||| NN
suggests  ||| S:43548 E:43557 ||| VBZ
that  ||| S:43557 E:43562 ||| IN
Smad1  ||| S:43562 E:43568 ||| NNP
and  ||| S:43568 E:43572 ||| CC
Az  ||| S:43572 E:43575 ||| NNP
both  ||| S:43575 E:43588 ||| CC
interact  ||| S:43588 E:43597 ||| NN
with  ||| S:43597 E:43602 ||| IN
HsN3  ||| S:43602 E:43607 ||| NNP
only  ||| S:43607 E:43612 ||| RB
before  ||| S:43612 E:43619 ||| IN
HsN3  ||| S:43619 E:43624 ||| NNP
is  ||| S:43624 E:43627 ||| VBZ
fully  ||| S:43627 E:43633 ||| RB
incorporated  ||| S:43633 E:43654 ||| VBN
into  ||| S:43654 E:43659 ||| IN
the  ||| S:43659 E:43663 ||| DT
mature  ||| S:43663 E:43670 ||| JJ
20S  ||| S:43670 E:43674 ||| CD
proteasome ||| S:43674 E:43684 ||| NNS
.  ||| S:43684 E:43686 ||| .
We  ||| S:43686 E:43689 ||| PRP
have  ||| S:43689 E:43694 ||| VBP
shown  ||| S:43694 E:43700 ||| VBN
that  ||| S:43700 E:43705 ||| IN
the  ||| S:43705 E:43717 ||| DT
reason  ||| S:43717 E:43724 ||| NN
for  ||| S:43724 E:43728 ||| IN
Smad1  ||| S:43728 E:43734 ||| CD
to  ||| S:43734 E:43737 ||| TO
only  ||| S:43737 E:43742 ||| JJ
bind  ||| S:43742 E:43747 ||| NN
to  ||| S:43747 E:43750 ||| TO
the  ||| S:43750 E:43754 ||| DT
unprocessed  ||| S:43754 E:43766 ||| JJ
form  ||| S:43766 E:43771 ||| NN
of  ||| S:43771 E:43782 ||| IN
HsN3  ||| S:43782 E:43787 ||| NNP
is  ||| S:43787 E:43790 ||| VBZ
not  ||| S:43790 E:43794 ||| RB
because  ||| S:43794 E:43802 ||| IN
the  ||| S:43802 E:43806 ||| DT
prosequence  ||| S:43806 E:43818 ||| NN
contains  ||| S:43818 E:43827 ||| VBZ
a  ||| S:43827 E:43837 ||| DT
Smad1-binding  ||| S:43837 E:43851 ||| JJ
site ||| S:43851 E:43855 ||| NN
.  ||| S:43855 E:43857 ||| .
Artificially  ||| S:43857 E:43870 ||| RB
removing  ||| S:43870 E:43879 ||| VBG
the  ||| S:43879 E:43883 ||| DT
prosequence  ||| S:43883 E:43903 ||| NN
of  ||| S:43903 E:43906 ||| IN
HsN3  ||| S:43906 E:43911 ||| CD
in  ||| S:43911 E:43914 ||| IN
fact  ||| S:43914 E:43919 ||| NN
allowed  ||| S:43919 E:43927 ||| VBD
Smad1  ||| S:43927 E:43933 ||| CD
to  ||| S:43933 E:43936 ||| TO
stably  ||| S:43936 E:43943 ||| VB
bind  ||| S:43943 E:43948 ||| VBN
to  ||| S:43948 E:43951 ||| TO
the  ||| S:43951 E:43963 ||| DT
prosequence-less  ||| S:43963 E:43980 ||| JJ
HsN3  ||| S:43980 E:43985 ||| NN
as  ||| S:43985 E:43988 ||| IN
well  ||| S:43988 E:43993 ||| RB
as  ||| S:43993 E:43996 ||| IN
multiple  ||| S:43996 E:44005 ||| JJ
proteins  ||| S:44005 E:44014 ||| NNS
that  ||| S:44014 E:44019 ||| WDT
are  ||| S:44019 E:44031 ||| VBP
bound  ||| S:44031 E:44037 ||| VBN
to  ||| S:44037 E:44040 ||| TO
the  ||| S:44040 E:44044 ||| DT
prosequence-less  ||| S:44044 E:44061 ||| JJ
HsN3 ||| S:44061 E:44065 ||| NN
,  ||| S:44065 E:44067 ||| ,
which  ||| S:44067 E:44073 ||| WDT
may  ||| S:44073 E:44077 ||| MD
represent  ||| S:44077 E:44087 ||| VB
the  ||| S:44087 E:44099 ||| DT
assembly  ||| S:44099 E:44108 ||| NN
intermediates  ||| S:44108 E:44122 ||| NNS
that  ||| S:44122 E:44127 ||| WDT
failed  ||| S:44127 E:44134 ||| VBD
to  ||| S:44134 E:44137 ||| TO
reach  ||| S:44137 E:44143 ||| VB
maturation  ||| S:44143 E:44154 ||| JJ
due  ||| S:44154 E:44166 ||| JJ
to  ||| S:44166 E:44169 ||| TO
the  ||| S:44169 E:44173 ||| DT
lack  ||| S:44173 E:44178 ||| NN
of  ||| S:44178 E:44181 ||| IN
HsN3  ||| S:44181 E:44186 ||| CD
prosequence  ||| S:44186 E:44198 ||| NNS
( ||| S:44198 E:44199 ||| -LRB-
Fig.  ||| S:44199 E:44204 ||| NNP
4D ||| S:44204 E:44206 ||| NNP
, ||| S:44206 E:44207 ||| ,
4E ||| S:44207 E:44209 ||| NNP
, ||| S:44209 E:44210 ||| ,
4F ||| S:44210 E:44212 ||| CD
) ||| S:44212 E:44213 ||| -RRB-
.  ||| S:44213 E:44215 ||| .
These  ||| S:44215 E:44221 ||| DT
data  ||| S:44221 E:44234 ||| NNS
collectively  ||| S:44234 E:44247 ||| RB
point  ||| S:44247 E:44253 ||| VB
out  ||| S:44253 E:44257 ||| RP
the  ||| S:44257 E:44261 ||| DT
transient  ||| S:44261 E:44271 ||| JJ
interaction  ||| S:44271 E:44283 ||| NN
between  ||| S:44283 E:44299 ||| IN
Smad1  ||| S:44299 E:44305 ||| NNP
and  ||| S:44305 E:44309 ||| CC
HsN3  ||| S:44309 E:44314 ||| CD
along  ||| S:44314 E:44320 ||| IN
the  ||| S:44320 E:44324 ||| DT
assembly  ||| S:44324 E:44333 ||| NN
of  ||| S:44333 E:44336 ||| IN
HsN3  ||| S:44336 E:44341 ||| CD
into  ||| S:44341 E:44346 ||| IN
the  ||| S:44346 E:44350 ||| DT
20S  ||| S:44350 E:44362 ||| JJ
proteasome ||| S:44362 E:44372 ||| NN
.  ||| S:44372 E:44374 ||| .
So  ||| S:44374 E:44377 ||| RB
far ||| S:44377 E:44380 ||| RB
,  ||| S:44380 E:44382 ||| ,
several  ||| S:44382 E:44390 ||| JJ
proteins  ||| S:44390 E:44399 ||| NNS
have  ||| S:44399 E:44404 ||| VBP
been  ||| S:44404 E:44409 ||| VBN
found  ||| S:44409 E:44415 ||| VBN
to  ||| S:44415 E:44426 ||| TO
interact  ||| S:44426 E:44435 ||| VB
with  ||| S:44435 E:44440 ||| IN
assembly  ||| S:44440 E:44449 ||| NN
intermediates  ||| S:44449 E:44463 ||| NN
of  ||| S:44463 E:44466 ||| IN
the  ||| S:44466 E:44470 ||| DT
20S  ||| S:44470 E:44474 ||| JJ
proteasome ||| S:44474 E:44484 ||| NN
.  ||| S:44484 E:44494 ||| .
A  ||| S:44494 E:44496 ||| DT
small  ||| S:44496 E:44502 ||| JJ
protein  ||| S:44502 E:44510 ||| NN
Ump1  ||| S:44510 E:44515 ||| CD
associates  ||| S:44515 E:44526 ||| NNS
with  ||| S:44526 E:44531 ||| IN
the  ||| S:44531 E:44535 ||| DT
premature  ||| S:44535 E:44553 ||| JJ
proteasome  ||| S:44553 E:44564 ||| JJ
complexes  ||| S:44564 E:44574 ||| NNS
and  ||| S:44574 E:44578 ||| CC
is  ||| S:44578 E:44581 ||| VBZ
shown  ||| S:44581 E:44587 ||| VBN
to  ||| S:44587 E:44590 ||| TO
be  ||| S:44590 E:44593 ||| VB
involved  ||| S:44593 E:44602 ||| VBN
in  ||| S:44602 E:44613 ||| IN
assisting  ||| S:44613 E:44623 ||| VBG
the  ||| S:44623 E:44627 ||| DT
maturation  ||| S:44627 E:44638 ||| NN
of  ||| S:44638 E:44641 ||| IN
20S  ||| S:44641 E:44645 ||| CD
proteasome ||| S:44645 E:44655 ||| NN
,  ||| S:44655 E:44657 ||| ,
possibly  ||| S:44657 E:44666 ||| RB
by  ||| S:44666 E:44677 ||| IN
interacting  ||| S:44677 E:44689 ||| NN
with  ||| S:44689 E:44694 ||| IN
the  ||| S:44694 E:44698 ||| DT
β  ||| S:44698 E:44700 ||| JJ
rings  ||| S:44700 E:44706 ||| NNS
of  ||| S:44706 E:44709 ||| IN
half  ||| S:44709 E:44714 ||| DT
proteasomes  ||| S:44714 E:44726 ||| NN
[  ||| S:44726 E:44728 ||| -LRB-
46  ||| S:44728 E:44731 ||| CD
]  ||| S:44731 E:44733 ||| -RRB-
.  ||| S:44733 E:44743 ||| .
Upon  ||| S:44743 E:44748 ||| IN
the  ||| S:44748 E:44752 ||| DT
maturation  ||| S:44752 E:44763 ||| NN
of  ||| S:44763 E:44766 ||| IN
the  ||| S:44766 E:44770 ||| DT
20S  ||| S:44770 E:44774 ||| JJ
proteasome ||| S:44774 E:44784 ||| NN
,  ||| S:44784 E:44786 ||| ,
Ump1  ||| S:44786 E:44791 ||| NNP
is  ||| S:44791 E:44794 ||| VBZ
trapped  ||| S:44794 E:44810 ||| VBN
inside  ||| S:44810 E:44817 ||| IN
the  ||| S:44817 E:44821 ||| DT
proteasome  ||| S:44821 E:44832 ||| NN
and  ||| S:44832 E:44836 ||| CC
is  ||| S:44836 E:44839 ||| VBZ
degraded  ||| S:44839 E:44848 ||| VBN
by  ||| S:44848 E:44851 ||| IN
proteasome  ||| S:44851 E:44862 ||| NNS
[  ||| S:44862 E:44864 ||| -LRB-
46  ||| S:44864 E:44867 ||| CD
]  ||| S:44867 E:44877 ||| -RRB-
.  ||| S:44877 E:44879 ||| .
The  ||| S:44879 E:44883 ||| DT
HSP70  ||| S:44883 E:44889 ||| NN
like  ||| S:44889 E:44894 ||| IN
chaperon  ||| S:44894 E:44903 ||| JJ
protein  ||| S:44903 E:44911 ||| NN
Hsc73  ||| S:44911 E:44917 ||| VBZ
also  ||| S:44917 E:44922 ||| RB
associates  ||| S:44922 E:44941 ||| NNS
with  ||| S:44941 E:44946 ||| IN
the  ||| S:44946 E:44950 ||| DT
16S  ||| S:44950 E:44954 ||| FW
proteasome  ||| S:44954 E:44965 ||| FW
precursor  ||| S:44965 E:44975 ||| FW
complexes  ||| S:44975 E:44985 ||| FW
[  ||| S:44985 E:44987 ||| -LRB-
35  ||| S:44987 E:44990 ||| CD
36  ||| S:44990 E:44993 ||| CD
]  ||| S:44993 E:44995 ||| -RRB-
.  ||| S:44995 E:44997 ||| .
The  ||| S:44997 E:45009 ||| DT
exact  ||| S:45009 E:45015 ||| JJ
role  ||| S:45015 E:45020 ||| NN
of  ||| S:45020 E:45023 ||| IN
Hsc73  ||| S:45023 E:45029 ||| CD
in  ||| S:45029 E:45032 ||| IN
16S  ||| S:45032 E:45036 ||| CD
precursor  ||| S:45036 E:45046 ||| CD
proteasome  ||| S:45046 E:45057 ||| JJ
complex  ||| S:45057 E:45065 ||| NN
is  ||| S:45065 E:45076 ||| VBZ
not  ||| S:45076 E:45080 ||| RB
known ||| S:45080 E:45085 ||| VBN
,  ||| S:45085 E:45087 ||| ,
but  ||| S:45087 E:45091 ||| CC
has  ||| S:45091 E:45095 ||| VBZ
been  ||| S:45095 E:45100 ||| VBN
suggested  ||| S:45100 E:45110 ||| VBN
to  ||| S:45110 E:45113 ||| TO
assist  ||| S:45113 E:45120 ||| VB
proteasome  ||| S:45120 E:45139 ||| JJ
maturation  ||| S:45139 E:45150 ||| NNS
[  ||| S:45150 E:45152 ||| -LRB-
35  ||| S:45152 E:45155 ||| CD
36  ||| S:45155 E:45158 ||| CD
]  ||| S:45158 E:45160 ||| -RRB-
.  ||| S:45160 E:45162 ||| .
Our  ||| S:45162 E:45166 ||| PRP$
studies  ||| S:45166 E:45174 ||| NNS
add  ||| S:45174 E:45178 ||| VBP
Smad1 ||| S:45178 E:45183 ||| RB
,  ||| S:45183 E:45185 ||| ,
Smad1  ||| S:45185 E:45199 ||| CD
interacting  ||| S:45199 E:45211 ||| CD
proteins  ||| S:45211 E:45220 ||| NNS
such  ||| S:45220 E:45225 ||| JJ
as  ||| S:45225 E:45228 ||| IN
SNIP1 ||| S:45228 E:45233 ||| NNP
,  ||| S:45233 E:45235 ||| ,
Smad4 ||| S:45235 E:45240 ||| NNP
,  ||| S:45240 E:45242 ||| ,
and  ||| S:45242 E:45246 ||| CC
Az  ||| S:45246 E:45249 ||| NNP
as  ||| S:45249 E:45260 ||| IN
additional  ||| S:45260 E:45271 ||| JJ
proteins  ||| S:45271 E:45280 ||| NNS
that  ||| S:45280 E:45285 ||| IN
associate  ||| S:45285 E:45295 ||| NN
with  ||| S:45295 E:45300 ||| IN
the  ||| S:45300 E:45304 ||| DT
assembly  ||| S:45304 E:45321 ||| NN
intermediates ||| S:45321 E:45334 ||| NN
.  ||| S:45334 E:45336 ||| .
How  ||| S:45336 E:45340 ||| WRB
does  ||| S:45340 E:45345 ||| VBZ
the  ||| S:45345 E:45349 ||| DT
association  ||| S:45349 E:45361 ||| NN
of  ||| S:45361 E:45364 ||| IN
HsN3  ||| S:45364 E:45369 ||| NNP
contribute  ||| S:45369 E:45388 ||| VBP
to  ||| S:45388 E:45391 ||| TO
the  ||| S:45391 E:45395 ||| DT
final  ||| S:45395 E:45401 ||| JJ
degradation  ||| S:45401 E:45413 ||| NN
or  ||| S:45413 E:45416 ||| CC
processing  ||| S:45416 E:45427 ||| NN
of  ||| S:45427 E:45430 ||| IN
these  ||| S:45430 E:45436 ||| DT
proteins ||| S:45436 E:45444 ||| NNS
?  ||| S:45444 E:45454 ||| .
Two  ||| S:45454 E:45458 ||| CD
possible  ||| S:45458 E:45467 ||| JJ
mechanisms  ||| S:45467 E:45478 ||| NNS
are  ||| S:45478 E:45482 ||| VBP
illustrated  ||| S:45482 E:45494 ||| VBN
in  ||| S:45494 E:45497 ||| IN
Fig.  ||| S:45497 E:45502 ||| CD
10A ||| S:45502 E:45505 ||| CD
.  ||| S:45505 E:45507 ||| .
The  ||| S:45507 E:45519 ||| DT
first  ||| S:45519 E:45525 ||| JJ
possible  ||| S:45525 E:45534 ||| JJ
mechanism  ||| S:45534 E:45544 ||| NN
is  ||| S:45544 E:45547 ||| VBZ
via  ||| S:45547 E:45551 ||| IN
"Unfold  ||| S:45551 E:45559 ||| NNP
and  ||| S:45559 E:45563 ||| CC
Trap ||| S:45563 E:45567 ||| NNP
" ||| S:45567 E:45568 ||| ''
.  ||| S:45568 E:45570 ||| .
The  ||| S:45570 E:45582 ||| DT
proteasome  ||| S:45582 E:45593 ||| JJ
assembly  ||| S:45593 E:45602 ||| NN
intermediates  ||| S:45602 E:45616 ||| NNS
could  ||| S:45616 E:45622 ||| MD
be  ||| S:45622 E:45625 ||| VB
a  ||| S:45625 E:45627 ||| DT
site  ||| S:45627 E:45632 ||| NN
for  ||| S:45632 E:45636 ||| IN
the  ||| S:45636 E:45648 ||| DT
entry  ||| S:45648 E:45654 ||| NN
of  ||| S:45654 E:45657 ||| IN
substrates  ||| S:45657 E:45668 ||| NN
into  ||| S:45668 E:45673 ||| IN
the  ||| S:45673 E:45677 ||| DT
degradation  ||| S:45677 E:45689 ||| JJ
chamber  ||| S:45689 E:45697 ||| NN
via  ||| S:45697 E:45701 ||| IN
an  ||| S:45701 E:45712 ||| DT
unfold-trap  ||| S:45712 E:45724 ||| JJ
mechanism  ||| S:45724 E:45734 ||| NN
that  ||| S:45734 E:45739 ||| WDT
is  ||| S:45739 E:45742 ||| VBZ
coupled  ||| S:45742 E:45750 ||| VBN
to  ||| S:45750 E:45753 ||| TO
the  ||| S:45753 E:45757 ||| DT
final  ||| S:45757 E:45771 ||| JJ
maturation  ||| S:45771 E:45782 ||| NN
of  ||| S:45782 E:45785 ||| IN
the  ||| S:45785 E:45789 ||| DT
20S  ||| S:45789 E:45793 ||| JJ
proteasome ||| S:45793 E:45803 ||| NN
.  ||| S:45803 E:45805 ||| .
The  ||| S:45805 E:45809 ||| DT
chaperon  ||| S:45809 E:45818 ||| JJ
proteins  ||| S:45818 E:45835 ||| NNS
such  ||| S:45835 E:45840 ||| JJ
as  ||| S:45840 E:45843 ||| IN
Hsc73  ||| S:45843 E:45849 ||| NNP
could  ||| S:45849 E:45855 ||| MD
be  ||| S:45855 E:45858 ||| VB
involved  ||| S:45858 E:45867 ||| VBN
in  ||| S:45867 E:45870 ||| IN
unfolding  ||| S:45870 E:45880 ||| VBG
the  ||| S:45880 E:45884 ||| DT
substrates  ||| S:45884 E:45903 ||| NN
for  ||| S:45903 E:45907 ||| IN
them  ||| S:45907 E:45912 ||| PRP
to  ||| S:45912 E:45915 ||| TO
fit  ||| S:45915 E:45919 ||| VB
into  ||| S:45919 E:45924 ||| IN
the  ||| S:45924 E:45928 ||| DT
degradation  ||| S:45928 E:45940 ||| JJ
chamber  ||| S:45940 E:45948 ||| NN
and  ||| S:45948 E:45952 ||| CC
the  ||| S:45952 E:45956 ||| DT
final  ||| S:45956 E:45970 ||| JJ
maturation  ||| S:45970 E:45981 ||| NN
of  ||| S:45981 E:45984 ||| IN
20S  ||| S:45984 E:45988 ||| CD
proteasome  ||| S:45988 E:45999 ||| NN
from  ||| S:45999 E:46004 ||| IN
the  ||| S:46004 E:46008 ||| DT
16S  ||| S:46008 E:46012 ||| JJ
assembly  ||| S:46012 E:46029 ||| NN
intermediates  ||| S:46029 E:46043 ||| NNS
could  ||| S:46043 E:46049 ||| MD
trap  ||| S:46049 E:46054 ||| VB
the  ||| S:46054 E:46058 ||| DT
substrates ||| S:46058 E:46068 ||| NN
,  ||| S:46068 E:46070 ||| ,
such  ||| S:46070 E:46075 ||| JJ
as  ||| S:46075 E:46078 ||| IN
Ump1  ||| S:46078 E:46083 ||| NNP
and  ||| S:46083 E:46095 ||| CC
Smads ||| S:46095 E:46100 ||| NNP
,  ||| S:46100 E:46102 ||| ,
inside  ||| S:46102 E:46109 ||| IN
the  ||| S:46109 E:46113 ||| DT
degradation  ||| S:46113 E:46125 ||| JJ
chamber ||| S:46125 E:46132 ||| NN
.  ||| S:46132 E:46134 ||| .
If  ||| S:46134 E:46137 ||| IN
so ||| S:46137 E:46139 ||| RB
,  ||| S:46139 E:46149 ||| ,
ubiquitination  ||| S:46149 E:46164 ||| NNS
may  ||| S:46164 E:46168 ||| MD
not  ||| S:46168 E:46172 ||| RB
be  ||| S:46172 E:46175 ||| VB
necessary  ||| S:46175 E:46185 ||| JJ
for  ||| S:46185 E:46189 ||| IN
the  ||| S:46189 E:46193 ||| DT
degradation ||| S:46193 E:46204 ||| NN
.  ||| S:46204 E:46214 ||| .
This  ||| S:46214 E:46219 ||| DT
could  ||| S:46219 E:46225 ||| MD
be  ||| S:46225 E:46228 ||| VB
a  ||| S:46228 E:46230 ||| DT
common  ||| S:46230 E:46237 ||| JJ
mechanism  ||| S:46237 E:46247 ||| NN
for  ||| S:46247 E:46251 ||| IN
ubiquitin-independent  ||| S:46251 E:46281 ||| JJ
degradation  ||| S:46281 E:46293 ||| JJ
pathways ||| S:46293 E:46301 ||| NN
.  ||| S:46301 E:46303 ||| .
The  ||| S:46303 E:46307 ||| DT
second  ||| S:46307 E:46314 ||| JJ
possible  ||| S:46314 E:46323 ||| JJ
mechanism  ||| S:46323 E:46333 ||| NN
is  ||| S:46333 E:46336 ||| VBZ
via  ||| S:46336 E:46348 ||| IN
"docking  ||| S:46348 E:46357 ||| NNP
and  ||| S:46357 E:46361 ||| CC
delivery ||| S:46361 E:46369 ||| NN
" ||| S:46369 E:46370 ||| ''
.  ||| S:46370 E:46372 ||| .
HsN3  ||| S:46372 E:46377 ||| NNP
may  ||| S:46377 E:46381 ||| MD
simply  ||| S:46381 E:46388 ||| RB
bring  ||| S:46388 E:46394 ||| VB
the  ||| S:46394 E:46398 ||| DT
Smad ||| S:46398 E:46402 ||| NNP
/ ||| S:46402 E:46403 ||| NNP
Az  ||| S:46403 E:46414 ||| NNP
containing  ||| S:46414 E:46425 ||| VBG
complex  ||| S:46425 E:46433 ||| JJ
close  ||| S:46433 E:46439 ||| NN
enough  ||| S:46439 E:46446 ||| RB
to  ||| S:46446 E:46449 ||| TO
the  ||| S:46449 E:46453 ||| DT
26S  ||| S:46453 E:46457 ||| CD
proteasome  ||| S:46457 E:46468 ||| NNS
and  ||| S:46468 E:46480 ||| CC
then  ||| S:46480 E:46485 ||| RB
delivers  ||| S:46485 E:46494 ||| VBZ
it  ||| S:46494 E:46497 ||| PRP
to  ||| S:46497 E:46500 ||| TO
the  ||| S:46500 E:46504 ||| DT
19S  ||| S:46504 E:46508 ||| JJ
complex  ||| S:46508 E:46516 ||| NN
via  ||| S:46516 E:46520 ||| IN
Az  ||| S:46520 E:46523 ||| NNP
interaction  ||| S:46523 E:46535 ||| NN
with  ||| S:46535 E:46548 ||| IN
its  ||| S:46548 E:46552 ||| PRP$
receptor  ||| S:46552 E:46561 ||| NN
within  ||| S:46561 E:46568 ||| IN
19S  ||| S:46568 E:46572 ||| CD
regulator ||| S:46572 E:46581 ||| NN
.  ||| S:46581 E:46591 ||| .
We  ||| S:46591 E:46594 ||| PRP
have  ||| S:46594 E:46599 ||| VBP
so  ||| S:46599 E:46602 ||| RB
far  ||| S:46602 E:46606 ||| RB
identified  ||| S:46606 E:46617 ||| VBN
two  ||| S:46617 E:46621 ||| CD
functional  ||| S:46621 E:46632 ||| CD
outcomes  ||| S:46632 E:46641 ||| NNS
of  ||| S:46641 E:46644 ||| IN
the  ||| S:46644 E:46656 ||| DT
observed  ||| S:46656 E:46665 ||| JJ
physical  ||| S:46665 E:46674 ||| JJ
interaction  ||| S:46674 E:46686 ||| NN
between  ||| S:46686 E:46694 ||| IN
Smad1 ||| S:46694 E:46699 ||| NNP
,  ||| S:46699 E:46701 ||| ,
HsN3  ||| S:46701 E:46706 ||| NNP
and  ||| S:46706 E:46710 ||| CC
Az  ||| S:46710 E:46713 ||| NNP
in  ||| S:46713 E:46724 ||| IN
the  ||| S:46724 E:46728 ||| DT
signaling  ||| S:46728 E:46738 ||| JJ
pathways  ||| S:46738 E:46747 ||| NN
of  ||| S:46747 E:46750 ||| IN
BMPs ||| S:46750 E:46754 ||| JJ
.  ||| S:46754 E:46756 ||| .
First ||| S:46756 E:46761 ||| NNP
,  ||| S:46761 E:46763 ||| ,
in  ||| S:46763 E:46766 ||| IN
a  ||| S:46766 E:46768 ||| DT
separate  ||| S:46768 E:46785 ||| JJ
report ||| S:46785 E:46791 ||| NN
,  ||| S:46791 E:46793 ||| ,
we  ||| S:46793 E:46796 ||| PRP
showed  ||| S:46796 E:46803 ||| VBD
that  ||| S:46803 E:46808 ||| IN
Smad1  ||| S:46808 E:46814 ||| NNP
itself  ||| S:46814 E:46821 ||| PRP
is  ||| S:46821 E:46824 ||| VBZ
targeted  ||| S:46824 E:46833 ||| VBN
to  ||| S:46833 E:46844 ||| TO
proteasome  ||| S:46844 E:46855 ||| VB
and  ||| S:46855 E:46859 ||| CC
is  ||| S:46859 E:46862 ||| VBZ
subsequently  ||| S:46862 E:46875 ||| RB
degraded  ||| S:46875 E:46884 ||| VBN
by  ||| S:46884 E:46887 ||| IN
the  ||| S:46887 E:46891 ||| DT
proteasome ||| S:46891 E:46901 ||| NN
,  ||| S:46901 E:46911 ||| ,
an  ||| S:46911 E:46914 ||| DT
event  ||| S:46914 E:46920 ||| NN
that  ||| S:46920 E:46925 ||| WDT
is  ||| S:46925 E:46928 ||| VBZ
triggered  ||| S:46928 E:46938 ||| VBN
by  ||| S:46938 E:46941 ||| IN
the  ||| S:46941 E:46945 ||| DT
activation  ||| S:46945 E:46956 ||| NN
of  ||| S:46956 E:46959 ||| IN
BMP  ||| S:46959 E:46963 ||| NN
type  ||| S:46963 E:46968 ||| NN
I  ||| S:46968 E:46978 ||| NN
receptor  ||| S:46978 E:46987 ||| NN
and  ||| S:46987 E:46991 ||| CC
involves  ||| S:46991 E:47000 ||| VBZ
the  ||| S:47000 E:47004 ||| DT
targeting  ||| S:47004 E:47014 ||| JJ
role  ||| S:47014 E:47019 ||| NN
of  ||| S:47019 E:47022 ||| IN
Az  ||| S:47022 E:47025 ||| NNP
and  ||| S:47025 E:47029 ||| CC
HsN3  ||| S:47029 E:47034 ||| NNP
[  ||| S:47034 E:47044 ||| -LRB-
39  ||| S:47044 E:47047 ||| CD
]  ||| S:47047 E:47049 ||| -RRB-
.  ||| S:47049 E:47051 ||| .
Proteasomal  ||| S:47051 E:47063 ||| JJ
degradation  ||| S:47063 E:47075 ||| NN
of  ||| S:47075 E:47078 ||| IN
Smad1  ||| S:47078 E:47084 ||| NNP
appears  ||| S:47084 E:47092 ||| VBZ
to  ||| S:47092 E:47095 ||| TO
also  ||| S:47095 E:47108 ||| RB
play  ||| S:47108 E:47113 ||| VB
a  ||| S:47113 E:47115 ||| DT
role  ||| S:47115 E:47120 ||| NN
in  ||| S:47120 E:47123 ||| IN
regulating  ||| S:47123 E:47134 ||| VBG
the  ||| S:47134 E:47138 ||| DT
constitutive  ||| S:47138 E:47151 ||| JJ
level  ||| S:47151 E:47157 ||| NN
of  ||| S:47157 E:47160 ||| IN
Smad1  ||| S:47160 E:47174 ||| CD
in  ||| S:47174 E:47177 ||| IN
cell  ||| S:47177 E:47182 ||| NN
as  ||| S:47182 E:47185 ||| IN
a  ||| S:47185 E:47187 ||| DT
way  ||| S:47187 E:47191 ||| NN
to  ||| S:47191 E:47194 ||| TO
adjust  ||| S:47194 E:47201 ||| VB
the  ||| S:47201 E:47205 ||| DT
cellular  ||| S:47205 E:47214 ||| JJ
responsiveness  ||| S:47214 E:47229 ||| NN
of  ||| S:47229 E:47240 ||| IN
BMPs  ||| S:47240 E:47245 ||| NNP
[  ||| S:47245 E:47247 ||| -LRB-
47  ||| S:47247 E:47250 ||| CD
]  ||| S:47250 E:47252 ||| -RRB-
.  ||| S:47252 E:47254 ||| .
However ||| S:47254 E:47261 ||| RB
,  ||| S:47261 E:47263 ||| ,
the  ||| S:47263 E:47267 ||| DT
targeting  ||| S:47267 E:47277 ||| JJ
mechanism  ||| S:47277 E:47287 ||| NN
and  ||| S:47287 E:47291 ||| CC
the  ||| S:47291 E:47303 ||| DT
regulation  ||| S:47303 E:47314 ||| NN
involved  ||| S:47314 E:47323 ||| VBN
in  ||| S:47323 E:47326 ||| IN
these  ||| S:47326 E:47332 ||| DT
two  ||| S:47332 E:47336 ||| CD
cases  ||| S:47336 E:47342 ||| NNS
of  ||| S:47342 E:47345 ||| IN
Smad1  ||| S:47345 E:47351 ||| CD
degradation  ||| S:47351 E:47371 ||| NN
by  ||| S:47371 E:47374 ||| IN
proteasome  ||| S:47374 E:47385 ||| NNS
are  ||| S:47385 E:47389 ||| VBP
likely  ||| S:47389 E:47396 ||| RB
fundamentally  ||| S:47396 E:47410 ||| RB
different  ||| S:47410 E:47420 ||| JJ
[  ||| S:47420 E:47422 ||| -LRB-
39  ||| S:47422 E:47425 ||| CD
]  ||| S:47425 E:47427 ||| -RRB-
.  ||| S:47427 E:47437 ||| .
The  ||| S:47437 E:47441 ||| DT
second  ||| S:47441 E:47448 ||| JJ
functional  ||| S:47448 E:47459 ||| JJ
outcome  ||| S:47459 E:47467 ||| NN
of  ||| S:47467 E:47470 ||| IN
the  ||| S:47470 E:47474 ||| DT
physical  ||| S:47474 E:47483 ||| JJ
link  ||| S:47483 E:47488 ||| NN
between  ||| S:47488 E:47504 ||| IN
Smad1 ||| S:47504 E:47509 ||| NNP
,  ||| S:47509 E:47511 ||| ,
HsN3  ||| S:47511 E:47516 ||| NNP
and  ||| S:47516 E:47520 ||| CC
Az  ||| S:47520 E:47523 ||| NNP
is  ||| S:47523 E:47526 ||| VBZ
the  ||| S:47526 E:47530 ||| DT
ability  ||| S:47530 E:47538 ||| NN
of  ||| S:47538 E:47541 ||| IN
Smad1  ||| S:47541 E:47547 ||| CD
to  ||| S:47547 E:47550 ||| TO
regulate  ||| S:47550 E:47559 ||| VB
the  ||| S:47559 E:47571 ||| DT
proteasomal  ||| S:47571 E:47583 ||| JJ
degradation  ||| S:47583 E:47595 ||| NN
of  ||| S:47595 E:47598 ||| IN
SNIP1 ||| S:47598 E:47603 ||| NNP
,  ||| S:47603 E:47605 ||| ,
which  ||| S:47605 E:47611 ||| WDT
is  ||| S:47611 E:47614 ||| VBZ
clearly  ||| S:47614 E:47630 ||| RB
dependent  ||| S:47630 E:47640 ||| JJ
upon  ||| S:47640 E:47645 ||| IN
high  ||| S:47645 E:47650 ||| JJ
levels  ||| S:47650 E:47657 ||| NNS
of  ||| S:47657 E:47660 ||| IN
Smad1 ||| S:47660 E:47665 ||| NNP
,  ||| S:47665 E:47667 ||| ,
Az  ||| S:47667 E:47670 ||| NNP
and  ||| S:47670 E:47674 ||| CC
a  ||| S:47674 E:47676 ||| DT
strong  ||| S:47676 E:47691 ||| JJ
activation  ||| S:47691 E:47702 ||| JJ
signal  ||| S:47702 E:47709 ||| NN
from  ||| S:47709 E:47714 ||| IN
the  ||| S:47714 E:47718 ||| DT
type  ||| S:47718 E:47723 ||| NN
I  ||| S:47723 E:47725 ||| PRP
receptor ||| S:47725 E:47733 ||| VBP
,  ||| S:47733 E:47735 ||| ,
as  ||| S:47735 E:47738 ||| RB
suggested  ||| S:47738 E:47748 ||| VBN
by  ||| S:47748 E:47759 ||| IN
the  ||| S:47759 E:47763 ||| DT
observations  ||| S:47763 E:47776 ||| NNS
that  ||| S:47776 E:47781 ||| IN
the  ||| S:47781 E:47785 ||| DT
protein  ||| S:47785 E:47793 ||| NN
levels  ||| S:47793 E:47800 ||| NNS
of  ||| S:47800 E:47803 ||| IN
Smad1 ||| S:47803 E:47808 ||| NNP
,  ||| S:47808 E:47810 ||| ,
Az  ||| S:47810 E:47813 ||| NNP
and  ||| S:47813 E:47825 ||| CC
ALK3Q233D  ||| S:47825 E:47835 ||| NNP
directly  ||| S:47835 E:47844 ||| RB
influence  ||| S:47844 E:47854 ||| VB
the  ||| S:47854 E:47858 ||| DT
degree  ||| S:47858 E:47865 ||| NN
of  ||| S:47865 E:47868 ||| IN
SNIP1  ||| S:47868 E:47882 ||| CD
degradation ||| S:47882 E:47893 ||| NN
.  ||| S:47893 E:47895 ||| .
While  ||| S:47895 E:47901 ||| IN
the  ||| S:47901 E:47905 ||| DT
detailed  ||| S:47905 E:47914 ||| JJ
mechanisms  ||| S:47914 E:47925 ||| NNS
for  ||| S:47925 E:47929 ||| IN
such  ||| S:47929 E:47934 ||| PDT
a  ||| S:47934 E:47936 ||| DT
novel  ||| S:47936 E:47950 ||| NN
mode  ||| S:47950 E:47955 ||| NN
of  ||| S:47955 E:47958 ||| IN
regulation  ||| S:47958 E:47969 ||| NN
still  ||| S:47969 E:47975 ||| RB
requires  ||| S:47975 E:47984 ||| VBZ
many  ||| S:47984 E:47989 ||| JJ
additional  ||| S:47989 E:48000 ||| JJ
studies ||| S:48000 E:48007 ||| NNS
,  ||| S:48007 E:48017 ||| ,
so  ||| S:48017 E:48020 ||| RB
far  ||| S:48020 E:48024 ||| RB
we  ||| S:48024 E:48027 ||| PRP
observed  ||| S:48027 E:48036 ||| VBD
several  ||| S:48036 E:48044 ||| JJ
important  ||| S:48044 E:48054 ||| JJ
steps  ||| S:48054 E:48060 ||| NNS
that  ||| S:48060 E:48065 ||| WDT
may  ||| S:48065 E:48077 ||| MD
contribute  ||| S:48077 E:48088 ||| VB
to  ||| S:48088 E:48091 ||| TO
SNIP1  ||| S:48091 E:48097 ||| CD
degradation ||| S:48097 E:48108 ||| NN
.  ||| S:48108 E:48110 ||| .
First ||| S:48110 E:48115 ||| NNP
,  ||| S:48115 E:48117 ||| ,
Smad1  ||| S:48117 E:48123 ||| NNP
binds  ||| S:48123 E:48129 ||| VBD
both  ||| S:48129 E:48142 ||| DT
HsN3  ||| S:48142 E:48147 ||| NNP
and  ||| S:48147 E:48151 ||| CC
Az  ||| S:48151 E:48154 ||| NNP
in  ||| S:48154 E:48157 ||| IN
the  ||| S:48157 E:48161 ||| DT
cytoplasm  ||| S:48161 E:48171 ||| NN
and  ||| S:48171 E:48175 ||| CC
brings  ||| S:48175 E:48182 ||| VBZ
them  ||| S:48182 E:48187 ||| PRP
into  ||| S:48187 E:48192 ||| IN
the  ||| S:48192 E:48204 ||| DT
nucleus  ||| S:48204 E:48212 ||| NN
upon  ||| S:48212 E:48217 ||| IN
the  ||| S:48217 E:48221 ||| DT
activation  ||| S:48221 E:48232 ||| NN
of  ||| S:48232 E:48235 ||| IN
BMP  ||| S:48235 E:48239 ||| NN
type  ||| S:48239 E:48244 ||| NN
I  ||| S:48244 E:48246 ||| PRP
receptor  ||| S:48246 E:48255 ||| VBP
( ||| S:48255 E:48256 ||| -LRB-
Fig.  ||| S:48256 E:48269 ||| CD
6 ||| S:48269 E:48270 ||| CD
) ||| S:48270 E:48271 ||| -RRB-
.  ||| S:48271 E:48273 ||| .
Second ||| S:48273 E:48279 ||| LS
,  ||| S:48279 E:48281 ||| ,
SNIP1  ||| S:48281 E:48287 ||| NNP
is  ||| S:48287 E:48290 ||| VBZ
recruited  ||| S:48290 E:48300 ||| VBN
to  ||| S:48300 E:48303 ||| TO
Az  ||| S:48303 E:48306 ||| NNP
and  ||| S:48306 E:48310 ||| CC
HsN3 ||| S:48310 E:48314 ||| NNP
,  ||| S:48314 E:48316 ||| ,
which  ||| S:48316 E:48322 ||| WDT
are  ||| S:48322 E:48334 ||| VBP
likely  ||| S:48334 E:48341 ||| RB
in  ||| S:48341 E:48344 ||| IN
a  ||| S:48344 E:48346 ||| DT
complex  ||| S:48346 E:48354 ||| NN
with  ||| S:48354 E:48359 ||| IN
Smad1  ||| S:48359 E:48365 ||| NNP
and  ||| S:48365 E:48369 ||| CC
Smad4  ||| S:48369 E:48375 ||| NNP
( ||| S:48375 E:48376 ||| -LRB-
Fig.  ||| S:48376 E:48381 ||| NNP
7D ||| S:48381 E:48383 ||| NNP
&  ||| S:48383 E:48385 ||| CC
7E ||| S:48385 E:48387 ||| CD
) ||| S:48387 E:48388 ||| -RRB-
.  ||| S:48388 E:48398 ||| .
Third ||| S:48398 E:48403 ||| JJ
,  ||| S:48403 E:48405 ||| ,
SNIP1  ||| S:48405 E:48411 ||| NNP
is  ||| S:48411 E:48414 ||| VBZ
co-targeted  ||| S:48414 E:48426 ||| JJ
into  ||| S:48426 E:48431 ||| IN
the  ||| S:48431 E:48435 ||| DT
proteasome  ||| S:48435 E:48446 ||| NN
with  ||| S:48446 E:48451 ||| IN
Smad1 ||| S:48451 E:48456 ||| NNP
,  ||| S:48456 E:48466 ||| ,
Smad4  ||| S:48466 E:48472 ||| NNP
and  ||| S:48472 E:48476 ||| CC
Az  ||| S:48476 E:48479 ||| NNP
via  ||| S:48479 E:48483 ||| IN
the  ||| S:48483 E:48487 ||| DT
rapid  ||| S:48487 E:48493 ||| JJ
assembly  ||| S:48493 E:48502 ||| NN
of  ||| S:48502 E:48505 ||| IN
HsN3  ||| S:48505 E:48510 ||| CD
into  ||| S:48510 E:48515 ||| IN
the  ||| S:48515 E:48527 ||| DT
proteasome ||| S:48527 E:48537 ||| NN
.  ||| S:48537 E:48539 ||| .
This  ||| S:48539 E:48544 ||| DT
is  ||| S:48544 E:48547 ||| VBZ
suggested  ||| S:48547 E:48557 ||| VBN
by  ||| S:48557 E:48560 ||| IN
the  ||| S:48560 E:48564 ||| DT
observations  ||| S:48564 E:48577 ||| NNS
that  ||| S:48577 E:48582 ||| IN
the  ||| S:48582 E:48594 ||| DT
targeting  ||| S:48594 E:48604 ||| VBG
of  ||| S:48604 E:48607 ||| IN
SNIP1  ||| S:48607 E:48613 ||| NNP
is  ||| S:48613 E:48616 ||| VBZ
positively  ||| S:48616 E:48627 ||| RB
regulated  ||| S:48627 E:48637 ||| VBN
by  ||| S:48637 E:48640 ||| IN
Smad1  ||| S:48640 E:48646 ||| CD
level  ||| S:48646 E:48660 ||| NN
and  ||| S:48660 E:48664 ||| CC
is  ||| S:48664 E:48667 ||| VBZ
dependent  ||| S:48667 E:48677 ||| JJ
upon  ||| S:48677 E:48682 ||| IN
Smad1 ||| S:48682 E:48687 ||| NNP
,  ||| S:48687 E:48689 ||| ,
Smad4  ||| S:48689 E:48695 ||| NNP
and  ||| S:48695 E:48699 ||| CC
Az  ||| S:48699 E:48702 ||| NNP
( ||| S:48702 E:48703 ||| -LRB-
Fig.  ||| S:48703 E:48708 ||| NNP
8A ||| S:48708 E:48710 ||| NNP
&  ||| S:48710 E:48720 ||| CC
8B ||| S:48720 E:48722 ||| CD
) ||| S:48722 E:48723 ||| -RRB-
.  ||| S:48723 E:48725 ||| .
Fourth ||| S:48725 E:48731 ||| JJ
,  ||| S:48731 E:48733 ||| ,
Smad4  ||| S:48733 E:48739 ||| NNP
is  ||| S:48739 E:48742 ||| VBZ
a  ||| S:48742 E:48744 ||| DT
positive  ||| S:48744 E:48753 ||| JJ
regulator  ||| S:48753 E:48763 ||| NN
of  ||| S:48763 E:48766 ||| IN
the  ||| S:48766 E:48770 ||| DT
targeting  ||| S:48770 E:48788 ||| VBG
of  ||| S:48788 E:48791 ||| IN
SNIP1  ||| S:48791 E:48797 ||| CD
to  ||| S:48797 E:48800 ||| TO
proteasome ||| S:48800 E:48810 ||| VB
.  ||| S:48810 E:48812 ||| .
The  ||| S:48812 E:48816 ||| DT
requirement  ||| S:48816 E:48828 ||| NN
of  ||| S:48828 E:48831 ||| IN
both  ||| S:48831 E:48836 ||| DT
Smad1  ||| S:48836 E:48842 ||| NNP
and  ||| S:48842 E:48854 ||| CC
Smad4  ||| S:48854 E:48860 ||| CD
in  ||| S:48860 E:48863 ||| IN
the  ||| S:48863 E:48867 ||| DT
down-regulation  ||| S:48867 E:48883 ||| JJ
of  ||| S:48883 E:48886 ||| IN
SNIP1  ||| S:48886 E:48892 ||| NNP
is  ||| S:48892 E:48895 ||| VBZ
interesting  ||| S:48895 E:48907 ||| JJ
since  ||| S:48907 E:48921 ||| IN
this  ||| S:48921 E:48926 ||| DT
may  ||| S:48926 E:48930 ||| MD
represent  ||| S:48930 E:48940 ||| VB
an  ||| S:48940 E:48943 ||| DT
important  ||| S:48943 E:48953 ||| JJ
molecular  ||| S:48953 E:48963 ||| JJ
mechanism  ||| S:48963 E:48973 ||| NN
for  ||| S:48973 E:48977 ||| IN
the  ||| S:48977 E:48989 ||| DT
co-operative  ||| S:48989 E:49002 ||| JJ
property  ||| S:49002 E:49011 ||| NN
of  ||| S:49011 E:49014 ||| IN
these  ||| S:49014 E:49020 ||| DT
Smads  ||| S:49020 E:49026 ||| NNP
to  ||| S:49026 E:49029 ||| TO
modulate  ||| S:49029 E:49046 ||| VB
transcription ||| S:49046 E:49059 ||| NNS
.  ||| S:49059 E:49061 ||| .
The  ||| S:49061 E:49065 ||| DT
functional  ||| S:49065 E:49076 ||| JJ
significance  ||| S:49076 E:49089 ||| NN
of  ||| S:49089 E:49092 ||| IN
SNIP1  ||| S:49092 E:49106 ||| CD
degradation  ||| S:49106 E:49118 ||| NN
is  ||| S:49118 E:49121 ||| VBZ
apparent ||| S:49121 E:49129 ||| JJ
,  ||| S:49129 E:49131 ||| ,
since  ||| S:49131 E:49137 ||| IN
SNIP1  ||| S:49137 E:49143 ||| NNP
is  ||| S:49143 E:49146 ||| VBZ
a  ||| S:49146 E:49148 ||| DT
constitutive  ||| S:49148 E:49169 ||| JJ
interactor  ||| S:49169 E:49180 ||| NN
and  ||| S:49180 E:49184 ||| CC
functional  ||| S:49184 E:49195 ||| JJ
repressor  ||| S:49195 E:49205 ||| NN
of  ||| S:49205 E:49208 ||| IN
the  ||| S:49208 E:49212 ||| DT
master  ||| S:49212 E:49227 ||| NN
transcription  ||| S:49227 E:49241 ||| FW
co-activator  ||| S:49241 E:49254 ||| FW
CBP ||| S:49254 E:49257 ||| FW
/ ||| S:49257 E:49258 ||| FW
p300  ||| S:49258 E:49263 ||| FW
[  ||| S:49263 E:49265 ||| -LRB-
25  ||| S:49265 E:49268 ||| CD
]  ||| S:49268 E:49270 ||| -RRB-
.  ||| S:49270 E:49272 ||| .
In  ||| S:49272 E:49275 ||| IN
the  ||| S:49275 E:49279 ||| DT
BMP  ||| S:49279 E:49291 ||| NN
signaling  ||| S:49291 E:49301 ||| VBG
pathways ||| S:49301 E:49309 ||| NN
,  ||| S:49309 E:49311 ||| ,
SNIP1  ||| S:49311 E:49317 ||| NNP
is  ||| S:49317 E:49320 ||| VBZ
a  ||| S:49320 E:49322 ||| DT
potent  ||| S:49322 E:49329 ||| JJ
inhibitor  ||| S:49329 E:49339 ||| NN
of  ||| S:49339 E:49350 ||| IN
Smad-responsive  ||| S:49350 E:49366 ||| JJ
genes  ||| S:49366 E:49372 ||| NNS
via  ||| S:49372 E:49376 ||| IN
inhibiting  ||| S:49376 E:49387 ||| FW
CBP ||| S:49387 E:49390 ||| FW
/ ||| S:49390 E:49391 ||| FW
p300  ||| S:49391 E:49396 ||| FW
( ||| S:49396 E:49397 ||| -LRB-
Fig.  ||| S:49397 E:49402 ||| NNP
9A ||| S:49402 E:49404 ||| NNP
) ||| S:49404 E:49405 ||| -RRB-
.  ||| S:49405 E:49415 ||| .
Thus  ||| S:49415 E:49420 ||| RB
the  ||| S:49420 E:49424 ||| DT
down-regulation  ||| S:49424 E:49440 ||| JJ
of  ||| S:49440 E:49443 ||| IN
SNIP1  ||| S:49443 E:49449 ||| CD
likely  ||| S:49449 E:49456 ||| JJ
leads  ||| S:49456 E:49462 ||| NNS
to  ||| S:49462 E:49465 ||| TO
the  ||| S:49465 E:49477 ||| DT
liberation  ||| S:49477 E:49488 ||| NN
of  ||| S:49488 E:49491 ||| IN
CBP ||| S:49491 E:49494 ||| NNP
/ ||| S:49494 E:49495 ||| NNP
p300  ||| S:49495 E:49500 ||| NNP
and  ||| S:49500 E:49504 ||| CC
directly  ||| S:49504 E:49513 ||| RB
contributes  ||| S:49513 E:49525 ||| VBZ
to  ||| S:49525 E:49528 ||| TO
the  ||| S:49528 E:49540 ||| DT
well-known  ||| S:49540 E:49551 ||| JJ
transcriptional  ||| S:49551 E:49567 ||| JJ
modulator  ||| S:49567 E:49577 ||| JJ
functions  ||| S:49577 E:49587 ||| NNS
of  ||| S:49587 E:49590 ||| IN
Smad1  ||| S:49590 E:49596 ||| NNP
and  ||| S:49596 E:49608 ||| CC
Smad4 ||| S:49608 E:49613 ||| NNP
.  ||| S:49613 E:49615 ||| .
These  ||| S:49615 E:49621 ||| DT
ideas  ||| S:49621 E:49627 ||| NNS
are  ||| S:49627 E:49631 ||| VBP
summarized  ||| S:49631 E:49642 ||| VBN
in  ||| S:49642 E:49645 ||| IN
a  ||| S:49645 E:49647 ||| DT
cartoon  ||| S:49647 E:49655 ||| NN
in  ||| S:49655 E:49658 ||| IN
Fig.  ||| S:49658 E:49663 ||| CD
10B ||| S:49663 E:49666 ||| CD
.  ||| S:49666 E:49676 ||| .
Specifically ||| S:49676 E:49688 ||| RB
,  ||| S:49688 E:49690 ||| ,
the  ||| S:49690 E:49694 ||| DT
activated  ||| S:49694 E:49704 ||| JJ
Smad1  ||| S:49704 E:49710 ||| NN
and  ||| S:49710 E:49714 ||| CC
Smad4  ||| S:49714 E:49720 ||| RB
enter  ||| S:49720 E:49726 ||| VB
the  ||| S:49726 E:49738 ||| DT
nucleus ||| S:49738 E:49745 ||| NN
,  ||| S:49745 E:49747 ||| ,
where  ||| S:49747 E:49753 ||| WRB
Smad1  ||| S:49753 E:49759 ||| NNP
and  ||| S:49759 E:49763 ||| CC
Smad4  ||| S:49763 E:49769 ||| NNP
together  ||| S:49769 E:49778 ||| RB
recruit  ||| S:49778 E:49786 ||| VB
SNIP1  ||| S:49786 E:49792 ||| NNP
and  ||| S:49792 E:49804 ||| CC
CBP ||| S:49804 E:49807 ||| NNP
/ ||| S:49807 E:49808 ||| NNP
p300 ||| S:49808 E:49812 ||| NNP
.  ||| S:49812 E:49814 ||| .
The  ||| S:49814 E:49818 ||| DT
inhibition  ||| S:49818 E:49829 ||| NN
of  ||| S:49829 E:49832 ||| IN
SNIP1  ||| S:49832 E:49838 ||| CD
on  ||| S:49838 E:49841 ||| IN
CBP ||| S:49841 E:49844 ||| NNP
/ ||| S:49844 E:49845 ||| NNP
p300  ||| S:49845 E:49850 ||| NNP
is  ||| S:49850 E:49853 ||| VBZ
considered  ||| S:49853 E:49872 ||| VBN
to  ||| S:49872 E:49875 ||| TO
act  ||| S:49875 E:49879 ||| VB
through  ||| S:49879 E:49887 ||| IN
its  ||| S:49887 E:49891 ||| PRP$
interaction  ||| S:49891 E:49903 ||| NN
with  ||| S:49903 E:49908 ||| IN
the  ||| S:49908 E:49912 ||| DT
C ||| S:49912 E:49913 ||| $
/ ||| S:49913 E:49914 ||| CD
H1  ||| S:49914 E:49917 ||| CD
domain  ||| S:49917 E:49924 ||| NN
of  ||| S:49924 E:49935 ||| IN
CBP ||| S:49935 E:49938 ||| NNP
/ ||| S:49938 E:49939 ||| NNP
p300 ||| S:49939 E:49943 ||| NNP
,  ||| S:49943 E:49945 ||| ,
thereby  ||| S:49945 E:49953 ||| RB
blocking  ||| S:49953 E:49962 ||| VBG
the  ||| S:49962 E:49966 ||| DT
recruitment  ||| S:49966 E:49978 ||| NN
of  ||| S:49978 E:49981 ||| IN
CBP ||| S:49981 E:49984 ||| NNP
/ ||| S:49984 E:49985 ||| NNP
p300  ||| S:49985 E:49990 ||| NNP
by  ||| S:49990 E:50001 ||| IN
other  ||| S:50001 E:50007 ||| JJ
transcription  ||| S:50007 E:50021 ||| JJ
factors  ||| S:50021 E:50029 ||| NNS
including  ||| S:50029 E:50039 ||| VBG
Smad4  ||| S:50039 E:50045 ||| NNP
[  ||| S:50045 E:50047 ||| -LRB-
25  ||| S:50047 E:50050 ||| CD
]  ||| S:50050 E:50052 ||| -RRB-
.  ||| S:50052 E:50054 ||| .
Such  ||| S:50054 E:50067 ||| PDT
an  ||| S:50067 E:50070 ||| DT
inhibition  ||| S:50070 E:50081 ||| NN
is  ||| S:50081 E:50084 ||| VBZ
counteracted  ||| S:50084 E:50097 ||| VBN
by  ||| S:50097 E:50100 ||| IN
the  ||| S:50100 E:50104 ||| DT
ability  ||| S:50104 E:50112 ||| NN
of  ||| S:50112 E:50115 ||| IN
Smad4  ||| S:50115 E:50121 ||| CD
to  ||| S:50121 E:50132 ||| TO
compete  ||| S:50132 E:50140 ||| VB
off  ||| S:50140 E:50144 ||| RP
SNIP1  ||| S:50144 E:50150 ||| CD
from  ||| S:50150 E:50155 ||| IN
CBP ||| S:50155 E:50158 ||| NNP
/ ||| S:50158 E:50159 ||| NNP
p300  ||| S:50159 E:50164 ||| NNP
[  ||| S:50164 E:50166 ||| -LRB-
25  ||| S:50166 E:50169 ||| CD
]  ||| S:50169 E:50171 ||| -RRB-
.  ||| S:50171 E:50173 ||| .
So  ||| S:50173 E:50176 ||| RB
at  ||| S:50176 E:50179 ||| IN
early  ||| S:50179 E:50185 ||| JJ
phase  ||| S:50185 E:50199 ||| NN
of  ||| S:50199 E:50202 ||| IN
Smad  ||| S:50202 E:50207 ||| NNP
activation ||| S:50207 E:50217 ||| NN
,  ||| S:50217 E:50219 ||| ,
although  ||| S:50219 E:50228 ||| IN
SNIP1  ||| S:50228 E:50234 ||| NNP
is  ||| S:50234 E:50237 ||| VBZ
still  ||| S:50237 E:50243 ||| RB
bound  ||| S:50243 E:50249 ||| VBN
to  ||| S:50249 E:50252 ||| TO
Smad1  ||| S:50252 E:50266 ||| CD
and  ||| S:50266 E:50270 ||| CC
Smad4 ||| S:50270 E:50275 ||| NNP
,  ||| S:50275 E:50277 ||| ,
it  ||| S:50277 E:50280 ||| PRP
is  ||| S:50280 E:50283 ||| VBZ
no  ||| S:50283 E:50286 ||| RB
longer  ||| S:50286 E:50293 ||| RBR
directly  ||| S:50293 E:50302 ||| RB
bound  ||| S:50302 E:50308 ||| VBN
to  ||| S:50308 E:50311 ||| TO
CBP ||| S:50311 E:50314 ||| NNP
/ ||| S:50314 E:50315 ||| NNP
p300 ||| S:50315 E:50319 ||| NNP
,  ||| S:50319 E:50329 ||| ,
which  ||| S:50329 E:50335 ||| WDT
now  ||| S:50335 E:50339 ||| RB
can  ||| S:50339 E:50343 ||| MD
activate  ||| S:50343 E:50352 ||| VB
transcription ||| S:50352 E:50365 ||| NNS
.  ||| S:50365 E:50367 ||| .
Our  ||| S:50367 E:50371 ||| PRP$
data  ||| S:50371 E:50376 ||| NNS
suggested  ||| S:50376 E:50394 ||| VBD
that  ||| S:50394 E:50399 ||| IN
the  ||| S:50399 E:50403 ||| DT
Smad1 ||| S:50403 E:50408 ||| FW
/ ||| S:50408 E:50409 ||| FW
Smad4  ||| S:50409 E:50415 ||| FW
bound  ||| S:50415 E:50421 ||| FW
SNIP1  ||| S:50421 E:50427 ||| FW
can  ||| S:50427 E:50431 ||| MD
be  ||| S:50431 E:50434 ||| VB
further  ||| S:50434 E:50442 ||| RB
targeted  ||| S:50442 E:50451 ||| VBN
to  ||| S:50451 E:50462 ||| TO
proteasome  ||| S:50462 E:50473 ||| VB
for  ||| S:50473 E:50477 ||| IN
degradation ||| S:50477 E:50488 ||| NN
.  ||| S:50488 E:50490 ||| .
Smad1  ||| S:50490 E:50496 ||| NNP
and  ||| S:50496 E:50500 ||| CC
Smad4  ||| S:50500 E:50506 ||| NNP
are  ||| S:50506 E:50510 ||| VBP
indeed  ||| S:50510 E:50517 ||| RB
both  ||| S:50517 E:50530 ||| DT
degraded ||| S:50530 E:50538 ||| NN
.  ||| S:50538 E:50540 ||| .
However ||| S:50540 E:50547 ||| RB
,  ||| S:50547 E:50549 ||| ,
we  ||| S:50549 E:50552 ||| PRP
propose  ||| S:50552 E:50560 ||| VBP
that  ||| S:50560 E:50565 ||| IN
such  ||| S:50565 E:50570 ||| JJ
degradation  ||| S:50570 E:50582 ||| NN
is  ||| S:50582 E:50593 ||| VBZ
coupled  ||| S:50593 E:50601 ||| VBN
to  ||| S:50601 E:50604 ||| TO
the  ||| S:50604 E:50608 ||| DT
recruitment  ||| S:50608 E:50620 ||| NN
of  ||| S:50620 E:50623 ||| IN
the  ||| S:50623 E:50627 ||| DT
SNIP1-free  ||| S:50627 E:50638 ||| NNP
CBP ||| S:50638 E:50641 ||| NNP
/ ||| S:50641 E:50642 ||| NNP
p300  ||| S:50642 E:50647 ||| NNP
to  ||| S:50647 E:50650 ||| TO
a  ||| S:50650 E:50660 ||| DT
nearby  ||| S:50660 E:50667 ||| JJ
DNA-binding  ||| S:50667 E:50679 ||| JJ
transcription  ||| S:50679 E:50693 ||| JJ
factor ||| S:50693 E:50699 ||| NN
,  ||| S:50699 E:50701 ||| ,
thus  ||| S:50701 E:50706 ||| RB
carrying  ||| S:50706 E:50715 ||| VBG
out  ||| S:50715 E:50727 ||| RP
the  ||| S:50727 E:50731 ||| DT
commonly  ||| S:50731 E:50740 ||| RB
observed  ||| S:50740 E:50749 ||| JJ
role  ||| S:50749 E:50754 ||| NN
of  ||| S:50754 E:50757 ||| IN
Smads  ||| S:50757 E:50763 ||| NNP
as  ||| S:50763 E:50766 ||| IN
transcriptional  ||| S:50766 E:50790 ||| JJ
co-modulators ||| S:50790 E:50803 ||| NN
.  ||| S:50803 E:50805 ||| .
Smads  ||| S:50805 E:50811 ||| NNS
have  ||| S:50811 E:50816 ||| VBP
been  ||| S:50816 E:50821 ||| VBN
shown  ||| S:50821 E:50827 ||| VBN
to  ||| S:50827 E:50830 ||| TO
mediate  ||| S:50830 E:50846 ||| VB
transcription  ||| S:50846 E:50860 ||| VBN
via  ||| S:50860 E:50864 ||| IN
modulating  ||| S:50864 E:50875 ||| VBG
the  ||| S:50875 E:50879 ||| DT
transcriptional  ||| S:50879 E:50895 ||| JJ
activity  ||| S:50895 E:50912 ||| NN
of  ||| S:50912 E:50915 ||| IN
many  ||| S:50915 E:50920 ||| JJ
other  ||| S:50920 E:50926 ||| JJ
DNA-binding  ||| S:50926 E:50938 ||| JJ
proteins ||| S:50938 E:50946 ||| NNS
.  ||| S:50946 E:50948 ||| .
The  ||| S:50948 E:50952 ||| DT
ability  ||| S:50952 E:50960 ||| NN
of  ||| S:50960 E:50963 ||| IN
Smad1  ||| S:50963 E:50977 ||| NNP
and  ||| S:50977 E:50981 ||| CC
Smad4  ||| S:50981 E:50987 ||| CD
to  ||| S:50987 E:50990 ||| TO
target  ||| S:50990 E:50997 ||| VB
SNIP1  ||| S:50997 E:51003 ||| CD
for  ||| S:51003 E:51007 ||| IN
degradation ||| S:51007 E:51018 ||| NN
,  ||| S:51018 E:51020 ||| ,
thereby  ||| S:51020 E:51028 ||| RB
freeing  ||| S:51028 E:51044 ||| VBG
CBP ||| S:51044 E:51047 ||| NNP
/ ||| S:51047 E:51048 ||| NNP
p300  ||| S:51048 E:51053 ||| NNP
for  ||| S:51053 E:51057 ||| IN
other  ||| S:51057 E:51063 ||| JJ
transcriptional  ||| S:51063 E:51079 ||| JJ
factors  ||| S:51079 E:51087 ||| NNS
is  ||| S:51087 E:51090 ||| VBZ
likely  ||| S:51090 E:51097 ||| RB
an  ||| S:51097 E:51108 ||| DT
important  ||| S:51108 E:51118 ||| JJ
mechanism  ||| S:51118 E:51128 ||| NN
for  ||| S:51128 E:51132 ||| IN
the  ||| S:51132 E:51136 ||| DT
transcriptional  ||| S:51136 E:51152 ||| JJ
modulator  ||| S:51152 E:51162 ||| JJ
role  ||| S:51162 E:51175 ||| NN
of  ||| S:51175 E:51178 ||| IN
these  ||| S:51178 E:51184 ||| DT
two  ||| S:51184 E:51188 ||| CD
Smads ||| S:51188 E:51193 ||| NNP
.  ||| S:51193 E:51203 ||| .
We  ||| S:51203 E:51206 ||| PRP
have  ||| S:51206 E:51211 ||| VBP
observed  ||| S:51211 E:51220 ||| VBN
that  ||| S:51220 E:51225 ||| IN
several  ||| S:51225 E:51233 ||| JJ
other  ||| S:51233 E:51239 ||| JJ
Smad1  ||| S:51239 E:51245 ||| CD
interactors ||| S:51245 E:51256 ||| NN
,  ||| S:51256 E:51266 ||| ,
including  ||| S:51266 E:51276 ||| VBG
some  ||| S:51276 E:51281 ||| DT
cytoplasmic  ||| S:51281 E:51293 ||| JJ
interactors  ||| S:51293 E:51305 ||| NN
of  ||| S:51305 E:51308 ||| IN
Smad1 ||| S:51308 E:51313 ||| NNP
,  ||| S:51313 E:51315 ||| ,
are  ||| S:51315 E:51319 ||| VBP
also  ||| S:51319 E:51332 ||| RB
degraded  ||| S:51332 E:51341 ||| VBN
by  ||| S:51341 E:51344 ||| IN
proteasome  ||| S:51344 E:51355 ||| NNS
( ||| S:51355 E:51356 ||| -LRB-
Wang  ||| S:51356 E:51361 ||| NNP
et  ||| S:51361 E:51364 ||| NNP
al. ||| S:51364 E:51367 ||| NNP
,  ||| S:51367 E:51369 ||| ,
unpublished  ||| S:51369 E:51381 ||| JJ
data ||| S:51381 E:51385 ||| NNS
) ||| S:51385 E:51386 ||| -RRB-
.  ||| S:51386 E:51396 ||| .
Thus ||| S:51396 E:51400 ||| RB
,  ||| S:51400 E:51402 ||| ,
the  ||| S:51402 E:51406 ||| DT
location  ||| S:51406 E:51415 ||| NN
for  ||| S:51415 E:51419 ||| IN
the  ||| S:51419 E:51423 ||| DT
targeting  ||| S:51423 E:51433 ||| VBG
of  ||| S:51433 E:51436 ||| IN
Smad1  ||| S:51436 E:51442 ||| NNP
may  ||| S:51442 E:51446 ||| MD
not  ||| S:51446 E:51450 ||| RB
be  ||| S:51450 E:51461 ||| VB
limited  ||| S:51461 E:51469 ||| VBN
to  ||| S:51469 E:51472 ||| TO
only  ||| S:51472 E:51477 ||| RB
inside  ||| S:51477 E:51484 ||| RB
of  ||| S:51484 E:51487 ||| IN
the  ||| S:51487 E:51491 ||| DT
nucleus ||| S:51491 E:51498 ||| NN
,  ||| S:51498 E:51500 ||| ,
as  ||| S:51500 E:51503 ||| RB
illustrated  ||| S:51503 E:51515 ||| VBN
in  ||| S:51515 E:51526 ||| IN
Fig.  ||| S:51526 E:51531 ||| CD
10B ||| S:51531 E:51534 ||| CD
.  ||| S:51534 E:51536 ||| .
Future  ||| S:51536 E:51543 ||| JJ
studies  ||| S:51543 E:51551 ||| NNS
are  ||| S:51551 E:51555 ||| VBP
needed  ||| S:51555 E:51562 ||| VBN
to  ||| S:51562 E:51565 ||| TO
verify  ||| S:51565 E:51572 ||| VB
and  ||| S:51572 E:51576 ||| CC
enrich  ||| S:51576 E:51591 ||| VBP
the  ||| S:51591 E:51595 ||| DT
details  ||| S:51595 E:51603 ||| NNS
of  ||| S:51603 E:51606 ||| IN
the  ||| S:51606 E:51610 ||| DT
illustrated  ||| S:51610 E:51622 ||| JJ
molecular  ||| S:51622 E:51632 ||| JJ
events ||| S:51632 E:51638 ||| NNS
.  ||| S:51638 E:51662 ||| .
Conclusions  ||| S:51662 E:51682 ||| NNS
The  ||| S:51682 E:51686 ||| DT
subject  ||| S:51686 E:51694 ||| NN
of  ||| S:51694 E:51697 ||| IN
proteasomal  ||| S:51697 E:51709 ||| JJ
degradation  ||| S:51709 E:51721 ||| NN
of  ||| S:51721 E:51724 ||| IN
Smads  ||| S:51724 E:51730 ||| NNP
and  ||| S:51730 E:51734 ||| CC
Smad  ||| S:51734 E:51747 ||| NNP
interacting  ||| S:51747 E:51759 ||| NN
proteins  ||| S:51759 E:51768 ||| NNS
has  ||| S:51768 E:51772 ||| VBZ
now  ||| S:51772 E:51776 ||| RB
become  ||| S:51776 E:51783 ||| VB
a  ||| S:51783 E:51785 ||| DT
major  ||| S:51785 E:51791 ||| JJ
focus  ||| S:51791 E:51797 ||| NN
of  ||| S:51797 E:51808 ||| IN
interest  ||| S:51808 E:51817 ||| NN
in  ||| S:51817 E:51820 ||| IN
the  ||| S:51820 E:51824 ||| DT
field  ||| S:51824 E:51830 ||| NN
due  ||| S:51830 E:51834 ||| JJ
to  ||| S:51834 E:51837 ||| TO
its  ||| S:51837 E:51841 ||| PRP$
broad  ||| S:51841 E:51847 ||| JJ
implication  ||| S:51847 E:51859 ||| NN
in  ||| S:51859 E:51870 ||| IN
signaling  ||| S:51870 E:51880 ||| VBG
regulation  ||| S:51880 E:51891 ||| NN
and  ||| S:51891 E:51895 ||| CC
execution ||| S:51895 E:51904 ||| NN
.  ||| S:51904 E:51906 ||| .
The  ||| S:51906 E:51910 ||| DT
work  ||| S:51910 E:51915 ||| NN
reported  ||| S:51915 E:51924 ||| VBD
here  ||| S:51924 E:51937 ||| RB
represents  ||| S:51937 E:51948 ||| VBZ
our  ||| S:51948 E:51952 ||| PRP$
major  ||| S:51952 E:51958 ||| JJ
efforts  ||| S:51958 E:51966 ||| NNS
during  ||| S:51966 E:51973 ||| IN
the  ||| S:51973 E:51977 ||| DT
past  ||| S:51977 E:51982 ||| JJ
several  ||| S:51982 E:51990 ||| JJ
years  ||| S:51990 E:52004 ||| NNS
to  ||| S:52004 E:52007 ||| TO
follow  ||| S:52007 E:52014 ||| VB
a  ||| S:52014 E:52016 ||| DT
novel  ||| S:52016 E:52022 ||| NN
concept  ||| S:52022 E:52030 ||| NN
of  ||| S:52030 E:52033 ||| IN
proteasomal  ||| S:52033 E:52045 ||| JJ
degradation  ||| S:52045 E:52057 ||| NN
in  ||| S:52057 E:52068 ||| IN
TGF-β ||| S:52068 E:52073 ||| NNP
/ ||| S:52073 E:52074 ||| NNP
BMP  ||| S:52074 E:52078 ||| NNP
signaling  ||| S:52078 E:52088 ||| VBD
based  ||| S:52088 E:52094 ||| VBN
upon  ||| S:52094 E:52099 ||| IN
the  ||| S:52099 E:52103 ||| DT
yeast  ||| S:52103 E:52109 ||| NN
two-hybrid  ||| S:52109 E:52120 ||| JJ
data  ||| S:52120 E:52133 ||| NNS
obtained  ||| S:52133 E:52142 ||| VBN
in  ||| S:52142 E:52145 ||| IN
1996 ||| S:52145 E:52149 ||| CD
.  ||| S:52149 E:52151 ||| .
Although  ||| S:52151 E:52160 ||| IN
there  ||| S:52160 E:52166 ||| EX
are  ||| S:52166 E:52170 ||| VBP
multiple  ||| S:52170 E:52179 ||| JJ
reports  ||| S:52179 E:52187 ||| NNS
on  ||| S:52187 E:52198 ||| IN
proteasomal  ||| S:52198 E:52210 ||| JJ
degradation  ||| S:52210 E:52222 ||| NN
of  ||| S:52222 E:52225 ||| IN
Smads  ||| S:52225 E:52231 ||| NNP
and  ||| S:52231 E:52235 ||| CC
Smad  ||| S:52235 E:52240 ||| NNP
interacting  ||| S:52240 E:52260 ||| NN
proteins ||| S:52260 E:52268 ||| NNS
,  ||| S:52268 E:52270 ||| ,
primarily  ||| S:52270 E:52280 ||| RB
in  ||| S:52280 E:52283 ||| IN
TGF-β  ||| S:52283 E:52289 ||| JJ
signaling  ||| S:52289 E:52299 ||| JJ
pathways  ||| S:52299 E:52308 ||| NNS
[  ||| S:52308 E:52310 ||| -LRB-
47  ||| S:52310 E:52313 ||| CD
48  ||| S:52313 E:52316 ||| CD
49  ||| S:52316 E:52327 ||| CD
50  ||| S:52327 E:52330 ||| CD
51  ||| S:52330 E:52333 ||| CD
52  ||| S:52333 E:52336 ||| CD
53  ||| S:52336 E:52339 ||| CD
54  ||| S:52339 E:52342 ||| CD
]  ||| S:52342 E:52344 ||| -RRB-
,  ||| S:52344 E:52346 ||| ,
our  ||| S:52346 E:52350 ||| PRP$
observations  ||| S:52350 E:52363 ||| NNS
reported  ||| S:52363 E:52372 ||| VBD
here  ||| S:52372 E:52377 ||| RB
are  ||| S:52377 E:52389 ||| VBP
entirely  ||| S:52389 E:52398 ||| RB
based  ||| S:52398 E:52404 ||| VBN
upon  ||| S:52404 E:52409 ||| IN
our  ||| S:52409 E:52413 ||| PRP$
own  ||| S:52413 E:52417 ||| JJ
original  ||| S:52417 E:52426 ||| JJ
observations  ||| S:52426 E:52439 ||| NNS
and  ||| S:52439 E:52443 ||| CC
show  ||| S:52443 E:52456 ||| VB
a  ||| S:52456 E:52458 ||| DT
novel  ||| S:52458 E:52464 ||| NN
connection  ||| S:52464 E:52475 ||| NN
of  ||| S:52475 E:52478 ||| IN
Smads  ||| S:52478 E:52484 ||| NNP
with  ||| S:52484 E:52489 ||| IN
the  ||| S:52489 E:52493 ||| DT
proteasome  ||| S:52493 E:52504 ||| JJ
system  ||| S:52504 E:52511 ||| NN
that  ||| S:52511 E:52524 ||| IN
no  ||| S:52524 E:52527 ||| DT
other  ||| S:52527 E:52533 ||| JJ
groups  ||| S:52533 E:52540 ||| NNS
have  ||| S:52540 E:52545 ||| VBP
reported ||| S:52545 E:52553 ||| VBN
.  ||| S:52553 E:52555 ||| .
Our  ||| S:52555 E:52559 ||| PRP$
observations  ||| S:52559 E:52572 ||| NNS
provide  ||| S:52572 E:52580 ||| VBP
new  ||| S:52580 E:52592 ||| JJ
revenues  ||| S:52592 E:52601 ||| NNS
for  ||| S:52601 E:52605 ||| IN
future  ||| S:52605 E:52612 ||| JJ
understanding  ||| S:52612 E:52626 ||| NN
of  ||| S:52626 E:52629 ||| IN
the  ||| S:52629 E:52633 ||| DT
functional  ||| S:52633 E:52652 ||| JJ
mechanisms  ||| S:52652 E:52663 ||| NNS
of  ||| S:52663 E:52666 ||| IN
Smads ||| S:52666 E:52671 ||| NNP
,  ||| S:52671 E:52673 ||| ,
which  ||| S:52673 E:52679 ||| WDT
are  ||| S:52679 E:52683 ||| VBP
likely  ||| S:52683 E:52690 ||| RB
not  ||| S:52690 E:52694 ||| RB
limited  ||| S:52694 E:52702 ||| VBN
to  ||| S:52702 E:52713 ||| TO
transcriptional  ||| S:52713 E:52729 ||| VB
regulation  ||| S:52729 E:52740 ||| NN
but  ||| S:52740 E:52744 ||| CC
are  ||| S:52744 E:52748 ||| VBP
quite  ||| S:52748 E:52754 ||| RB
extensively  ||| S:52754 E:52766 ||| RB
linked  ||| S:52766 E:52781 ||| VBN
to  ||| S:52781 E:52784 ||| TO
the  ||| S:52784 E:52788 ||| DT
regulation  ||| S:52788 E:52799 ||| NN
of  ||| S:52799 E:52802 ||| IN
proteasomal  ||| S:52802 E:52814 ||| JJ
degradation  ||| S:52814 E:52826 ||| NN
of  ||| S:52826 E:52829 ||| IN
multiple  ||| S:52829 E:52846 ||| JJ
cytoplasmic  ||| S:52846 E:52858 ||| NN
and  ||| S:52858 E:52862 ||| CC
nuclear  ||| S:52862 E:52870 ||| JJ
proteins ||| S:52870 E:52878 ||| NNS
.  ||| S:52878 E:52902 ||| .
Materials  ||| S:52902 E:52912 ||| NNS
and  ||| S:52912 E:52916 ||| CC
Methods  ||| S:52916 E:52943 ||| NNP
Construction  ||| S:52943 E:52956 ||| NNP
of  ||| S:52956 E:52959 ||| IN
expression  ||| S:52959 E:52970 ||| NN
plasmids  ||| S:52970 E:52989 ||| NN
For  ||| S:52989 E:52993 ||| IN
the  ||| S:52993 E:52997 ||| DT
yeast  ||| S:52997 E:53003 ||| NN
two-hybrid  ||| S:53003 E:53014 ||| JJ
screen ||| S:53014 E:53020 ||| NN
,  ||| S:53020 E:53022 ||| ,
full-length  ||| S:53022 E:53034 ||| JJ
Smad1  ||| S:53034 E:53040 ||| NN
was  ||| S:53040 E:53054 ||| VBD
subcloned  ||| S:53054 E:53064 ||| VBN
into  ||| S:53064 E:53069 ||| IN
BamH1 ||| S:53069 E:53074 ||| CD
/ ||| S:53074 E:53075 ||| CD
Not1  ||| S:53075 E:53080 ||| CD
sites  ||| S:53080 E:53086 ||| NNS
of  ||| S:53086 E:53089 ||| IN
PEG202  ||| S:53089 E:53096 ||| CD
by  ||| S:53096 E:53099 ||| IN
a  ||| S:53099 E:53101 ||| DT
PCR  ||| S:53101 E:53115 ||| NNP
method ||| S:53115 E:53121 ||| NN
,  ||| S:53121 E:53123 ||| ,
resulting  ||| S:53123 E:53133 ||| VBG
in  ||| S:53133 E:53136 ||| IN
the  ||| S:53136 E:53140 ||| DT
inframe  ||| S:53140 E:53148 ||| JJ
fusion  ||| S:53148 E:53155 ||| NN
between  ||| S:53155 E:53163 ||| IN
the  ||| S:53163 E:53167 ||| DT
LexA  ||| S:53167 E:53182 ||| JJ
DNA  ||| S:53182 E:53186 ||| NN
binding  ||| S:53186 E:53194 ||| JJ
domain  ||| S:53194 E:53201 ||| NN
( ||| S:53201 E:53202 ||| -LRB-
1-202 ||| S:53202 E:53207 ||| NNP
)  ||| S:53207 E:53209 ||| -RRB-
and  ||| S:53209 E:53213 ||| CC
Smad1 ||| S:53213 E:53218 ||| NNP
.  ||| S:53218 E:53220 ||| .
The  ||| S:53220 E:53224 ||| DT
Smad1  ||| S:53224 E:53230 ||| NNP
( ||| S:53230 E:53231 ||| -LRB-
G419S ||| S:53231 E:53236 ||| NNP
)  ||| S:53236 E:53248 ||| -RRB-
mutant  ||| S:53248 E:53255 ||| NN
was  ||| S:53255 E:53259 ||| VBD
a  ||| S:53259 E:53261 ||| DT
kind  ||| S:53261 E:53266 ||| NN
gift  ||| S:53266 E:53271 ||| NN
from  ||| S:53271 E:53276 ||| IN
J.  ||| S:53276 E:53279 ||| NNP
Wrana  ||| S:53279 E:53285 ||| NNP
[  ||| S:53285 E:53287 ||| -LRB-
40  ||| S:53287 E:53290 ||| CD
]  ||| S:53290 E:53292 ||| -RRB-
.  ||| S:53292 E:53294 ||| .
The  ||| S:53294 E:53308 ||| DT
subcloning  ||| S:53308 E:53319 ||| NN
of  ||| S:53319 E:53322 ||| IN
Smad1  ||| S:53322 E:53328 ||| NNP
( ||| S:53328 E:53329 ||| -LRB-
G419S ||| S:53329 E:53334 ||| NNP
) ||| S:53334 E:53335 ||| -RRB-
,  ||| S:53335 E:53337 ||| ,
Smad1NL  ||| S:53337 E:53345 ||| NNP
( ||| S:53345 E:53346 ||| -LRB-
1-271 ||| S:53346 E:53351 ||| NNP
) ||| S:53351 E:53352 ||| -RRB-
,  ||| S:53352 E:53354 ||| ,
Smad1L  ||| S:53354 E:53371 ||| NNP
( ||| S:53371 E:53372 ||| -LRB-
147-271 ||| S:53372 E:53379 ||| NNP
)  ||| S:53379 E:53381 ||| -RRB-
into  ||| S:53381 E:53386 ||| IN
pEG202  ||| S:53386 E:53393 ||| NNP
were  ||| S:53393 E:53398 ||| VBD
all  ||| S:53398 E:53402 ||| DT
carried  ||| S:53402 E:53410 ||| VBN
out  ||| S:53410 E:53414 ||| RP
similarly  ||| S:53414 E:53424 ||| RB
by  ||| S:53424 E:53437 ||| IN
the  ||| S:53437 E:53441 ||| DT
PCR  ||| S:53441 E:53445 ||| NNP
approach ||| S:53445 E:53453 ||| NN
.  ||| S:53453 E:53455 ||| .
The  ||| S:53455 E:53459 ||| DT
mammalian  ||| S:53459 E:53469 ||| JJ
expression  ||| S:53469 E:53480 ||| NN
constructs  ||| S:53480 E:53491 ||| NN
of  ||| S:53491 E:53504 ||| IN
Smad1  ||| S:53504 E:53510 ||| NNP
and  ||| S:53510 E:53514 ||| CC
its  ||| S:53514 E:53518 ||| PRP$
deletion  ||| S:53518 E:53527 ||| FW
mutant  ||| S:53527 E:53534 ||| FW
Smad1C  ||| S:53534 E:53541 ||| FW
( ||| S:53541 E:53542 ||| -LRB-
271-465 ||| S:53542 E:53549 ||| NNP
)  ||| S:53549 E:53551 ||| -RRB-
were  ||| S:53551 E:53556 ||| VBD
made  ||| S:53556 E:53571 ||| VBN
by  ||| S:53571 E:53574 ||| IN
subcloning  ||| S:53574 E:53585 ||| JJ
Smad1  ||| S:53585 E:53591 ||| NN
into  ||| S:53591 E:53596 ||| IN
two  ||| S:53596 E:53600 ||| CD
modified  ||| S:53600 E:53609 ||| CD
pCMV6  ||| S:53609 E:53615 ||| CD
vectors ||| S:53615 E:53622 ||| NN
,  ||| S:53622 E:53634 ||| ,
which  ||| S:53634 E:53640 ||| WDT
have  ||| S:53640 E:53645 ||| VBP
either  ||| S:53645 E:53652 ||| RB
the  ||| S:53652 E:53656 ||| DT
Flag  ||| S:53656 E:53661 ||| JJ
epitope  ||| S:53661 E:53669 ||| NNS
( ||| S:53669 E:53670 ||| -LRB-
F-pCMV6 ||| S:53670 E:53677 ||| NNP
)  ||| S:53677 E:53679 ||| -RRB-
or  ||| S:53679 E:53682 ||| CC
the  ||| S:53682 E:53686 ||| DT
T7  ||| S:53686 E:53699 ||| CD
epitope  ||| S:53699 E:53707 ||| NNS
( ||| S:53707 E:53708 ||| -LRB-
T7-pCMV6 ||| S:53708 E:53716 ||| NNP
)  ||| S:53716 E:53718 ||| -RRB-
placed  ||| S:53718 E:53725 ||| VBD
upstream  ||| S:53725 E:53734 ||| RB
of  ||| S:53734 E:53737 ||| IN
an  ||| S:53737 E:53740 ||| DT
array  ||| S:53740 E:53746 ||| NN
of  ||| S:53746 E:53749 ||| IN
new  ||| S:53749 E:53763 ||| JJ
multiple  ||| S:53763 E:53772 ||| JJ
cloning  ||| S:53772 E:53780 ||| JJ
sites ||| S:53780 E:53785 ||| NNS
.  ||| S:53785 E:53787 ||| .
T7-ΔN3  ||| S:53787 E:53794 ||| NNP
pCMV6  ||| S:53794 E:53800 ||| NNP
was  ||| S:53800 E:53804 ||| VBD
made  ||| S:53804 E:53809 ||| VBN
by  ||| S:53809 E:53812 ||| IN
PCR  ||| S:53812 E:53826 ||| NNP
amplification  ||| S:53826 E:53840 ||| NN
of  ||| S:53840 E:53843 ||| IN
HsN3  ||| S:53843 E:53848 ||| NNP
( ||| S:53848 E:53849 ||| -LRB-
a.a.  ||| S:53849 E:53854 ||| NNP
45-263 ||| S:53854 E:53860 ||| NNP
)  ||| S:53860 E:53862 ||| -RRB-
followed  ||| S:53862 E:53871 ||| VBD
by  ||| S:53871 E:53884 ||| IN
subcloning  ||| S:53884 E:53895 ||| VBG
the  ||| S:53895 E:53899 ||| DT
PCR  ||| S:53899 E:53903 ||| NNP
products  ||| S:53903 E:53912 ||| NNS
into  ||| S:53912 E:53917 ||| IN
the  ||| S:53917 E:53921 ||| DT
EcoR1 ||| S:53921 E:53926 ||| CD
/ ||| S:53926 E:53927 ||| CD
Xho1  ||| S:53927 E:53932 ||| CD
sites  ||| S:53932 E:53938 ||| NNS
of  ||| S:53938 E:53951 ||| IN
the  ||| S:53951 E:53955 ||| DT
modified  ||| S:53955 E:53964 ||| JJ
T7-pCMV6  ||| S:53964 E:53973 ||| CD
vector ||| S:53973 E:53979 ||| NN
.  ||| S:53979 E:53981 ||| .
N3-F  ||| S:53981 E:53986 ||| NNP
pCMV6  ||| S:53986 E:53992 ||| NNP
was  ||| S:53992 E:53996 ||| VBD
made  ||| S:53996 E:54001 ||| VBN
by  ||| S:54001 E:54004 ||| IN
PCR  ||| S:54004 E:54018 ||| NNP
amplification  ||| S:54018 E:54032 ||| NN
of  ||| S:54032 E:54035 ||| IN
HsN3  ||| S:54035 E:54040 ||| NNP
( ||| S:54040 E:54041 ||| -LRB-
1-263 ||| S:54041 E:54046 ||| NNP
)  ||| S:54046 E:54048 ||| -RRB-
followed  ||| S:54048 E:54057 ||| VBD
by  ||| S:54057 E:54060 ||| IN
subcloning  ||| S:54060 E:54071 ||| VBG
the  ||| S:54071 E:54085 ||| DT
PCR  ||| S:54085 E:54089 ||| NNP
products  ||| S:54089 E:54098 ||| NNS
into  ||| S:54098 E:54103 ||| IN
the  ||| S:54103 E:54107 ||| DT
EcoR1 ||| S:54107 E:54112 ||| CD
/ ||| S:54112 E:54113 ||| CD
EcoRV  ||| S:54113 E:54119 ||| JJ
sites  ||| S:54119 E:54125 ||| NNS
of  ||| S:54125 E:54128 ||| IN
pFlag-CMV5C  ||| S:54128 E:54150 ||| CD
vector  ||| S:54150 E:54157 ||| NNS
( ||| S:54157 E:54158 ||| -LRB-
Kodak ||| S:54158 E:54163 ||| NNP
) ||| S:54163 E:54164 ||| -RRB-
.  ||| S:54164 E:54166 ||| .
The  ||| S:54166 E:54170 ||| DT
fidelity  ||| S:54170 E:54179 ||| NN
of  ||| S:54179 E:54182 ||| IN
the  ||| S:54182 E:54186 ||| DT
PCR  ||| S:54186 E:54190 ||| NNP
products  ||| S:54190 E:54199 ||| NNS
was  ||| S:54199 E:54213 ||| VBD
determined  ||| S:54213 E:54224 ||| VBN
by  ||| S:54224 E:54227 ||| IN
DNA  ||| S:54227 E:54231 ||| NNP
sequencing ||| S:54231 E:54241 ||| NN
.  ||| S:54241 E:54243 ||| .
The  ||| S:54243 E:54247 ||| DT
constitutively  ||| S:54247 E:54262 ||| JJ
active  ||| S:54262 E:54279 ||| JJ
mutant  ||| S:54279 E:54286 ||| JJ
BMP  ||| S:54286 E:54290 ||| NN
type  ||| S:54290 E:54295 ||| NN
I  ||| S:54295 E:54297 ||| PRP
receptor  ||| S:54297 E:54306 ||| VBP
( ||| S:54306 E:54307 ||| -LRB-
ALK3Q233D ||| S:54307 E:54316 ||| NNP
)  ||| S:54316 E:54318 ||| -RRB-
is  ||| S:54318 E:54321 ||| VBZ
a  ||| S:54321 E:54323 ||| DT
gift  ||| S:54323 E:54328 ||| NN
from  ||| S:54328 E:54333 ||| IN
J.  ||| S:54333 E:54346 ||| NNP
Massagué ||| S:54346 E:54354 ||| NNP
;  ||| S:54354 E:54356 ||| :
Tlx-2  ||| S:54356 E:54362 ||| CD
reporter  ||| S:54362 E:54371 ||| NN
is  ||| S:54371 E:54374 ||| VBZ
from  ||| S:54374 E:54379 ||| IN
J.  ||| S:54379 E:54382 ||| NNP
Wrana ||| S:54382 E:54387 ||| NNP
;  ||| S:54387 E:54389 ||| :
full  ||| S:54389 E:54394 ||| JJ
length  ||| S:54394 E:54411 ||| NN
rat  ||| S:54411 E:54415 ||| NN
Az  ||| S:54415 E:54418 ||| NNP
is  ||| S:54418 E:54421 ||| VBZ
from  ||| S:54421 E:54426 ||| IN
P.  ||| S:54426 E:54429 ||| NNP
Coffino ||| S:54429 E:54436 ||| NNP
.  ||| S:54436 E:54466 ||| .
Yeast  ||| S:54466 E:54472 ||| JJ
two-hybrid  ||| S:54472 E:54483 ||| JJ
screen  ||| S:54483 E:54490 ||| NN
and  ||| S:54490 E:54494 ||| CC
tests  ||| S:54494 E:54510 ||| NNS
A  ||| S:54510 E:54512 ||| DT
modified  ||| S:54512 E:54521 ||| JJ
yeast  ||| S:54521 E:54527 ||| NN
two-hybrid  ||| S:54527 E:54538 ||| JJ
system  ||| S:54538 E:54545 ||| NN
developed  ||| S:54545 E:54555 ||| VBN
by  ||| S:54555 E:54558 ||| IN
Brent  ||| S:54558 E:54574 ||| NNP
and  ||| S:54574 E:54578 ||| CC
colleagues  ||| S:54578 E:54589 ||| NNS
[  ||| S:54589 E:54591 ||| -LRB-
26  ||| S:54591 E:54594 ||| CD
27  ||| S:54594 E:54597 ||| CD
]  ||| S:54597 E:54599 ||| -RRB-
.  ||| S:54599 E:54601 ||| .
was  ||| S:54601 E:54605 ||| VBD
used  ||| S:54605 E:54610 ||| VBN
to  ||| S:54610 E:54613 ||| TO
isolate  ||| S:54613 E:54621 ||| VB
Smad1  ||| S:54621 E:54637 ||| CD
interactors ||| S:54637 E:54648 ||| NNS
.  ||| S:54648 E:54650 ||| .
Briefly ||| S:54650 E:54657 ||| RB
,  ||| S:54657 E:54659 ||| ,
yeast  ||| S:54659 E:54665 ||| FW
strain  ||| S:54665 E:54672 ||| FW
EGY48  ||| S:54672 E:54678 ||| FW
( ||| S:54678 E:54679 ||| -LRB-
leu2 ||| S:54679 E:54683 ||| NNP
,  ||| S:54683 E:54685 ||| ,
his3 ||| S:54685 E:54689 ||| NNP
,  ||| S:54689 E:54701 ||| ,
trp1 ||| S:54701 E:54705 ||| NNP
,  ||| S:54705 E:54707 ||| ,
ura3 ||| S:54707 E:54711 ||| CD
) ||| S:54711 E:54712 ||| -RRB-
,  ||| S:54712 E:54714 ||| ,
which  ||| S:54714 E:54720 ||| WDT
has  ||| S:54720 E:54724 ||| VBZ
an  ||| S:54724 E:54727 ||| DT
integrated  ||| S:54727 E:54738 ||| JJ
Leu2  ||| S:54738 E:54743 ||| CD
reporter ||| S:54743 E:54751 ||| NN
,  ||| S:54751 E:54753 ||| ,
was  ||| S:54753 E:54767 ||| VBD
first  ||| S:54767 E:54773 ||| RB
transformed  ||| S:54773 E:54785 ||| VBN
with  ||| S:54785 E:54790 ||| IN
a  ||| S:54790 E:54792 ||| DT
LexAop-LacZ  ||| S:54792 E:54804 ||| JJ
reporter ||| S:54804 E:54812 ||| NN
.  ||| S:54812 E:54814 ||| .
The  ||| S:54814 E:54828 ||| DT
selected  ||| S:54828 E:54837 ||| JJ
transformants  ||| S:54837 E:54851 ||| NN
were  ||| S:54851 E:54856 ||| VBD
transformed  ||| S:54856 E:54868 ||| VBN
again  ||| S:54868 E:54874 ||| RB
with  ||| S:54874 E:54879 ||| IN
the  ||| S:54879 E:54893 ||| DT
bait  ||| S:54893 E:54898 ||| JJ
construct  ||| S:54898 E:54908 ||| JJ
Smad1pEG202 ||| S:54908 E:54919 ||| NN
.  ||| S:54919 E:54921 ||| .
The  ||| S:54921 E:54925 ||| DT
selected  ||| S:54925 E:54934 ||| JJ
bait  ||| S:54934 E:54949 ||| NN
transformants  ||| S:54949 E:54963 ||| NNS
were  ||| S:54963 E:54968 ||| VBD
transformed  ||| S:54968 E:54980 ||| VBN
with  ||| S:54980 E:54985 ||| IN
a  ||| S:54985 E:54987 ||| DT
human  ||| S:54987 E:54993 ||| JJ
fetal  ||| S:54993 E:54999 ||| JJ
brain  ||| S:54999 E:55015 ||| NN
cDNA  ||| S:55015 E:55020 ||| JJ
library  ||| S:55020 E:55028 ||| NN
( ||| S:55028 E:55029 ||| -LRB-
a  ||| S:55029 E:55031 ||| DT
gift  ||| S:55031 E:55036 ||| NN
from  ||| S:55036 E:55041 ||| IN
Roger  ||| S:55041 E:55047 ||| NNP
Brent ||| S:55047 E:55052 ||| NNP
) ||| S:55052 E:55053 ||| -RRB-
.  ||| S:55053 E:55055 ||| .
About  ||| S:55055 E:55061 ||| IN
one  ||| S:55061 E:55065 ||| CD
million  ||| S:55065 E:55083 ||| CD
original  ||| S:55083 E:55092 ||| JJ
transformants  ||| S:55092 E:55106 ||| NN
were  ||| S:55106 E:55111 ||| VBD
obtained ||| S:55111 E:55119 ||| VBN
.  ||| S:55119 E:55121 ||| .
From  ||| S:55121 E:55126 ||| IN
the  ||| S:55126 E:55130 ||| DT
pooled  ||| S:55130 E:55147 ||| JJ
stock  ||| S:55147 E:55153 ||| NN
of  ||| S:55153 E:55156 ||| IN
the  ||| S:55156 E:55160 ||| DT
transformants ||| S:55160 E:55173 ||| NN
,  ||| S:55173 E:55175 ||| ,
ten  ||| S:55175 E:55179 ||| CD
million  ||| S:55179 E:55187 ||| CD
cells  ||| S:55187 E:55193 ||| NNS
were  ||| S:55193 E:55208 ||| VBD
screened  ||| S:55208 E:55217 ||| VBN
on  ||| S:55217 E:55220 ||| IN
U  ||| S:55220 E:55222 ||| NNP
-H  ||| S:55222 E:55225 ||| FW
-W  ||| S:55225 E:55228 ||| FW
-L  ||| S:55228 E:55231 ||| FW
-galactose  ||| S:55231 E:55242 ||| FW
plates  ||| S:55242 E:55249 ||| FW
containing  ||| S:55249 E:55260 ||| FW
X-Gal  ||| S:55260 E:55276 ||| FW
( ||| S:55276 E:55277 ||| -LRB-
5-bromo-4-chloro-3-indolyl-β-D-galactosidase ||| S:55277 E:55321 ||| NNP
) ||| S:55321 E:55322 ||| -RRB-
.  ||| S:55322 E:55324 ||| .
Only  ||| S:55324 E:55339 ||| RB
those  ||| S:55339 E:55345 ||| DT
that  ||| S:55345 E:55350 ||| WDT
form  ||| S:55350 E:55355 ||| VBP
blue  ||| S:55355 E:55360 ||| JJ
colonies  ||| S:55360 E:55369 ||| NNS
were  ||| S:55369 E:55374 ||| VBD
picked  ||| S:55374 E:55381 ||| VBN
as  ||| S:55381 E:55384 ||| IN
candidate  ||| S:55384 E:55404 ||| NN
positives ||| S:55404 E:55413 ||| NN
.  ||| S:55413 E:55415 ||| .
The  ||| S:55415 E:55419 ||| DT
cDNAs  ||| S:55419 E:55425 ||| JJ
from  ||| S:55425 E:55430 ||| IN
the  ||| S:55430 E:55434 ||| DT
candidate  ||| S:55434 E:55444 ||| NN
positives  ||| S:55444 E:55454 ||| NNS
were  ||| S:55454 E:55469 ||| VBD
purified ||| S:55469 E:55477 ||| CD
,  ||| S:55477 E:55479 ||| ,
re-tested  ||| S:55479 E:55489 ||| JJ
for  ||| S:55489 E:55493 ||| IN
Smad1  ||| S:55493 E:55499 ||| CD
interaction  ||| S:55499 E:55511 ||| NN
in  ||| S:55511 E:55514 ||| IN
yeast ||| S:55514 E:55519 ||| NN
,  ||| S:55519 E:55521 ||| ,
and  ||| S:55521 E:55535 ||| CC
then  ||| S:55535 E:55540 ||| RB
sequenced ||| S:55540 E:55549 ||| VBN
.  ||| S:55549 E:55551 ||| .
For  ||| S:55551 E:55555 ||| IN
testing  ||| S:55555 E:55563 ||| VBG
protein-protein  ||| S:55563 E:55579 ||| JJ
interaction  ||| S:55579 E:55601 ||| NNS
using  ||| S:55601 E:55607 ||| VBG
the  ||| S:55607 E:55611 ||| DT
yeast  ||| S:55611 E:55617 ||| NN
two-hybrid  ||| S:55617 E:55628 ||| JJ
system ||| S:55628 E:55634 ||| NN
,  ||| S:55634 E:55636 ||| ,
the  ||| S:55636 E:55640 ||| DT
same  ||| S:55640 E:55645 ||| JJ
yeast  ||| S:55645 E:55651 ||| NN
strain  ||| S:55651 E:55668 ||| NN
was  ||| S:55668 E:55672 ||| VBD
first  ||| S:55672 E:55678 ||| RB
transformed  ||| S:55678 E:55690 ||| VBN
with  ||| S:55690 E:55695 ||| IN
the  ||| S:55695 E:55699 ||| DT
LexA-fusion  ||| S:55699 E:55711 ||| JJ
construct ||| S:55711 E:55720 ||| NN
,  ||| S:55720 E:55732 ||| ,
selected  ||| S:55732 E:55741 ||| VBN
on  ||| S:55741 E:55744 ||| IN
U  ||| S:55744 E:55746 ||| NNP
-H  ||| S:55746 E:55749 ||| NNP
-plates ||| S:55749 E:55756 ||| NNP
,  ||| S:55756 E:55758 ||| ,
then  ||| S:55758 E:55763 ||| RB
re-transformed  ||| S:55763 E:55778 ||| JJ
with  ||| S:55778 E:55793 ||| IN
B42-fusion  ||| S:55793 E:55804 ||| CD
constructs ||| S:55804 E:55814 ||| NN
,  ||| S:55814 E:55816 ||| ,
and  ||| S:55816 E:55820 ||| CC
selected  ||| S:55820 E:55829 ||| VBN
on  ||| S:55829 E:55832 ||| IN
U  ||| S:55832 E:55834 ||| NNP
-H  ||| S:55834 E:55837 ||| NNP
-W  ||| S:55837 E:55840 ||| NNP
-plates ||| S:55840 E:55847 ||| NNP
.  ||| S:55847 E:55859 ||| .
The  ||| S:55859 E:55863 ||| DT
transformants  ||| S:55863 E:55877 ||| NN
were  ||| S:55877 E:55882 ||| VBD
first  ||| S:55882 E:55888 ||| JJ
streaked  ||| S:55888 E:55897 ||| NN
onto  ||| S:55897 E:55902 ||| IN
a  ||| S:55902 E:55904 ||| DT
master  ||| S:55904 E:55921 ||| NN
plate ||| S:55921 E:55926 ||| NN
,  ||| S:55926 E:55928 ||| ,
then  ||| S:55928 E:55933 ||| RB
replicated  ||| S:55933 E:55944 ||| VBN
onto  ||| S:55944 E:55949 ||| IN
two  ||| S:55949 E:55953 ||| CD
testing  ||| S:55953 E:55961 ||| NN
plates ||| S:55961 E:55967 ||| NNS
:  ||| S:55967 E:55969 ||| :
U  ||| S:55969 E:55971 ||| NNP
-H  ||| S:55971 E:55974 ||| JJ
-W  ||| S:55974 E:55987 ||| JJ
-glucose  ||| S:55987 E:55996 ||| JJ
plate  ||| S:55996 E:56002 ||| NN
with  ||| S:56002 E:56007 ||| IN
X-Gal  ||| S:56007 E:56013 ||| JJ
and  ||| S:56013 E:56017 ||| CC
U  ||| S:56017 E:56019 ||| NNP
-H  ||| S:56019 E:56022 ||| NNP
-W  ||| S:56022 E:56035 ||| NNP
-galactose ||| S:56035 E:56045 ||| NNP
/ ||| S:56045 E:56046 ||| NNP
raffinose  ||| S:56046 E:56056 ||| JJ
plate  ||| S:56056 E:56062 ||| NN
with  ||| S:56062 E:56067 ||| IN
X-Gal ||| S:56067 E:56072 ||| JJ
.  ||| S:56072 E:56074 ||| .
For  ||| S:56074 E:56078 ||| IN
presentation ||| S:56078 E:56090 ||| NN
,  ||| S:56090 E:56102 ||| ,
yeast  ||| S:56102 E:56108 ||| NN
transformants  ||| S:56108 E:56122 ||| NNS
were  ||| S:56122 E:56127 ||| VBD
also  ||| S:56127 E:56132 ||| RB
directly  ||| S:56132 E:56141 ||| RB
streaked  ||| S:56141 E:56150 ||| VBN
onto  ||| S:56150 E:56155 ||| IN
U  ||| S:56155 E:56157 ||| NNP
-H  ||| S:56157 E:56170 ||| NNP
-W  ||| S:56170 E:56173 ||| NNP
-galactose ||| S:56173 E:56183 ||| NNP
/ ||| S:56183 E:56184 ||| NNP
raffinose  ||| S:56184 E:56194 ||| JJ
plate  ||| S:56194 E:56200 ||| NN
with  ||| S:56200 E:56205 ||| IN
X-Gal ||| S:56205 E:56210 ||| NNP
,  ||| S:56210 E:56212 ||| ,
after  ||| S:56212 E:56228 ||| IN
confirming  ||| S:56228 E:56239 ||| VBG
lack  ||| S:56239 E:56244 ||| NN
of  ||| S:56244 E:56247 ||| IN
the  ||| S:56247 E:56251 ||| DT
auto-activation  ||| S:56251 E:56267 ||| JJ
on  ||| S:56267 E:56270 ||| IN
glucose  ||| S:56270 E:56288 ||| JJ
plates ||| S:56288 E:56294 ||| NN
.  ||| S:56294 E:56324 ||| .
Transient  ||| S:56324 E:56334 ||| JJ
transfection ||| S:56334 E:56346 ||| NN
,  ||| S:56346 E:56348 ||| ,
35S-metabolic  ||| S:56348 E:56362 ||| CD
labeling ||| S:56362 E:56370 ||| NN
,  ||| S:56370 E:56382 ||| ,
immunoprecipitation  ||| S:56382 E:56402 ||| NN
and  ||| S:56402 E:56406 ||| CC
western  ||| S:56406 E:56414 ||| JJ
blot  ||| S:56414 E:56429 ||| JJ
Equal  ||| S:56429 E:56435 ||| NNP
amount  ||| S:56435 E:56442 ||| NN
of  ||| S:56442 E:56445 ||| IN
total  ||| S:56445 E:56451 ||| JJ
plasmids  ||| S:56451 E:56460 ||| NN
were  ||| S:56460 E:56465 ||| VBD
used  ||| S:56465 E:56470 ||| VBN
to  ||| S:56470 E:56483 ||| TO
transiently  ||| S:56483 E:56495 ||| VB
transfect  ||| S:56495 E:56505 ||| NNS
COS-1  ||| S:56505 E:56511 ||| VBP
using  ||| S:56511 E:56517 ||| VBG
the  ||| S:56517 E:56521 ||| DT
DEAE  ||| S:56521 E:56526 ||| NNP
dextran  ||| S:56526 E:56534 ||| JJ
method  ||| S:56534 E:56551 ||| NN
[  ||| S:56551 E:56553 ||| -LRB-
40  ||| S:56553 E:56556 ||| CD
]  ||| S:56556 E:56558 ||| -RRB-
.  ||| S:56558 E:56560 ||| .
A  ||| S:56560 E:56562 ||| DT
GFP  ||| S:56562 E:56566 ||| NNP
construct  ||| S:56566 E:56576 ||| NN
was  ||| S:56576 E:56580 ||| VBD
used  ||| S:56580 E:56585 ||| VBN
to  ||| S:56585 E:56588 ||| TO
monitor  ||| S:56588 E:56596 ||| VB
the  ||| S:56596 E:56610 ||| DT
transfection  ||| S:56610 E:56623 ||| JJ
efficiency.  ||| S:56623 E:56635 ||| CD
293  ||| S:56635 E:56639 ||| CD
cells  ||| S:56639 E:56645 ||| NNS
were  ||| S:56645 E:56650 ||| VBD
transfected  ||| S:56650 E:56662 ||| VBN
by  ||| S:56662 E:56675 ||| IN
the  ||| S:56675 E:56679 ||| DT
standard  ||| S:56679 E:56688 ||| JJ
CaPO  ||| S:56688 E:56704 ||| JJ
4  ||| S:56704 E:56706 ||| CD
procedure  ||| S:56706 E:56716 ||| NN
[  ||| S:56716 E:56718 ||| -LRB-
55  ||| S:56718 E:56721 ||| CD
]  ||| S:56721 E:56723 ||| -RRB-
and  ||| S:56723 E:56727 ||| CC
cells  ||| S:56727 E:56733 ||| NNS
were  ||| S:56733 E:56748 ||| VBD
harvested  ||| S:56748 E:56758 ||| VBN
24  ||| S:56758 E:56761 ||| CD
hrs  ||| S:56761 E:56765 ||| NN
after  ||| S:56765 E:56771 ||| IN
tansfection ||| S:56771 E:56782 ||| NN
.  ||| S:56782 E:56784 ||| .
For  ||| S:56784 E:56788 ||| IN
metabolic  ||| S:56788 E:56808 ||| JJ
labeling ||| S:56808 E:56816 ||| NN
,  ||| S:56816 E:56818 ||| ,
cells  ||| S:56818 E:56824 ||| NNS
were  ||| S:56824 E:56829 ||| VBD
incubated  ||| S:56829 E:56839 ||| VBN
with  ||| S:56839 E:56844 ||| IN
250  ||| S:56844 E:56848 ||| CD
μCi  ||| S:56848 E:56862 ||| JJ
35S-methionine  ||| S:56862 E:56877 ||| NN
per  ||| S:56877 E:56881 ||| IN
plate  ||| S:56881 E:56887 ||| NN
for  ||| S:56887 E:56891 ||| IN
4  ||| S:56891 E:56893 ||| CD
hrs ||| S:56893 E:56896 ||| NN
,  ||| S:56896 E:56898 ||| ,
two  ||| S:56898 E:56902 ||| CD
days  ||| S:56902 E:56907 ||| NNS
after  ||| S:56907 E:56923 ||| IN
transfection ||| S:56923 E:56935 ||| NN
.  ||| S:56935 E:56937 ||| .
To  ||| S:56937 E:56940 ||| TO
make  ||| S:56940 E:56945 ||| VB
lysates ||| S:56945 E:56952 ||| NNS
,  ||| S:56952 E:56954 ||| ,
transfected  ||| S:56954 E:56966 ||| JJ
cells  ||| S:56966 E:56972 ||| NNS
were  ||| S:56972 E:56987 ||| VBD
washed  ||| S:56987 E:56994 ||| VBN
with  ||| S:56994 E:56999 ||| IN
cold  ||| S:56999 E:57004 ||| JJ
HBSS ||| S:57004 E:57008 ||| NNP
,  ||| S:57008 E:57010 ||| ,
scraped ||| S:57010 E:57017 ||| NN
,  ||| S:57017 E:57019 ||| ,
lysed  ||| S:57019 E:57025 ||| VBG
on  ||| S:57025 E:57028 ||| IN
ice  ||| S:57028 E:57032 ||| NN
in  ||| S:57032 E:57035 ||| IN
300  ||| S:57035 E:57039 ||| CD
μl  ||| S:57039 E:57052 ||| CD
lysis  ||| S:57052 E:57058 ||| JJ
buffer  ||| S:57058 E:57065 ||| NN
( ||| S:57065 E:57066 ||| -LRB-
20  ||| S:57066 E:57069 ||| CD
mM  ||| S:57069 E:57072 ||| JJ
Tris ||| S:57072 E:57076 ||| NNP
,  ||| S:57076 E:57078 ||| ,
PH  ||| S:57078 E:57081 ||| NNP
7.4 ||| S:57081 E:57084 ||| CD
,  ||| S:57084 E:57086 ||| ,
150  ||| S:57086 E:57090 ||| CD
mM  ||| S:57090 E:57093 ||| JJ
NaCl ||| S:57093 E:57097 ||| NN
,  ||| S:57097 E:57099 ||| ,
and  ||| S:57099 E:57103 ||| CC
0.5 ||| S:57103 E:57106 ||| CD
%  ||| S:57106 E:57118 ||| NN
Triton  ||| S:57118 E:57125 ||| NNP
X-100 ||| S:57125 E:57130 ||| NNP
,  ||| S:57130 E:57132 ||| ,
1mM  ||| S:57132 E:57136 ||| NNP
EDTA ||| S:57136 E:57140 ||| NNP
)  ||| S:57140 E:57142 ||| -RRB-
containing  ||| S:57142 E:57153 ||| VBG
protease  ||| S:57153 E:57162 ||| JJ
inhibitors ||| S:57162 E:57172 ||| NN
.  ||| S:57172 E:57184 ||| .
Protein  ||| S:57184 E:57192 ||| NN
expression  ||| S:57192 E:57203 ||| NN
level  ||| S:57203 E:57209 ||| NN
was  ||| S:57209 E:57213 ||| VBD
determined  ||| S:57213 E:57224 ||| VBN
by  ||| S:57224 E:57227 ||| IN
Western  ||| S:57227 E:57235 ||| JJ
blot  ||| S:57235 E:57250 ||| JJ
analyses  ||| S:57250 E:57259 ||| NNS
of  ||| S:57259 E:57262 ||| IN
20  ||| S:57262 E:57265 ||| CD
μl  ||| S:57265 E:57268 ||| JJ
lysates  ||| S:57268 E:57276 ||| NN
before  ||| S:57276 E:57283 ||| IN
any  ||| S:57283 E:57287 ||| DT
immunoprecipitation  ||| S:57287 E:57317 ||| JJ
assays ||| S:57317 E:57323 ||| NN
.  ||| S:57323 E:57325 ||| .
For  ||| S:57325 E:57329 ||| IN
immunoprecipitation ||| S:57329 E:57348 ||| NN
,  ||| S:57348 E:57350 ||| ,
150  ||| S:57350 E:57354 ||| CD
μl  ||| S:57354 E:57357 ||| JJ
cell  ||| S:57357 E:57362 ||| NN
lysates  ||| S:57362 E:57370 ||| NNS
were  ||| S:57370 E:57385 ||| VBD
pre-cleaned  ||| S:57385 E:57397 ||| JJ
by  ||| S:57397 E:57400 ||| IN
protein  ||| S:57400 E:57408 ||| VBG
A  ||| S:57408 E:57410 ||| DT
sepharose  ||| S:57410 E:57420 ||| JJ
beads  ||| S:57420 E:57426 ||| NNS
( ||| S:57426 E:57427 ||| -LRB-
Pharmacia ||| S:57427 E:57436 ||| NNP
) ||| S:57436 E:57437 ||| -RRB-
,  ||| S:57437 E:57449 ||| ,
incubated  ||| S:57449 E:57459 ||| VBG
with  ||| S:57459 E:57464 ||| IN
3  ||| S:57464 E:57466 ||| CD
μl  ||| S:57466 E:57469 ||| NN
of  ||| S:57469 E:57472 ||| IN
anti-T7  ||| S:57472 E:57480 ||| NNP
( ||| S:57480 E:57481 ||| -LRB-
1  ||| S:57481 E:57483 ||| CD
mg ||| S:57483 E:57485 ||| CD
/ ||| S:57485 E:57486 ||| CD
ml ||| S:57486 E:57488 ||| CD
)  ||| S:57488 E:57490 ||| -RRB-
or  ||| S:57490 E:57493 ||| CC
anti-Flag  ||| S:57493 E:57503 ||| NNP
( ||| S:57503 E:57504 ||| -LRB-
3  ||| S:57504 E:57516 ||| CD
mg ||| S:57516 E:57518 ||| CD
/ ||| S:57518 E:57519 ||| CD
ml ||| S:57519 E:57521 ||| CD
)  ||| S:57521 E:57523 ||| -RRB-
( ||| S:57523 E:57524 ||| -LRB-
M2  ||| S:57524 E:57527 ||| CD
monoclonal ||| S:57527 E:57537 ||| NN
,  ||| S:57537 E:57539 ||| ,
IBI ||| S:57539 E:57542 ||| NNP
,  ||| S:57542 E:57544 ||| ,
Eastman  ||| S:57544 E:57552 ||| NNP
Kodak ||| S:57552 E:57557 ||| NNP
)  ||| S:57557 E:57559 ||| -RRB-
on  ||| S:57559 E:57562 ||| IN
ice  ||| S:57562 E:57576 ||| NN
overnight ||| S:57576 E:57585 ||| RB
.  ||| S:57585 E:57587 ||| .
Protein  ||| S:57587 E:57595 ||| NNP
A  ||| S:57595 E:57597 ||| NNP
( ||| S:57597 E:57598 ||| -LRB-
for  ||| S:57598 E:57602 ||| IN
anti-T7 ||| S:57602 E:57609 ||| CD
)  ||| S:57609 E:57611 ||| -RRB-
and  ||| S:57611 E:57615 ||| CC
protein  ||| S:57615 E:57623 ||| NN
G  ||| S:57623 E:57625 ||| NNP
( ||| S:57625 E:57626 ||| -LRB-
for  ||| S:57626 E:57640 ||| IN
anti-Flag ||| S:57640 E:57649 ||| NNP
)  ||| S:57649 E:57651 ||| -RRB-
sepharose  ||| S:57651 E:57661 ||| JJ
beads  ||| S:57661 E:57667 ||| NN
were  ||| S:57667 E:57672 ||| VBD
used  ||| S:57672 E:57677 ||| VBN
to  ||| S:57677 E:57680 ||| TO
absorb  ||| S:57680 E:57687 ||| VB
the  ||| S:57687 E:57701 ||| DT
antibodies ||| S:57701 E:57711 ||| NNS
.  ||| S:57711 E:57713 ||| .
After  ||| S:57713 E:57719 ||| IN
washing ||| S:57719 E:57726 ||| NN
,  ||| S:57726 E:57728 ||| ,
beads  ||| S:57728 E:57734 ||| NN
were  ||| S:57734 E:57739 ||| VBD
treated  ||| S:57739 E:57747 ||| VBN
with  ||| S:57747 E:57762 ||| IN
protein  ||| S:57762 E:57770 ||| NN
sample  ||| S:57770 E:57777 ||| NN
buffer  ||| S:57777 E:57784 ||| NN
to  ||| S:57784 E:57787 ||| TO
elute  ||| S:57787 E:57793 ||| VB
immunoprecipitates ||| S:57793 E:57811 ||| NNS
.  ||| S:57811 E:57813 ||| .
Eluted  ||| S:57813 E:57830 ||| JJ
proteins  ||| S:57830 E:57839 ||| NNS
were  ||| S:57839 E:57844 ||| VBD
separated  ||| S:57844 E:57854 ||| VBN
on  ||| S:57854 E:57857 ||| IN
SDS-PAGE ||| S:57857 E:57865 ||| JJ
.  ||| S:57865 E:57867 ||| .
The  ||| S:57867 E:57871 ||| DT
detection  ||| S:57871 E:57881 ||| NN
of  ||| S:57881 E:57884 ||| IN
the  ||| S:57884 E:57898 ||| DT
co-precipitated  ||| S:57898 E:57914 ||| JJ
proteins  ||| S:57914 E:57923 ||| NNS
was  ||| S:57923 E:57927 ||| VBD
carried  ||| S:57927 E:57935 ||| VBN
out  ||| S:57935 E:57939 ||| RP
either  ||| S:57939 E:57946 ||| RB
by  ||| S:57946 E:57959 ||| IN
autoradiography ||| S:57959 E:57974 ||| NN
,  ||| S:57974 E:57976 ||| ,
if  ||| S:57976 E:57979 ||| IN
proteins  ||| S:57979 E:57988 ||| NNS
were  ||| S:57988 E:57993 ||| VBD
metabolically  ||| S:57993 E:58007 ||| VBN
labeled  ||| S:58007 E:58025 ||| VBN
or  ||| S:58025 E:58028 ||| CC
by  ||| S:58028 E:58031 ||| IN
Western  ||| S:58031 E:58039 ||| JJ
blot  ||| S:58039 E:58044 ||| NNS
using  ||| S:58044 E:58050 ||| VBG
the  ||| S:58050 E:58054 ||| DT
ECL  ||| S:58054 E:58058 ||| NNP
kit ||| S:58058 E:58061 ||| NN
.  ||| S:58061 E:58063 ||| .
When  ||| S:58063 E:58068 ||| WRB
proteasome  ||| S:58068 E:58089 ||| JJ
inhibitors  ||| S:58089 E:58100 ||| NN
were  ||| S:58100 E:58105 ||| VBD
applied ||| S:58105 E:58112 ||| VBN
,  ||| S:58112 E:58114 ||| ,
the  ||| S:58114 E:58118 ||| DT
inhibitors  ||| S:58118 E:58129 ||| JJ
LLnL  ||| S:58129 E:58134 ||| NN
( ||| S:58134 E:58135 ||| -LRB-
50  ||| S:58135 E:58138 ||| CD
mM  ||| S:58138 E:58141 ||| NN
in  ||| S:58141 E:58154 ||| IN
DMSO ||| S:58154 E:58158 ||| NNP
)  ||| S:58158 E:58160 ||| -RRB-
or  ||| S:58160 E:58163 ||| CC
lactacystin  ||| S:58163 E:58175 ||| NNS
( ||| S:58175 E:58176 ||| -LRB-
10  ||| S:58176 E:58179 ||| CD
mM  ||| S:58179 E:58182 ||| NN
in  ||| S:58182 E:58185 ||| IN
H  ||| S:58185 E:58198 ||| NNP
2  ||| S:58198 E:58200 ||| CD
O ||| S:58200 E:58201 ||| NNP
)  ||| S:58201 E:58203 ||| -RRB-
were  ||| S:58203 E:58208 ||| VBD
added  ||| S:58208 E:58214 ||| VBN
directly  ||| S:58214 E:58223 ||| RB
to  ||| S:58223 E:58226 ||| TO
the  ||| S:58226 E:58230 ||| DT
cell  ||| S:58230 E:58245 ||| NN
medium  ||| S:58245 E:58252 ||| NN
at  ||| S:58252 E:58255 ||| IN
1 ||| S:58255 E:58256 ||| CD
: ||| S:58256 E:58257 ||| :
1000  ||| S:58257 E:58262 ||| CD
dilutions ||| S:58262 E:58271 ||| NNS
.  ||| S:58271 E:58273 ||| .
Lactacystin  ||| S:58273 E:58285 ||| NNP
was  ||| S:58285 E:58289 ||| VBD
purchased  ||| S:58289 E:58309 ||| VBN
from  ||| S:58309 E:58314 ||| IN
E.  ||| S:58314 E:58317 ||| NNP
J.  ||| S:58317 E:58320 ||| NNP
Corey  ||| S:58320 E:58326 ||| NNP
laboratory  ||| S:58326 E:58337 ||| NN
at  ||| S:58337 E:58340 ||| IN
Harvard  ||| S:58340 E:58348 ||| NNP
University ||| S:58348 E:58358 ||| NNP
.  ||| S:58358 E:58360 ||| .
LLnL  ||| S:58360 E:58375 ||| NNP
was  ||| S:58375 E:58379 ||| VBD
purchased  ||| S:58379 E:58389 ||| VBN
from  ||| S:58389 E:58394 ||| IN
Sigma ||| S:58394 E:58399 ||| NNP
.  ||| S:58399 E:58429 ||| .
Immunocytochemistry  ||| S:58429 E:58449 ||| NNP
and  ||| S:58449 E:58453 ||| CC
confocal  ||| S:58453 E:58462 ||| JJ
microscopy  ||| S:58462 E:58483 ||| JJ
Immunocytochemistry  ||| S:58483 E:58503 ||| NNP
was  ||| S:58503 E:58507 ||| VBD
carried  ||| S:58507 E:58515 ||| VBN
out  ||| S:58515 E:58519 ||| RP
as  ||| S:58519 E:58522 ||| RB
described  ||| S:58522 E:58542 ||| VBN
previously  ||| S:58542 E:58553 ||| RB
[  ||| S:58553 E:58555 ||| -LRB-
40  ||| S:58555 E:58558 ||| CD
]  ||| S:58558 E:58560 ||| -RRB-
.  ||| S:58560 E:58562 ||| .
Briefly ||| S:58562 E:58569 ||| RB
,  ||| S:58569 E:58571 ||| ,
COS  ||| S:58571 E:58575 ||| NNP
cells  ||| S:58575 E:58581 ||| NNS
were  ||| S:58581 E:58586 ||| VBD
grown  ||| S:58586 E:58592 ||| VBN
to  ||| S:58592 E:58595 ||| TO
50 ||| S:58595 E:58597 ||| CD
%  ||| S:58597 E:58609 ||| NN
confluency  ||| S:58609 E:58620 ||| NN
on  ||| S:58620 E:58623 ||| IN
gelatin-coated  ||| S:58623 E:58638 ||| JJ
glass  ||| S:58638 E:58644 ||| NN
cover  ||| S:58644 E:58650 ||| NN
slips ||| S:58650 E:58655 ||| VBZ
.  ||| S:58655 E:58657 ||| .
Cells  ||| S:58657 E:58673 ||| NNS
were  ||| S:58673 E:58678 ||| VBD
transiently  ||| S:58678 E:58690 ||| JJ
transfected  ||| S:58690 E:58702 ||| NN
with  ||| S:58702 E:58707 ||| IN
the  ||| S:58707 E:58711 ||| DT
indicated  ||| S:58711 E:58721 ||| JJ
plasmids  ||| S:58721 E:58740 ||| NNS
( ||| S:58740 E:58741 ||| -LRB-
total  ||| S:58741 E:58747 ||| JJ
10  ||| S:58747 E:58750 ||| CD
μg ||| S:58750 E:58752 ||| CD
)  ||| S:58752 E:58754 ||| -RRB-
using  ||| S:58754 E:58760 ||| VBG
the  ||| S:58760 E:58764 ||| DT
DEAE  ||| S:58764 E:58769 ||| NNP
dextran  ||| S:58769 E:58777 ||| JJ
method ||| S:58777 E:58783 ||| NN
.  ||| S:58783 E:58785 ||| .
About  ||| S:58785 E:58791 ||| IN
48  ||| S:58791 E:58794 ||| CD
hrs  ||| S:58794 E:58808 ||| NN
after  ||| S:58808 E:58814 ||| IN
transfection ||| S:58814 E:58826 ||| NN
,  ||| S:58826 E:58828 ||| ,
cells  ||| S:58828 E:58834 ||| NNS
were  ||| S:58834 E:58839 ||| VBD
fixed  ||| S:58839 E:58845 ||| VBN
in  ||| S:58845 E:58848 ||| IN
4 ||| S:58848 E:58849 ||| CD
%  ||| S:58849 E:58861 ||| NN
paraformaldehyde  ||| S:58861 E:58878 ||| NN
for  ||| S:58878 E:58882 ||| IN
10  ||| S:58882 E:58885 ||| CD
min ||| S:58885 E:58888 ||| NN
,  ||| S:58888 E:58890 ||| ,
and  ||| S:58890 E:58894 ||| CC
then  ||| S:58894 E:58899 ||| RB
permeablized  ||| S:58899 E:58912 ||| VBN
with  ||| S:58912 E:58927 ||| IN
methanol  ||| S:58927 E:58936 ||| NN
for  ||| S:58936 E:58940 ||| IN
2  ||| S:58940 E:58942 ||| CD
mins ||| S:58942 E:58946 ||| NNS
.  ||| S:58946 E:58948 ||| .
Cells  ||| S:58948 E:58954 ||| NNS
were  ||| S:58954 E:58959 ||| VBD
blocked  ||| S:58959 E:58967 ||| VBN
in  ||| S:58967 E:58970 ||| IN
10 ||| S:58970 E:58972 ||| CD
%  ||| S:58972 E:58974 ||| NN
goat  ||| S:58974 E:58989 ||| FW
serum ||| S:58989 E:58994 ||| FW
/ ||| S:58994 E:58995 ||| FW
PBS  ||| S:58995 E:58999 ||| NNP
for  ||| S:58999 E:59003 ||| IN
1  ||| S:59003 E:59005 ||| CD
hr  ||| S:59005 E:59008 ||| NN
at  ||| S:59008 E:59011 ||| IN
room  ||| S:59011 E:59016 ||| NN
temperature ||| S:59016 E:59027 ||| NN
,  ||| S:59027 E:59029 ||| ,
before  ||| S:59029 E:59036 ||| IN
the  ||| S:59036 E:59050 ||| DT
sequential  ||| S:59050 E:59061 ||| JJ
incubation  ||| S:59061 E:59072 ||| NN
with  ||| S:59072 E:59077 ||| IN
the  ||| S:59077 E:59081 ||| DT
primary  ||| S:59081 E:59089 ||| JJ
and  ||| S:59089 E:59093 ||| CC
secondary  ||| S:59093 E:59113 ||| JJ
antibodies ||| S:59113 E:59123 ||| NNS
.  ||| S:59123 E:59125 ||| .
The  ||| S:59125 E:59129 ||| DT
monoclonal  ||| S:59129 E:59140 ||| JJ
anti-HsN3  ||| S:59140 E:59150 ||| NNP
( ||| S:59150 E:59151 ||| -LRB-
MCP444 ||| S:59151 E:59157 ||| NNP
)  ||| S:59157 E:59159 ||| -RRB-
is  ||| S:59159 E:59162 ||| VBZ
a  ||| S:59162 E:59164 ||| DT
gift  ||| S:59164 E:59179 ||| NN
from  ||| S:59179 E:59184 ||| IN
K.  ||| S:59184 E:59187 ||| NNP
B.  ||| S:59187 E:59190 ||| NNP
Hendil ||| S:59190 E:59196 ||| NNP
.  ||| S:59196 E:59198 ||| .
The  ||| S:59198 E:59202 ||| DT
polyclonal  ||| S:59202 E:59213 ||| JJ
anti-Smad1  ||| S:59213 E:59224 ||| CD
antibody  ||| S:59224 E:59233 ||| NN
is  ||| S:59233 E:59246 ||| VBZ
a  ||| S:59246 E:59248 ||| DT
gift  ||| S:59248 E:59253 ||| NN
from  ||| S:59253 E:59258 ||| IN
A.  ||| S:59258 E:59261 ||| NNP
Roberts ||| S:59261 E:59268 ||| NNP
.  ||| S:59268 E:59270 ||| .
The  ||| S:59270 E:59274 ||| DT
secondary  ||| S:59274 E:59284 ||| JJ
antibodies  ||| S:59284 E:59295 ||| NNS
were  ||| S:59295 E:59310 ||| VBD
either  ||| S:59310 E:59317 ||| DT
FITC-conjugated ||| S:59317 E:59332 ||| JJ
,  ||| S:59332 E:59334 ||| ,
or  ||| S:59334 E:59337 ||| CC
Rodamine-conjugated  ||| S:59337 E:59357 ||| JJ
goat  ||| S:59357 E:59372 ||| JJ
anti-mouse  ||| S:59372 E:59383 ||| JJ
IgG  ||| S:59383 E:59387 ||| NN
( ||| S:59387 E:59388 ||| -LRB-
Jackson  ||| S:59388 E:59396 ||| NNP
ImmunoResearch ||| S:59396 E:59410 ||| NNP
,  ||| S:59410 E:59412 ||| ,
Westgrove  ||| S:59412 E:59432 ||| NNP
PA ||| S:59432 E:59434 ||| NNP
) ||| S:59434 E:59435 ||| -RRB-
.  ||| S:59435 E:59447 ||| .
Confocal  ||| S:59447 E:59456 ||| NNP
Microscopy  ||| S:59456 E:59467 ||| NNP
was  ||| S:59467 E:59471 ||| VBD
carried  ||| S:59471 E:59479 ||| VBN
out  ||| S:59479 E:59483 ||| RP
on  ||| S:59483 E:59486 ||| IN
a  ||| S:59486 E:59488 ||| DT
Leica  ||| S:59488 E:59494 ||| NNP
TCS  ||| S:59494 E:59498 ||| NNP
4D  ||| S:59498 E:59511 ||| NNP
Confocal  ||| S:59511 E:59520 ||| NNP
Laser  ||| S:59520 E:59526 ||| NNP
Scanning  ||| S:59526 E:59535 ||| NNP
Microscope  ||| S:59535 E:59546 ||| NNP
at  ||| S:59546 E:59549 ||| IN
the  ||| S:59549 E:59553 ||| DT
Schepens  ||| S:59553 E:59562 ||| NNP
Eye  ||| S:59562 E:59576 ||| NNP
Research  ||| S:59576 E:59585 ||| NNP
Institute  ||| S:59585 E:59595 ||| NNP
( ||| S:59595 E:59596 ||| -LRB-
Boston  ||| S:59596 E:59603 ||| NNP
MA ||| S:59603 E:59605 ||| NNP
) ||| S:59605 E:59606 ||| -RRB-
.  ||| S:59606 E:59636 ||| .
Luciferase  ||| S:59636 E:59647 ||| NNP
assays  ||| S:59647 E:59664 ||| VBD
P19  ||| S:59664 E:59668 ||| CD
cells  ||| S:59668 E:59674 ||| NNS
were  ||| S:59674 E:59679 ||| VBD
seeded  ||| S:59679 E:59686 ||| VBN
in  ||| S:59686 E:59689 ||| IN
100  ||| S:59689 E:59693 ||| CD
mm  ||| S:59693 E:59696 ||| JJ
dish  ||| S:59696 E:59701 ||| NN
and  ||| S:59701 E:59705 ||| CC
cultured  ||| S:59705 E:59714 ||| NN
for  ||| S:59714 E:59728 ||| IN
24  ||| S:59728 E:59731 ||| CD
hrs  ||| S:59731 E:59735 ||| NN
before  ||| S:59735 E:59742 ||| IN
they  ||| S:59742 E:59747 ||| PRP
were  ||| S:59747 E:59752 ||| VBD
transfected  ||| S:59752 E:59764 ||| VBN
with  ||| S:59764 E:59769 ||| IN
luciferase  ||| S:59769 E:59790 ||| JJ
reporter  ||| S:59790 E:59799 ||| NN
constructs  ||| S:59799 E:59810 ||| VBZ
using  ||| S:59810 E:59816 ||| VBG
Fugene  ||| S:59816 E:59823 ||| NNP
Kit  ||| S:59823 E:59827 ||| NNP
( ||| S:59827 E:59828 ||| -LRB-
Roche ||| S:59828 E:59833 ||| NNP
) ||| S:59833 E:59834 ||| -RRB-
.  ||| S:59834 E:59836 ||| .
Each  ||| S:59836 E:59841 ||| DT
group  ||| S:59841 E:59857 ||| NN
of  ||| S:59857 E:59860 ||| IN
transfected  ||| S:59860 E:59872 ||| JJ
cells  ||| S:59872 E:59878 ||| NNS
was  ||| S:59878 E:59882 ||| VBD
re-seeded  ||| S:59882 E:59892 ||| JJ
into  ||| S:59892 E:59897 ||| IN
eight  ||| S:59897 E:59903 ||| CD
separate  ||| S:59903 E:59922 ||| JJ
wells  ||| S:59922 E:59928 ||| NNS
in  ||| S:59928 E:59931 ||| IN
a  ||| S:59931 E:59933 ||| DT
24-well  ||| S:59933 E:59941 ||| CD
plate  ||| S:59941 E:59947 ||| CD
18  ||| S:59947 E:59950 ||| CD
hrs  ||| S:59950 E:59954 ||| NN
after  ||| S:59954 E:59960 ||| IN
transfection ||| S:59960 E:59972 ||| NN
.  ||| S:59972 E:59984 ||| .
Eighteen  ||| S:59984 E:59993 ||| JJ
hrs  ||| S:59993 E:59997 ||| NN
after  ||| S:59997 E:60003 ||| IN
re-seeding ||| S:60003 E:60013 ||| NNP
,  ||| S:60013 E:60015 ||| ,
cells  ||| S:60015 E:60021 ||| NNS
were  ||| S:60021 E:60026 ||| VBD
washed  ||| S:60026 E:60033 ||| VBN
twice  ||| S:60033 E:60049 ||| RB
with  ||| S:60049 E:60054 ||| IN
1  ||| S:60054 E:60056 ||| CD
ml  ||| S:60056 E:60059 ||| CD
serum-free  ||| S:60059 E:60070 ||| JJ
media  ||| S:60070 E:60076 ||| NNS
and  ||| S:60076 E:60080 ||| CC
left  ||| S:60080 E:60085 ||| VBN
in  ||| S:60085 E:60088 ||| IN
200  ||| S:60088 E:60092 ||| CD
μl  ||| S:60092 E:60095 ||| CD
media ||| S:60095 E:60100 ||| NNS
.  ||| S:60100 E:60102 ||| .
Four  ||| S:60102 E:60117 ||| CD
out  ||| S:60117 E:60121 ||| IN
of  ||| S:60121 E:60124 ||| IN
eight  ||| S:60124 E:60130 ||| CD
dishes  ||| S:60130 E:60137 ||| NNS
of  ||| S:60137 E:60140 ||| IN
each  ||| S:60140 E:60145 ||| DT
group  ||| S:60145 E:60151 ||| NN
were  ||| S:60151 E:60156 ||| VBD
exposed  ||| S:60156 E:60164 ||| VBN
to  ||| S:60164 E:60167 ||| TO
BMP7  ||| S:60167 E:60182 ||| CD
( ||| S:60182 E:60183 ||| -LRB-
25  ||| S:60183 E:60186 ||| CD
ng ||| S:60186 E:60188 ||| CD
/ ||| S:60188 E:60189 ||| CD
ml  ||| S:60189 E:60192 ||| CD
BMP7 ||| S:60192 E:60196 ||| CD
) ||| S:60196 E:60197 ||| -RRB-
,  ||| S:60197 E:60199 ||| ,
which  ||| S:60199 E:60205 ||| WDT
was  ||| S:60205 E:60209 ||| VBD
directly  ||| S:60209 E:60218 ||| RB
added  ||| S:60218 E:60224 ||| VBN
into  ||| S:60224 E:60229 ||| IN
the  ||| S:60229 E:60233 ||| DT
media  ||| S:60233 E:60249 ||| NNS
for  ||| S:60249 E:60253 ||| IN
24  ||| S:60253 E:60256 ||| CD
hrs ||| S:60256 E:60259 ||| NNS
.  ||| S:60259 E:60261 ||| .
Culture  ||| S:60261 E:60269 ||| NN
media  ||| S:60269 E:60275 ||| NNS
was  ||| S:60275 E:60279 ||| VBD
then  ||| S:60279 E:60284 ||| RB
removed  ||| S:60284 E:60292 ||| VBN
and  ||| S:60292 E:60296 ||| CC
100  ||| S:60296 E:60300 ||| CD
μl  ||| S:60300 E:60303 ||| NN
of  ||| S:60303 E:60316 ||| IN
Reporter  ||| S:60316 E:60325 ||| NNP
Lysis  ||| S:60325 E:60331 ||| NNP
Buffer  ||| S:60331 E:60338 ||| NNP
( ||| S:60338 E:60339 ||| -LRB-
Promega  ||| S:60339 E:60347 ||| NNP
5X  ||| S:60347 E:60350 ||| NNP
stock ||| S:60350 E:60355 ||| NN
,  ||| S:60355 E:60357 ||| ,
diluted  ||| S:60357 E:60365 ||| VBN
with  ||| S:60365 E:60370 ||| IN
H  ||| S:60370 E:60383 ||| NNP
2  ||| S:60383 E:60385 ||| CD
O ||| S:60385 E:60386 ||| NNP
)  ||| S:60386 E:60388 ||| -RRB-
was  ||| S:60388 E:60392 ||| VBD
added  ||| S:60392 E:60398 ||| VBN
to  ||| S:60398 E:60401 ||| TO
the  ||| S:60401 E:60405 ||| DT
cells ||| S:60405 E:60410 ||| NNS
,  ||| S:60410 E:60412 ||| ,
which  ||| S:60412 E:60428 ||| WDT
were  ||| S:60428 E:60433 ||| VBD
then  ||| S:60433 E:60438 ||| RB
frozen  ||| S:60438 E:60445 ||| VBN
at  ||| S:60445 E:60448 ||| IN
-80°C  ||| S:60448 E:60454 ||| CD
for  ||| S:60454 E:60458 ||| IN
3  ||| S:60458 E:60460 ||| CD
hrs ||| S:60460 E:60463 ||| NNS
.  ||| S:60463 E:60465 ||| .
The  ||| S:60465 E:60469 ||| DT
plates  ||| S:60469 E:60476 ||| NN
were  ||| S:60476 E:60491 ||| VBD
thawed  ||| S:60491 E:60498 ||| JJ
and  ||| S:60498 E:60502 ||| CC
70  ||| S:60502 E:60505 ||| CD
μl  ||| S:60505 E:60508 ||| NN
of  ||| S:60508 E:60511 ||| IN
supernatant  ||| S:60511 E:60523 ||| NN
was  ||| S:60523 E:60527 ||| VBD
transferred  ||| S:60527 E:60539 ||| VBN
to  ||| S:60539 E:60552 ||| TO
luciferase  ||| S:60552 E:60563 ||| VB
plates ||| S:60563 E:60569 ||| NNS
,  ||| S:60569 E:60571 ||| ,
mixed  ||| S:60571 E:60577 ||| VBN
with  ||| S:60577 E:60582 ||| IN
70  ||| S:60582 E:60585 ||| CD
μl  ||| S:60585 E:60588 ||| NN
of  ||| S:60588 E:60591 ||| IN
luciferase  ||| S:60591 E:60602 ||| JJ
reagent  ||| S:60602 E:60620 ||| NNS
( ||| S:60620 E:60621 ||| -LRB-
Promega ||| S:60621 E:60628 ||| NNP
) ||| S:60628 E:60629 ||| -RRB-
.  ||| S:60629 E:60631 ||| .
The  ||| S:60631 E:60635 ||| DT
luciferase  ||| S:60635 E:60646 ||| JJ
activity  ||| S:60646 E:60655 ||| NN
was  ||| S:60655 E:60659 ||| VBD
detected  ||| S:60659 E:60668 ||| VBN
on  ||| S:60668 E:60671 ||| IN
Wallac  ||| S:60671 E:60688 ||| NNP
Victor  ||| S:60688 E:60695 ||| NNP
1420  ||| S:60695 E:60700 ||| CD
plate  ||| S:60700 E:60706 ||| NN
reader ||| S:60706 E:60712 ||| NN
.  ||| S:60712 E:60714 ||| .
To  ||| S:60714 E:60717 ||| TO
normalize  ||| S:60717 E:60727 ||| VB
data ||| S:60727 E:60731 ||| NNS
,  ||| S:60731 E:60733 ||| ,
cells  ||| S:60733 E:60739 ||| NNS
were  ||| S:60739 E:60754 ||| VBD
also  ||| S:60754 E:60759 ||| RB
transfected  ||| S:60759 E:60771 ||| VBN
with  ||| S:60771 E:60776 ||| IN
β-Gal  ||| S:60776 E:60782 ||| JJ
reporter  ||| S:60782 E:60791 ||| NN
and  ||| S:60791 E:60795 ||| CC
the  ||| S:60795 E:60809 ||| DT
β-galactosidase  ||| S:60809 E:60825 ||| JJ
activities  ||| S:60825 E:60836 ||| NNS
measured  ||| S:60836 E:60845 ||| VBN
using  ||| S:60845 E:60851 ||| VBG
the  ||| S:60851 E:60865 ||| DT
Galacto-star  ||| S:60865 E:60878 ||| JJ
kit  ||| S:60878 E:60882 ||| NN
( ||| S:60882 E:60883 ||| -LRB-
Tropix ||| S:60883 E:60889 ||| NNP
,  ||| S:60889 E:60891 ||| ,
BM300S ||| S:60891 E:60897 ||| CD
) ||| S:60897 E:60898 ||| -RRB-
.  ||| S:60898 E:60931 ||| .
Authors ||| S:60931 E:60938 ||| NNP
'  ||| S:60938 E:60940 ||| POS
contributions  ||| S:60940 E:60962 ||| NNS
Y.  ||| S:60962 E:60965 ||| NNP
L.  ||| S:60965 E:60968 ||| NNP
carried  ||| S:60968 E:60976 ||| VBD
out  ||| S:60976 E:60980 ||| RP
most  ||| S:60980 E:60985 ||| JJS
of  ||| S:60985 E:60988 ||| IN
the  ||| S:60988 E:60992 ||| DT
immunoprecipitation  ||| S:60992 E:61020 ||| JJ
experiments  ||| S:61020 E:61032 ||| NNS
to  ||| S:61032 E:61035 ||| TO
confirm  ||| S:61035 E:61043 ||| VB
the  ||| S:61043 E:61047 ||| DT
protein-protein  ||| S:61047 E:61063 ||| JJ
interactions  ||| S:61063 E:61084 ||| NNS
presented  ||| S:61084 E:61094 ||| VBN
in  ||| S:61094 E:61097 ||| IN
the  ||| S:61097 E:61101 ||| DT
paper ||| S:61101 E:61106 ||| NN
.  ||| S:61106 E:61108 ||| .
J.  ||| S:61108 E:61111 ||| NNP
M.  ||| S:61111 E:61114 ||| NNP
carried  ||| S:61114 E:61122 ||| VBD
out  ||| S:61122 E:61126 ||| RP
most  ||| S:61126 E:61131 ||| JJS
of  ||| S:61131 E:61134 ||| IN
the  ||| S:61134 E:61138 ||| DT
yeast  ||| S:61138 E:61152 ||| NN
two-hybrid  ||| S:61152 E:61163 ||| JJ
system  ||| S:61163 E:61170 ||| NN
studies ||| S:61170 E:61177 ||| NNS
.  ||| S:61177 E:61179 ||| .
C.  ||| S:61179 E:61182 ||| NNP
G.  ||| S:61182 E:61185 ||| NNP
carried  ||| S:61185 E:61193 ||| VBD
out  ||| S:61193 E:61197 ||| RP
the  ||| S:61197 E:61201 ||| DT
domain  ||| S:61201 E:61216 ||| NN
mapping  ||| S:61216 E:61224 ||| NN
studies  ||| S:61224 E:61232 ||| NNS
for  ||| S:61232 E:61236 ||| IN
Az  ||| S:61236 E:61239 ||| NNP
interaction  ||| S:61239 E:61251 ||| NN
with  ||| S:61251 E:61256 ||| IN
Smad1  ||| S:61256 E:61262 ||| NNP
and  ||| S:61262 E:61266 ||| CC
HsN3 ||| S:61266 E:61270 ||| NNP
.  ||| S:61270 E:61272 ||| .
J.  ||| S:61272 E:61283 ||| NNP
F.  ||| S:61283 E:61286 ||| NNP
carried  ||| S:61286 E:61294 ||| VBD
out  ||| S:61294 E:61298 ||| RP
the  ||| S:61298 E:61302 ||| DT
studies  ||| S:61302 E:61310 ||| NNS
to  ||| S:61310 E:61313 ||| TO
determine  ||| S:61313 E:61323 ||| VB
the  ||| S:61323 E:61327 ||| DT
endogenous  ||| S:61327 E:61346 ||| JJ
level  ||| S:61346 E:61352 ||| NN
change  ||| S:61352 E:61359 ||| NN
of  ||| S:61359 E:61362 ||| IN
SNIP1  ||| S:61362 E:61368 ||| CD
in  ||| S:61368 E:61371 ||| IN
response  ||| S:61371 E:61380 ||| NN
to  ||| S:61380 E:61383 ||| TO
BMPs ||| S:61383 E:61387 ||| JJ
;  ||| S:61387 E:61389 ||| :
X.  ||| S:61389 E:61392 ||| NNP
M.  ||| S:61392 E:61395 ||| NNP
and  ||| S:61395 E:61399 ||| CC
B.-Y ||| S:61399 E:61403 ||| NNP
.  ||| S:61403 E:61413 ||| .
L.  ||| S:61413 E:61416 ||| NNP
carried  ||| S:61416 E:61424 ||| VBD
out  ||| S:61424 E:61428 ||| RP
all  ||| S:61428 E:61432 ||| DT
preparations  ||| S:61432 E:61445 ||| NN
of  ||| S:61445 E:61448 ||| IN
the  ||| S:61448 E:61452 ||| DT
constructs  ||| S:61452 E:61463 ||| NN
and  ||| S:61463 E:61467 ||| CC
many  ||| S:61467 E:61480 ||| JJ
technical  ||| S:61480 E:61490 ||| JJ
supports ||| S:61490 E:61498 ||| NNS
.  ||| S:61498 E:61500 ||| .
R.L.  ||| S:61500 E:61505 ||| NNP
provided  ||| S:61505 E:61514 ||| VBD
the  ||| S:61514 E:61518 ||| DT
bait  ||| S:61518 E:61523 ||| JJ
construct  ||| S:61523 E:61533 ||| NN
for  ||| S:61533 E:61545 ||| IN
the  ||| S:61545 E:61549 ||| DT
yeast  ||| S:61549 E:61555 ||| NN
two-hybrid  ||| S:61555 E:61566 ||| JJ
screen  ||| S:61566 E:61573 ||| NN
study  ||| S:61573 E:61579 ||| NN
of  ||| S:61579 E:61582 ||| IN
Smad1  ||| S:61582 E:61588 ||| NNP
and  ||| S:61588 E:61592 ||| CC
worked  ||| S:61592 E:61599 ||| VBN
with  ||| S:61599 E:61612 ||| IN
C.H.  ||| S:61612 E:61617 ||| NNP
and  ||| S:61617 E:61621 ||| CC
R.  ||| S:61621 E:61624 ||| NNP
H.  ||| S:61624 E:61627 ||| NNP
K.  ||| S:61627 E:61630 ||| NNP
to  ||| S:61630 E:61633 ||| TO
screen  ||| S:61633 E:61640 ||| NN
and  ||| S:61640 E:61644 ||| CC
clone  ||| S:61644 E:61650 ||| VBG
the  ||| S:61650 E:61654 ||| DT
full  ||| S:61654 E:61659 ||| JJ
length  ||| S:61659 E:61666 ||| NN
clone  ||| S:61666 E:61680 ||| NN
of  ||| S:61680 E:61683 ||| IN
SNIP1 ||| S:61683 E:61688 ||| CD
.  ||| S:61688 E:61690 ||| .
W.G.  ||| S:61690 E:61695 ||| NNP
and  ||| S:61695 E:61699 ||| CC
V.  ||| S:61699 E:61702 ||| NNP
P.  ||| S:61702 E:61705 ||| NNP
carried  ||| S:61705 E:61713 ||| VBD
out  ||| S:61713 E:61717 ||| RP
functional  ||| S:61717 E:61728 ||| JJ
studies  ||| S:61728 E:61736 ||| NNS
of  ||| S:61736 E:61747 ||| IN
SNIP1  ||| S:61747 E:61753 ||| CD
in  ||| S:61753 E:61756 ||| IN
BMP-responsive  ||| S:61756 E:61771 ||| JJ
cells ||| S:61771 E:61776 ||| NNS
.  ||| S:61776 E:61778 ||| .
T.  ||| S:61778 E:61781 ||| NNP
W.  ||| S:61781 E:61784 ||| NNP
conceived  ||| S:61784 E:61794 ||| VBD
the  ||| S:61794 E:61798 ||| DT
study ||| S:61798 E:61803 ||| NN
,  ||| S:61803 E:61813 ||| ,
participated  ||| S:61813 E:61826 ||| VBD
in  ||| S:61826 E:61829 ||| IN
its  ||| S:61829 E:61833 ||| PRP$
design  ||| S:61833 E:61840 ||| NN
and  ||| S:61840 E:61844 ||| CC
coordination  ||| S:61844 E:61857 ||| NN
and  ||| S:61857 E:61861 ||| CC
the  ||| S:61861 E:61873 ||| DT
preparation  ||| S:61873 E:61885 ||| NN
of  ||| S:61885 E:61888 ||| IN
the  ||| S:61888 E:61892 ||| DT
Figures  ||| S:61892 E:61900 ||| NNS
and  ||| S:61900 E:61904 ||| CC
texts  ||| S:61904 E:61910 ||| NNS
of  ||| S:61910 E:61913 ||| IN
the  ||| S:61913 E:61917 ||| DT
paper ||| S:61917 E:61922 ||| NN
.  ||| S:61922 E:61932 ||| .
All  ||| S:61932 E:61936 ||| DT
authors  ||| S:61936 E:61944 ||| NNS
read  ||| S:61944 E:61949 ||| VBP
and  ||| S:61949 E:61953 ||| CC
approved  ||| S:61953 E:61962 ||| VBD
the  ||| S:61962 E:61966 ||| DT
final  ||| S:61966 E:61972 ||| JJ
manuscript ||| S:61972 E:61982 ||| NN
.  ||| S:61982 E:61999 ||| .
